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Abstract
This doctoral research aims to investigate the reputation building process of companies
and to examine the applicability of western-developed theories about the uses of
corporate reputation in a non-western context. It is the first study that synthesises three
theories (value creation, strategic resources and corporate communication) to examine
the strategic consequences of the uses of corporate reputation.

Corporate reputation is an attribute or a set of attributes ascribed to a firm and inferred
from the firm’s past actions. It is the belief of market participants about a firm’s
strategic character (Weigelt and Camerer, 1988). Also, corporate reputation is the
public’s cumulative judgement of a firm over time (Roberts and Dowling, 2002).

The review of theoretical literature indicates the uses of corporate reputation by
business organizations can be theorized along six dominant paradigmatic perspectives:
1-public relations; 2-marketing; 3-management, 4-economic; 5-sociological; 6-finance
and accounting. The uses of corporate reputation in these six paradigms are
comprehensively discussed. The objective of this study is to establish the use of
corporate reputation in the development of brand image strategy. A review of the uses
of the concept of corporate reputation is discussed in detail in chapter 2.

The review of the literature also identified a research gap by showing that scarce
research has been conducted on how these three main functions (value creation,
strategic resources and corporate communication) affect a company’s brand positioning
strategy.

The following research question thus is proposed: How do (Taiwanese

pharmaceutical) companies use their corporate reputation to develop a brand image
strategy?

The research hypotheses based on three theories (value-based theory, resource-based
theory and integrated marketing communication theory) appear in Chapter 3. The
research question is constructed theoretically, and then a conceptual model, which
begins with three antecedents of corporate reputation and simultaneously illustrates the
outcomes of their use, are discussed.
vi

The construct of the uses of corporate reputation has three dimensions: value creation,
strategic resources and corporate communication.

Each of these three dimensions

includes several items. The items were proposed based on the previous researchers’
summaries and the qualitative interview. The researcher will then depict the proposed
research conceptual framework and a number of hypotheses that will be further
investigated and tested.

Then the quantative study was completed by providing the data analysis and the results
were explained. A multi-stage procedure was involved in this research. First, data
examination and screening to prepare for subsequent quantitative analyses and then the
descriptive statistics were presented. Second, a reliability test was performed on
measurement scales to ensure that they achieve an acceptable level of reliability for
further analysis. The resulting solutions were then re-assessed using confirmatory factor
analysis. Finally, PLS (Partial Least Squares) was used to test the hypothesized
relationships between the research constructs as postulated in the conceptual model, and
to assess the overall goodness-of-fit between the proposed model and the collected data
set.

The researcher then discusses the validation of the measurement model and the research
findings. The findings are then further discussed in terms of the contribution to
marketing theory and relevance to marketing managers. Then the items of adapted
scales were subjected to several rounds of adjustments and were finally found to
possess acceptable measurement properties. Reliability and construct validity tests
indicated that all scales satisfied widely accepted criteria such as the minimum
reliability of 0.7. The results of scale purification will be discussed. And an evaluation
of the research hypotheses and their significance are summarized, the findings of all
hypotheses testing will be reviewed and compared with previous research.

According to the research findings, the hypotheses that value creation, as one dimension
of corporate reputation, has a positive impact on brand segmentation, brand
differentiation and brand positioning are all accepted. The hypotheses that strategic
resource, as one dimension of corporate reputation, has a positive impact on brand
segmentation and brand differentiation are rejected. However, the hypothesis that
strategic resource, as one dimension of corporate reputation, has a positive impact on
vii

brand positioning is accepted. The hypotheses that corporate communication, as one
dimension of corporate reputation, has a positive impact on brand segmentation and
brand differentiation are both accepted. The hypothesis that corporate communication,
as one dimension of corporate reputation, has a positive impact on brand positioning is
partially supported. Finally, the hypothesis that the (see in Table 5.18) moderating effect
of price policy on corporate reputation has a positive impact on brand image strategy is
partially but negatively supported.

This thesis makes a significant contribution to the study of corporate reputation of firms
in the Taiwanese pharmaceutical industry from the robustness of the qualitative and
quantitative data collection.
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CHAPTER ONE: INTRODUCTION

1.1 Introduction
A well-developed corporate reputation can be used as a resource to develop a firm’s
strategic value (Weigelt and Camerer, 1988; Roberts and Dowling, 2002). It can be
used as a trait or a signal to forecast the potential behaviour of a firm (Kreps and Wilson,
1982; Shapiro, 1989) or to signify an organisation’s perceived capacity to meet their
stakeholders’ expectations (Waddock, 2000), allowing a stakeholder to evaluate how
key resource providers interpret a company’s initiatives and, from its past actions, to
assess its ability to deliver value outcomes (Fombrun, 2002; Day, 1994). Therefore, an
understanding of how to effectively signify a firm’s corporate reputation to its
consumers is needed. However, very few studies of corporate reputation are available.
This doctoral research is primarily concerned with the uses of corporate reputation,
particularly developing a brand image strategy from it, within the pharmaceutical
industry in Taiwan. The research employs three theories – value creation, strategic
resources and corporate communication – to study the effects of the uses of corporate
reputation as well as relevant underlining mechanisms. This chapter explains the
background of the research, provides a statement of the problem, identifies research
objectives and questions, offers a rationale for the context, indicates expected research
contributions, clarifies the proposed methodology, states the limitations of the research
and outlines the structure of the thesis.

1.2 The research background
In order to have a clearer understanding about the research background, this section will
first present the challenges facing pharmaceutical companies in Taiwan regarding the
reputation a company can create in order to establish its corporate brand image, which
1

`

will influence its perception by doctors when they prescribe medicines to their patients.
Therefore, in order to have a better understanding of the brand strategy created by the
brand manager, it is essential to find out the importance and the uses of corporate
reputation. In the last part of the research background, the importance of a firm’s
reputation for companies in the pharmaceutical industry in general will be introduced.
According to a report by BCC research (market research reports and technical
publications provider) (Natale, 2008), “the global market for pharmaceuticals increased
from $693.7 billion in 2007 to an estimated $737.6 billion by the end of 2008. It should
reach over $1 trillion by 2013, a compound annual growth rate (CAGR) of 6.9%. The
generic prescription drugs segment will experience the highest growth rate over the
study period. Worth an estimated $88.7 billion in 2008, it will reach $151.4 billion by
the end of 2013, a CAGR of 11.3%.” (Figure 1.1)
Figure 1.1: Worldwide market for pharmaceutical products, 2006–2013 (US$ Billions)

Source: BCC Research (Natale, 2008:1)

According to another report from BCC (Evers, 2009), “The global market for generic
drugs was worth $81 billion in 2008, a figure that is expected to reach $84 billion in
2009. In 2014, the market is expected to amount to $168.7 billion, for a compound
annual growth rate (CAGR) of 15% in the 5-year period. Sales of U.S. generic drugs
currently dominate the market, estimated at $33 billion in 2009 and projected to
increase at a CAGR of 10.4% to $54 billion in 2014.”
2
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Based on the numbers estimated from the market report, therefore, we can forecast that
there is a huge market space for generic medicine growth, basically in the US market.
There are five reasons for this: (1) medical insurance requiring decreasing costs, (2)
patent expirations of popular used medicines, (3) people living longer, (4) support from
government policy and (5) prescription medicine changing to non-prescription
medicines.

1.2.1

Challenges for the pharmaceutical industry in Taiwan

Since there are only 23 million people in Taiwan, also, generic drug manufacturers are
too many and too small compared to their counterparts in India and China. “The
national health insurance system, which while doing immense good for improving the
health of the general population, has budget provisions which discourage the use – and
therefore the development – of newer, more costly drugs” (Silver, 2006). The new
issued drug price policy caused the outlook of the whole industry to become bleak.
When faced with the facts that Taiwanese pharmaceutical companies are master in
manufacturing, no big name research-based drug or drug maker has emerged to date.
So Taiwan’s pharmaceutical sector is facing a considerable challenge right now. Also,
according to Silver (2006), looking in further, “exports make up only three percent of
the total production value of the local drug manufacturing industry (2004 figures),
which either means the industry has tremendous potential, or it’s a brutal reflection of
the realities of the international marketplace.”

1.2.1.1 Generic pharmaceuticals
A very large number of generic in drug makers then arose in the Taiwan pharmaceutical
industry under the circumstances stated above – many hundreds at last count. Although
many of these companies are too small to compete with giant overseas generics
companies, they are being kept alive by their close relationships with local hospitals, in
turn supported by the policies of the Bureau of National Health Insurance (BNHI).
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There is a special market condition in Taiwan, according to Silver (2006:1),
“representatives of overseas business groups in Taiwan such as the
American Chamber of Commerce and the European Chamber of
Commerce have long claimed that while more expensive drugs particularly cancer drugs - produced by US, European and
Japanese firms are not being paid for by the BNHI in Taiwan,
hospital purchasing departments were buying cheaper drugs and
being paid back by BNHI for more than what they paid. This
situation leads to over-prescribing. Hence drug prescribing is
becoming a profit centre for a hospital. This gradually led to
prescription decisions being based on profit instead of efficacy and
value of the drug to the patient. It’s been estimated that over
US$600 million is lost annually in BNHI funds due to this payment
reimbursement mechanism. Just where these funds get lost may
explain how many small generics companies are still keeping their
doors open, and why many of Taiwan’s big hospitals are doing
very well for themselves.”
Nowadays, there is a trend for Taiwanese generic manufacturers to obtain the US
FDA’s (Food and Drug Administration) GMP (good manufacturing practice)
certification, cGMP (current good manufacturing practice) certification, or the European
ISO

(International

Organization

for

Standardization)

certification

and

PIC

(Pharmaceutical Inspection Co-operation Scheme) certification for their factories,
because currently this industry is facing a big challenge. There are some government
policies that may affect the industry. For example, pharmaceutical prices are now under
the control of the National Health Institute. However, since Taiwan has proven expertise
in engineering and manufacturing, generics is where it should be able to compete – if
not on price then on quality, flexibility or where more precise or complicated processes
are required to make the end product. Therefore, they all hope to market their products
on the international market.
Recently, the government threw a lifeline to the generics manufacturing sector by
demanding self-sufficiency in certain drug supplies, such as vaccines and medical
consumables. The policy was set from lessons learned during the 2003 SARS crisis
when vital medical supplies ran out, and the policy reinforced by the current H5N1
scare resulting in worldwide shortage of the antiviral Tamiflu. The increase in
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competition in the pharmaceutical market has been seen as the key driver of
pharmaceutical industry marketisation across the world1.

1.2.1.2 Research-based pharmaceutical companies
While not exactly in the same league as Pfizer or GSK, there are a small number of
research-based pharmaceutical companies producing innovative drugs, or at least
modified existing drugs for new uses, such as TTY Biopharm, which is a publicly listed
company making oncology drugs with improved disease-targeting behaviour. TTY
Biopharm does its own research, as well as its own manufacturing. And moreover, it
also has developed its own network of distributors islandwide.
Other drug discovery companies also have good prospects in therapeutics for Asianprevalent diseases such as hepatitis. While some will look towards the traditional
“licensing-to-Big-Pharma” model for their big break, others will try
to go it alone and research, manufacture and market their own
products as TTY has done. There are several companies in this area,
such as TaiGen Biotechnology and PharmaEssentia. TaiGen is
previously research leader for Oncology and Virology for over 10
years at Hoffmann-La Roche, USA. TaiGen focuses on oncology,
chronic inflammation and viral infection therapeutics and received
early financing from MPM Capital to the extent of US$37 million. The
company is also in research collaboration with TTY. PharmaEssentia
is a drug discovery company with promising liver disease drugs in the
pipeline.” (Silver, 2006:1)

However, as we all agree, funding is vital and unavoidable for the long drug
development process.

Unlike drug manufacturers in other countries, Taiwanese

1

Including: North America (Allen and Shen, 1999; Dill, 2003; Kwong, 2000; Young, 2002); Europe
(Middleton, 1996; Williams, 1997; Gibbs, 2001; Taylor, 2003; Binsardi and Ekwulugo, 2003; Jongbloed,
2003; Mora, 1997; Czarniawska and Genell, 2002); Africa (Ivy, 2001; Maringe and Foskett, 2002;
Maringe, 2004); Asia (Arimoto, 1997; Oplatka, 2002; Gray et al., 2003; Williams et al., 1997; Mok, 1999,
2000); Australia (Baldwin and James, 2000); New Zealand (Ford et al., 1999); Russia (Hare and
Lugachev, 1999).
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companies have not tended to list their companies on foreign stock exchanges (Silver,
2006:1).
“Whilst Taiwan has its own vibrant venture capital industry, local
funds are not yet flowing into the life sciences on their own accord.
However, with its continued efforts to fund and promote the industry’s
development, and to source and set up international collaboration
opportunities, the government remains a force behind much of the
continued growth of Taiwan’s life sciences industries, including the
pharmaceutical sector. When measured together with the prospects
for the island’s burgeoning drug discovery industry, and considering
the boost the recent government emphasis on drug self sufficiency has
had on Taiwan’s bio-product manufacturing industry, it all adds up to
a future optimistic for the industry than expected it to be.”

On the other hand, product price regulation is an issue for the Taiwan pharmaceutical
industry. The idea of drawing links within modes of consumer perceptions of price,
advertising, product quality and values has been long appreciated by marketing scholars
who are interested in understanding the significance of a firm’s reputation (Milgrom
and Roberts, 1986; Zeithaml, 1988). In the pharmaceutical industry, branding strategies
such as advertising and academic reports mainly influence a doctor’s perception of a
product (or brand). However, a basic for understanding of a company also helps the
customer make a decision.

The information a company sends about itself has an

influential and unexpected impact on consumer perception. The signals sent by a firm
through its reputation, advertisements and product price are usually interpreted
differently by their customers. Therefore, there is a need to understand the link of how
do managers use their corporate reputation to establish a firm’s brand image strategy
(Schultz et al., 2000; Bickerton, 2000).
The signal a product’s price gives to customers regarding their perception of a product’s
quality has been noted by marketing scholars (Milgrom and Roberts, 1986; Fombrun
and Shanley, 1990; Kalita et al., 2004). Previous scholars asserted that a warranty is
positively related to a firm’s reputation (Balachander, 2001). Previous scholars have
asserted that a warranty is positively related to a firm’s reputation (Balachander, 2001).
Previous literature (see Chapter 2) suggests that the firm organises its reputation
according to three dimensions: (1) the way the firm organizes its strategic resources
6
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(strategic resources), (2) the way the firm communicates with its customers (corporate
communication) and (3) through the type of value it offers to its customers (value
creation). This information enables brand managers to operate a better strategy for their
products’ brand image (mainly about brand segmentation and positioning their
products).
Because each firm differs in how it becomes established and the methods it uses to
survive, establishing the factors of the study’s focus is important.

For example,

automobile companies try to build their own style or image to differentiate themselves
from their competitors (Hsieh, 2002), though they tend to consider the same safety
issues. Pharmaceutical companies try to achieve international standard requirements and
build reputations to survive (Nakra, 2000; Bennett and Gabriel, 2001; Rose and
Thomsen, 2004). Without a well-crafted or sound reputation, it is difficult for
pharmaceutical companies to sustain their customers’ trust, and thereby they lose
ground against competitors.
For the above reason, pharmaceuticals are encouraged to develop a good reputation for
their quality of product and services (Fombrun and Shanley, 1990; Berndt et al., 1997),
for innovativeness (Prentis et al., 1988; Fombrun and Shanley, 1990; Valle and
Gambardella, 1993; Achilladelis and Antonakis, 2001), for honest communication and
for environmental responsibilities (Fombrun and Shanley, 1990; Byrne and Kavanagh,
1996). In turn, these factors can also be converted subconsciously into the brand image
of the products belonging to the company (Kim et al., 1989; Panigyrakis and Veloutsou,
1999). Because a firm’s corporate reputation tends to highly influence the initiation of a
brand strategy decisions and brand scene-setting in pharmaceutical companies (Keller
and Aaker, 1998; Nakra, 2000), the literature regarding this topic will be reviewed in
the following paragraphs.
First, in Taiwan, ‘biotechnology’ is defined as including the pharmaceutical, medical
device and modern biotech sectors. Besides, the API (Active Pharmaceutical Ingredient)
manufacturing model fits well to Taiwan’s seemingly natural propensity to excel in
engineering

and

precision manufacturing.

However,

nowadays,

Taiwanese

pharmaceutical companies are trying to transform its business model from original
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equipment manufacturer (OEM) model to knowledge-creation model in producing
pharmaceutical ingredients on contract for some of the international brand and nonbrand drug companies seen in the modern biotech environment of gene identification
and drug discovery. Pharmaceuticals in Taiwan therefore are heading to a way towards
to the innovation of the industry (Berndt et al., 1996; Lichtenberg, 1998) or focus on
generic knowledge strategies (Bierly and Chakrabarti, 1996).
Second, there is an encouraging use of generic medicines in several countries in recent
years (King and Kanavos, 2002). However, even the same constituents, produced by
different manufacturers, may contain different quality ingredients or different excipients
(an inactive substance used as a carrier for the active ingredients of a medication) to
work with the main constituents to produce medicines that perform differently (or are
perceived to perform differently). These differences are related to a firm’s knowledge,
R&D and also its producing experience (Vendelo, 1998). Moreover, a firm’s reputation
has an impact on the brand message, and might even make or break the success of a
brand depending on its marketing capability (Ling and Jaw, 2006). Therefore, in this
vein, generic medicine producers need to build their own brand on their corporate
reputation for marketing purposes.
Third, in pharmaceutical companies, apart from the research-and-development (R&D)
cost, the marketing cost usually occupies a significant portion of the budget (Bulger,
1999). Moreover, a pharmaceutical company should have the ability to hire and retain
good and experienced sales representatives (Ziegler et al., 1995).

Therefore, the

marketing campaign or marketing strategy is another key focus for the marketing
manager.
In pharmaceuticals, good corporate reputation leads to good dealings with customers –
from being able to raise a price to a deal solidifying the customer’s confidence in a
purchase (Davies, 2003; Keh and Xie, 2008). It has been discussed frequently that
corporate reputation is the key to customer satisfaction (Gray and Balmer, 1998; Moss,
2007). A good marketing campaign which enables good sales probably has to build a
brand especially upon the firm’s experience and knowledge (Bierly and Chakrabarti,
1996; Yeoh and Roth, 1999; Powell, 2000; Nerkar and Roberts, 2004; Hung et al.,
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2005). In addition, according to its style of leadership, a firm uses different strategies to
market its products (Ogbonna and Harris, 2000; Harris and Ogbonna, 2001; Cable and
Judge, 2003), such as more product-oriented or customer-oriented strategies.
Based on the arguments and market situations or environment stated above,
pharmaceuticals are inspired and encouraged to build their corporate reputation and
apply it to the setting of its brand strategy. A firm’s corporate reputation can be used to
communicate its benefit to its customers or to the public, to enhance value for its
customer, and has a strategic role that serves as an intangible asset for a firm
(Fombrun, 1996; Roberts and Dowling, 2002). Once brand managers create a brand
image which is coherent with a firm’s image or reputation, the firm in turn can
create a more flexible strategy regarding image for its products.

1.2.2

Pharmaceuticals and their uses of corporate reputation

For pharmaceuticals, it is vital to develop an organisation’s brand from its intangible
assets (such as corporate reputation).

Evidence suggests that organisations with a

consistent corporate strategy and can convey it consistently into its brand strategy are
likely to perform better than those organisations with a less clear and inconsistent ethos
(Schendel and Patton, 1978; Wind and Robertson, 1983; Varadarajan, 1992; Hatch and
Schultz, 2001; Rao et al., 2004). Nowadays, the pharmaceutical industry is becoming
increasingly complex and subject to a number of critical influences. This suggests that
participant organisations need to actively consider how they are perceived by key
stakeholders (Fill and Dimopoulou, 1999). Recently, studies shows that customers
focus on a firm’s corporate reputation by conveying and committing to a coherent brand
message perception, especially for pharmaceutical companies (Wiedmann, 2002).
Therefore, in order to deliver a clearer signal to its customers, corporate strategy in
pharmaceuticals must focus on a thorough understanding of the brand perception, not
only from the brand itself but also from the corporate perspective (Hoffman, 2006;
Brammer and Pavelin, 2004). Which means to look at a brand it is suggested to
incorporate a firm’s corporate background and the corporate reputation in general.
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As explained above, in a pharmaceutical context, in order to build up a firm’s reputation
and its brand image, brand managers play an important role – the pharmaceutical brand
is built to gain trust from professional people such as physicians and doctors
(Panigyrakis and Veloutsou, 1999; Fugh-Berman and Ahari, 2007). The brand strategy
decision makers are highly influential in the representation of a pharmaceutical
company or its brand to its customers (for example, as a result of targeting a brand as
having upper-class customers, being well-reputed within the target andmarket and
having top quality products) (Easingwood and Koustelos, 2000; Smith and Awopetu,
2007; Robin, 2007). Brand orientation means that the formulation of company strategy
is based on brands (Urde, 1994).
There is a novel view from a brand practitioner, John Nosta, the vice president and
creative director at Catalyst Communications, saying that: brand-makers seek out mind
share while marketers seek out market share. “I call it (the brand) the personification of
a product. A brand is what sticks to the roof of your customer’s brain. It’s memorable.
And it’s what differentiates a product in the marketplace.… Branding is an exercise in
perception.” (Laitin, 2000, p. 5) The brand “signature”, or “personality”, is based on
sound strategic thinking. Brand positioning is an exercise in customer perception. It
decides the way you want the audience to perceive your product (Sujan and Bettman,
1989), and it is the first step in successful branding (Park et al., 1986; Carpenter, 1989).
For example, a reputation for innovation enhances credibility among customers. In
particular, experimental studies have shown that innovation has made the acceptance of
new product offerings more likely. It also helps a firm to gain reputation if it makes the
customers think that it shows concerns for the customer (Aaker and Joachimsthaler,
2004).
For the reasons above, it is crucial to take a firm’s reputation as a basis and set a brand
strategy based on its current reputation in order for it to remain a corporate brand
strategy consistent with the corporate image or reputation. However, in order to ensure
the brand strategy is in alignment with the corporate strategy, the branding strategy
creation process must address such fundamental questions as “who are we targeting?”
and “what is our core value?” (Belanger et al., 2002). Therefore, in order to encourage
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a coherent brand strategy, managers should have the same perceptions of the values that
are embedded in the corporation (Hatch and Schultz, 2003).

1.3 Statement of the problem
Corporate reputation is about a firm’s quality management of its corporate name. A
firm’s corporate reputation involves several aspects of a firm: its long-term investment
value, its financial soundness, whether it makes a wise use of corporate assets, its
quality of management, products and services, its ability to innovate, its ability to attract
develop or keep talented people, its communication and environment responsibilities
(Fombrun and Shanley, 1990; Fryxell and Wang, 1994; Caruana, 1997; Hammond and
Slocum, 1996; Barnett et al., 2006). As discussed above, in a pharmaceutical context,
corporate reputation is likely to play the crucial role in the branding process. However,
very few studies on corporate branding are available. Although, there are studies on
corporate reputation and how a pharmaceutical company builds or extends its corporate
brand (e.g. Keller and Aaker, 1998; Argenti et al., 2003), the studies are not specific on
how firms use their corporate reputation to give more strategic insights to its brand.
Dolphin’s (2004) study seems to be the most relevant study, giving a full review of how
firms put the reputation idea into the branding process. However, the concept of the
uses of corporate reputation in pharmaceuticals still remains unclear as most of the
studies regarding this issue were conducted solely from customer perspectives.
One of the most important concerns is the fact that a firm’s reputation in
pharmaceuticals is based on the strength in the organisation. This factor raises the
question of the applicability of the uses of corporate reputation in the pharmaceutical
industry context. There is the need for research that examines the effects of uses of
corporate reputation at the firm level. A firm can manage the impression it creates or its
reputation by engaging in corporate social responsibility (Hooghiemstra, 2000; Bronn
and Vrioni, 2001). The literature suggests three kinds of the uses offer corporate
reputation: value creation, strategic resources and corporate communication. Therefore,
strategy variables are included within a proposed conceptual model in order to examine
the underlying mechanisms of the link between the brand image strategy and its effect
11
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from marketing and communication perspectives. In addition, based on a review of the
literature, most studies on the uses of corporate reputation in pharmaceuticals have been
conducted in Western countries, such as the USA, the UK and Germany, thus, limiting
the generalisablility of any theory. In order to bridge this gap, Taiwan, as a country in
far eastern Asia, has therefore been selected as the setting of this study.

1.4 Research objectives
Given the importance of a firm’s reputation in pharmaceuticals, it is worthwhile
investigating the concept further in order to harmonise with existing research. This
doctoral study has two main research objectives. First, the research attempts to develop
a model to explain the effects of aspects of the uses of corporate reputation in
pharmaceuticals on the brand image strategy of brand managers. Second, the research
intends to empirically test the model in a non-Western setting, which will help the
researcher to examine the external validity of Western-developed theories (i.e. the
applicability of these theories in other contexts). This includes the assessment of the
dimensionality and operationalisation of constructs, and the assessment of certain
assumptions associated with findings reported in the existing literature (e.g. the
connection between the uses of a firm’s reputation and its brand image strategy).
In particular, this study intends to answer the following research question: from the
manager perspective, what are the effects of the uses of corporate reputation on the
brand image strategy? This question can be divided into two sub-research questions.
First, it is essential to find out what the previous studies have regarded as the main uses
of a firm’s corporate reputation. Therefore, the first question will be: what are the main
uses of corporate reputation? After this, it is important to find out the link between the
uses of a firm’s corporate reputation and brand image strategies. Therefore, a second
question is proposed as: can a firm’s corporate reputation have an impact on its brand
image strategies? Answers to the previous two questions will be sought through
examining the previous literature regarding the uses of corporate reputation and the
relationship between each construct. Moreover, the above questions are mainly based
on the construction of the theoretical literature. These questions try to find out the
12
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relationships between the dimensions of the uses of corporate reputation and brand
image strategy.
By achieving these research objectives, the researcher expects that this study will
advance current knowledge about building a strategy for firms using their corporate
reputation to create or match up with their brand strategy and offer practical insights to
managers in practice. Therefore, a set of questions are asked in this research as research
hypotheses (see Table 1.1) in order to find out the answer for the research.
Table 1.1: List of research hypotheses
Value creation as one dimension of the uses of corporate
H1
reputation has a positive impact on a firm’s brand
segmentation strategy.
H2

Value creation as one dimension of the uses of corporate
reputation has a positive impact on a firm’s brand
differentiation strategy.

H3

Value creation as one dimension of the uses of corporate
reputation has a positive impact on a firm’s brand
positioning strategy.

H4

Strategic resource as one dimension of the uses of
corporate reputation has a positive impact on a firm’s
brand segmentation strategy.

H5

Strategic resource as one dimension of the uses of
corporate reputation has a positive impact on a firm’s
brand differentiation strategy.

H6

Strategic resource as one dimension of the uses of
corporate reputation has a positive impact on a firm’s
brand positioning strategy.

H7

Corporate communication as one dimension of
the uses of corporate reputation has a positive
impact on a firm’s brand segmentation strategy.

H8

Corporate communication as one dimension of the uses of
corporate reputation has a positive impact on a firm’s
brand differentiation strategy.

H9

Corporate communication as one dimension of the uses of
corporate reputation has a positive impact on a firm’s
brand positioning strategy.

Source: Developed by the author
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1.5 Rationale for the research
The purpose of this research stems from the observation that pharmaceutical companies
require a good reputation to survive. As Alsop (2004) argues, the CEO’s own reputation
affects corporate reputation. However, reputation management is an ongoing job, and
therefore companies should allocate certain managers or departments as primary
guardians.
Duncan Burke, former vice president of corporate image and reputation at
GlaxoSmithKline, one of the world’s largest pharmaceutical companies, said: “I’m
trying to get people to think about reputation systematically, to remind them to take it
seriously all the time.” “Big pharmaceutical companies are seen as pariahs right now
because of the issue of access to medicine at a reasonable price,” Mr. Burke continued.
“So it’s especially important that there’s one person in my position to reflect on how the
world thinks of Glaxo and how we want the world to see us.” Moreover, according to
Alsop (2004, p. 23):
“If they ever hope to maximize the value of their reputations,
companies must make reputation management a fundamental part of
the corporate culture and value system. Companies must spread the
message of reputation management throughout the organization and
make employees cognizant of how each and every one of them affects
reputation on a daily basis. Reputation must be central to the
corporate identity, not merely clever image advertising and
manipulative public-relations ploys.”

Moreover, a pharmaceutical company’s reputation has a large impact on its brand image.
Therefore, this research aims to investigate how pharmaceutical managers make brand
decisions based on corporate reputation. Prior research has addressed the issues of
corporate communication and corporate branding in the pharmaceutical industry. A
pharmaceutical company that develops innovative products based on a sound scientific
approach usually enjoys a high reputation while also producing generic products (Dhir
and Vinen, 2005; Krishna, 2006). The pharmaceutical industry faces considerable
pressure from ethical groups. Workplace health and safety concerns are stressed more
highly in the pharmaceutical industry than in any other industry (Brammer and
Millington, 2005), and this industry has significant social externalities (Brammer and
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Millington, 2005). That is, intangible assets, such as corporate reputation, tend to be
more important for pharmaceutical companies than for other types of companies.
Prior research has argued that in addition to a pharmaceutical firm’s corporate
reputation, corporate branding and communication must be properly managed. For
example, Moss (2001) and Hall and Jones (2007) found that pharmaceutical companies
engage in corporate branding issues and focus their branding activities on products and
product attributes. Moreover, to manage corporate communications efficiently, Dolphin
and Ying (2000) suggested that a pharmaceutical company must understand the almost
unlimited potential of branding issues and thus ensure consistency of its communication
message to a wide range of stakeholders.
Elaborating on the strategic communications of GlaxoSmithKline, former CEO JeanPierre Garnier said: “Corporate communications are separate functions that work very
closely together. But we still have one story here—one basic message.” He further
elaborated, “At the end of the day, the communications aren’t owned by the
communication department. You have to have good executives who can and will
communicate” (Argenti et al., 2005, p. 88).
Thus, the current research investigates the relationship between corporate reputation and
communication and branding issues in the pharmaceutical industry and examines how
the personnel involved manage these in a practical way. In addition, few studies have
theoretically investigated how firms use their corporate reputation to enhance their
brand image strategy in terms of brand segmentation, differentiation and positioning.
Therefore, this research explores how firms can use their corporate reputation to
enhance their brand image strategy.

1.6 Rationale for the context

In accordance with the research objective, the researcher intends to empirically test the
model in a non-Western setting in order to examine the external validity of Western15
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developed theories.. In order to test the external validity of Western-developed theories,
several researchers (e.g. Boyacigiller and Adler, 1991; Peng et al., 1991) recommend
collecting data in a non-Western country. Therefore, Taiwan, a country in South-east
Asia, has been selected as the setting of this study.
Taiwan has been selected as the setting of this study because its oriental culture (which
is mainly followed by Chinese culture) is clearly different from Western culture
(Hofstede, 1984). Taiwan can represent non-Western countries 2 for several reasons.
For example, Taiwan is different from many Western countries e.g., USA, UK, and
other developed countries with regard to the distribution of power. That is, Taiwan has
higher inequality between people and organisations than those developed countries
(Hofstede, 1984). “Taiwan is a model for newly emerging economies. Since WWII,
high levels of economic development have been achieved, due largely to a national
policy of promoting manufacturing in the information technology sector.” (Filatotchev
et al., 2005) In addition, compared to those developed countries, Taiwanese have high
uncertainly avoidance, implying that Taiwanese people have a higher tolerance for
ambiguity, and less emotional resistance to change, etc. Moreover, Taiwan has a very
low score for individualism when compared to Western counties (Hofstede, 1984). In
addition, the values and norms of Taiwanese employees have a strong root in Buddhism
and Taoism, which is different from those in Western countries which are mainly
Christian – Catholicor Protestant (Hofstede, 1984).
The Taiwanese generic medicine market is getting stronger and more solid. In the 1990s,
Taiwan pharmaceutical companies were consistently among the top ten-ranked in the
US market. In the past two years, many companies have been turning to Taiwan to seek
new technologies and to reduce costs. This indicates that Taiwan’s own pharmaceutical
industry technology has greatly improved and is reaching international standards
(Swinbanks and Cyranoski, 2000). This trend in turn encourages competition in the
Taiwanese pharmaceutical industry (Agoramoorthy and Hsu, 2007).

Companies in

Taiwan, especially in the pharmaceutical industry therefore increasingly recognise the
importance of the uses of a firm’s reputation.

2

More details about the research setting are provided in Chapter 4.
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Moreover, due to the new corporate management trend in Taiwan during the last twenty
years (Young, 1996; Wu, 2002; Solomon et al., 2003; Lien et al., 2005; Filatotchev et
al., 2005; 2008), companies have made efforts to build their corporate reputation in
order to attract new customers or retain old ones. Companies increasingly recognise the
importance of a firm’s reputation as judged by its financial or social performance and its
uses when developing their own corporate brands. They create various strategies for
marketing and promoting their corporate brands, providing a good opportunity for this
research to examine the effects of these communications on the pharmaceutical
manager’s brand strategy decisions.

As this research is conducted in an attempt to

investigate the effects of brand strategy with brand managers, as well as its underlining
mechanism, the research will therefore have significant managerial implications,
especially for pharmaceuticals in Taiwan, as well as other developing countries in Asia.

1.7 Expected research contributions
Two kinds of contributions are expected from this study: theoretical and managerial
contributions. Each is explained in the following section.

1.7.1 Theoretical contributions
This research is expected to make several theoretical contributions. First of all, the
findings will advance current knowledge by adding alternative insights to the uses of
corporate reputation. It will also add views on the uses of corporate reputation to
possible outcomes of brand image strategy. Additionally, relevant mechanisms
underlying the relationships between the uses of corporate reputation and the design of
brand image strategy will be investigated in a non-Western context. That is, this
research will illustrate how each dimension of the use of corporate reputation affects the
design of brand image strategy in the pharmaceutical industry in Taiwan.
In addition, the research will provide further understanding about the dimensionality
and operationalsation of the studied concepts (the uses of corporate reputation, brand
image strategy) from the perspective of pharmaceutical brand managers.
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1.7.2 Managerial contributions
As discussed earlier, the uses of corporate reputation in pharmaceuticals is based on
imported knowledge from either the theoretical literature or the business sector. Thus, it
raises the question of the applicability of the uses of the corporate reputation concept in
the context of pharmaceuticals.

By recognising the effectiveness of the uses of

corporate reputation in pharmaceuticals in the setting of a firm’s brand image strategy
from the brand manager’s perspective, the pharmaceutical management team can devise
their branding and marketing plans more successfully. That is, in order to create an
effective brand image strategy, the manager can concentrate on particular aspects of
ways to build the firm’s reputation (e.g. value creation, strategic resources and corporate
communication) which are seen by the brand manager as effective tools for creating
brand image strategy.
In addition, by comparing which uses of corporate reputation dimensions (value
creation, strategic resources and corporate communication) are more effective for
influencing brand image strategy, the findings can be used by the managers as a
guideline for allocating their resources effectively. Therefore, the findings are likely to
be a useful tool for brand managers of pharmaceutical companies to apply in situations
where they need to make brand strategy decisions.

1.8 Proposed methodology
The researcher plans to employ a mixed-methods approach (Tashakkori and Teddlie,
2003), with a dominant quantitative and qualitative component involving semistructured interviews and a pilot study to collect data for the development of
measurement scales.
For data collection, semi-structured interviews will be conducted in order to gain a
deeper understanding about the topic, as well as to comprehend the constructs in the
conceptual model and to generate their domains and measurement.
18
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followed by a pilot study which will be conducted in order to gather data for purifying
measurement scales. Afterwards, sample questionnaires containing will be distributed
to managers of Taiwanese pharmaceutical companies. Before the completed
questionnaires are returned, the researcher will ask the respondents to point out any
items that tend to be either ambiguous or difficult to answer. Subsequently,
questionnaires for the main survey will be developed.

Managers or firm strategy

decision-makers of Taiwanese pharmaceutical companies will be respondents for the
main survey. According to the aforementioned discussion, conducting the research in
Taiwan will facilitate the evaluation of the external validity of theories (i.e. the
applicability of theories in other contexts).

1.9 Limitations of the research
This study will be conducted in a single country and within a single industry setting,
which therefore does limit the external validity (generalisability of findings). However,
conducting research in a single setting provides the researcher with a better control over
market and environmental differences (Conant et al., 1990) and industry effects (Rao,
1994).
In addition, the causality of the relationships in this research cannot be proven.
Therefore, the results should be interpreted with caution in terms of the exact direction
of the relationships among the constructs in this research. Since cross-sectional data
captures the linkages among variables at a specific point in time, it may not be
generalised to other periods of time. To understand the development of uses of the
corporate reputation process over time, longitudinal data collection will be necessary.
Furthermore, this study comprehensively examines the effect of the uses of corporate
reputation in pharmaceutical companies on brand image strategy. According to several
of the variables affecting brand image strategy creation, therefore, it tends to be difficult
to make a study providing a detailed investigation of all elements affecting the studied
phenomena. Therefore, it is possible that other constructs could be used.
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1.10 Structure of the thesis
The researcher plans to present this doctoral thesis in seven chapters, as follows:

Chapter 1 Introduction
Chapter 2 Literature review: a review of literature on the uses of corporate reputation
as well as its effects is the focus of this chapter.

The chapter will first provide

background by initially discussing the movement and influence of corporate reputation
and brand image strategy management within pharmaceutical companies and then
explaining further the concept of brand image strategy. Previous studies on the effects
of brand image strategy will subsequently be reviewed. Finally, research gaps will be
identified and discussed.
Chapter 3 Conceptual framework and hypotheses: the discussion on the uses of
corporate reputation in a pharmaceutical company from a value creation, strategic
resources and corporate communication perspective is presented in this section.
Furthermore, the effect of the uses of corporate reputation in the pharmaceutical
industry on a firm’s brand image strategy application will be discussed.

Finally,

research hypotheses will be provided after the discussion of each component of the
framework. Measurement scales will be presented at the end of the chapter.
Chapter 4 Research methodology: the research philosophy will be briefly reviewed.
Then, two general approaches in theory construction, qualitative and quantitative, will
be discussed. The research design, including the research setting and data collection
process will be elaborated. Finally, issues regarding data analysis will be highlighted
and explained.
Chapter 5 Data analysis and research findings: the findings from both qualitative and
quantitative studies will be presented in this chapter. The outcomes of the scale
development (the researcher plans to conduct a literature search, semi-structured
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interviews and a pilot study) will be reviewed. The results of scale reliability and
validity tests will be presented. Then, the results of hypotheses testing will be shown.
Chapter 6 Discussion: a discussion about the findings from the previous chapter will
be presented in this chapter. The outcomes of the scale development and the results of
hypotheses testing will be discussed respectively.
Chapter 7 Conclusion: a summary of the study results will be presented. Research
implications (theoretical, managerial, policy establishing), research limitations and
possible future research directions will be discussed in this chapter.
The literature review follows in the next chapter, Chapter 2.
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CHAPTER TWO: LITERATURE REVIEW

2.1 Introduction
A positive corporate reputation brings multiple benefits to a firm, such as the ability to
withstand occasional adverse publicity (Fombrun and Shanley, 1990), higher levels of
customer purchase intention (Yoon et al., 1993), strong organisational identification
among employees (Dutton et al., 1994), better attitudes towards the company’s
salespeople and products on the part of industrial buyers (Brown, 1997), customer
loyalty (Saxton, 1998), the attraction of investors (Fombrun and Shanley, 1990) and
greater competitive advantage (Fombrun and Shanley, 1990; McMillan and Joshi, 1997).
Based on the above findings by previous scholars, it is assumed that corporate
reputation can increase financial performance. However, Gök and Özkaya’s (2011)
study finds that a portfolio of highly reputated firms in an emerging economy (such as
Turkey) earns about 10 percent less than that market’s overall portfolio annually.
Fombrun and Shanley (1990) note that a good reputation can serve as a value signal in
situations of information overload, complexity or inadequacy. Buyers frequently
employ their perceptions of an organisation’s reputation to interpret “ambiguous
informational signals” about it and hence to “gauge its relative merits” (p. 233). They
suggest that reputation represents an important cue about how a supplier’s products,
strategies and prospects compare with those of competing enterprises (Bennett and
Gabriel, 2001).
In conformity with the objective of this thesis, which is to establish the use of corporate
reputation in the development of brand image strategy and its effect on sales increases,
this chapter provides a theoretical review of the uses of the concept of corporate
reputation, and the strategic uses of corporate reputation in its relationship with brand
image strategy. In order to accomplish this objective, scholars’ view on the concept of
corporate reputation on marketing, management, organisational studies, economics and
business studies will be reviewed.
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In the first section, there is a brief review of the definition of corporate reputation. This
is followed by a review of six areas of study (i.e. public relations, marketing,
management, economics, sociological, and finance and accounting) where the uses of
corporate reputation have been constructed as a concept. An attempt is made to identify
and integrate the arguments within the theoretical paradigms into a cohesive synthesis
which shows the uses of corporate reputation. In the second section, following the
review of these different perspectives, the author will define the gaps in this study by
arguing that there is a limited understanding of how corporate reputation enhances the
development of brand image strategy in order to enhance its market share. In the third
section, new paradigmatic concepts emerging from this review together with the
problem of this area of study will be highlighted and summarised. The final section
reviews the research question of this dissertation.

2.2 The definition of corporate reputation
Several definitions purporting to explain the concept of corporate reputation have been
offered by various authors (e.g. Bennett and Kottasz, 2000, p.224). The majority of
these definitions have emerged from public relations (Hutton et al., 2001), marketing
(Herbig and Milewicz, 1995; Gray and Balmer, 1998; Weiss et al., 1999), economics
(Shapiro, 1982, 1983), sociology (Camic, 1992) and strategic management (Weigelt and
Camerer, 1988; Hall, 1992; Fombrun, 1996; Roberts and Dowling, 2002).
One of the most cited definitions of corporate reputation was put forward by Weigelt
and Camerer (1988) in strategic management. They argued that corporate reputation is
an attribute or a set of attributes ascribed to a firm and inferred from the firm’s past
actions. It is the belief of market participants about a firm’s strategic character (Weigelt
and Camerer, 1988). Similarly, another important definition which has been cited in
many works is that presented in the work of Roberts and Dowling (2002). They
contend that corporate reputation is the public’s cumulative judgement of firms over
time.

Some other researchers have discussed corporate reputation as a history of

customer perception about the firm, such as collective beliefs that exist in the
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organisational field about a firm’s identity and prominence (Rao, 1994; Rindova and
Kotha, 2001), media visibility and the business favour gained by a firm (Deephouse,
2000).
Corporate reputation was initially studied in the field of sociology with regard to an
individual’s reputation. Topics studied included the impact of reputation on
occupational change (e.g. Gold, 1952; Kriesberg, 1952; Wardwell and Wood, 1956) and
the power and decision-making of individuals (e.g. Klapp, 1948; Schulze and Blumber,
1957; Walton, 1966).
In economics, corporate reputation is described as either a trait or signal (Kreps and
Wilson, 1982; Shapiro, 1989) which can be transmitted from a company to its
customers to give some clues about products or give an advance warning about
retaliations if competitors make any adversarial moves (Weight and Camerer, 1988).
From the strategic management perspective, corporate reputation is regarded either as a
strategic resource or mobility barrier (Cave and Porter, 1977; Hall, 1992, 1993; Rao,
1994; Roberts and Dowling, 2002; Carmeli and Tishler, 2004). It is an asset that cannot
be bought, is not easy to imitate, and cannot be substituted (Barney, 1986; Dierickx and
Cool, 1989).

In general, it is difficult to copy interaction between a firm and its

stakeholders (Fombrun and van Riel, 1997). In addition, it takes some time for new
entrants to a competitive market to acquire a reputation (Hall, 1993) to a level
comparable to those of its rivals. Empirical studies show that in order for a corporate
reputation to be established, a company must consistently maintain credible transactions
over time (Herbig and Milewicz, 1993; Herbig et al., 1994). During the reputationbuilding process, the new entrants usually would have a difficult time in trying to attract
customers as they are likely to be sceptical about a company’s existence as well as its
products and services.
On the other hand, sociologists do not view corporate reputation as an asset or a thing
under possession but rather regard it as a social construction which can be built through
the relationship between a company and its stakeholders (Perrow, 1961a; 1961b; Shrum
and Wuthnow, 1988). To sociologists, reputation is an indicator of legitimacy or social
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acceptance, which reflects the fit between expectations (Galaskiewicz, 1985; Fombrun
and van Riel, 1997). An empirical study (Rao, 1994) demonstrates that by winning a
certification contest in the automobile industry, a company can acquire acceptances
from its stakeholders, justify its existence, especially for a young organisation, and build
its reputation by accumulating more victories over time.
Additionally, corporate reputation also has one of its roots in social identity theory
(SIT). At the individual level, SIT refers to the perception a person develops to identify
who he/she is in terms of his/her group membership (Turner, 1984) and stems from
several sources such as the categorisation of individuals, and the distinctiveness and
prestige (i.e. reputation) of the group (Ashforth and Mael, 1989). It provides a partial
answer to the question “Who am I?” (Abrams and Hogg, 1990; Hogg and McGarty,
1990). Social identification normally leads to activities that are consistent with his/her
core values and the support for any institutions that embody those values (Ashforth and
Mael, 1989). Essentially, reputation can be viewed as the estimation of how well one’s
behaviour fits with “who” one claims to be and is captured by public opinion (LongTolbert, 2000). In other words, reputation acts as a reflection of someone’s activities
and identity and simultaneously as a source from which a person derives his/her
individuality.
In general management, organisational theorists usually view corporate reputation from
the same angle as that of sociologists. The relationship between corporate reputation
and corporate identity appears to be a never-ending story. On the one hand, corporate
reputation is considered a projection of both an organisation’s identity (who we are) and
image (what we think other people think about us) (Fombrun, 1996; Davies et al., 2003).
On the other hand, an impression formed by a stakeholder of an organisation results in
his/her positive or negative reactions towards the organisation (Long-Tolbert 2000,
p.34), hence enhancing the reformulation or maintenance of its identity.
In addition, this circular relationship also implies that corporate reputation is collective
and is shaped and reshaped over time. These characteristics of corporate reputation are
embedded in the development of definitions proposed by management scholars. For
example, Fombrun and Shanley (1990) had defined the term as “the outcome of a
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competitive process in which firms signal their key characteristics to constituents to
maximise their social statuses”. The definition is borrowed from economics literature
and focuses only on the evaluation of past actions (i.e. the outcome of the competitive
process over a time horizon).
Subsequently, Fombrun (1996, p.72) defined corporate reputation as “a perceptual
representation of a company’s past actions and future perceptual representation of a
company’s past actions and future prospects that describes the firm’s overall appeal to
all of its key constituents when compared with other leading rivals”. In the latter
definition, the elements regarding the competitive process, the key characteristics of a
company and communication with key constituents are still included but another
element, about future expectations about a company’s activities, is added as a part of
overall assessment of corporate reputation.
Corporate reputation is also found as a signal of a firm’s actions in marketing literature
as a signal to its customers of a firm’s actions (i.e. Fombrun and Shanley, 1990; Herbig
et al., 1994; Acquaah, 2003). Marketers send, seek for and interpret marketing cues to
try to understand the beliefs, attitudes, or intentions of market participants (Herbig and
Milewicz, 1993). According to attitude theories such as the expectancy-value theory
(Fishbein and Ajzen, 1975), market participants (e.g. consumer, retailer, supplier, etc.)
make decisions by selecting the alternative which is perceived to be most promising and
is likely to lead to the most favourable outcomes for them. Consistent positive signals
about a company’s products or services quality can enhance its credibility (Herbig et al.,
1994) and positively influence customers’ attitudes as well as purchase intentions (e.g.
Campbell, 1999; Goldberg and Hartwick, 1990). On the other hand, less positive or
negative signals can render opposite results, especially when signals are sent out
inconsistently (e.g. LaBarbera, 1982).
Corporate reputation is also found as a combination of personalities of a company (e.g.
Spector, 1961; Davies et al., 2003) in another stream of marketing literature.

A

company is personified and assigned relevant personalities usually borrowed from
psychological research. A company can have up to seven types of human-like traits
such as agreeableness, chicness and ruthlessness (Davies et al., 2003). Two relevant
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issues, however, should be noted here. First, conceptualising reputation as trait is not
always evaluative (Berens and van Riel, 2004). A certain type of personality is assessed
to be positive or negative partly based on the perceived fit between that personality and
an observer’s personality (Huston and Levinger, 1978 cited in Berens and van Riel,
2004). Moreover, empirical evidence (e.g. Davies et al., 2003, 2004) has confirmed the
complex nature of corporate reputation. It has been shown that corporate reputation has
multiple characteristics, each of which can be interpreted altogether or separately to
describe a company.
However, in the past, some marketing scholars used the term corporate reputation
interchangeably with corporate image. The definition of this concept is also varied. For
instance, it used to be defined as “the whole sensory perceptions and thought
interrelationships associated with an entity by one individual” (Enis, 1967, p.51) and as
“impressions and mental pictures about things” (Kennedy, 1977, p.152). It can be seen
that the mental picture of constituents is an important element in these early definitions.
In recent years, the mental component has been less salient. The definitions offered by
marketing scholars and those of general management researchers have started to
converge. To marketing researchers, corporate reputation has become distinct from
corporate image.

According to Balmer (1998), corporate reputation refers to the

perception of an organisation which is built up over a period of time and which focuses
on what it does and how it behaves. More examples of definitions by different scholars
are shown in Table 2.1.
Table 2.1: Examples of definitions of corporate reputation
Research Areas

Definition

Related References

Economics

Customer expectation and belief about a firm’s product quality.

Shapiro (1982, 1983)

Sociology

A prevailing collective agreement about an actor’s attributes or
achievement based on what the relevant public knows about the
actor.

Camic (1992)

Strategic
Management

An attribute or a set of attributes ascribed to a firm, inferred
from the firm’s past actions.

Weigelt and Camerer
(1988)

Strategic
Management

Public’s cumulative judgements of firms over time.

Roberts and Dowling
(2002)

Strategic
Management

Stakeholder’s knowledge and emotional reactions (e.g. affect,
esteem, etc.) towards a firm.

Hall (1992); Fombrun
(1996)

Marketing

The estimation of the consistency over time of an attribute of an
entity.

Herbig and Milewicz
(1995)
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Marketing

Public esteem judged by others

Weiss et al. (1999)

Marketing

A value judgement about a company’s attributes that evolves
over time as a result of consistent performance, reinforced by
effective communication.

Gray and Balmer
(1998)

Source: Adapted from Bennett and Kottasz (2000, p.224).
According to Bensiali (2011), corporate reputation is based on intangible aspects of an
organisation’s performance, culture, marketing and quality of product and service and
takes time to spread.
Furthermore, Burke (2011) argues that corporate reputation is becoming increasingly
important. The advantages of corporate reputation are summarised (p. 5):
“…A positive organization reputation will increasingly influence
purchase decisions when there is little difference in price, quality
design and product. There is even more competition, lack of
differentiation, and pricing concerns in the service sector. Thus
building a highly regarded corporate reputation or corporate
brand had become even more important.”
Burke (2011) moreover argued that there could be threats for a firm’s if it doesn’t pay
attention to build its corporate reputation:
“These include “bad behavior” by executives, unsafe or defective
products, customer complaints, employee complaints, poor
treatment of employees, poor handling of layoffs and/or
termination.”(p. 19)
“Interestingly, most people have a low opinion of corporations in
general. So being admired offers an even more substantial benefit.
In addition, there are more threats to a company’s reputation today
than previously.”(p. 6)

2.2.1 The uses of corporate reputation: a theoretical analysis
The review of theoretical literature indicates that academic and practitioner
contributions towards the understanding of the uses of corporate reputation by business
organisations can be theorized along six dominant paradigmatic perspectives. These are:
sociological;(1) public relations; (2) marketing; (3) management, (4) economic; (5) 6financesociological; (6) finance and accounting. Some ideas regarding the uses of
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corporate reputation are drawn from a public relations perspective. However, most of
the arguments are suggested by the marketing, management, financial and accounting
scholars in the broad field of management studies.

These are discussed

comprehensively in the paragraphs that follow.

2.2.1.1 The uses of corporate reputation in public relations literature
There is a common notion that public relations academics and practitioners are the
premier proponents of the concept of corporate reputation. Works by Jeffries-Fox
Associates (2000) suggests that this may be true. Previous research has examined the
concept of corporate social responsibility in terms of how firms can use it to
articulate social responsibilities to various stakeholders (Lerbinger, 1965). According to
Grunig et al. (1992), these goals can be achieved through the development of
relationships with their publics. Therefore, public relations fulfil its responsibility by
promoting human welfare.

It also contributes towards the development of social

systems that are needed to adapt to the changing needs of the environment (Cutlip et al.,
2003).
Another use of corporate reputation within the public relations paradigm is that
corporate reputation is a tool used by firms to attract the best employees, raise capital
effectively, become a good community member, or gain and retain loyal customers. In
the same vein, L’Etang (2006) shows that corporate reputation helps to protect firms
from excessive interpretations by reducing media to “secondary definers” (Chibnall,
1977; Hall et al., 1978; McNair, 1996).

2.2.1.2 The uses of corporate reputation in marketing literature
Marketing literature also provides a variety of papers addressing the uses of corporate
reputation. For instance, corporate reputation is commonly used as a signal by business
organisations to attract customers or enable customers’ trust in their company products
or services (Herbig and Milewicz, 1993). Marketers and business organisations use and
deploy reputational cues that are interpreted by stakeholders, who often make a
conscious attempt towards understanding the beliefs, attitudes, or intentions of market
participants (Herbig and Milewicz, 1993). A firm with a good reputation can use this as
a tool to underpin that aspect of the market value stock price that is not directly
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attributable to organisational assets and liabilities. It enables firms to make higher
profits than would be derived from the selling of its tangible assets.

The use of

corporate reputation often occurs in the case of an acquisition (Walsh et al., 2008).
A particular area in marketing, which is in the consumer behaviour literature, is that
corporate reputation assists consumers who are constantly challenged by purchase
decision- making. This means that reputation provides important clues about how a
supplier’s products, strategies and prospects compare with those of competing
enterprises (Fombrun and Shanley, 1990). For instance, the reputation developed by
firms often helps customers to select an alternative which is perceived to be most
promising and is likely to lead to the most favourable outcomes (Srivoravilai, 2006).
Fombrun and Shanley (1990) also note that a good reputation serves as a value signal in
situations of information overload, complexity or inadequacy. In other words, firms use
their reputation to enable customers to gauge the merits of a product or service,
especially when customers are faced with vague corporate or product information
(Fombrun and Shanley, 1990). In addition, consistent positive reputational signals
about the quality of a company’s products or services can enhance credibility (Herbig et
al., 1994) and positively influence customers’ attitudes as well as their purchasing
intentions (e.g. Goldberg and Hartwick, 1990; Campbell, 1999). For example, Nguyen
and Leblanc (2001) claimed that in the services sector, firms increase their corporate
reputation by influencing consumer behaviour through the use of factors such as contact
personnel and the physical environment. These factors provide benefits promised to
customers during service transactions.
Similarly, some researchers (Day, 1994; Srivoravilai, 2006) asserted that if a company
has strong marketing capabilities, it will signal the use of part of the firm’s capabilities
to meet the needs of stakeholders (Acquaah, 2003). Consequently, firms use such
capabilities as reputational platforms that create a distinctive position about the
company in the minds of stakeholders (Fombrun and van Riel, 2004).
Devine and Halpern (2001) argued that corporate reputation plays a role in value creation for
shareholders. These authors contended that a firm’s corporate reputation is a signal for top-quality
products, good working conditions and excellent service quality. Dolphin (2004) also
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suggested that corporate reputation is used as a value-creating tool. Similarly, Caruana
(1997) believed that corporate reputation is used as a means of generating good returns
on a firm’s investment over time (Fombrun, 1996). Bennett and Gabriel (2001) mention
that in the event of corporate scandals, a positive reputation is usually drawn to counter
unjustifiable attacks and negative publicity arising from stakeholders. It is also used to
attract investors (Fombrun and Shanley, 1990).
A good corporate reputation reduced transaction costs and provides beneficial financial
and non-financial outcomes (Caruana et al., 2004) to business organisations. A firm
with an established corporate reputation can use its history-based reputation to further
or court even better reputations among customers (Fombrun and Shanly, 1990).
It is commonly argued among marketing scholars that the idea of a favourable corporate
reputation is used to develop competitive advantage (Worcester, 1986; Fombrun and
Shanley, 1990; Maathuis, 1993; Greyser, 1996) and firm value (Fombrun and Shanley,
1990; Gregory, 1991; Marconi, 1991; Fortune, 1995). Moreover, the development of a
good corporate reputation enhances organisational impact on customers’ retention
decisions and increases customer loyalty (Saxton, 1998). In a similar vein, Fombrun
(1996) contended that corporate reputation is commonly drawn by business
organisations as a form of goodwill. This is often used to effectively position the
business itself favourably in the minds of stakeholders as well as a means of
differentiating themselves from competitors (Day, 1994). Similarly, Fombrun (2002)
proposed that corporate reputation provides signals about the future of organisations.
Such signals provide insights into the firm’s profit-making ability as well as the firm’s
ability to achieve well-defined organisational goals.

2.2.1.3 The uses of corporate reputation in management literature
However, similarly to marketing perspectives, in management studies, general
management scholars argue that a favourable corporate reputation is used by firms to
generate a competitive advantage (Caves and Porter, 1977; Wilson, 1985; McMillan and
Joshi, 1997). They regard corporate reputation as a strategic resource (Cave and Porter,
1977; Hall, 1992, 1993; Rao, 1994; Roberts and Dowling, 2002; Carmeli and Tishler,
2004) used to protect firms from new competitors in the market. For instance, corporate
31

`

reputation is regarded by some researchers (Shenkar and Yuchtman-Yaar, 1997) as an
important factor that enables business organisations to exist over a long period of time
and it is difficult for businesses to even operate without a corporate reputation.
Moreover, a good corporate reputation allows a firm not only to attract new consumers
but also keep the existing ones. Some consumers rely on a trustworthy corporate image
and a company’s history-based reputation in environments where they are unaware of
the quality or other features of a product (Shkolnikov et al., 2004).

Researchers

(Shkolnikov et al., 2004) moreover argued that firms build up their corporate reputation
in order to increase customer loyalty, reduce business risk and improve their bottom line.
In modern corporations, reputation is used as a value-creating mechanism and
stakeholders pay close attention to it.
Reputation is a tool that is used to signify an organisation’s perceived capacity to meet
their stakeholders’ expectations (Waddock, 2000). In other words, firms use corporate
reputation in order to give a positional advantage by using various strategies to
differentiate themselves from competitors (Hall, 1992). A positive corporate reputation
will not only provide a greater competitive advantage for a firm (McMillan and Joshi,
1997) but also accrue strong organisational identification among employees (Dutton et
al., 1994) and better attitudes towards the company’s salespeople and products on the
part of industrial buyers (Brown, 1997).
Consequently, it is agreed by many management scholars that a successful corporate
reputation increases a firm’s financial performance. For instance, Roberts and Dowling
(2002) asserted that good corporate reputations are crucial because of their potential for
value creation, but also because of their intangible character which make replication by
competing firms considerably more difficult. McGuire et al. (1990) also confirm the
expected benefits associated with good reputations, providing strong evidence that the
customers’ perceptions of a firm quality can be a cause or result of a firm’s performance.
Roberts and Dowling (2002) proved that a successful corporate reputation is capable of
increasing a company’s financial performance. They added that firms with relatively
good reputations are better able to sustain superior profits over time.
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In the same vein, Stanwick and Stanwick (1998) argue that building a firm’s corporate
reputation requires the development or generation of feedback from stakeholders within
the environment. They use the corporate reputation measures – which are consistently
used in many studies (i.e. McGuire et al., 1988; Fombrun and Shanley, 1990; Thomas
and Simerly, 1994) – to measure corporate social responsibility. They found empirically
that corporate reputation increases corporate social performance resulting in a better
environmental performance.
In light of its potential impact on financial performance, the idea of corporate reputation
has been developed in a wider scope.

Fryxell and Wang’s (1994) crucial insight

provides a detailed analysis of the multi-dimensionality of corporate reputation. They
argued that corporate reputation impacts significantly on the perceptions of shareholders
and stakeholders. Similarly, Smith (1994) presented some evidence supporting the
positive influence and the use of a good corporate reputation on the development of
organisational value. Clardy (2005) argued that there is a synergy between a firm’s
corporate reputation and its goodwill, since the accounting profession has rules for how
to calculate and report goodwill in financial statements. Based on this assertion, one
could argue that corporate reputation is capable of being used as a means of developing
goodwill among stakeholders (Clardy, 2005).

2.2.1.4 The uses of corporate reputation in economics literature
In economics, as with marketing and management scholars, Brammer and Pavelin (2006)
also suggested that the multi-dimensionality of corporate reputation impacts on the
perceptions of shareholders and stakeholders. Thus, it is possible to see corporate
reputation as a very important phenomenon that creates trust in the minds of consumers.
Akerlof (1970) argued that corporate reputation is an information signal that firms often
use to protect their accumulated capital and assets.
Similarly, Punete et al. (2007) argued that good corporate reputation signals enable
businesses to predict human behaviour in the future. Consequently, the use of corporate
reputation as a behaviour signal contributes towards a thorough understanding of not
only consumers but also of a firm’s key competitors of (Kreps and Wilson, 1982;
Milgrom and Roberts, 1982). More importantly, the development of a good corporate
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reputation, especially among customers, encourages the production of top-quality
products (Nelson, 1970; Milgrom and Roberts, 1986) and services (Wilson, 1983; de
Angelo, 1981; Dranove, 1983; Rogerson, 1983; Eichenseher and Shields, 1985; Beatty
and Ritter, 1986).
Equally, Weigelt and Camerer (1988) argued that corporate reputation is strategically
important. It is used as either a trait or a signal (Kreps and Wilson, 1982; Shapiro, 1989)
which can be transmitted from a company to its customers in order to give information
about products or give an advance warning of competitor retaliation (Weigelt and
Camerer, 1988). They argued that it is used by stakeholders to forecast the potential
behaviour of a firm.

Weigelt and Camerer (1988) also indicated that corporate

reputation gives an organisation some return on its investment over time in “nonsalvageable goodwill”.
Some economic scholars (Stigler, 1962; Klein and Leffler, 1981; Milgrom and Roberts,
1986) suggested that a good corporate reputation gives an organisation a competitive
advantage.

It is also regarded by some other economic researchers that corporate

reputation is used, drawn and presented to stakeholders as an asset which cannot be
bought, and thus is not easy to imitate or substitute (Dierickx and Cool, 1989). Shapiro
(1983) argued that a strong corporate reputation has been shown to be associated with
reduced transaction costs, together with beneficial financial and non-financial outcomes.
Corporate reputation is a cyclical phenomenon that signifies the character of a firm to
competitors (Milgrom and Roberts, 1982) and customers (Rogerson, 1983). Puente et al.
(2007) asserted that well-regarded firms use their previous reputation to occupy
privileged positions in the business environment, using it to attract better resources on
more favourable terms.

Landon and Smith’s (1997) empirical work indicates that

consumers use the established reputation of firms when making their purchase decisions.
In another empirical study, Sabate and Puente (2003) argued that consumers take note
of corporate reputation in their individual purchasing decisions. This again signifies the
usefulness of corporate reputation to firms.

2.2.1.5 The uses of corporate reputation in sociology literature
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However, in sociology, corporate reputation is regarded as a social construction that is
used to build up the relationship between a company and its stakeholders (Perrow,
1961a; Perrow, 1961b; Shrum and Wuthnow, 1988) rather than as an asset or possession
as theorised under marketing (see For instance Fombrun and van Riel). Similarly,
Cornell and Shapiro (1987) asserted that it is possible for firms to lose accumulated
reputation if they fail to keep stakeholders happy or satisfy their expectations. Thus, the
notion of corporate reputation is used as a guarantor of contracts.

Following this

argument, reputation is used as an indicator of legitimacy or social acceptance, which
reflects the congruence of expectations (Galaskiewicz, 1985).

2.2.1.6 The uses of corporate reputation in finance and accounting literature
Apart from these, the use of corporate reputation has also generated interest among
finance and accounting authors. In accounting, corporate reputation is used to generate
goodwill amongst stakeholders (Rose and Thomsen, 2004) – and when firms have a
reputation based on a good history of performance, it impacts positively on the
perceptions of shareholders and stakeholders (Rose and Thomsen, 2004).

More

importantly, it helps to increase the value of returns to shareholders and stakeholders
(Rose and Thomsen, 2004). Thus, it is possible to see corporate reputation as the very
phenomenon that creates trust in the minds of stakeholders. It contributes towards
reduced transaction costs and provides beneficial financial and non-financial outcomes
(Rose and Thomsen, 2004).
Goodwill, which is commonly conceived among accountants as the basis of corporate
reputation, was originally used to describe the “intrinsic value” inherent in an ongoing
business. Therefore, from an accounting perspective, goodwill is an intangible asset
(Higson, 1998) which gives stakeholders extra value. Thus, firms use their goodwill or
reputation as plausible factors that enable a rise in sales level higher than the value of
their net assets.
According to Beatty and Ritter (1986), a favourable corporate reputation gives a firm a
competitive advantage. It can be used to reflect the portion of the market value of a
business entity not directly attributable to its assets and liabilities. Moreover, a good
corporate reputation is also used to highlight the ability of firms to make a higher profit
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than would be derived from selling only their tangible assets. It also enhances the
ability to raise loans from financial institutions, which, in turn, influences a firm’s easy
access to financial capital (Beatty and Ritter, 1986; Garbett, 1988). In some other
accounting studies, a firm’s good reputation encourages employees to be devoted and
stay longer (Markham, 1972; IOD, 1999) and it is increasingly seen as an intangible
asset that create value in the future (DTI, 2001).
However, in a world where a significant number of the most powerful economic entities
are corporations, intangible assets like reputation are used and presented to stakeholders
as corporate valuables (Moerman and Laan, 2006). Moreover, as argued by Okano et al.
(1999), goodwill or corporate reputation is often used as an experiential asset. It is
conceived as a phenomenon which enables firms to profit from a variety of benefits,
such as increase in share price and positive financial performance (see Herremans et al.,
1993).

2.2.2 Diversities and similarities in the theoretical conceptualisation of the use of
corporate reputation
The review of theoretical literature from various academic areas (i.e. public relations,
marketing, management, economic, sociological, finance and accounting) indicates a
strong overlap in the theoretical concept building of the uses of the concept of corporate
reputation among business organisations. As seen in the review of literature, scholars
belonging to different areas appear to have conceptualised the uses of corporate
reputation in similar ways. Thus, there is very little difference between the ways that
public relations and marketing academics have theorised the use of corporate reputation.
Nor is there a significant divergence between the ways in which management academics
and economics and accounting and finance academics have theorised the use of
corporate reputation.
Now because the uses of corporate reputation (as attested in the review of corporate
reputation in the paragraphs above) are conceptually related, it becomes imperative and
highly necessary to bring together various overlapping theories to enable us to focus on
the discourse in this chapter. Thus, an attempt shall be made in the following paragraph
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to develop a synthesis that brings together all related theories concerning the use of
corporate reputation into a holistic, cohesive and coherent synthesis in order to develop
a useful and deeper understanding of the uses of corporate reputation.

2.2.2.1 The uses of corporate reputation: a synthesis of overlaps
Attention was drawn to the emergence of a number of conceptual overlaps in the
literature concerning use of corporate reputation. This paragraph makes a follow-up by
presenting a synthesis underscoring the emergence of eleven conceptual overlaps on
(see Table2.2, 2.2) within the literature relating to the focus of this chapter. The
interconnected arguments leading to these overlaps are discussed below. Mainly, the
uses of corporate reputation are categorized into three groups: value creation,
influencing competitor’s actions and developing the relationship with stakeholders.

Value creation
Corporate reputation is used as a tool for creating value in much previous research (see
synthesis S3 in Table 2.2). Arguments highlighted under the marketing perspective
point to the use of corporate reputation as a value-creating tool (Dolphin, 2004) which
has a positive influence on firm value (Fombrun and Shanley, 1990; Gregory, 1991;
Marconi, 1991; Fortune, 1995). A similar argument was presented under the finance
and accounting perspective.

For instance, Moerman and Laan (2006) state that

corporate reputation is used and presented to stakeholders as a corporate valuable
(Okano et al., 1999) or as an intangible asset that creates value in the future (DTI, 2001).
The same idea is supported by economics scholars (see Dierickx and Cool, 1989) who
contend that corporate reputation is used as an asset, which cannot be bought, and thus
is not easy to imitate or substitute. Some management scholars also hold a similar idea
in that corporate reputation is regarded as an asset which cannot be bought, and thus is
not easy to imitate or substitute (Barney, 1986). Similarly, Shkolnikov et al. (2004)
declare that corporate reputation is used as a value-creating mechanism. Corroborating,
Smith (1994) averred that corporate reputation is commonly drawn as a tool for the
development of organisational value.

Roberts and Dowling (2002) also say that

corporate reputation is used to express a firm’s strategic value. Similar arguments are
supported by sociology scholars (see Rose and Thomsen, 2004) who declared that
corporate reputation is used to increase the value of returns to shareholders.
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Moreover, corporate reputation is used as a tool for promising good-quality products
and service to customers (see S9 in Table 2.2).

Arguments presented under the

marketing perspective point to the notion that positive reputational signals about the
quality of a company’s products or services can enhance credibility (Herbig et al., 1994).
Similarly, Devine and Halpern (2001) also support the idea that a firm’s corporate
reputation is used as a promise for good brand quality and good service levels.
Economics scholars also hold parallel ideas: a good corporate reputation encourages the
production of top-quality products and services (Nelson, 1970; De Angelo, 1981;
Wilson, 1983; Dranove, 1983; Rogerson, 1983; Eichenseher and Shields, 1985;
Milgrom and Roberts, 1986; Beatty and Ritter, 1986).
Furthermore, corporate reputation is used to reduce transaction costs (see S11 in Table
2.2,). Marketing scholars (see Caruana et al., 2004) argue that a strong corporate
reputation is connected to reducing the generation of transaction costs. Works within
the economic perspective (Shapiro, 1983) also support this idea. Shapiro (1983) argued
that corporate reputation reduces transaction costs, yielding beneficial financial and
non-financial outcomes. Similarly this idea is also supported by management scholars
(see Eberl and Schwaiger, 2005).
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Table 2.2: Theoretical conceptualisations of the uses of corporate reputation
Statements

Author

Syn

Public relations perspective
Communicate firm’s social responsibility to various stakeholders

Lerbinger (1965); Grunig et al.
(1992)

Attract the best employees, raise capital effectively, become a good community
member or gain and retain loyal customers

S1
DC

Protect firms from excessive interpretations among stakeholders

L’Etang (2006); Chibnall (1977);
Hall et al. (1978); McNair (1996)

S3

Used as an indicator of legitimacy or social acceptance, reflecting a congruence
of expectations

Fombrun and van Riel (1997)

DC

Commonly used as a signal. Cues are interpreted by stakeholders who often
make a conscious attempt to understand the beliefs, attitudes or intentions of
market participants are sent use or deploy

Herbig and Milewicz (1993)

S8

Create a distinctive position of the company in the mind of stakeholders

Fombrun and van Riel (2004)

S9

Generate good returns on a firm’s investment over time

Caruana (1997); Fombrun (1996);
Day (1994)

S11

Give positional advantage through strategies to differentiate itself from other
competitors

Day (1994)

S9

Use as a value-creating tool

Dolphin (2004)

S5

Have influence on firm

Fombrun and Shanley (1990);
Fortune (1995); Gregory (1991);
Marconi (1991)

S5

A favourable corporate reputation gives an organisation a competitive
advantage

Fombrun and Shanley (1990);
Greyser (1996); Maathuis (1993);
Worcester (1986)

S9

Enhance “the ability to withstand occasional adverse publicity”

Fombrun and Shanley (1990)

DC

Counter unjustifiable attacks and negative publicity among stakeholders

Bennett and Gabriel (2001)

DC

Attract investors

Fombrun and Shanley (1990)

DC

Further or court even better reputations among customers

Fombrun and Shanly (1990)

S2

Affect corporate performance

Srivastava et al. (1997)

S11

Help customers to select the alternative which is perceived to be most
promising and is likely to lead to the most favourable outcomes

Srivoravilai (2006)

S3

Serve as a value signal in situations of information overload, complexity or
inadequacy.

Fombrun and Shanley (1990)

S3

Consistent positive reputational signals about the quality of a company’s
products or services can enhance credibility

Herbig et al. (1994)

S6

Provide important clues about how a supplier’s products, strategies and
prospects compare with those of competing enterprises

Fombrun and Shanley (1990)

DC

Involve customers to act as advocates of the company

Walsh et al. (2008)

DC

Marketing perspective

Gives the stakeholder a prospect about how key resource providers interpret a
company’s initiatives and assess its ability to deliver value outcomes’ from a
firm’s past actions (Fombrun, 2002)

Enable customers to gauge the merits of a product or service, especially when
customers are faced by vague corporate or product information
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Enhance higher levels of customer purchasing and customer loyalty

Yoon et al. (1993); Saxton (1998)

DC

Positively influence customers’ attitudes as well as their purchasing intentions

Campbell (1999); Goldberg and
Hartwick (1990)

DC

Enhance the impact on customers’ retention decisions, having a huge impact on
customer loyalty

Nguyen and Leblanc (2001)

DC

A strong corporate reputation has been shown to be associated with reduced
transaction costs together with beneficial financial and non-financial outcomes

Caruana et al. (2004)

S7

Plays a role in value creation for their shareholders, promising quality, good
working conditions and service levels which are not explicitly stated in any
contracts, but when present, it also permit a company to sell products and/or
services at higher prices, and purchase goods and services from suppliers at
lower prices than competitors

Devine and Halpern (2001)

S6

Is firm’s intangible asset which stakeholders believe it will give them some
extra value

Higson (1998)

DC

Influences firm’s easy access to financial capital

Beatty and Ritter (1986); Garbett
(1988)

DC

Encourages employees to be devoted and stay longer with a firm

IOD (1999); Markham (1972)

DC

Used as an experiencial asset

Okano et al. (1999)

S5

Used and presented to stakeholders as corporate valuables

Moerman and Laan (2006)

S5

Increasingly seen as an intangible asset that creates value in the future

DTI (2001)

S5

Enable firms to profit from a variety of benefits

Herremans et al. (1993)

S5

Give a firm competitive advantage

Beatty and Ritter (1986)

S9

Impacts on both the perceptions of shareholders and stakeholders

Brammer and Pavelin (2006)

S2

Gives an organisation a competitive advantage

Klein and Leffler (1981); Milgrom
and Roberts (1986); Stigler (1962)

S9

Used as a signal to forecast the potential behaviour of a firm.

Kreps and Wilson (1982); Shapiro
(1989)

S8

Has an impact on financial performance

Sabate and Puente (2003); Sobol
and Farrell (1988)

S11

Regarded as an asset which cannot be bought, and thus is not easy to imitate or
substitute

Dierickx and Cool (1989)

S5

Can be transmitted from a company to its customers in order to give
information about products or give an advance warning of retaliation if
competitors make any adversarial moves

Weight and Camerer (1988)

DC

Signals or enables businesses to predict human behaviour in the future

Puente et al. (2007)

S2

Encourages the production of top-quality products and top services

Nelson (1970); Milgrom and
Roberts (1986); Wilson (1983); De
Angelo (1981); Eichenseher and
Shields (1985); Dranove (1983);
Rogerson (1983); Beatty and Ritter
(1986)

S6

Finance & Accounting perspective

Economic perspective
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Reduce transaction costs together with beneficial financial and non-financial
outcomes

Shapiro (1983)

S7

Used by consumers to make their purchasing decisions

Landon and Smith (1997); Sabate
and Puente (2003)

S3

Is strategically important

Weigelt and Camerer (1988)

S4

Signifies the character of a firm to competitors and customers

Milgrom and Roberts (1982);
Rogerson (1983)

S4

Occupies a privileged position in markets, and used to attract better resources
on more favourable terms

Puente et al. (2007)

DC

Stanwick and Stanwick (1998)

S1

Generate a competitive advantage

Caves and Porter (1977); Wilson
(1985); McMillan and Joshi (1997)

S9

Sustain superior profits over time. (Its potential for value creation.)

Roberts and Dowling (2002)

DC

Increase a firm’s financial performance

Roberts and Dowling (2002)

S11

Corporate reputation and financial performance effects operate in both
directions

McGuire et al. (1990)

S11

Use as a means of developing goodwill amongst stakeholders

Clardy (2005)

DC

Can accrue the benefits of strong organisational identification among
employees

Dutton et al. (1994)

DC

Increase a firm’s financial performance

Roberts and Dowling (2002)

S11

Enhance firm performance (in a sample of pure internet firms)

Kotha et al. (2001)

S11

Improve attitudes towards the company’s salespeople and products on the part
of industrial buyers

Brown (1997)

DC

Give a positional advantage by using various strategies to differentiate itself
from other competitors

Hall (1992)

S9

Use as a value-creating mechanism

Shkolnikov et al. (2004)

S5

Used to signify an organisation’s perceived capacity to meet their stakeholders’
expectations

Waddock (2000)

S8

Impacts on both the perceptions of shareholders and stakeholders

Fryxell and Wang (1994)

S2

Is regarded by some researchers an asset which cannot be bought, and thus is
not easy to imitate or substitute

Barney (1986)

S5

Is regarded either as a strategic resource or a mobility barrier

Carmeli and Tishler (2004); Hall
(1992; 1993); Cave and Porter
(1977); Rao (1994); Roberts and
Dowling (2002)

DC

Reduce transaction costs together with beneficial financial and non-financial
outcomes

Eberl and Schwaiger (2005)

S7

Provide strategic value

Roberts and Dowling (2002)

S5

Develop organisational value

Smith (1994)

S5

Management perspective
Lead towards the development or generation of feedback from stakeholders
within the environment.
Increase corporate social performance, resulting in a better environmental
performance

Is used to protect a corporation from its new competitors
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Enable business organisations to exist over a long period of time

Shenkar and Yuchtman-Yaar
(1997)

DC

Affect corporate performance

Deephouse (1997); Brown (1997);
Roberts and Dowling (1997)

S11

Attract new consumers but also keep the existing ones.

Shkolnikov et al. (2004)

S3

Is regarded as a social construction which can be built up through the
relationship between a company and its stakeholders

Perrow (1961a); Perrow (1961b);
Shrum and Wuthnow (1988)

S4

A guarantor of contracts

Cornell and Shapiro (1987)

S10

Serves to generate goodwill among stakeholders

Rose and Thomsen (2004)

DC

Impact positively on the perceptions of shareholders and stakeholders

Rose and Thomsen (2004)

DC

Helpi increase the value of returns to shareholders and stakeholders

Rose and Thomsen (2004)

S5

Reduce transaction costs together with beneficial financial and non-financial
outcomes

Rose and Thomsen (2004)

DC

Increase customer loyalty, reduce business risk and improve their bottom line
Sociological perspective

Summaries of synthesis
S1:
use of corporate reputation as a means of communication
S2:
use of corporate reputation as a means of shaping the perception of shareholders and stakeholders
S3:
use of corporate reputation as a means of influencing consumer choices
S4:
use of corporate reputation as a tool for building a relationship between the firm and the customers
S5:
use of corporate reputation as a tool for creating value
S6:
use of corporate reputation as tool for promising good quality products and service to customers
S7:
use of corporate reputation to reduce transaction costs
S8:
use of corporate reputation as a signal to customers
S9:
use of corporate reputation as competitive advantage
S10:
use of corporate reputation as a strategic value or resource
S11:
use of corporate reputation as a tool for developing good financial performance
*S: Synthesis *DC: Divergent conceptualisation *Dimensions of the uses of corporate reputation: a. Communication: S1,S2,S3,S4; b.
Value creation: S5,S6,S8; c. Strategic sources: S9,S10,S11

Source: Developed by the author

Strategic resource: influencing competitor’s actions/strategies
Corporate reputation is used as a strategic value or resource by some Economic scholars
(see synthesis S6 in Table 2.2,). Some economic scholars (see Weigelt and Camerer,
1988) have asserted that corporate reputation is a strategic resource as well as scholars
belonging to the management perspective (Roberts and Dowling, 2002) and sociological
scholars. The latter claimed that corporate reputation is commonly used as a defence
strategy to ward off competitors (Cornell and Shapiro, 1987).
Moreover, corporate reputation is used as a signal to customers (see synthesis S4 in
Table 2.2,). Marketing scholars have suggested that corporate reputation is commonly
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used as a means of highlighting and signifying (Herbig and Milewicz, 1993) a firm’s
beliefs, attitudes and intentions to market participants – and thus interpreted by
stakeholders.

In a similar dimension, Fombrun (2002) contended that corporate

reputation is often deployed by firms as a useful signal that gives stakeholders the
needed insight into the future of a firm. It may be used as a signal that enables key
resource providers such as banks and other financial institutions to interpret a
company’s initiatives from its past actions and assess its ability to deliver value
outcomes’ The use of corporate reputation as a signal-laden phenomenon has also been
argued from an economic perspective.

Succinctly, authors within the economic

perspective are of the view that corporate reputation can be used as a trait or signal to
forecast the potential behaviour of a firm (see Kreps and Wilson, 1982; Shapiro, 1989).
Management also authors also argue that corporate reputation is used on many
occasions to signify an organisation’s perceived capacity to meet their stakeholders’
expectations (Waddock, 2000).
Moreover, corporate reputation is used for competitive advantage (see synthesis S5 in
Table 2.2,). It is commonly agreed by marketing scholars that firms use corporate
reputation to create a distinctive position in the mind of stakeholders (Fombrun and van
Riel, 2004) in order to attain competitive advantage (Worcester, 1986; Fombrun and
Shanley, 1990; Maathuis, 1993; Greyser, 1996). Consequently, firms aspire to achieve
competitive advantage by deploying strategies that will effectively differentiate them
from competitors (Day, 1994). A similar argument has been put forward by scholars
belonging to accounting perspectives (see Beatty and Ritter, 1986), economic
perspectives (see Stigler, 1962; Klein and Leffler, 1981; Milgrom and Roberts, 1986),
and management perspectives (see Caves and Porter, 1977; Wilson, 1985; Hall, 1992;
McMillan and Joshi, 1997). Authors belonging to these disparate disciplines have all
agreed that a favourable corporate reputation gives an organisation a competitive
advantage.

Corporate communication: developing the relationship with stakeholders
Corporate reputation is commonly agreed by scholars to function as a means of
communication. It is argued under the public relations perspective (see Lerbinger, 1965;
Grunig et al., 1992) that corporate reputation is used to communicate a firm’s social
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responsibility activities to stakeholders within the business environment. Scholars
within the management area have also been highly vocal about the positioning of
corporate reputation as that which enhances the generation of better feedback from
stakeholders within the business environment (see Stanwick and Stanwick, 1998). See
also synthesis S1 in Table 2.2.
Moreover, corporate reputation is used as a means of shaping the perception of
shareholders and stakeholders (see synthesis S2 in Table 2.2,). A review of theoretical
literature belonging to the marketing perspective (Fombrun and Shanly, 1990) indicates
that a firm’s previous corporate reputation can enhance its future reputation among
customers. Management scholars (Brammer and Pavelin, 2006) suggested that a firm’s
corporate reputation commonly shapes the opinions and perceptions of shareholders and
stakeholders alike. Puente et al. (2007) argues that a firm’s corporate reputation signals
or enables businesses to predict human behaviour in future. A similar argument was put
forward under the management perspective (Fryxell and Wang, 1994). These authors
also agree that corporate reputation is often deployed to develop favourable perceptions
of the firm among stakeholders.
Furthermore, corporate reputation is used as a tool for building a relationship between
the firm and the customers (see synthesis S10 in Table 2.2). A review of economic
literature (see Kreps and Wilson, 1982; Milgrom and Roberts, 1982) suggests that
corporate reputation is used as a signal contributing towards a thorough understanding
not only of consumers but also, more importantly, the key competitors of the firm
(Kreps and Wilson, 1982; Milgrom and Roberts, 1982). This inadvertently enhances
the development of a sound relationship. Sociological scholars (see to Perrow, 1961a;
Perrow, 1961b; Shrum and Wuthnow, 1988) agree. They hold the view that corporate
reputation is a device that could be drawn to build a relationship between a company
and its stakeholders.
Corporate reputation is used for influencing consumer choices (see synthesis S8 in
Table 2.2, s). Lterature from a public relations perspective indicates that corporate
reputation is drawn to protect firms from excessive interpretation among stakeholders
(L’Etang, 2006; Chibnall, 1977; Hall et al., 1978; McNair, 1996). Scholars belonging
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to a marketing perspective also support this viewpoint. They observe that a corporate
reputation helps customers to select the best choice among many alternatives in the
market (Srivoravilai, 2006) and serves as a value signal that enables customers to gauge
the merits of a product or service especially in situations where customers are
overloaded with information or in cases where there is inadequate information
(Fombrun and Shanley, 1990) about a product. Economic scholars agreed too. They
argued that corporate reputation is used by consumers to make purchasing decisions
(Landon and Smith, 1997; Sabate and Puente, 2003). Corroborating this viewpoint,
management scholars contend that a good corporate reputation enables the generation of
increased customer loyalty (Shkolnikov et al., 2004).

2.2.2.2 Use of corporate reputation: practical implications in previous research
Previous studies have identified several best practices in brand building that firms can
undertake to sustain and improve their corporate reputation.
In terms of practical implications, Siano et al. (2010) suggested that the use of corporate
finance management and corporate reputation management (e.g., organization
development management,

cooperative management,

risk management,

crisis

management) helps firms develop an appropriate cultural background to assist managers
in maintaining corporate reputation. The integration of corporate finance with corporate
communication and reputation allows firms to provide better training for managers in a
deeper cultural environment, creating advantages for both large and small companies. A
shared cultural background and language helps improve interactions and dialogue on
both intra- and inter-organizational levels among managers, who must have a broad
view of the company’s resources and its competences in resources management.
Especially in smaller firms, skills that are broad based rather than specific help
managers make correct management decisions. In larger companies, the common
management principles of financial resources and corporate reputation can be
particularly useful.
Kotha et al. (2001) examined the relationship between three types of reputation-building
activities and firms’ performance. These activities include marketing investments in
reputation, reputation borrowing and media exposure. Kotha et al. (2001) indicated that
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the effects of marketing-related expenditures tend to be transient, in line with doubts
raised by sceptics about the long-term viability of a brand-building strategy on the
Internet. The Economist (1999, p. 24) similarly noted:
Most [Internet firms] despite today’s towering market capitalizations,
will simply fade from view, unable to hold on to their much-vaunted
“eye-balls,” or turn them into solid profits that build long-term
businesses.
Moreover, according to Lloyd (2007), there is a strategic approach to managing
corporate reputation based on stakeholder segmentation. An improved understanding of
the characteristics of stakeholder targets gives management a stronger position to build
valuable stakeholder relationships. Lloyd’s research serves as a tool for strategy
planning and for tracking a company’s reputation and provides a research approach for
exploring other stakeholder segments.
In their study, Shamma and Hassan (2009) classified the dimensions of corporate
reputation into primary (products and services) and secondary (emotional appeal, vision
and leadership, financial performance and social and environmental responsibility)
pillars. The purpose of these pillars is to offer better guidance for managers who need to
manage multiple facets of a company’s reputation.
According to Ewing et al. (2010), many business-to-business firms are unable or
unwilling to invest in long-term strategies designed to foster positive reputation among
stakeholders, because their focus is centered more on short-term survival. Firms find it
difficult to market their reputation beyond their current customers because they perceive
a lack of understanding/interest among broader stakeholder groups.
For event planning businesses, Campiranon (2005) recommended that to strengthen
their corporate reputations, companies should build their image on reliability, credibility,
trustworthiness and responsibility. This recommendation is based on Fombrun’s (1996)
reputation drivers, which can be used by firms that depend heavily on their reputations
to attract customers.
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For the services sector, Walsh et al. (2009) suggested that to achieve a good corporate
reputation, firms must continuously deliver customer satisfaction. That is, rather than
focusing on the facets of corporate reputation, such as being a good employer, ensuring
a financially sound company, and engaging in social responsibility, service companies
should pay more attention to customer orientation and product and service quality
because of these factors’ direct impact on customer satisfaction. Moreover, because
customers often form their sense of a firm’s reputation by interacting with its employees,
service firms should ensure that employees are empowered to address all customer
needs, which in turn leads to customer satisfaction and trust.
However, Walsh et al. (2009) also suggested that if the firm has a good reputation, it
should invest in customer loyalty as well. However, when a firm has a poor reputation,
it should attempt to increase customer satisfaction through service and further explore
the reasons customers are dissatisfied. Moreover, when managers understand the nature
of their firms’ reputation, they can determine whether to initiate dedicated word-ofmouth campaigns to sustain other ongoing promotional activities or new product
launches.
Similarly, Dickinson-Delaporte et al. (2010) argued that to enhance corporate reputation,
social marketers should orient themselves to their stakeholders and conduct ongoing
research to identify their goals, their biases, and the cues they use to inform judgments
about the legitimacy of the firm’s actions. As part of this strategy, firms should receive
or allow stakeholder dialogue by developing a web forum, which can serve to
communicate the firm’s situation and reinforce the firm’s positioning. Moreover,
Dickinson-Delaporte et al. (2010) suggested that firms should reinforce their
communication strategy by using multiple perceptions of the firms’ actions to craft an
ambiguous position in the marketplace and to develop multiple messages to their
stakeholders. Walsh et al. (2009) also suggested that newly deregulated energy suppliers
should try to achieve a good reputation quickly because doing so can become a marketentry barrier for competitors that might want to enter the newly opened market.
On the one hand, Srivoravilai et al.’s (2011) study offers practical guidelines for
managers in especially highly institutionalised companies (e.g., private hospitals) in
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terms of enhancing their reputation and commitment to value through the achievement
of organisational legitimacy and the use of impression management tactics.

2.3 The brand and the corporate reputation
According to some previous studies, a firm’s reputation is revealed to have an effect on
the brand advertisement (Goldberg and Hartwick, 1990). Umbrella branding plays a
role at the corporate level (Berry et al., 1988). Sometimes the company name is
regarded as the brand name, particularly with service firms (Low and Blois, 2002).
Also, a firm’s corporate identity, its corporate reputation, and the corporate brands are
examined by Schultz et al. (2000) about the inter-relationship between the three
constructs.
On the other hand, the corporate reputation management process that Gotsi and Wilson
(2001) proposed shows a two-step process: First, a firm must align its internal
communication with its brand values, and second, the firm must align its human
resource management practices with its brand values. Gotsi and Wilson (2001) also
illustrated the essential role of employees in the corporate reputation management
process. Their study presents ways that organisations can encourage commitment,
enthusiasm and consistent employee behaviour in delivering brand values (Gotsi and
Wilson, 2001). Similarly, Fombrun (1996) argued that what accountants call ‘goodwill’
is similar to what marketers term ‘brand equity’.
According to Hatch and Schultz (2003, p. 1041),
“Among the changes that businesses make as they move toward
globalisation is a shift in marketing emphasis from product brands to
corporate branding (e.g. Kapferer, 1992; Dowling, 1993, 2001;
Balmer, 1995, 2001a; Aaker, 1996; Ind, 1997; Schmitt and Simonsen,
1997; de Chernatony, 1999; Aaker and Joachimsthaler, 2000; Keller,
2000; Knox et al., 2000; Olins, 2000; Harris and de Chernatony,
2001; Hatch and Schultz, 2001). This is usually ascribed to the
difficulties of maintaining credible product differentiation in the face
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of imitation and homogenisation of products and services, and the
fragmentation of traditional market segments that occurs as customers
become more sophisticated and markets more complex. In an era
when companies can no longer base their strategy on a predictable
market or a stable preferential product range, the ground rules for
competition have changed. Differentiation requires positioning, not
products, but the whole corporation. Accordingly, the values and
emotions symbolised by the organisation become key elements of
differentiation strategies, and the corporation itself moves centre
stage.”
Gotsi and Wilson (2001) suggested that a firm’s corporate reputation is affected by the
actions of every business unit, department and employee that comes into contact with
the stakeholders. Gotsi and Wilson (2001) explore what a firm’s management actions
are required to be if employees are to support and enhance a firm’s corporate reputation.
How employees can be directed or encouraged to “live the brand” is an area which has
received relatively limited coverage (Gotsi and Wilson, 2001).

2.3.1 The uses of corporate reputation and brand image strategy
First of all, it is summarised from the previous researchers (Gardner and Levy, 1955;
Newman, 1957; Herzog, 1963; Levy, 1978; Bullmore, 1984; Runyon and Stewart, 1987)
that brand image is defined as a totality of a consumer’s perceptions about a product’s
attributes. The perceptions of a brand that are reflected in the brand associations that
exist in the minds of consumers (Newman, 1957; Herzog, 1963). However, a brand
image not only reflects a perceptual phenomenon of the customers affected by the
firm’s communication activities alone (Stern et al., 2001) but also represents the
understanding consumers derive from the total set of brand-related activities engaged in
by the firm (Park et al., 1986). In other words, brand image is the collection of
attributes and associations that consumers connect with a brand name (Biel, 1993).
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Customer brand choice is based on emotional and intuitive feelings about brands, their
images and meanings for consumers and how these brands satisfy consumer needs and
seem to fit into the consumer’s relationship with his/her world (Meenaghan, 1995).
Therefore, customer buying behaviour can be reliably predicted when while a
distinguished a distinctive segment is formed (van Raaij and Verhallen, 1994).
Segmentation acts as a counterpart for product differentiation and positioning (Van
Raaij and Verhallen, 1994). However, positioning concepts are developed, selected and
communicated for these target segmented stakeholders (Kotler, 2003). In this section,
developing a brand image strategy by considering the uses of corporate reputation will
be investigated through answers to a research question.
Efforts have been made to investigate the strategic use of brand image by reviewing the
works of the following scholars: Park et al. (1986), Debevec and Iyer (1986), Swartz
(1983), Roth (1992) and Roth (1995). Consumer needs represent an important factor
influencing the selection of a particular brand concept. Brand image strategy is first
proposed by Park et al. (1986) in brand concept management (BCM), which is derived
from segmenting and positioning in marketing strategies. In practice, it is a genuine
response for a firm to differentiate its products in order to respond to differing consumer
needs (Samuelson, 1976). Thereafter, companies apply different brand image strategies
(in terms of segmentation and positioning) to satisfy and fulfil the various needs of their
consumers (Ries and Trout, 1969; Park et al., 1986; Trout and Rivkin, 1996; Nandan,
2005; Kotler, 2006). For instance, segmentation is achieved by advertising, which is the
most influential way to position a brand in a marketing campaign (Galbraith, 1967).
When considering a well-structured and long-term marketing process plan as stated
above, we sense that the brand image is constructed based on consumer needs,
perceptions and its relationships with the producing company (Keller, 1993; 2000; Roth,
1995).
According to earlier literature, brand image can be examined through investigating three
types of needs that it satisfies: functional needs, symbolic needs and experiential needs
(Park et al., 1986; Bhat and Reddy, 1998; Roth, 1995). First of all, “functional needs”
are defined as those that motivate the search for products intended to solve
consumption-related problems (e.g. solve a current problem, prevent a potential
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problem, resolve conflict and restructure a frustrating situation; see Fennell, 1978). A
brand with a functional concept is defined as one designed to satisfy externally
generated consumption needs. Second, “symbolic needs” are defined as desires for
products that fulfil internally generated needs for self-enhancement, role position, group
membership or ego-identification.

Finally, the most complex type is “experiential

needs”. It is complex because experiential needs should not neglect the first two types
but integrate the feelings of the customer towards to the company. According to the
literature, experiential needs are defined as desires for products that provide sensory
pleasure, variety and/or cognitive stimulation. Work on variety seeking (McAlister and
Pessemier 1982), consumer aesthetics and experiential consumption (Holbrook and
Hirschman, 1982; Holbrook et al., 1984) illustrate the importance of experiential needs
in consumption.

A brand with an experiential concept is designed to fulfil these

internally generated needs for stimulation and/or variety.

2.4

Brand

image

strategy:

segmentation,

differentiation

and

positioning
A firm’s reputation not only enhances the value of corporate image (Fombrun, 1996)
but also has an effect on the brand advertising (Goldberg and Hartwick, 1990). This
issue is especially important in the generic product market because the threat of the
brand name becoming used in a generic fashion is always present, and so a company
must take steps to try to avoid this happening. These decisions or strategies involve
identifying the problem and then determining what action should be taken by the
company (Low and Blois, 2002). Moreover, Low and Blois (2002) argue that the issue
of branding in industrial markets has received little attention relative to that accorded to
it in consumer markets. On the other hand, Berry et al. (1988) suggest that umbrella
branding plays a role at the corporate level. Also, sometimes the company name is
regarded as the brand name, particularly with service firms (Low and Blois, 2002).
However, according to Low and Blois (2002), reaching the appropriate decision
regarding a company’s response to the use of its brand name in a generic manner is
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difficult. Inevitably, there are a number of assumptions and “guesstimates” that have to
be made. Low and Blois (2002, p. 391) argued further:
“[E]ven a large firm, which might have the resources to carry out a
thorough assessment of the costs associated with each policy and the
likelihood of their being successful, will still have to reach a decision
on the basis of a high degree of uncertainty. For a small firm with
limited resources, the decision will necessarily be based almost
entirely on managerial judgement for the cost of even the simple
market survey may be too great for it to be undertaken.”
Therefore, in the consumer markets, on either the product or brand level, the author
assumes the branding strategy is related to the corporate strategy or corporate decisions.
Based on the arguments above, the management of corporate reputation not only
regenerates a brand (Gotsi and Wilson, 2001), a firm’s reputation also has an impact on
its brand image indirectly (Biel, 1993; Christensen and Askegaard, 2001).
It is commonly agreed by both academic scholars and practitioners that a brand image
(the perception by customers) becomes strongly related to a brand’s segmentation and
positioning strategy while the initial brand concept is being formed (e.g. Leisen, 2001;
Haley, 1968; Shank and Langmeyer, 1994; Hsieh, 2002). Therefore, a firm’s brand
manager creates brand strategies targeting their products to a particular group of
customers, but needing to effectively operate for each of the firm’s business units.
For example, Anderson and Jolson (1980) showed that the wording in advertising
influences product-market segmentation.

Thus, it is important to understand the

strategy orientation when a brand makes a coherent advertising decision to match the
corporate strategy. Moreover, as Dawar and Parker (1994) suggested, marketers use
retailer reputation to signal product quality. Different quality level perceived by
consumers from the degree of signal use should differ significantly in segmentating a
product across countries. Therefore, marketers should determine whether to segment or
adapt the marketing mix depending on the specific culture.
Although corporate reputation can enhance a firm’s brand segmentation strategy, Brown
et al. (1989) noted that for marketing effectiveness, firms should develop strategies for
markets, not products. Brown et al. suggested that market selection comes first, even
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when a product geared for that market already exists, and that reputation is one of the
factors that firms can use to distinguish the different market segments.
Similarly, in service firms, Walsh et al. (2006) noted that when determining which and
how many segments to target, firms should focus on only one group—namely
customers—and attempt to use their corporate reputation to distinguish the markets
further. Walsh et al. conducted a hierarchical cluster analysis with a sample of more
than 500 consumers and discovered three groups of consumers that have specific
reputation-related attitudes towards the firms they rated. These attitudes include
‘reputation admirers’, ‘reputation ambivalents’ and ‘reputation criticals’, which firms
can use to tailor their segment-specific marketing mixes.
Moreover, the brand has a strong relationship with its product. From the beginning,
when the brand concept is proposed, there is a never-ending discussion regarding a
brand and the product (e.g. Gardner and Levy, 1955). A consistent product quality
perceived by the customer can strongly affect a firm’s reputation. Therefore, product
quality has been seen as an important factor by previous scholars (e.g. Steenkamp, 1989)
that have a huge impact on the perception of consumers. In discussing the relationship
between perceived quality and brand image, Zeithaml (1988) argues that “extrinsic cues
are product related, but not part of the physical product itself. By definition, they are
external to the product, and changing them does not change the physical product. Price,
brand name, level of advertising, and warranty are examples of extrinsic cues to quality”
(p.6). However, when the extrinsic cues of a product are changed, the physical product
is not changed (Kirmani and Zeithaml, 1993).
On the other hand, Kirmani and Zeithaml (1993) cite the effects of concrete attributes
on perceived quality. Also Aaker and Biel (1993) assert that brand image includes
perceptions of quality, value and attitude, as well as brand associations and feelings. It
is more multidimensional than perceived quality and, consequently, has a higher level
of abstraction. A large amount of literature regarding the impact of intrinsic and
extrinsic cues on perceived quality exists. According to Kirmani and Zeithaml (1993),
the perceived quality is formed by advertising. The advertising, on a concrete level and
a lower level, is categorized by the customer’s different perceptual level of abstractions.
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Midlevel perceptual abstractions are defined as covering such things as style and
performance.

The increasing level of abstraction is consistent with other

conceptualizations of a product’s attributes (e.g. Olson and Reynolds, 1983; Geistfeld et
al., 1997) known as “means–end chains”. Kirmani and Zeithaml (1993, p. 147) say that
“the intrinsic cues refer to concrete, physical properties of the product (i.e. lower level
specific brand beliefs). These intrinsic attributes cannot be changed without altering the
nature of the product itself and are consumed as the product is consumed (Olson and
Jacoby, 1972; Olson, 1977; 1978)”.
However, in Kirmani and Zeithaml’s (1993) study, there are inter-reactions within the
three constructs of advertising, perceived quality and brand image. The extrinsic cues in
Kirmani and Zeithaml’s (1993) categorization of the perceived quality belong to a
firm’s branding strategy decisions. This is strongly related to the brand manager’s
decisions regarding a corporate product and the brand image they want to build.
Therefore, The statement above suggests that a firm’s corporate reputation also belongs
to a product’s abstraction attributes, and the reputation of a firm is related to a firm’s
brand image.
A product’s intrinsic and extrinsic cues also have some impact on price and the target
groups. It is difficult for the branding team to directly convey a product’s quality to
potential customers, but sometimes setting a high price can convey this. This is because
concrete intrinsic attributes differ widely across products, as do the attributes consumers
use to infer quality. Pincus and Waters (1975) verified intrinsic cues as well as the price
of ballpoint pens and found that intrinsic cues accounted for most of the variance in
product quality ratings. Kirmani and Zeithaml (1993) investigated the different product
attributes and their advertisement effects on a product’s image perception. For example,
the attributes that signal quality in fruit juice (colour, presence of pulp) are the concrete
attributes, indicating that higher-level abstract dimensions of quality can be generalised
to categories of products (Zeithaml, 1988).
On the other hand, Garvin (1987) proposed that product quality can be captured in eight
dimensions: performance, features, reliability, conformance, durability, serviceability,
aesthetics, and perceived quality (i.e. image).
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consumers compare non-comparable alternatives. Johnson (1984) posited that
consumers represent the attributes in memory at abstract levels. Similarly, Olson (1978)
discussed “descriptive beliefs”, which involve a restatement of the original information
into more abstract terms (e.g. “accelerates from 0 to 60 mph in 5 seconds” generates the
belief “high performance”).

Olson (1978) suggested that consumers may use

informational cues (e.g. intrinsic and extrinsic cues) to develop descriptive beliefs about
products. These beliefs, in turn, could affect evaluation and choice.
Parasuraman et al. (1985) found consistent dimensions of perceived quality across
seven service industries. These dimensions include: (a) reliability, (b) responsiveness,
(c) assurance, (d) empathy and (e) tangibles. This study tried to measure dimensions of
quality. However, in another study, Brucks and Zeithaml (1991) contend on the basis of
exploratory research that six abstract dimensions could be generalised across categories
of durable goods: (a) ease of use, (b) functionality, (c) performance, (d) durability, (d)
serviceability and (f) prestige. For instance, in the product category of beer, Jacoby et al.
(1971) found that both brand name and actual composition characteristics were more
important determinants of product quality perceptions than price.
On the other hand, these abstract dimensions of quality also indicated the price that can
be requested from consumers. Price was important in judging the style dimension. For
example, Valenzie and Andrews (1971) found that actual tasting of margarine samples
had a stronger influence on taste perceptions (a quality dimension) than the price. Etgar
and Malhotra (1981) varied both intrinsic (sole, colour, upper) and extrinsic (place of
purchase, price) attributes of running shoes and revealed that both types of cues were
important in determining product quality. Respondents in these studies used different
extrinsic and intrinsic cues for different dimensions of quality (e.g. comfort, durability
and style).
Extrinsic cues other than price also affect quality perceptions. As mentioned earlier,
brand name, product warranties (Bearden and Shimp, 1982; Boulding and Kirmani,
1991) and advertising costs (Kirmani and Wright, 1989; Kirmani, 1990) have also been
considered and documented as a signal of quality. For example, a brand name can
represent a cluster of intrinsic attributes. However, intrinsic and extrinsic attributes can
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affect each other. Intrinsic cues (such as size of a stereo speaker) can lead to an
inference about price (an extrinsic attribute) of the speakers. Conversely, the price of a
product can lead the consumer to a lower level belief about the concrete aspects of the
product. A £5 price for a candy bar, for instance, would likely signal ‘large size’.
Extrinsic cues can affect each other as well. For instance, advertisement expenditures
can affect the perceived price of the product (Kirmani, 1990), and a high warranty on a
product is likely to lead to the inference that the product carries a high price, despite the
importance of extrinsic cues in forming quality cue. However, when advertisement
content was informative (i.e. comfort or durability of an athletic shoe), subjects relied
on advertising expenditures as a quality cue.

However, when ad content was

informative (i.e. showed a photo of a shoe) about a quality dimension (style), subjects
did not rely on advertising expenditures as a quality cue. Boulding and Kirmani (1991)
found that an extrinsic cue in an ad (i.e. information about product warranty) affected
durability perceptions although the advertisement was informative about intrinsic
product cues.
Several studies have linked the notion of differentiation to a firm’s corporate reputation.
Ghose et al. (2006) suggested that several dimensions of reputation, including problem
response, customer service, packaging, delivery and product-specific comments, present
the principle points that customers look for when buying from a given seller. These
dimensions not only provide a basis on which a seller can improve but also help the
seller differentiate itself from the competition.
In addition, according to Brammer and Pavelin (2006), corporate reputation can be
augmented by activities that also are closely related to the vertical differentiation of
products, such as technological advancement and the cultivation of a strong brand
image. However, a good corporate reputation can also help differentiate the brand (Fan,
2005). Aitchison’s (1999) Emotional Selling Proposition provides brand advertisers
with a powerful tool to manipulate consumers’ emotions to achieve brand
differentiation. According to traditional knowledge, the crucial goal of branding is to
situate a favourable position in the minds of consumers, one that is distinct from
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competitors (Ries and Trout, 1982). This target can easily be achieved when a firm
builds its own reputation.
Furthermore, Gotsi and Wilson (2001) argued that organisations are increasingly
recognising customers as their most important assets for building a favourable corporate
reputation. Through respondent interviews of the importance of employees in corporate
reputation management, Gotsi and Wilson emphasised that employees, as one factor to
enhance a firm’s corporate reputation, can help differentiate an organisation from its
rivals because consumers evaluate the corporate reputation behind the brand and
products presented to them.

2.5 The development and conceptualization of the research problem
and gap
The review of theoretical literature (above) has led to the development of an analytical
framework which presents a cohesive insight into the uses of corporate reputation.
Importantly, the review of works from a variety of perspectives (i.e. public relations,
marketing, management, economic, sociological, finance and accounting), together with
the development of the eleven syntheses (see Table 2.2,) indicate that work on corporate
reputation has focused principally on a number of issues. These include the use of
corporate reputation and corporate social and financial performance (Sobol and Farrell,
1988; McGuire et al., 1990; Herremans et al., 1993; Fombrun, 1996; Deephouse, 1997;
Brown, 1997; Roberts and Dowling, 1997; Roberts; Caruana, 1997; Srivastava et al.,
1997; Kotha et al., 2001; and Dowling, 2002; Sabate and Puente, 2003) and the use of
corporate reputation and its relationship with company value and asset (Barney, 1986;
Dierickx and Cool, 1989; Fombrun and Shanley, 1990; Gregory, 1991; Marconi, 1991;
Smith, 1994; Fortune, 1995; Okano et al., 1999; Shkolnikov et al., 2004; Moerman and
Laan, 2006). Others include the use of corporate reputation and competitive advantage
(Worcester, 1986; Fombrun and Shanley, 1990; Maathuis, 1993; Greyser, 1996;
Fombrun and van Riel, 2004), the use of corporate strategy (Cornell and Shapiro, 1987;
Weigelt and Camerer, 1988) and the use of corporate reputation and communication
(Lerbinger, 1965; Grunig et al., 1992). There are also a number of works that mention
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the use of corporate reputation in customer purchase decision-making (Chibnall, 1977;
Hall et al., 1978; McNair, 1996; Fombrun and Shanley, 1990; Landon and Smith, 1997;
Sabate and Puente, 2003; L’Etang, 2006).
However, it appears that there is limited work highlighting the relationship between the
uses of corporate reputation on the one hand and the development of brand image
strategy and corporate reputation on the other. In fact, some of the works of Okano et
al., 1999; Michell et al., 2001; Davies and Chun, 2002) that have attempted to address
the relationship between these constructs appear to have done so without any sound
empirical evidence explicating the relationship between these constructs.
This problem, which has been developed from the review of conceptual literature, will
be the core focus of this thesis. Based on this assertion therefore, the question that will
be addressed throughout this thesis shall be: how do (Taiwanese pharmaceutical)
companies use their corporate reputations to develop their brand segmentation and
positioning strategy? This question, which is constructed as the key focus of this study,
will be addressed conceptually in chapter three.

2.6 Summary
This chapter reviewed existing literature as it concerns the uses of corporate reputation.
In addressing the course of this objective, an outline (see public relations, marketing,
management, economic, sociological, finance and accounting) highlighting the various
perspectives on the uses of corporate reputation was developed. Thus a framework of
synthesis, highlighting eleven overlaps or integrants running through the public
relations, marketing, management, economic, sociological, finance and accounting
perspectives on the uses of corporate reputation was developed.
Moreover, previous studies regarding the corporate reputation and the brand are
reviewed. Links between a firm’s reputation and its brand strategy are revealed from
previous studies. Consequently, the review of these theoretical perspectives encouraged
the development and conceptualisation of a research problem highlighting the gap in
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literature together with the research question (RQ) of this study: how do (Taiwanese
pharmaceutical) companies use their corporate reputation to develop brand image
strategy? The development of this question sets the scene for this research.
The next stage of this study will be to examine how the question stated above can be
answered conceptually and empirically in the following chapters. Consequently, the
objective of the next chapter will be to (in a broader sense) develop a conceptual
framework that attempts to offer an answer or answers to the theoretical question being
investigated in this study.
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CHAPTER THREE: CONCEPTUAL FRAMEWORK
AND THE DEVELOPMENT OF HYPOTHESES

3.1 Introduction
The previous chapters reviewed existing works on the uses of corporate reputation from
six different perspectives (i.e. public relations,-marketing, management, economic,
sociological, finance and accounting) under which the use of corporate reputation has
been conceptualised. Although there were differences between the disciplines, three
main uses emerged: value creation, strategic resources and corporate communication.
The literature review also identified a research gap by showing that there has been little
research about how these three main functions (value creation, strategic resources and
corporate communication) impact on a company’s brand positioning strategy.
Therefore, the research question (RQ) is: how do (Taiwanese pharmaceutical)
companies use their corporate reputation to develop a brand image strategy?
The aim of this chapter is to explain the research hypothesis.

First, the research

question will be constructed theoretically, and then a conceptual model, which begins
with three antecedents for the uses of corporate reputation and illustrates simultaneously
the outcomes of the uses of corporate reputation, will be created.
Here the main construct is the uses of corporate reputation. This construct has three
dimensions: value creation, strategic resources and corporate communication. Each of
these three dimensions includes several items. First, the uses of corporate reputation as
a value-creation tool include promising good quality products and service to customers,
reducing transaction costs and sending signals to its customers. Second, the uses of a
firm’s corporate reputation as a strategic resource include use as a competitive
advantage, as a strategic value or resource and developing good financial performance.
Third, the uses of corporate reputation as a communication tool include shaping the
perception of shareholders and stakeholders, influencing consumer choices and building
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a relationship between the firm and its customers. The following section will depict the
proposed research conceptual framework and a number of hypotheses that will be
further investigated and tested.

3.2 Research framework and hypotheses development
In order to guide this study, the key constructs need to be explained. Based on the
conclusion of the reviewed literature and research question, three antecedents (see Table
3.1) pertaining to value creation, influencing competitor’s actions and a development
the relationship with its stakeholders are hypothesised to be related to brand image
strategy. Brand image strategy in the research model is utilised as an output of the uses
of corporate reputation.
Table 3.1: Twelve antecedents pertaining to three dimensions of the uses
of corporate reputation
Value creation:

creating value
promising good quality products and service to customers
reduce transaction costs
is used as a signal to customers

Strategic resources:

influencing competitor’s actions/strategies
using as a competitive advantage
is used as a strategic value or resource
develop good financial performance

Communication:

developing the relationship with its stakeholders
shaping the perception of shareholders and stakeholders
influence consumer choices
build a relationship between the firm and the customers

Source: Summarized by the author
In this research a framework (Figure 3.1.), which is based primarily on the three
syntheses of the uses of corporate reputation, is examined. As described in the literature
review, this framework has been developed by summarizing and synthesising the works
of a number of scholars (such as Fombrun and Shanley, 1990; Sabate and Puente, 2003;
Shkolnikov et al., 2004; L’Etang, 2006) who have previously studied the uses of
corporate reputation. The various uses of corporate reputation identified by the scholars
(shown in Figure 3.1) were grouped into three categories. This synthesis of the uses of
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corporate reputation has been chosen because its importance is supported by
contemporary theoretical developments. In the following chapter, explanations of the
relationship between the constructs will be presented.
Figure 3.1: Research conceptual framework

Resource: Developed by the author

3.3 The uses of corporate reputation
The aim of this research is to find out the uses of corporate reputation in the strategic
branding decision.

This section explains the dimensions of the uses of corporate

reputation separately.
From the review of the literature, three dimensions of the uses of corporate reputation
may be summarised as value creation, strategic resources and corporate communication.
These dimensions of corporate reputation will help the firm to develop its brand strategy
dimensions. These dimensions will be discussed in the following section.

3.4 Consequences of the uses of corporate reputation
From the review of literature, scholars belonging to the marketing perspective declared
that a good corporate reputation generates good returns on a firm’s investment over time
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(Fombrun, 1996; Caruana, 1997) and affects corporate performance (Srivastava et al.,
1997).

Caruana (1997) suggested that the concept of corporate reputation and

improving its measurement have had beneficial consequences for firms. It has also been
noticed that it has positive impacts on factors such as a customer’s purchase intentions
(Yoon et al., 1993), the attitude of buyers to salespersons and products (Brown, 1995)
and the perceived quality of products and services (Rao, 1994).
An important study regarding the implications of corporate reputation was carried out
by Caruana (1997); a summary of the studies on the consequences of corporate
reputation is presented in Table 3.2.

Table 3.2: Consequences of corporate reputation
Consequence of corporate reputation

Author

intention to purchase a service

Yoon et al., 1993

the attitude of buyers to salespersons and
products

Brown, 1995

the perceived quality and deterring
competitor entry when a tough stance is
adopted

Weigelt and Camerer, 1988

contributing to performance differences
between firms

Rao, 1994

attracting investors, lowering cost of capital
and enhancing competitive ability of firms

Fombrum and Shanley,
1990

financial performance

Hall , 1993; Eberl and
Schwaiger, 2005

enabling strong organisation identification
by employees and “inter-organisational
cooperation or citizenship” behaviour

Dutton et al., 1994

Source: Template provided by Caruana (1997), developed by the
author.
Corporate reputation can help to deter competitors from entering markets (Weigelt and
Camerer, 1988) and contribute to performance differences between firms (Rao, 1994).
Therefore, increased understanding of corporate reputation helps to attract investors,
lower the cost of capital and enhance the competitive performance of firms (Fombrum
and Shanley, 1990). The reasons above imply that a firm’s reputation can help to
improve the level of organisational identification of employees with a firm and enhance
‘inter-organisational cooperation or citizenship behaviour’ (Dutton et al., 1994).
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According to Table 3.2, a firm’s financial performance is affected by corporate
reputation (Caruana, 1997). Several accounting scholars also affirm that a firm’s
corporate reputation enables firms to profit from a variety of benefits (Herremans et al.,
1993). Scholars within the economic perspective observed that a firm’s corporate
reputation has an impact on financial performance (Sobol and Farrell, 1988; Sabate and
Puente, 2003). Sharing similar thoughts, some management scholars indicate that a
good corporate reputation is used by firms to enhance corporate performance
(Deephouse, 1997; Brown, 1997; Roberts and Dowling, 1997) as well as financial
performance (McGuire et al., 1990; Kotha et al., 2001; Roberts and Dowling, 2002).
For example, concerned with elucidating the effect of corporate reputation on financial
performance, Eberl and Schwaiger (2005) concluded that two kinds of phenomena—
cognitive and affective—constitute corporate reputation. On this basis, they argued that
corporate reputation is an attitudinal construct that exists and operates in the minds of
the general public. Thus, they argue that it is vital for reputation management to focus
on communication with the relevant stakeholder groups rather than those internal to the
company.

In other words, although external agents view financially successful

companies favourably, they also tend to be risk averse. That is, companies with a good
reputation gain more trust from the external agents or their direct customers, thus
leading to more business or better performance.
Based on the efforts of previous scholars on the uses of corporate reputation in different
perspectives, good uses of a firm’s corporate reputation will certainly lead to a good
financial performance. This proven causal relationship shows the huge impact of a
corporate reputation on a firm’s brand image strategy, which can also be seen as an
outcome of building a good corporate reputation.

3.4.1 The uses of corporate reputation and brand image strategy
As discussed in chapter 2, there is a strong causal relationship between a firm’s image
and its brand image. Much literature has been concerned with investigating whether
corporate reputation has an inevitable impact on brand image because it can influence
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the perception of customers. Therefore, in this section, we are going to investigate the
impact of not corporate reputation on brand image strategy-setting among brand
manager decision makers. The relationship between corporate reputation and a firm’s
brand image has not been comprehensively defined in previous literature. Nevertheless,
when considering the three dimensions of the uses of corporate reputation mentioned
above, brand managers’ views will be important in brand image strategy decisions. In
this section, the brand image strategy-setting (when brand managers lay out their
strategies) will be investigated in connection with the uses of corporate reputation.
Based on the previous conceptualization of the use of corporate reputation, the more
significant three schools of thought emerged involving these uses of corporate
reputation: value creation, strategic resources and corporate communication. Following
the argument of brand image strategy above, it is important to discuss how the three
dimensions of the uses of corporate reputation have an impact on brand managers’
strategy-setting. The next section, will review earlier literature examining the
relationship uses between each use of corporate reputation and the setting of brand
image strategy by brand managers.

3.4.1.1 Value creation: value creation and brand image strategy
The value provided by a firm to a customer is always judged during the customer
purchasing process. Therefore, the value creation ability of a firm is deeply related to
the its relationship with its customers and influences the perception of its customers. In
essence, the resource-based theory (Grant, 1991; Peteraf, 1993; Barney and Zajac, 1994;
Conner and Prahalad, 1996) provides a general way for a firm to find its core value.
The resource-based theory suggested that a firm tries to achieve superior returns by
exploiting internal resources and capabilities. Corporate reputation is commonly used
by a firm as a strategic resource (Roberts and Dowling, 2002) or as a tool for the
development of organisational value (Smith, 1994). Since corporate reputation cannot
be and bought and is not easy to imitate or substitute, it is therefore regarded as an asset
of a firm (Dierickx and Cool, 1989; Barney, 1986).
In finance and accounting disciplines, for stakeholders, corporate reputation is presented
and seen as a corporate valuable (Okano et al., 1999; Moerman and Laan, 2006) or used
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as an intangible asset that can create value in the future (Dierickx and Cool, 1989; DTI,
2001; Dolphin, 2004; Shkolnikov et al., 2004). Therefore, it is used to increase the
value of returns to shareholders (Rose and Thomsen, 2004) and to have a positive
influence on firm value (Fombrun and Shanley, 1990; Gregory, 1991; Marconi, 1991;
Fortune, 1995).
In addition, according to some other researchers (e.g. Herbig et al., 1994; Devine and
Halpern, 2001), corporate reputation is used as a tool for promising good quality
products and service to customers in marketing. A firm’s corporate reputation is used
as a promise for good brand quality and good service levels (Devine and Halpern, 2001)
since positive reputational signals about the quality of a company’s products or services
can enhance credibility (Herbig et al., 1994). Therefore, it is agreed by economic
scholars that a good corporate reputation encourages a firm to produce top-quality
products and services (Nelson, 1970; de Angelo, 1981; Wilson, 1983; Rogerson, 1983;
Dranove, 1983; Eichenseher and Shields, 1985; Milgrom and Roberts, 1986; Beatty and
Ritter, 1986).
Marketing scholars argued that a strong corporate reputation enhances the generation of
transaction costs (Caruana et al., 2004). In the same vein, Shapiro (1983) and Eberl and
Schwaiger (2005) also agreed that corporate reputation reduces transaction costs
together with beneficial financial and non-financial outcomes.
A review of the value-based theory will be conducted in order to better understand the
intentions and mind-interaction in consumers when they are trying to evaluate the
benefits that can be derived from the brand or the product. Moreover, and consequently,
by reviewing a customer value-based theory of the firm, it is easier for researchers to
understand a firm’s marketing strategy (Slater, 1997). Such a focus is understandable
for marketing strategy nowadays because market forces predominantly drive strategic
decision-making (Cravens, 1998).
Schwartz and Bilsky (1987) claim that values are cognitive representations of universal
human requirements: biological needs, social interactional requirements and social
institutional demands on the individual. Subsequently, some scholars – Parasuraman
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(1997) and Woodruff (1997) – proposed that a thorough understanding is needed to
clarify the complexities of customer value perceptions, the processes for customer value
monitoring and the processes for leveraging the firm knowledge. These help to validate
the strategy the managers follow by creating, developing, and delivering value to the
customers (Piercy, 1998; Flint, 2004).
Following from the above, human values have been increasingly used as a basis for
market segmentation (Kamakura and Novak, 1992). Similarly, Flint (2004) also argues
that customer valued-based strategy resides in segmentation, branding, positioning,
integrated marketing communication, professional selling, advertising, pricing, product
development, and distribution/logistics strategies.
From the arguments above, the value system has been used by marketers to explain
phenomena such as consumer behaviour (Henry, 1976; Vinson and Munson, 1976; Pitts
and Woodside, 1983) as well as strategic marketing (Flint, 2004). As has been stressed,
that creating a value-based strategy relating to customers gains a reputation for a firm,
we confirmed that a firm with a good corporate reputation as an intangible asset can
also benefit the firm by reducing transaction costs, indirectly creating a value for the
firm.
Given the focus of this study on the relationship between value creation and branding
strategy, it is also proposed that:
H1: Value creation as a dimension of the uses of corporate reputation
has a positive impact on a firm’s brand segmentation strategy.

H2: Value creation as a dimension of the uses of corporate reputation
has a positive impact on a firm’s brand differentiation strategy.

H3: Value creation as a dimension of the uses of corporate reputation
has a positive impact on a firm’s brand positioning strategy.
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3.4.1.2 Strategic resource: influencing a competitor’s actions/strategies and brand
image strategy
Strong financial performance generally signals an effective corporate strategy. It helps
a firm to establish or maintain a good reputation (Roberts and Dowling, 2002; Sabate
and Puente, 2003). This confirms the notion that corporate reputation is an undervalued
strategic asset (Smythe et al., 1992) because it gives the stakeholders an idea about a
firm’s financial stability background and shows which direction the firm is heading to.
In comparison with other more tangible assets, it is rarely the subject of investment
(Weigelt and Camerer, 1988).
In sociology, corporate reputation is commonly used as a defence strategy to ward off
competitors (Cornell and Shapiro, 1987). Thus, it is argued in economics that corporate
reputation is found to be a strategic resource (Weigelt and Camerer, 1988). In addition,
Roberts and Dowling (2002) contended from a management perspective that corporate
reputation, as used among business organisations, has a strategic value. These
arguments above are based on the fact that corporate reputation is not easy to build nor
easy to replicate (Barney, 1986; Dierickx and Cool, 1989). It takes some time for new
entrants to a competitive market to develop a reputation that is comparable with those
competing in the market before it (Hall, 1993).
Therefore, corporate reputation may well result in gaining a competitive advantage for
an organisation. According to the literature, it is commonly agreed within marketing,
accounting, economics and management scholars that firms deploy strategies by using
their corporate reputation to effectively differentiate them from competitors (Stigler,
1962; Caves and Porter, 1977; Klein and Leffler, 1981; Wilson, 1985; Beatty and Ritter,
1986; Milgrom and Roberts, 1986; Hall, 1992; Day, 1994; McMillan and Joshi, 1997)
and to create a distinctive position in the mind of stakeholders (Fombrun and van Riel,
2004) in order to attain competitive advantage (Worcester, 1986; Fombrun and Shanley,
1990; Maathuis, 1993; Greyser, 1996).
Corporate reputation is seen by economic and management scholars (Kreps and Wilson,
1982; Shapiro, 1989) and as a signal-laden phenomenon that can be used to forecast the
potential behaviour of a firm and also by management scholars (Waddock, 2000).
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In Milewicz and Herbig’s (1994) study, they evaluated brand extension by building a
brand extension reputation model. The model represents consumer cognitive processes,
showing that corporate reputation is commonly used to highlight and signify (Herbig
and Milewicz, 1993) a firm’s beliefs, attitudes and intentions to market participants and
that is often deployed by marketers as a useful signal that gives stakeholders the needed
insight into the future of a firm (Fombrun, 2002).
For example, for banks and other financial institutions, the expression of corporate
reputation is used as a signal that enables key resource providers to interpret a
company’s initiatives and assess its ability to deliver value outcomes from the firm’s
past actions. Therefore, in management studies, corporate reputation is used on many
occasions to signify an organisation’s perceived capacity to meet their stakeholders’
expectations (Waddock, 2000).
In this part, we start to review the resource-based view (RBV) of a firm. This view has
been extensively summarised in contemporary strategy literature (Wernerfelt, 1984,
1995; Grant, 2010; Mahoney, 1995).
A definition and classification scheme of resources has been suggested. Barney (1991)
defined resources as a bundle of assets, capabilities, organisational processes, firm
attributes, information and knowledge. These resources can be broadly categorized as
tangible and intangible and consist of financial, physical, legal, human, organisational,
relational, technological and informational assets, skills and competencies.
Resource-based scholars suggested that certain assets (tangible or intangible) with
certain characteristics will lead to sustainable competitive advantage (Hooley et al.,
1998). Resource-based theorists suggest that for a strategy to be sustainable it needs to
be embedded in the firm’s resources and capabilities. For example, Grant (2010) argues
that as rates of change in the external environment increase firms have to increasingly
base their long term strategies on internal resources and capabilities rather than focus on
external market forces. Several years later, it was also proposed by Varadarajan and
Jayachandran (1999) that organisational issues (e.g. corporate reputation) are relevant to
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marketing strategy such as branding, competitive behaviour, positioning, and
segmentation, and have an impact on quality management, marketing and business
strategy (e.g. market orientation), and outcomes of marketing strategy (e.g. market share,
customer satisfaction).

Based on the above statements, we suggest that corporate

reputation can be used as a strategic resource that helps to make a brand image strategy.
As mentioned earlier, the terms “capabilities” and “competencies” are used
interchangeably as in most of the strategy literature (e.g. Prahalad and Hamel, 1990;
Day, 1994; Hooley et al., 1998). Hooley et al. (1998), (see Figure 3.2 ) proposes a
typology of resources, briefly explained below, focusing on marketing assets and
capabilities and relating these to competitive positioning alternatives. Two aspects of a
firm’s resources are presented: “organisational assets” and “company capabilities”.
According to Hooley et al. (1998), a basic distinction has been made between assets and
capabilities (Penrose, 1959; Mahoney, 1995; Kamoche, 1996). “This distinction was
perhaps most clearly articulated by Day (1994), who suggested that assets are the
resource endowments the business has accumulated (e.g. investments in scale, plant,
location and brand equity) while capabilities are the glue that binds these assets together
and enables them to be deployed advantageously. The latter are complex bundles of
skills and collective learning, exercised through organisational processes, which ensure
superior coordination of functional activities. In what follows we take resources to
contain both assets and capabilities”.
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Figure 3.2: Typology of organisation resources
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Therefore, from the review of the previous studies – which establishedthat the
resource-based theory (and market orientation) – corporate reputation has been
regarded by many researchers as a strategic resource for a firm (Wernerfelt, 1984),
which explains the rent- earning capability of resources (see Amit and Schoemaker,
1993). This dynamic capabilities approach examines how resources and capabilities
are developed in a firm context (Mahoney, 1995) and will also be developed into a
competitive positioning strategy (Hooley et al., 1998). Hooley et al. (1998) reconcile
the market orientation and resource-based view by developing a positioning strategy
concept.

As stated above (see Hooley et al., 1998), two main approaches to resources have
developed.

However, previous researchers investigated the strength of corporate

reputation used as a strategic resource of a firm. In this research, however, we propose
to view simply corporate reputation as one of the intangible assets.

Given the focus of the study on the relationship between the strategic resource role of
corporate reputation and brand image strategy, it is also proposed that:

H4: Strategic resource as a dimension of the corporate reputation has
a positive impact on a firm’s brand segmentation strategy.

H5: Strategic resource as a dimension of the corporate reputation has
a positive impact on a firm’s brand differentiation strategy.

H6: Strategic resource as a dimension of the corporate reputation has
a positive impact on a firm’s brand positioning strategy.
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3.4.1.3 Corporate communication: developing the relationship with its
stakeholders and brand image strategy
Corporate communication is regarded by researchers as a very important tool, directly
influencing consumer perception and creating competitive advantage for a company
(Gray and Balmer, 1998).

In an analysis of corporate communication, recognition

must be given to the idea that the information related to corporate reputation is used to
communicate a firm’s social responsibility activities to stakeholders within the
business environment (Lerbinger, 1965; Grunig et al., 1992). For instance, although a
medicine brand may have excellent medical performance; the manufacturer may use
other forms of its firm’s reputation to transmit a different image to their brands. For
example, a representation of an experience with this pharmaceutical corporation is
‘safe’ or trustable (e.g. “It was very reliable and could be trusted when I prescribed
the medicine to my patient)”.

The underlying reputation dimensions correspond to a strategic resource, which is
used to integrate the mass communication and being used under the resource-based
environment (Deephouse, 2000). Also, the corporate reputation can be positioned to
the specific target group that enhances the generation of better feedback from
stakeholders within the business environment (Stanwick and Stanwick, 1998).

According to an analogous school of thought (Fombrun and Shanley, 1990;
Shkolnikov et al., 2004), corporate reputation is developed on the basis of consumer
perception. Therefore, marketers portray corporate reputation as a benefit for the
customers because when they feel more secure about a firm’s ability they will buy
more.
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Moreover, a firm’s reputation can influence customer choice. Fombrun and Shanley
(1990) argued that corporate reputation serves as a value signal that enables customers
to gauge the merits of a product or service, especially in situations where customers
are overloaded with information or in cases where there is inadequate information
about a product. Similarly, Srivoravilai (2006) observe that a corporate reputation
helps customers to select the best choice among many alternatives in the market.
Landon and Smith (1997) and Sabate and Puente (2003) also confirmed that corporate
reputation is used by consumers to make purchasing decisions. Corroborating this
point of view, it is suggested by Shkolnikov et al. (2004) that a good corporate
reputation enables the generation of increased customer loyalty.

The review of literature in public relations indicated that corporate reputation is
devised to protect firms from excessive interpretation by stakeholders (Chibnall,
1977; Hall et al., 1978; McNair, 1996; L’Etang, 2006).

Furthermore, a company’s corporate reputation builds a relationship between the firm
and its customers. Firms are keen to employ their corporate reputation to enhance the
development of a sound relationship with their customers (see Perrow, 1961a; Perrow,
1961b; Shrum and Wuthnow, 1988).

This is based on the fact that corporate

reputation is frequently used as a signal contributing towards a thorough
understanding of not just consumers but, more importantly, the key competitors of the
firm (Kreps and Wilson, 1982; Milgrom and Roberts, 1982).

For this reason,

corporate reputation is a device that can be devised to build a relationship between a
company and its stakeholders.
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The last dimension to be considered relates to corporate communication. Earlier
literature also indicated that the relationship between a firm’s communications with
its customers has an impact on brand image strategy-setting.

Some researchers

(Birkigt and Stader, 1986; Gray and Balmer, 1997) have noted that communication
plays an important role in the branding process. Fombrun and Rindova (1998), in their
study on reputation management strategies of leading US/UK companies, concluded
that communication benefits result from the variety of issues about itself that a firm
reveals through its communications. It is also put forward by Fombrun and Rindova
(1998) that communications make a firm transparent, and enabling shareholders to
appreciate the firm’s operations better. This argument suggests that communication
can play a pivotal role in corporate brand management.

Several researchers have suggested that a firm’s communications have a direct impact
on setting the scene for segmenting and positioning a firm’s product, either in direct
marketing (e.g. Peltier and Schribrowsky, 1997) or in service sectors (e.g. Zineldi,
1996). To be more specific, a firm’s use of communication in any form (e.g. package
design, logo design, distribution channel and salesperson) creates a platform to make
their consumers understand more about themselves and their products (or services),
making it easier for brand managers to target their branding strategy to a clearly
defined or segmented market groups.

However, according to communication literature, communication can be categorised
into two streams of thought. Similar to Peltier and Schribrowsky (1997), Nandan
(2005) also indicated that marketing communications and brand management
influences brand image and enhances brand equity (Nandan, 2005). Moreover, Flint
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(2004) asserted that it is also necessary to gain considerable understanding of its
competitors through customer relationships if a firm focuses mostly on its customers.
Then it is easier for a firm to understand their customers’ needs, communicate with
them and set a brand aiming at and focusing on at specific segments in the market
(Dickson and Ginter, 1987).

Another stream of corporate communication thought can be found in consumer
behaviour research.

Scholars belonging to this group argued that marketing

communication (e.g. multi-attribute attitude models, self-image congruence models)
is a function of situational factors such as product utilitarianism and product valuevalue-expressiveness which expressiveness that is employed by managers to set their
positioning strategy (Johar and Sirgy, 1989). Accrding to van Raaij and Verhallen
(1994), a firm differentiates its product to position its brand in a specific market by
using different designs or campaigns to communicate with its customers. Similarly,
Schultz (1998) argued that brands are central to this integrated marketing
communication. Keller (1993) points out that customer-based brand equity emanates
from consumer familiarity and strong, favourable associations with thea brand. Keller
(1993) further argued that marketing communication represents the voice of a brand.
Through marketing communication, companies can establish a dialogue with
consumers concerning their product offerings (1993).

Additionally, Madhavaram et al. (2005) suggested that an effective use of IMC
(Integrated marketing communication) will result in a situation whereby a consumerheld brand image will be congruent with the strategist’s intended brand identity. This
is because that by clearly and consistently communicating the brand identity to other
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brand stewards, the brand strategist can ensure a more synergistic and effective IMC
(for an IMC construct conceptual framework see Figure 3.3).

Therefore, for

practitioners, according to Madhavaram et al., IMC has become an integral part of
brand strategy that requires extensive brand development activities within the firm
before beginning any external brand communications efforts. In addition, Vargo and
Lusch (2004) argued that marketing is evolving toward a dynamic and evolutionary
process based on a service-centred view.

In keeping with this evolution, they

suggested that brand management should be used for initiating and maintaining a
continuing dialogue with the customers.

Figure 3.3: IMC construct conceptual framework
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Based on Madhavaram et al.’s (2005) theory that a firm can use communication to
enhance its brand image strategy, they argued that a when a firm has a clear and
accurate understanding of the brand identity, it is able to develop a better IMC
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programme to communicate their brand identity more clearly and accurately. And
they might finally get feedback from customers, the prospects and the general public
regarding brand awareness and image. Feedback from other entities in the
environment, including competitors, will enable the brand owner to adjust its brand
image strategy, and/or its IMC strategy. Therefore, they suggested that a firm should
put more effort into communicating with to their customers to generate brand-related
market information from the environment.

Discussing communication, the two most common approaches used in marketing
communication to influence consumer choice are categorized as: Brand Image
Strategy (Ogilvy, 1963) and the Unique Selling Proposition (USP) strategy (Reeves,
1961). To summarise those previous researchers’ thinking stated above, Johar and
Sirgy (1989) asserted that the IMC based on brand image strategy – which is
essentially used to position a company’s brand in the market possess a dual nature of
both rational and emotional elements. These elements are based on the use of selfimage congruence models and the use of multi-attribute attitude models in brand
positioning. Image strategy involves the building of a “personality” for the product or
creating an image of the product user (Ogilvy, 1963). USP strategy, on the other hand,
involves informing consumers of one or more key benefits that are perceived to be
highly functional. Both of these theories are developed into a construct of brand
positioning (Johar and Sirgy, 1989; Hooley et al., 2004).

Given the focus of the study on the uses of corporate reputation, and that shaping the
perception of shareholders and stakeholders plays a role of communication in a
company’s branding strategy, it is proposed that:
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H7: Corporate communication as a dimension of corporate reputation
has a positive impact on a firm’s brand segmentation strategy.

H8: Corporate communication as a dimension of corporate reputation
has a positive impact on a firm’s brand differentiation strategy.

H9: Corporate communication as a dimension of corporate reputation
has a positive impact on a firm’s brand positioning strategy.

3.4.2 The application of a firm’s corporate reputation signals to brand image
strategy

From the review of literature on the uses of corporate reputation, although corporate
reputation has not been defined as a business function, a proper definition of this
concept will require a fusion between aspects of human resource management,
marketing, business strategy and corporate communications (Gray and Balmer, 1998;
Hooghiemstra, 2000). In Weigelt and Camerer’s (1988) review of the theory and
applications of the uses of corporate reputation on corporate strategy, they identified a
corporate reputation as a set of attributes ascribed to a firm, inferred from the firm’s
past actions, while strong financial performance generally signals an effective
corporate strategy. Therefore, a corporate reputation helps a brand to create customer
satisfaction, thus resulting in a higher level of financial performance for the firm
(Weigelt and Camerer, 1988). However, on the other way around, some researchers
(Roberts and Dowling, 2002; Sabate and Puente, 2003) suggested that a firm’s good
financial performance helps a firm to establish or maintain a good reputation.
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In order to understand the relationship between corporate reputation and brand image,
it is important to understand the context in which corporate branding operates (Hatch
et al., 1998; Bickerton, 2000). An UOVP (Unique Organization Value Proposition)
model was proposed by Knox and Maklan (1998) with the aim of positioning and
branding an organisation. This branding process consists of four “higher marketing
mix variables”: reputation; product and service performance; product brand and
customer portfolio; and networks. With these four components, the organisational or
corporate brand is created and the means by which this brand is differentiated from its
competitors. In this way, corporate reputation helps managers to lay out a brand
image strategy.

One year later, following Knox and Maklan’s (1998) study, Knox (1999) proposed
another model called “the organisation brand monitor” after proposing the UOVP
model for the organisation branding concept. This identified the existing brand and
mapped out the desired brand for the firm in the future. In this model, reputation is
used as a factor to monitor the development of an organisation.

Based on the

organisation brand monitor concept, it implies the existence of a causal link between a
firm’s corporate reputation and its brand image.

According to many corporate reputation scholars, a corporate reputation scale (Fryxell
and Wang, 1994) is extensively used in practice as a positioning instrument to
maintain or modify customer behaviour. For example, Nguyen and Leblanc (2001)
studied the relationship between corporate reputation and customer loyalty in the
service sector. A review of the literature reveals that it is a widely shared belief that a
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firm’s corporate reputation has a large impact on customer loyalty (Nguyen and
Leblanc, 2001). This implies the effect of corporate reputation on customer retention
indecisions in the service sector, since the service loyalty in itself represents the
customer’s rejection of competitive offerings aimed at changing buying habits and
constitutes one of the most reliable overall indicators of the service firm’s success.
Their study gave the managers a thorough understanding of these relationships which
contribute to establishing the distinction between image and reputation and help
management use them more effectively in their communication strategy, thereby
enhancing the firm’s positioning strategy.

In essence, they suggested that the

managers to use corporate reputation as a tool to help them devise a positioning
strategy for their products.

3.4.3 Price regulation

According to previous researchers, price policy has become an important issue for the
pharmaceutical industry world-wide (Huttin, 1992; Dickson and Redwood, 1998;
Scherer, 2004; de Wolf et al., 2005). In most of the advanced countries (e.g. the UK,
Germany, Canada, the USA and Japan) in the world, the price of medicines is an
important issue and may be affected by government policy.

However, previous literature (Myers and Reynolds, 1967; Lee, 2008) also has
suggested that a product’s price influences a customer’s brand perception. Marketing
studies also show that price can have an impact on customers’ evaluations of a brand
(Larkin, 2010). However, the more a customer is loyal to a particular brand, the lower
is his or her price elasticity of the demand functions (Starr and Rubinson, 1978).
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According to Aaker (1996, p. 17), when firms increase price to contribute to their
profitability, they must ensure that customers have a positive perception of their
brands’ quality. That is, “branded products enjoy higher prices than the generic
products, resulting in higher market valuation of firm assets, even if the production
technology is somewhat similar” (Larkin, 2010, p. 16). Larkin (2010) suggested that
firms can measure consumers’ preferences through their views of a brand. The more a
consumer prefers a brand, the more he or she is willing to pay for and the more
quantity he or she is will to purchase of the brand. Thus, Larkin (2010, p. 31)
maintains that “firms with strong brands have loyal consumers with high subjective
value for the firm’s products and who are willing to pay more and stick with the
product despite higher prices or price cuts by competitors.”

It was mentioned by Anis and Wen (1998, p. 21) that “patent holding pharmaceutical
firms are modeled as price-discriminating international monopolies. In an unregulated
world market, firms set monopoly prices in each national market. Three types of
regulatory rules: (i) ‘reasonable’ relationship rule, (ii) international price comparison
rule, and, (iii) therapeutic class comparison rule, are examined. While price regulation
may lead to lower introductory prices for new drugs, the price of existing drugs may
increase. Domestic price regulation may increase foreign prices. Canadian data
supported the model's predictions. Policy makers should anticipate these responses
that affect the entire vector of drug prices and not just those subject to specific
regulations.” And some other articles (Zweifel and Crivelli, 1996; Danzon and
Furukaw, 2003; Danzon and Furakawa, 2008) addressed on the similar issue in
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different countries such as Canada, France, Germany, Italy, Japan, Mexico, the United
Kingdom and the United States.

However, the literature doesn’t indicate strong support for price regulation as a factor
in the relationship between the uses of corporate reputation and brand image strategy.
This moderating effect of price regulation will be discussed in more detail in the
qualitative result in the next chapter.

3.5 Hypothesis developing

In the following section, based on the previous literature and arguments, a hypothesis
table (Table 3.3) is developed which established the relationship between each
constructs. This table bares an intension to explain the proposed framework in this
study.

Table 3.3: List of research hypotheses
H1
Value creation as one dimension of the uses of corporate reputation has
a positive impact on a firm’s brand segmentation strategy.
H2

Value creation as one dimension of the uses of corporate reputation has
a positive impact on a firm’s brand differentiation strategy.

H3

Value creation as one dimension of the uses of corporate reputation has
a positive impact on a firm’s brand positioning strategy.

H4

Strategic resource as one dimension of the uses of corporate reputation
has a positive impact on a firm’s brand segmentation strategy.

H5

Strategic resource as one dimension of the uses of corporate reputation
has a positive impact on a firm’s brand differentiation strategy.

H6

Strategic resource as one dimension of the uses of corporate reputation
has a positive impact on a firm’s brand positioning strategy.

H7

Corporate communication as one dimension of the uses of
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corporate reputation has a positive impact on a firm’s brand
segmentation strategy.
H8

Corporate communication as one dimension of the uses of corporate
reputation has a positive impact on a firm’s brand differentiation
strategy.

H9

Corporate communication as one dimension of the uses of corporate
reputation has a positive impact on a firm’s brand positioning strategy.

Source: Developed by the author

3.6 Conclusion

This chapter provides a detailed investigation of earlier literature on corporate
reputation, identifying three dimensions of antecedents in the use of corporate
reputation as: value creation, influencing competitor’s actions and developing a
relationship with its stakeholders. The study also highlights the impact of corporate
reputation on a firm’s brand image strategy as a consequence. Explanations of the
hypotheses on brand image strategy which are affected by the uses of corporate
reputation are proposed. Hypotheses demonstrated the different relationships between
the study constructs in the integrative framework provided.
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CHAPTER FOUR: METHODOLOGY

4.1. Introduction

The previous chapter detailed the conceptual framework and the hypotheses. The
purpose of this chapter is to justify and outline the methodology used to empirically
test the proposed conceptual model, and to answer the research questions of the study.
Following the introduction, this chapter is mainly divided into four sections. The first
section provides a description of the research design in the current study justifying the
choice of both qualitative and quantitative methodologies. The second section of this
two-phase study illustrates the qualitative study and its objectives. The third section
highlights the development of the questionnaire to be used in the data collection phase.
The pilot study, sampling procedures and the main survey will also be discussed in
this section as will data analysis techniques.

4.2. Research strategy

First of all, the researcher began by highlighting the nature of her research objectives
in order to identify the research approach to be used in this thesis. This study aims to
explain the significance and importance of the uses of corporate reputation for
managers. The study also aims to explain the impact of value creation, influencing
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competitors’ actions and developing the relationship with its stakeholders (which are
the uses of corporate reputation) and the consequences of the uses of corporate
reputation for brand managers when laying out brand image strategy. Those factors
have been derived from extant literature and theories from related fields of study (i.e.
corporate reputation, branding, communication and marketing strategy literature).
Hence, the research problem of this thesis has been built on what is already known
from previous studies.

As a consequence, a theoretical framework has been

developed as a start for the current study. This framework presents variables that are
claimed to be important in either fostering or discouraging the uses of corporate
reputation in setting brand image strategy in the pharmaceutical industry. In order to
achieve the research objectives, the researcher has taken into consideration the fact
that it is important to choose a research method based on her objectives and her
research questions. The following paragraphs attempt to illustrate and justify the
research methods used in this study.

In general, two approaches (i.e. deductive and inductive) are always applied by
researchers to build and test the built theory. In a deductive approach, the researcher
begins with an abstract, logical relationship among concepts, then moves towards
concrete empirical evidence. In the inductive approach, the researcher begins with
detailed observations of the world and moves towards more abstract generalisations
and ideas (Neuman, 2003). In practice, most researchers use both approaches at
various points in their studies. This research employs a deductive approach to
research the theoretical relationship. This implies that the research is built on theories
that already exist in the domain that is being researched (Bryman and Bell, 2007).
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Hypotheses are developed from those relevant theories and will be tested after data
collection and analysis phases.

Based on Crotty (1998), in designing a research proposal, we should consider four
questions, which are: (1) “what epistemology – theory of knowledge embedded in the
theoretical perspective – informs the research (e.g. objectivism, subjectivism, etc)? (2)
What theoretical perspective – philosophical stance – lies behind the methodology in
questions (e.g. positivism and post-positivism, interpretivism, critical theory, etc.)? (3)
What methodology – strategy or plan of action that links methods to outcomes –
governs our choice and use of methods (e.g. experimental research, survey research,
ethnography, etc.)? (4) What methods – techniques and procedures – do we propose
to use (e.g. questionnaire, interview… etc.)?” Based on Crotty’s model, Creswell
(2009) addressed three elements of inquiry (i.e. knowledge claim, strategies of inquiry
and methods) that pertain to the design of the research. With respect to the current
study, the researcher will follow Creswell’s (2003) model in order to illustrate the
research design. Figure 4.1 shows that how these elements merge together to outline
the approach of the research and, in turn, translate into processes in the design of the
research.
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Figure 4.1: Knowledge claims, strategies of inquiry and methods leading to
approaches and the design processes.

Source: Adapted from Creswell (2003, p.5)

According to Creswell (2009) the first step when designing a research is to evaluate
the knowledge claims brought to the study. “Knowledge claim means that researchers
start a project with certain assumptions about how they will learn and what they will
learn during their enquiry. These claims might be called paradigms (Mertens, 1998;
Lincoln and Guba, 2000); philosophical assumptions, epistemologies and ontologies
(Crotty, 1998); or broadly conceived research methodologies (Neuman, 2000).
Philosophically, researchers make claims about what is knowledge (ontology), how
we know it (epistemology), what values go into it (axiology), how we write about it
(rhetoric), and the process for studying it (methodology)” (Creswell, 1994) (Creswell,
2009, p.6). Four sets of assumptions are suggested by Creswell (2009) concerning the
knowledge claims: postpositivism, constructivism, advocacy/participatory and
pragmatism.

However, most ongoing social research is based on two major
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approaches – positivism and interpretivism. Positivism is the oldest and most widely
used approach. It is broadly defined as the approach of natural sciences. However,
interpretive researchers claim that the goal of social research is to develop and
understand social life and discover how people construct meaning in natural settings
in contrast to e positivism (Neuman, 2003). It is argued by Neuman (2003) that
ordinary people use common sense to guide their daily living, so one must first grasp
common sense.

Qualitative research allows researchers to formulate explanations of the subjects
under study and to give representations of these explanations in order to add to a body
of knowledge (Wright 2008). However, in the real life, neither common sense nor
scientific law has perfect answers.

Therefore, social researchers developed

triangulation by using qualitative and quantitative methods to provide a view from a
number of perspectives rather than from only one perspective to look at a concept,
some phenomenaor circumstances. Hence, Neuman (2003) proposes four types of
triangulation. First comes the measurement triangulation, which means using more
than one measure for the same phenomena. Second is triangulation of the observer, in
which the data are collected by a variety of observers to give a more complete picture
of the setting. The third one is triangulation of theory, which is when the researcher
uses multiple theoretical perspectives in the planning stage of the research. The last
one is triangulation of methods, which means conducting qualitative and quantitative
approaches of research.

The current study will employ the fourth type of triangulation or the “mixed methods
approach” (Tashakkori and Teddlie, 2003). It is an approach in social sciences which
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employs collecting data by both forms of research styles (i.e. qualitative and
quantitative concurrently or sequentially) (Creswell, 2009). Adopting this approach
also means that data will be integrated, related or mixed at some stage or research.
The reasons for combining the two methods are various and differ from one
researcher to another.

For example, Bryman (2006) classified two schemes for

justifying the combination of quantitative and qualitative research based on a content
analysis of 232 social science articles in which the two methods were combined (see
Table 4.1).

Table 4.1: The reasons for combining the qualitative and quantitative methods
Triangulation

Scheme one
Convergence, corroboration, correspondence or results from different
methods. In coding triangulation, the emphasis was placed on
seeking corroboration between quantitative and qualitative data.

Complementarity

Seeks elaboration, enhancement, illustration, clarification of the
results from one method with the results from another (Greene et. al,
1989, p. 259)

Development

Seeks to use the results from method to help develop or inform the
other method, were development is broadly construed to include
sampling and implementation, as well as measurement decisions
(Greene et al., 1989, p. 259)

Initiation

Seeks the discovery of paradox and contradiction, new perspective of
frameworks, the recasting of questions or results from one method
with questions or results from the other method (Greene et al., 1989,
p. 259)

Expansion

Seeks to extend the breadth and range of enquiry by using different
methods for different inquiry components (Greene et al., 1989, p.
259)

Triangulation or greater
validity

Scheme two
Refers to the traditional view that quantitative and qualitative
research might be combined to triangulate findings in order that they
may be mutually corroborated. If the term was used as a synonym for
integrating quantitative and qualitative research, it was not coded as
triangulation.

Offset

Refers to the suggestion that the research methods associated with
both quantitative and qualitative research have their own strength
weaknesses so that combining them allows the researcher to offset
their weaknesses to draw on the strength of both.

Completeness

Refers to the notion that the researcher can bring together a more
comprehensive account of the area of enquiry in which he or she is
interested if both quantitative and qualitative are employed.
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Process

Quantitative research provides an account of structures in social life
but qualitative research provides sense of process.

Different research
questions

This is an argument that quantitative and qualitative research can be
each answered in different research questions.

Explanation

One is used to help explain findings generated by the others.

Unexpected results

Refers to the suggestion that quantitative and qualitative research can
be fruitfully combined when one generates surprising results that can
be understood by employing the other.

Instrument development

Refers to contexts in which qualitative research is employed to
develop questionnaire and scale items- for example, so that better
wording or more comprehensive closed answers can be generated.

Sampling

Refers to situations in which one approach is used to facilitate the
sampling of respondents or cases

Credibility

Refers to suggestions that employing both approaches enhances the
integrity of findings

Context

Refers to cases in which the combination is rationalized in terms of
qualitative research providing contextual understanding coupled with
either generalizable, externally valid findings or broad relationships
among variables uncovered through a survey.

Illustration

Refers to the use of qualitative data to illustrate quantitative findings,
often referred to as putting ‘meats on the bones’ of dry quantitative
findings.

Utility or improving the
usefulness of findings

Refers to a suggestion which is more likely to be prominent among
articles with an applied focus, that combining the two approaches
will be more useful to practitioners and others.

Confirm and discover

This entails using qualitative data generate hypotheses and using
quantitative research to test them within a single project.

Diversity of views

This includes two slightly different rationales – namely, combining
researchers’ and participants’ perspective through quantitative and
qualitative research respectively, and uncovering relationships
between variables through quantitative research while also revealing
meanings among research participants through qualitative research.

Enhancement or building
upon
quantitative/qualitative
findings

This entails a reference to making more of or augmenting either
quantitative or qualitative findings by gathering data using a
qualitative or quantitative research approach.

Other/unclear
Not stated

Source: Adpted from Bryman (2006)

Many influential researchers in the social and behavioural sciences present different
paradigms, commonly called ‘pragmatism’ (Tashakkori and Teddlie, 1998). However,
the major concern for most of the pragmatism forms is the problem itself instead of
the problem-solving methods or the solution that is used (Patton, 2002). Therefore
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the researchers use all the approaches necessary to understand the problem (Creswell,
2009). The merit of this method is the fact that a qualitative study will excel at telling
the story, understanding complex social phenomena and assist the researcher in
developing themes from the respondents’ point of view, while quantitative research
will summarise a large amount of data for generalisation purposes.

After determining to use mixed methods for this research, it is necessary to consider
the strategy of inquiry that will be used (Creswell, 2009). Three strategies have been
illustrated in Creswell (2009) for mixed methods: sequential, concurrent and
transformative procedures. In sequential procedures, which is the strategy used in the
current study, researchers may start with a qualitative method for exploratory
purposes and then move towards a quantitative method using a large sample. Hence,
the qualitative data collection techniques of this study will be conducted prior to the
main quantitative survey to increase the validity of the research (Deshpande, 1983).
Alternatively, researchers could begin with a quantitative method to test the theory,
followed by a qualitative method to add depth of understanding.

Finally, the major element in the research approach is to find specific methods of data
collection and analysis. As mentioned earlier, this study will commence with a
qualitative research phase in order to (1) gain deeper understanding of the topic, (2)
refine and revise the preliminary research model and hypotheses and (3) purify
measures for the questionnaire (Churchill, 1979). In this phase, a qualitative method
will be adopted, using content analysis of managers’ opinions about their decisions
regarding brand image strategy for the pharmaceutical industry This method was
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previously adopted by several researchers (e.g. Deephouse, 2000; Bickerton, 2000;
Bromley, 2001) to reach similar research objectives for corporate reputation studies.

4.3 Research design

4.3.1 The first phase – qualitative data collection

Qualitative research is more suitable when there is a need for unfolding what
surrounds a phenomenon (Carson et al., 2001). van Maanen (1979) defines qualitative
methods as “an array of interpretative techniques which seek to describe, decode,
translate and otherwise come to terms with the meaning, not the frequency, of certain
more or less naturally occurring phenomena in the social world” (p. 520).

A considerable number of studies have used qualitative methods to gain insights into
the phenomena being investigated (e.g. Arnould and Price, 1993; Clesi et al., 1993;
Thompson, 1997). Therefore the researcher proposes to conduct exploratory research
in the first phase to e gain insights into the studied phenomenon (Zikmund, 2003).
The choice of exploratory research design for this first phase of the study was
influenced by the nature of the research objectives. With respect to the construct of
the uses of corporate reputation, the researcher is looking for a better understanding of
strategy, corporate communication and value creations between the firm and their
customers before undertaking the quantitative research in the second phase.
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The semi-structure interview was conducted as follows: First, a list of questions was
designed on the basis of the reviewed literature and the research question, along with
several open-ended questions (see Table 4.2). Second, a research framework was
designed and provided to the interviewees. Third, the interviewees answered the semistructure interview questionnaire to gain a better perspective on the relationship
between the hypotheses and related issues.
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Table 4.2: Research question, hypotheses, and qualitative questions
How do (Taiwanese pharmaceutical) companies use their corporate reputation to develop brand image strategy?
RQ:
*RQ: Research question

Hypotheses

Supporting
Literature

H1:
A firm’s corporate
reputation, which is used to
create value, has a positive
impact on a firm’s brand
segmentation strategy.

Ludlow
(1997);
Kaplan and Norton
(2000); Pires and
Aisbett
(2003);
Ulaga (2001); Priem
(2007);
Payne
(2002); Kamakura
and Novak (1992)

H2:
A firm’s corporate
reputation, which is used to
create value, has a positive
impact on a firm’s brand
differentiation strategy.

H3:
A
firm’s
corporate
reputation, which is used to
create value, has a positive
impact on a firm’s brand
positioning strategy.

Qualitative Questions
Can you suggest the characteristics of value creation which tend to encourage the
setting of brand segmentation strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand segmentation strategy, what value creation characteristics (of
the uses of corporate reputation) would you put more attention to or would like to
invest more? And why?
Can you suggest the characteristics of value creation which tend to encourage the
setting of brand differentiation strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand differentiation strategy, what value creation characteristics (of
the uses of corporate reputation) would you put more attention to or would like to
invest more? And why?
Can you suggest the characteristics of value creation which tend to encourage the
setting of brand positioning strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand positioning strategy, what value creation characteristics (of the
uses of corporate reputation) would you put more attention to or would like to invest
more? And why?
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H4:
A firm’s corporate
reputation, which is used as a
strategic resource, has a positive
impact on a firm’s brand
segmentation strategy.

Birger
(1984)

Wernerfelt

Can you suggest the characteristics of strategic resource which tend to encourage the
setting of brand segmentation strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand segmentation strategy, what strategic resource characteristics
(of the uses of corporate reputation) would you put more attention to or would like to
invest more? And why?

H5:
A
firm’s
corporate
reputation, which is used as a
strategic resource, has a positive
impact on a firm’s brand
differentiation strategy.

Can you suggest the characteristics of strategic resource which tend to encourage the
setting of brand differentiation strategy? And why?

H6:
A
firm’s
corporate
reputation, which is used as a
strategic resource, has a positive
impact on a firm’s brand
positioning strategy.

Can you suggest the characteristics of strategic resource which tend to encourage the
setting of brand positioning strategy? And why?

H7:
A firm’s corporate
reputation, which is used to
communicate
with
its
stakeholders, has a positive
impact on a firm’s brand
segmentation strategy.

You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand differentiation strategy, what strategic resource
characteristics (of the uses of corporate reputation) would you put more attention to
or would like to invest more? And why?

You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand positioning strategy, what strategic resource characteristics
(of the uses of corporate reputation) would you put more attention to or would like to
invest more? And why?
Reeves,
1961;
Ogilvy,
1963;
Dickson and Ginter,
1987; Johar and
Sirgy, 1989; Sirgy,
1989;
Peltier and
Schribrowsky, 1997;
Vargo and Lusch,

Can you suggest the characteristics of corporate communication which tend to
encourage the setting of brand segmentation strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in
the firm to create brand segmentation strategy, what communication characteristics
(of the uses of corporate reputation) would you put more attention to or would like to
invest more? And why?
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H8:
A
firm’s
corporate
reputation, which is used to
communicate
with
its
stakeholders, has a positive
impact on a firm’s brand
differentiation strategy.

2004;
Flint, 2004;
Hooley et al., 2004;
Madhavaram et al.,
2005; Nandan, 2005

H9:
A
firm’s
corporate
reputation, which is used to
communicate
with
its
stakeholders, has a positive
impact on a firm’s brand
positioning strategy.

Can you suggest the characteristics of corporate communication which tend to encourage the
setting of brand segmentation strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in the firm to
create brand segmentation strategy, what communication characteristics (of the uses of
corporate reputation) would you put more attention to or would like to invest more? And why?
Can you suggest the characteristics of corporate communication which tend to encourage the
setting of brand segmentation strategy? And why?
You, as a brand manager, who is responsible for controlling the quality of a brand in the firm to
create brand segmentation strategy, what communication characteristics (of the uses of
corporate reputation) would you put more attention to or would like to invest more? And why?

Source: Develop by the author
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4.3.2 Research setting: country and industry
Having chosen a specific country for study, companies in a single industry were
chosen as the setting for this research. Certain considerations led to this choice.
According to Baker (1994, p.109) and Bernard (2000, p.66), the selection of the
research setting is an important part of any successful research project. Considerations
about where to conduct research pose limitations on propositions generated from a
theoretical model. They set a boundary for generalisability. Moreover, an appropriate
research setting can facilitate a researcher in effectively taking note of social
phenomena, examining proposed theories and confidently drawing conclusions about
empirical tests (Eisenhardt, 1989; Doktor et al., 1991).

The review of literature shows that the majority of previous studies about the uses of
corporate reputation have been completed in Western countries (the USA, the UK,
Germany, Australia, Japan, Germany and the Netherlands, etc.) and concentrate less
on investigating the topic in other regions (e.g. Asia, Africa, or South America),
which have therefore limited any generalisability of theory (Boyacigiller and Adler,
1991; Peng et al., 1991; Trompenaars and Hampden-Turner, 1998). In order to bridge
this gap, Taiwan, one of the most dynamic business environment countries in Asia,
was selected as the setting of this study for several reasons.

First, Taiwan is culturally similar to its Asian neighbours (e.g. China) and clearly
different from Western countries (Hofstede, 1980; McGill, 1995), where most of the
corporate reputation studies have been carried out. According to Hofstede (1980,
pp.165–222), Taiwan is different from the USA, UK, and other developed countries
on both uncertainty avoidance and individualism aspects.
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relatively low score for uncertainty avoidance (i.e. has a higher tolerance for
ambiguity, less emotional resistance to change, etc.) and a very low score for
individualism (i.e. group decisions are considered better than individual decisions,
employees have strong emotional dependence on company, etc.). Moreover, the
values and norms of Taiwanese consumers have strong roots in Chinese folk
religion – which integrates Buddhist elements alongside a basically Taoist base
(Taiwan’s major religion adopted by more than 90 per cent of its population) (Taiwan
Yearbook, 2006; CIA world factbook). An important element in the philosophy of
Buddhism, the “anatta” or “no-self”, helps differentiate Taiwanese consumers from
those in Western countries who mainly are Catholic or Protestant (Wattanasuwan and
Elliot, 1999). It is also stated in Child and Tsai (2005) that Taiwan has developed to a
stage where the key stakeholders are very knowledgeable. Moreover, Taiwan is one
of the fastest-growing economies of the newly industrialized countries. Much of its
growth has come from multinational companies.

Second, Taiwan is also home to the regional headquarters of many multinational
companies in Asia.

It also has a language and cultural advantage, helping

multinational companies to carry out their ownership advantage, internal
nationalisation advantage and location-specific advantage when they try to invest in
Chinese market. Therefore, it is possible for multinational companies to use Taiwan
as a platform for developing their business in Chinese or other Asian markets.
Moreover, Taiwanese foreign exchange reserves consist of USD$266 billion and there
is a high percentage of experienced workers and researchers in Taiwan.
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Third, Taiwan has a high credit rating internationally. Taiwan has a stable and
dynamic business environment (Economist Information Unit; EIU, 2006). According
to the international credit rating company Standard and Poor, Taiwan’s sovereign
credit was rated at level of AA, which is better than other Asia countries (i.e. Japan –
AA; China – BBB; South Korea – A-; Malaysia – BBB+). The above statements
suggest that Taiwan has good financial stability.

Moreover, in 2006, Taiwan is

ranked as number three in Asia and number six in the world for its overall business
environment, as reported by the Business Environment Risk Intelligence (BERI)
when evaluating the risks attached to an investment environment. This is just next to
Switzerland, Singapore, Holland, Norway and Japan. Here are some comments from
two different company general managers in Taiwan:
“By contrast to China, the Taiwan authorities adopt a much more
uniform and universalistic approach to managing environmental
issues. The institutional constraints in Taiwan are stringent and less
open to negotiation. This reflects the fact that Taiwan has been
under western (especially American) influence for a longer period
of time and also that it is wealthy enough to address the cost of
dealing with environmental problems. The tough enforcement of
environmental regulations has in fact encouraged some enterprises
to relocate, often to China and Southeast Asian countries.” [General
Manager1, Taiwan]
“As a long experience in international business competition and
influences, Taiwanese enterprise is going towards to international
market. It has developed an operational model about production
and selling as follows: it used to stress on the production for
exporting, emphasising on the strategy of light, thin, short, and
small as bearing a strategy to sell high volume with low profit
margin.
Nowadays, it became a combination supply chain
production which possesses a more accurate, more profitability and
vertical division of labour supply chain associate production.
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Moreover, it enforce the high adding value on the product and
brand marketing strategy, therefore it has successfully enter the
international market.
It is pointed out in the data of Taiwanese ministry of economic
affairs that in the international business, Taiwanese small and
middle businesses have developed a tight relationship with the
international big company and forms an international marketing
network. The Taiwanese business competitive advantage is based
on that the business can become a first supplier in the international
market. Moreover, they develop the ability to gain the profit base on
not only the first-line supplier but also possess the ability of
invention in advance. Apart from this, the relationship between
Taiwanese businesses and international brand becomes a closely
related strategy union which maybe is a result of the effort on R&D
that Taiwanese businesses worked on. Moreover, according to
Fortune previous years statistics, multinational corporation from
the developing countries are increasing and becoming a new power,
which become a parallel situation with the multinational
corporations from Europe, American, and Japan (Taiwan Yearbook
2006; CIA - The World Factbook)” [General Manager2, Taiwan].

Following the selection of Taiwan, companies in a single industry were chosen as the
setting for this research. Certain considerations led to this choice. First, the singleindustry design provided the researcher with a better control over market and
environmental anomalies (Conant et al., 1990) and industry effects (Rao, 1994). It is
because a single industry would be more focused on a particular manufacturing
procedure, ways of marketing their goods and keeping their customer relationships.
Second, it was desirable to study a setting in which: (1) the three dimensions of the
uses of corporate reputation could be explained and clearly measured; (2) corporate
reputation played an important role in the general operations and the survival of
businesses; (3) previous research had identified the presence of various types of
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strategic use of a firm’s intangible assets, communication and value creation activities,
and (4) reliable and adequate data were available for the purification of measurement
scales and hypothesis testing.

Given the requirements above, the pharmaceutical industry was chosen because
reputation building is particularly important for it: since medicines are considered
vital for human life, corporate reputation thus plays an important role in the general
operations and the survival of business. Furthermore, a pharmaceutical firm can use
its reputation to signal its customers about its new technology, the standards they
require or just to build trust within its customers. As a result they might get a higher
price for their products.

The managers in this industry make mainly strategic

decisions on the use of a firm’s intangible assets, its corporate communication and
value-creation activities.

4.4 Scale Development and Validation

The scale development procedure included four major steps (see Figure 4.2). The first
step involved specifying operational definitions and dimensions of focal constructs to
help the subsequent generation of items hypothesised refer to each dimension. The
use of different definitions and dimensions constrains comparison and collection of
the findings (Churchill, 1979). A literature search helped achieve this step. Existing
scales and related domains were reviewed, and items from various marketing and
management journals (e.g, Corporate Reputation Review, Journal of Marketing, and
Academy of Management Journal) were adopted.
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Figure 4.2: Steps in measurement scales development

1) Specifying
Definition and Domain

Techniques Employed
•

Literature Search including the
review of existing related scales

2) Measurement Items

•

Literature Search

•

Experience Survey

Generation

3) Purifying

(Interview with experts)

Measurement Items

4) Validating

•

Coefficient Alpha

•

Item-to-total correlation

Measurement Scales

The second step involved creating additional measurement items using semistructured interviews with experts. The expert interviews included showing the
conceptual framework to respondents and asking questions about the measurement
items of each construct. Examples of questions included “What do you think are
important aspects to the uses of corporate reputaiton, and why?” and “What items on
this page do you think are not relevant to value creation, and why?” The face validity
and content validity were also examined in this step (Netemeyer et al., 2003, p. 16).

The third step involved subjecting the items generated in the previous phase to a pilot
test as an item-trimming procedure (DeVellis, 2003). Questionnaires containing all
potential items were distributed through a web-survey system to the managers in the
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sample companies in the Taiwanese pharmaceutical industry. From their experiences
with their companies, respondents rated items on the scale from 1 (“disagree”) to 5
(“agree”). I translated items extracted from English-based journals and dialogues with
English-speaking experts in the previous two steps into Mandarin Chinese, and an
expert in the English language back-translated them into English (Brislin, 1970).
Before the final questionnaires were completed, respondents were randomly asked to
point out any item that was either ambiguous or difficult to answer (Kohli et al., 1993).

Subsequently, coefficient alphas and item-to-total correlations were computed to
check for the reliability of measurement scales (Churchill, 1979; DeVellis, 2003). A
set of questionnaires along with purified items from this step was edited and prepared
for the main survey (Lagas, 2000; Long-Tolbert, 2000; Algesheimer et al., 2005).

In the fourth step, following the main survey, purified measurement scales were sent
to confirmatory factor analysis (CFA) as a method to confirm the scales. This
procedure was employed to examine scale properties, such as reliability, and construct
validity (convergent and discriminant validity). The tests based on the data from the
main survey were performed in the PLS software. A further discussion about the CFA
technique appears in section 4.5.1, and the results of the literature search, qualitative
studies, and the pre-test also are presented.

4.4.1 Literature search and existing measurement scales

The main objectives of conducting literature search and qualitative studies are to
identify the domains of measurement scales and generate items for each of them.
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Domains of constructs were derived from existing related concepts and scales in
various academic journals (see complete list in Appendix 1). In general, there are
various developed measurement scales, all of which are a Likert type with marketing
capabilities and operating performance. The researcher identified three domains for
the construct of the uses of corporate reputation (value creation, strategic resources
and corporate communication), and three domains for the construct of brand image
strategy (brand segmentation, brand differentiation and brand positioning).
According to past articles (e.g., Ashforth and Gibbs, 1990; Wayne and Ferris, 1990;
Suchman, 1995; Foreman and Whetten, 2002), the domains of all concepts can be
classified in many different ways. While not comprehensive, the domains of
constructs in this research were identified and integrated so as to be as concise as
possible. Examples of domains, including their corresponding items, are exhibited in
Table 4.3.

The uses of a corporate reputation construct were found to be named and
operationalised differently in the existing literature. The majority of articles focused
on specific forms of support such as value creation (e.g. Milgrom and Roberts, 1986;
Beatty and Ritter, 1986; Wong and Saunders, 1993; Herbig et al., 1994; Devine and
Halpern, 2001; Eberl and Schwaiger, 2005), strategic resources (e.g. Barney, 1986;
Cornell and Shapiro, 1987; Weigelt and Camerer, 1988; Dierickx and Cool, 1989;
Roberts and Dowling, 2002), and corporate communication (e.g. Lerbinger, 1965;
Grunig et al., 1992; Gray and Balmer, 1998).

Wong and Saunders (1993) researched value creation, which has been classified into
four

categories:

(function/instrumental
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symbolic/expressive value, cost/sacrifice value). These items of value creation,
developed fully by Wong and Saunders (1993) were taken by the researcher for
examination.

Strategic resources have been also found to be named differently in existing literature:
namely competitive advantage, capability to influence competitors’ actions, strategies
or decision making. The researcher developed items for strategic resources based on
competitive advantage scales/items (Wong and Saunders, 1993), such as efficient
sales and marketing, advanced R&D, early market entry and large cash resources.

The construct of corporate communication has been poorly addressed in existing
literature. However, it has been addressed collectively (e.g., Lerbinger, 1965; Grunig
et al., 1992; Gray and Balmer, 1998) with a similarity of terms, such as: corporate
reputation as used to communicate a firm’s social responsibility activities to
stakeholders within the business environment (Lerbinger, 1965; Grunig et al., 1992).
The corporate reputation is also used as a means of shaping the perception of
shareholders and stakeholders (Fombrun and Shanly, 1990), used as a tool for
building a relationship between the firm and the customers (Perrow, 1961a; Perrow,
1961b; Kreps and Wilson, 1982; Milgrom and Roberts, 1982; Shrum and Wuthnow,
1988), used as a means of influencing consumer choices (Chibnall, 1977; Hall et al.,
1978; Fombrun and Shanley, 1990; McNair, 1996; Landon and Smith, 1997; Sabate
and Puente, 2003; Shkolnikov et al., 2004; L’Etang, 2006; Srivoravilai, 2006), and
court better reputations among customers (Fryxell and Wang, 1994; Brammer and
Pavelin, 2006; Puente et al., 2007).
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In contrast, previous research has examined the three constructs of brand image
strategy under the names brand segmentation (Dickson and Ginter, 1987), brand
differentiation (Dickson and Ginter, 1987), and brand positioning (Wong and
Saunders, 1993). Dickson and Ginter (1987) indentify the domains of the brand
segmentation construct and brand differentiation.

Brand segmentation and brand

differentiation are constructed with items adopted from Dickson and Ginter (1987),
and brand positioning items are constructed with items adopted from Wong and
Saunders (1993). The construct items appear in Table 4.3.

Table 4.3: The domains and items of constructs in extent literature
Construct
Value
creation (25)

Examples of Domains and Items
Function/Instrumental Value (7)

Our firm’s corporate reputation promises good quality
products and service to customers.

Our firm competes by creating useful products.

Our firm competes by creating the correct product attributes
for its targeted customers.

Our firm competes by appropriate performances.

Our firm competes by appropriate outcomes.

Our firm’s value-chain activity is consistent with functional
value creation.

Our firm’s resource allocation is consistent with functional
value creation.
Experiential/Hedonic Value (6)

Our firm competes by appealing to the senses.

Our firm competes by creating appropriate emotions (fun,
pleasure, excitement, relaxation, etc.)

Our firm competes by facilitating social relationships (bonds,
attachments, and togetherness).

Our firm competes by creating epistemic value (knowledge,
novelty, fantasy).

Our firm’s value-chain activity is consistent with experiential
value creation.

Our firm’s resource allocation is consistent with experiential
value creation.
Symbolic/Expressive Value (5)

Our firm competes by enhancing its customers’ self-identity.

Our firm competes by enhancing its customers’ self-concept.

Our firm competes by enhancing its customers’ self-worth.

Our firm competes by creating personal meaning.

Our firm competes by facilitating self-expression.
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Cost/Sacrifice Value (7)

The corporate reputation of our firm helps to reduce
transaction costs.

Our firm competes by offering economic value (low prices,
value in use, life costs).

Our firm competes by simplifying the purchasing process for
its consumers (ease of use, ease of doing business, simplicity,
availability, accessibility).

Our firm compete by enabling ease of use of its products
(time, effort, energy).

Our firm compete by minimizing customer risk (personal,
technological, strategic).

Our firm’s value-chain activity is consistent with symbolic
value creation.

Our firm’s resource allocation is consistent with symbolic
value creation.
Strategic
value or
resource (5)







Corporate
communicati
on (3)





Segment
development
(5)







Product
Differentiati
on (7)









In our organization, corporate reputation serves as a
competitive advantage.
Our firm’s corporate reputation sends a strong signal to its
customers.
Our firm’s corporate reputation implies efficient sales and
marketing.
Our firm’s corporate reputation implies its advanced R&D.
Our firm’s corporate reputation implies that we are able to
enter markets early.

Wong and
Saunders (1993)

Wong and
Saunders (1993)

Our firm’s corporate reputation shapes the perceptions of
shareholders and other stakeholders.
Our firm’s corporate reputation builds a relationship between
the firm and its customers.
Our firm’s corporate reputation influences consumer choices.
Our corporate brand strategy has one particular form of
demand function modification.
Our corporate brand strategy requires product differentiation.
Our corporate brand strategy requires changes in point
distribution location.
Our corporate brand strategy requires changes in importance
attached to a non-physical product.
Our corporate brand strategy requires changes in importance
attached to a physical product.

Dickson and
Ginter (1987)

How our corporate brand is perceived varies according to
whether consumers have experienced our products.
How our corporate brand is perceived varies by word of
mouth.
How our corporate brand is perceived varies by promotion.
Our corporate brand is actually created differently by product
characteristics.
Our corporate branding maybe directed at different market
segments.
Our corporate brand may utilize physical product
characteristics.
Our corporate brand may utilize non-physical product
characteristics.

Dickson and
Ginter (1987)
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Competitive
position (8)










Our firm’s corporate brand positioning strategy signifies high
quality to its customers.
Our firm’s corporate brand positioning strategy signifies
better product performance to its customers.
Our firm’s corporate brand positioning strategy is to achieve
a higher frequency of advertising.
Our firm’s corporate brand positioning strategy involves a
long distribution chain.
Our firm’s corporate brand positioning strategy is to provide
a much better service to its customers.
Our firm’s corporate brand positioning strategy tries to fulfil
the basic needs of our customers.
Our firm’s corporate brand positioning strategy tries to fulfil
the basic needs of our customers.
Our firm’s corporate brand positioning strategy tries to target
upmarket audiences.

Wong and
Saunders (1993)

Source: Adapted from previous literature as stated

4.4.2 Generation of Measurement Items

Following the literature search, semi-structured interviews with experts were
conducted. Following Miles and Huberman (1994, pp.10–11), the researcher extracted
items from interview data by using data reduction and display functions in Nvivo 7
software. A coding scheme was designed based on literature and transcripts. Data
were grouped according to relevant codes. Items were subsequently drawn from each
group and compared with those obtained from literature (see Table 4.3). The profile
of interviewees and details about interviews are presented in Table 4.4 as follows:

Table 4.4: The list of respondents and their titles
Intervie
wee
1

The
Respondent
Vice Executive
Officer

2

Sales Manager

3
4

The Organisation

Duration
(minutes)
90

Interview
Date
November,
2009

A Japanese original medicine company
Taiwan branch (company B)

120

November,
2009

Chairman

A Taiwanese local pharmaceutical
manufacturing company (company C)

60

November,
2009

Manager
(Management)

A Taiwanese local pharmaceutical
manufacturing company (company D)

90

November,
2009

A Taiwanese local pharmaceutical
manufacturing company (company A)
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5

Chief Executive
Officer

A Taiwanese local pharmaceutical
manufacturing company (company E)

90

November,
2009

6

Chief Executive
Officer

A Taiwanese local pharmaceutical
manufacturing company (company F)

90

November,
2009

7

Chief Executive
Officer

A commercial agent selling European
imported raw material medicine and
local generic medicine (company G)

120

November,
2009

8

Marketing
Department
Manager

The largest Taiwanese local
pharmaceutical manufacturing company
(company H)

90

November,
2009

9

Sales Manager

A Japanese original medicine company
Taiwan branch (company I)

90

November,
2009

10

Chairman

A B2B marketing company selling
European imported medicine and local
generic medicine (company J)

90

November,
2009

11

Sales Manager

A leading American original medicine
company Taiwan branch (company K)

90

November,
2009

12

Chairman

A commercial agent selling European
imported raw material medicine and
local generic medicine (company L)

50

November,
2009

13

Sales Manager

A Japanese original medicine company
Taiwan branch (company M)

60

November,
2009

14

Sales Manager

A Taiwanese local pharmaceutical
manufacturing company (company N)

60

November,
2009

Resource: Developed by the researcher

The second step of Churchill’s (1979) paradigm is to generate sample items which
capture the domain as specified. It includs generating additional measurement items
by using, for example, literature searches, experience surveys, exploratory research,
critical incidents and focus groups (Churchill, 1979). The researcher plans to employ
a combination of literature search and exploratory research which will include semistructured interviews with the pharmaceutical company managers.

The items

representing the construct and their sub-components have been regenerated for the
initial item pool from the marketing literature (see Table 4.2). However, the issues
which are expected to emerge from the exploratory research will be integrated for
generating the items.
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In this study, each construct is a multi-item scale. Churchill (1979, p. 66) suggests
that single items usually have considerable “uniqueness or specificity in that each
item seems to have only a low correlation with the attribute being measured and tends
to relate to other attributes as well.” In addition, single items also have considerable
measurement error; they produce “unreliable responses in the sense that the same
scale position is unlikely to be check in successive administrations of an instrument”
(Churchill, 1979, p. 66).

The initial measurement for the dimensions of the uses of corporate reputation is
mainly based on the work by Wong and Saunders (1993). This study covered the
relationship between business orientation and performance. Their results are based on
structured interviews conducted with 90 chief executives of companies all operating
in the United Kingdom. Data was gathered on the business orientations and broad
strategy directions of the firms using a battery of 45 items based on Kotler (1991) and
O’Shaughnessy (1984) examining the following seven dimensions: (1) strategic
objectives, (2) strategic focus, (3) target markets, (4) competitive targets, (5)
differential advantage, (6) marketing mix emphasis and (7) current competitive
position.

Moreover, organisational traits were measured with the McKinsey 7-S

framework as the basis for the following six dimensions: 5) (1) strategy, (2) structure,
(3) systems, (4) style and (5) staff (Wong and Saunders, 1993). The items regarding
corporate communications originate from van Riel (2000).

Items of the other

construct about brand image strategy are adapted from original items in the studies by
Park et al. (1986), Dickson and Ginter (1987), Roth (1995) and Hsieh (2001). More
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details about the domains and items of constructs in existing literature can be found in
Table 4.3.

According to Carson et al. (2001), when there is the need to clarify circumstances that
surround a phenomenon, conducting qualitative research tends to be suitable. Several
studies on the uses of corporate reputation (e.g. Clayman, 1987; Weigelt and Camerer,
1988; McGuire et al., 1990; Shefrin and Statman, 1995, 1997; Nanda et al., 1996;
Antunovich and Laster, 1998; Groenland, 2002; Schwaiger, 2004) use qualitative
methods to gain insight into the investigated phenomena. The researcher, therefore,
plans to conduct exploratory research for the first phase to gain insights into the
studied phenomenon.

The objective of this study is to investigate the effects of the uses of corporate
reputation on brand image strategy in the pharmaceutical industry from the
managerial perspective. Therefore, this research was conducted through in-depth
interviews with managers in the pharmaceutical industry in Taiwan. Fourteen brand
managers from pharmaceutical companies in Taiwan were used as respondents. The
respondents were selected because they have experience in implementing brand
segmentation and positioning strategies in their pharmaceutical company. They were
able to provide information about how their firms’ current situations affect corporate
strategy.

The 14 interviewees were selected from companies within the Taiwanese
pharmaceutical industry. The following section provides a brief introduction of each
interviewee. The interviewed manager from company A is a vice executive officer
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with more than 20 years’ experience in big pharmaceutical companies in Europe (e.g.,
Germany, Holland). The manager in company B is now a sales manager in the
Japanese original company with more than 20 years’ prior experience working at
Pfizer in Taiwan as a sales director and marketing manager. The interviewee from
company C is the chairman of the company, which is a local pharmaceutical company
with high-quality supply-chain management. The company, which has sought
international cooperation and has been approved by the Pharmaceutical Inspection
Convention

and

Pharmaceutical

Inspection

Co-operation

Scheme

(PIC/S)

international standard, is the first Taiwanese company to sell medicine into the
European market. The interviewee from company D, the largest local pharmaceutical
company in Taiwan, is the speaker of the company who has served in that capacity
for more than 30 years. Company D is well known for its effort in building corporate
social responsibility and in providing feedback to the local area and society with
social services.

The interviewee in company E is the CEO of the company. Company E is a local
Taiwanese pharmaceutical company with 40 years’ experience in pharmaceutical
manufacturing and selling. The interviewee from company F is also the company’s
CEO. Company F is a medium-sized pharmaceutical company with more than 80
years of pharmaceutical experience and is well known for its high-quality products.
The interviewee from Company G is the CEO of the company. Company G’s main
practice is distributing imported and locally produced medicine to hospitals, both
regular and teaching. The interviewee from company H is the marketing department
manager. Company H is the largest Taiwanese local pharmaceutical manufacturing
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company that produces its own patent medicine as well as generic medicine; the
company holds the leading position in the Taiwanese pharmaceutical market.

The interviewee from company I, which is a local branch of a Japanese original
medicine company situated in Taiwan for more than 40 years, is a sales manager.
Company I hosts international conferences and seminars and is well connected with
research in academia and practice. The interviewee from company J is the chairman
of the company. Company J’s business is mainly importing European original
medicine and health care products, such as vitamins, ointment and hand cream. The
interviewee from company K, which is a branch of a leading U.S. original medicine
company in Taiwan, is a sales manager. The original company is among the largest
pharmaceutical companies in the world and is advanced in R&D and sales. It was the
first foreign company to be approved to build a factory in Taiwan. The interviewee
from company L is also the company’s chairman. Company L’s business area is
mainly importing medicinal material, turning the material into medicine and then
selling the medicine to hospitals. Interviewee from company M, which is a branch of
a Japanese original medicine company in Taiwan, is a sales manager. The core value
of company M is its R&D; it has invented many patent medicines over several
decades, though it specialises in diabetics and cardiovascular patent medicines. The
interviewee from company N, which is a local Taiwanese pharmaceutical
manufacturing company, is a sales manager. The firm mainly focuses on injection
medicine products. The background information of each interviewee and the company
to which he or she belongs appears in Table 4.5.
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Table 4.5: Qualitative interviewee and belonged company background information
No.
1

Title of the
interviewee
Vice
Executive
Officer

Number
of
employee
700

Company
size: Capital
or Turnover
Capital:
US$33,000,00
0

NA

Capital:
US$12,000,00
0

The biggest producing company of
Taiwanese antibiotics.

80

Capital:
US$5,000,000

Producing human medicine, animal
medicine, facial skincare, healthy food,
API
(Active
Pharmaceutical
Ingredients), Refined Chemicals, and
medical supplies products

1100

Capital:
US$84,579,00
0

Company name

Business type

Taiwan Biotech co. Ltd. A
Taiwanese
local
pharmaceutical
manufacturing company
(company A)
FUJISAWA TAIWAN
CO., LTD. - A Japanese
original
medicine
company: Taiwan branch
(company B)
Gentle Pharma - A
Taiwanese
local
pharmaceutical
manufacturing company
(company C)
Yung Shin Phar. IND.
Co., Ltd - A Taiwanese
local
pharmaceutical
manufacturing company
(company D)

Producing western medicine, medical
medicine, medical supplies product,
healthy food, import and export trading,
offer medical information service and
health care service.
Producing antibiotics powder, injection,
capsule and pills.

2

Sales
Manager

3

Chairman

4

Management
Manager

5

Chief
Executive
Officer

Swiss Pharmaceutical Co
Ltd. - A Taiwanese local
pharmaceutical
manufacturing company
(company E)

Producing, processing and selling
western medicine and raw material,
animal medicine, Chinese medicine,
agricultural pesticides. Trading medicial
supplies products.

190

Capital:
US$5,200,000

6

Chief
Executive
Officer

Ying
Yuan
Pharmaceutical co., Ltd A
Taiwanese
local
pharmaceutical
manufacturing company
(company F)
Wide Pharmaceutical - A
commercial agent selling
European imported raw
material medicine and
local generic medicine
(company G)
CCPC - The largest
Taiwanese
local
pharmaceutical
manufacturing company
(company H)
Tanabe Pharmaceuticals
Taiwan, Ltd. - A
Japanese
original
medicine
company:
Taiwan branch (company
I)
Weal-Chance
Trading
Co. Ltd. - A business-tobusiness
marketing

R&D and selling NHI medicine, human
medicine, animal medicine.

160

Capital:
US$2,700,000

Exclusive distribute local pharmaceutical
products and serve as a general agent of
European medicine products

25

Turnover:
US$2,500,000

R&D and Generation of labor on
medicine and medical products. Serve as
medical brand agent and channel
marketing and provide home care
service.
Producing and selling NHI medical and
medicine products, and healthy food.
And sell as a consignee for any kind of
healthy food.

1000

Capital:
US$100,000,0
00

170

Capital:
US$3,000,000

Serve as a wholesaler of western and
Chinese medicine. Quoted price, bid and
sell local and foreign products. Act as an

NA

Capital:
US$250,000

7

Chief
Executive
Officer

8

Marketing
Department
Manager

9

Sales
Manager

10

Chairman
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11

Sales
Manager

12

Chairman

13

Sales
Manager

14

Sales
Manager

company
selling
European
imported
medicine
and
local
generic
medicine
(company J)
Pfizer (Taiwan) Co. Ltd.
- A leading U.S. original
medicine
company:
Taiwan branch (company
K)
Yang
De
Pharmaceutical Co Ltd. A commercial agent
selling
European
imported raw material
medicine
and
local
generic
medicine
(company L)
Takeda Pharmaceuticals
Taiwan, Ltd. - A
Japanese
original
medicine
company:
Taiwan branch (company
M)

Nang
Kuang
Pharmaceutical Co. Ltd. A
Taiwanese
local
pharmaceutical
manufacturing company
(company N)

agent, import and export healthy food,
customics, raw material medicine
products and toy.
R&D and producing all kinds of western
medicine products.

400

Capital:
US$9,100,000

Exclusive distribute local pharmaceutical
products and serve as a general agent of
European medicine products

10

Turnover:
US$1,000,000

Producing and selling medine and food
additives. Import foreign mother
company and related enterprise products;
buy raw material, finished products, and
semi-finished products to provide forign
Mother Company and related enterprises.
Import and export animal medicine,
forage and forage additives. Import,
export and sell environmental sanitation
medicine.
P roduci n g
west ern
medi cine
produ ct, especi al l y medi ci al drop
an d inj ect i on produ ct s.

NA

Capital:
US$3,000,000

300

Capital:
US$21,000,00
0

Note: NA = not available. The company identification information is for the examiners only and will be
deleted from the published thesis.

In conducting the interviews, questions based on the measurement items of each
construct were asked. For example, for the uses of corporate reputation construct,
questions such as: “What do you think are the uses of corporate reputation
dimensions?” and “Why?” were employed. More details about the questions can be
found in Appendix 2. Appendix 2 shows how the qualitative questions are related to
the research questions and the research hypotheses. It should be noted that content
and face validity 3are also examined in this step (Netemeyer et al., 2003). In this step,
3

The definition of several types of validity will be provided later in the last section of this chapter.
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a diagram (see Figure 3.1) representing the conceptual framework and a table of items
(see Table 4.2) were shown to the respondents. The respondents were asked if they
agreed with the list of existing items, or whether they could suggest additional items.

The information from the interviews was integrated with the items regenerated from
the literature. The questionnaire statements for these items were constructed by the
researcher. Afterwards, the first draft of the quantitative questionnaire was designed.

In general, the respondents agreed with the existing items shown during the
interviews; nobody suggested that any of the constructs be deleted. Rather, a few
additional items were suggested for insertion into relevant scales. Three major issues,
which were raised by the interviewees, are going to be stated one by one in the
following section.

4.5 Pilot Test

4.5.1 Measurement Scales of Corporate Background Variables

Measurement Scales of four corporate background variables known to affect
corporate reputation were adapted from existing literature and subjected to tests as
explained below.

Corporate history

A measurement scale for corporate history was developed

according to Balmer and Greyser (2006). The scale ranges from “less than 10 years”
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to “more than 81 years” of history. Since this data is an objective indicator, reliability
and validity tests were not needed.

Operating performance Operating performance can be measured in different ways.
In this study, since the researcher could not acquire financial figures of all private
companies, subjective performance indicators were used instead in hypotheses testing
as recommended by Dess and Robinson Jr. (1984) and Covin and Slevin (1989).
Turnover was the item used to measure this construct.

Corporate characteristics A measurement scale for corporate characteristics in this
study was adapted from the qualitative interview. The scale has “manufacturing +
sales

(America

original)”,

“manufacturing

+

sales

(European

original)”,

“manufacturing + sales (Asia [e.g. Japan, South Korea, India] original)”, “Dealer for
America original company products”, “Dealer for European original company
products”, “Dealer for Asia original company products”, “Local (Taiwan)
manufacturer + sales”. Respondents were asked to pick which one their business
belongs to. Since this data is an objective indicator, reliability and validity tests were
not needed.

Firm size Size has been operationalised in various ways in the literature. In this study,
number of staff was used as an indicator of size. Note that a monetary indicator such
as total assets was not employed because of the limited availability of data. Since this
data is an objective indicator, reliability and validity tests were not undertaken.

118

`

4.5.2 Sampling

Since it is not possible to collect data from all brand managers, the researcher
employed a sampling method to initiate a sample of pharmaceutical managers.
Sampling techniques can be divided into the two broad categories of probability and
non-probability samples (Churchill, 1996). In survey research, a probability sampling
method is generally more appropriate than a non-probability one because “the
resulting sample is likely to provide a representative cross-section of the whole”
(Denscombe, 2002, p. 12). Moreover, researchers can make an unambiguous
statement about “the accuracy and validity of the finding from the survey by
referencing to the degree of error and/or bias which may be present in it as measured
by well understood statistical methods” (Baker, 2002, p. 106).

In a probability

sample, “each member of the population has a known, nonzero chance of being
included in the sample. The chance of each member of the population being included
in the sample may not be equal, but everyone has probability of inclusion” (Churchill,
1996, p. 479).

Conversely, with non-probability samples, “there is no way of

estimating the probability that any population element will be included in the sample”
(Churchill, 1996, p. 479).

However, because of data protection, it is likely that the pharmaceutical companies
may not allow the researcher to access the staff database. In this case, the research
could neither identify nor enumerate sampling units. Therefore, a probability-based
sampling could not be conducted. However, when a probability-based sampling
cannot be conducted due to some limitations, a non-probability sampling technique is
considered to be an appropriate choice although the generalisability of statistical
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results can be relatively limited (Baker, 2002; Denscombe, 2002). Examples of nonprobability based sampling techniques include convenience samples, judgement
samples and quota samples (Churchill, 1996).

This study will use a judgement sample as a non-probability-based sampling
technique.

The key feature of this judgement is that population elements are

purposely selected because it is believed that they are representative of the population
of interest, and they are expected to serve the research propose (Churchill, 1996).
With a judgement sample, the researcher is not interested in sampling a cross-section
of opinion but rather in sampling those who can offer some perspective on the
research question (Churchill, 1996). Therefore, the researcher plans to distribute a
questionnaire to pharmaceutical managers because they tend to be familiar with brand
strategy decision making within the pharmaceutical industry.

4.5.3 Pretest Scale Items

Table 4.6: Pre-test Data Profile
Details about Questionnaires and Respondents
No. of Distributed Questionnaires
No. of Returned Questionnaires
Pharmaceutical managers and above

20 sets
16 sets (80 % response rate)
100 % of total respondents

Corporate history between 11 to 30 years
Corporate history between 30 to 50 years

81.25%
18.75%

Size more than 100 staff (include)

25 %

Size less than 100 staff (exclude)

75 %

Local company (manufacturing + sales )
Original company or dealers of European or
American pharmaceuticals

43.75 %
56.25 %
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Turnover over 150 million TW dollars
43.75 %
Turnover less than 150 million TW dollars
56.25 %
*(1 British pound = 1.45 US dollar = 50 TW dollars)

Source: Developed by the author

Participants were recruited from managers in the Taiwanese pharmaceutical industry.
Eighty per cent of distributed questionnaires (n=16) were returned online to the
researcher.

All respondents held the position of manager or above. The majority of the companies
(81.25 per cent) the respondents have a 31–50-year corporate history. The majority of
the companies (75per cent) have fewer than 100 staff. More than half (56.25 per cent)
are original companies or dealers of European or American pharmaceuticals, and
more than half (56.25 per cent) of the companies have less than 150 million TW
dollars turnover. Respondents were also randomly asked to indicate their opinion on
the clarity and comprehensibility of questionnaire items (Bearden et al., 2001; Kohli
et al., 1993).

4.5.4 Measurement Purification

The third step of Churchill’s (1979) paradigm involves reliability and validity 4testing
for the scale items because it is very important to ensure that the data which
researchers plan to collect is meaningful and accurate. Therefore, the researcher plans
to use expert judgement (managers or so-called practitioners) and the application of
the first draft of the questionnaire to a sample of individuals – i.e. a pilot study

4

See Section 4.6, for more details about the assessment of reliability and validity.
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(Churchill, 1979) in order to complete this step. Thus, the questionnaire containing
the items obtained from the existing literature and the qualitative study will be
distributed to respondents after the evaluation of the managers.

A pilot study will be conducted (de Vellis, 2003) followed by the pool of items
generated in the previous phase.

After the evaluation of the managers, the

questionnaires which contain all potential items will be distributed to group of up to
16 managers in companies within the Taiwanese pharmaceutical industry. Examples
from the literature suggest that pre-test sample sizes of up to 100 respondents are
appropriate (e.g., Diamantopoulos et al., 1994). However, because of the small total
number of people in the target group, the pilot study sample is small as well. In this
research, 20 sets of questionnaires were distributed in the pre-quantative-study and 16
were collected (80% response rate).

Based on the respondents’ experience within the pharmaceutical industry, they will be
asked to rate items on a scale from “1” (Strongly disagree) to “5” (Strongly agree).
Items extracted from English journals in the two steps above will be translated into
Taiwanese by the researcher and translated back into English by a qualified translator
in English language (Brislin, 1970). In addition, the researcher plans to randomly ask
the respondents to point out any item that is either ambiguous or difficult to answer
(Kohli et al., 1993). The data will then be subjected to a further purification process.
This will involve reliability analysis and exploratory factor analysis (EFA).
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4.5.5 Reliability Analysis

In line with Melewar (2001, p. 38), before the main survey is conducted, it is vital that
“the measures used are developed and investigated for their reliability”. According to
de Vellis (1991, p. 24) scale reliability is “the proportion of variance attributable to
the true score of the latent variable”. Based on the literature, the types of scale
reliability include: (1) internal consistency reliability, which is concerned with “the
homogeneity of the items comprising a scale” (de Vellis, 1991, p. 25; Churchill,
1979); 2) the test-retest reliability, which is concerned with “the stability of item
responses over time” (Nunnally, 1967,

p. 206); and (3) the alternative-form of

reliability, which refers to “the extent to which two different statements can be used to
measure the same construct at two different times” (Netemeyer et al., 2003, p. 46).
However, to be consistent with several authors (e.g. Churchill, 1979; de Vellis, 1991;
Melewar and Saunders, 1999; Melewar; 2001), the research refers to the scale
reliability as internal consistency reliability. Internal consistency implies that items
are highly inter-correlated (de Vellis, 1991; Melewar, 2001).

High inter-item

correlation infers that items of scale share a common core and measure the same thing
(de Vellis, 1991; Melewar, 2001; Netemeyer et al., 2003).

In order to assess the internal consistency, several researchers (e.g. Churchill, 1979;
de Vellis, 1991; Melewar, 2001) recommend measuring the coefficient alphas
(Cronbach, 1951). The coefficient α is widely used as a measure of reliability (de
Vellis, 1991). The research will, therefore, assess the internal consistency of a set of
items by measuring their coefficient alphas (Churchill, 1979). Internal consistency is
typically equated with Cronbach’s (1951) coefficient α. Theoretically, the coefficient
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α is concerned with “the degree of interrelatedness among a set of items designed to
measure a single construct” (Netemeyer et al., 2003, p. 49).

The coefficient α

(Cronbach, 1951) can be defined as:

The coefficient alpha (α) = N. / [ + (N-1). ]
Where:

N = the number of items in the scale
= the average variance
= the average of all correlation among items in the scale

The coefficient alphas will be computed as a means of checking the reliability of
measurement scales (Churchill, 1979; Melewar, 2001; de Vellis, 2003). According to
Melewar (2001, p. 39), “A low coefficient α indicates the sample of items performs
poorly in capturing the construct”. Based on a standard of reliability, it suggests that
the values of α equal to or above 0.70 indicate that the items are reliable (Nunnally,
1967; Nunnally and Bernstein, 1994; Melewar, 2001; de Vaus, 2002). Hair et al.
(2006) assert that a coefficient α which is greater than 0.70 is highly satisfactory for
most research purposes.

4.5.6 Pre-test

The purpose of the pre-test was to determine whether the survey questions were
contradictory or inappropriate before commencing formal research. The pre-test
process helped us to find out issues with the survey questions and to fix these issues.
Most importantly, it was to test the reliability and validity of the survey questionnaire.
According to Punck (1998:100), when the reliability of a questionnaire or a measure
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is pretty low, the difference between respondents is not a real difference but a faked
difference. Therefore, if a survey questionnaire that is used for collection of research
data is not stable, reliable and precise; the data collected will be questioned. The pretest questionnaire was reviewed by industry professionals and scholars, and issued to
the research target respondents, the managers of the pharmaceutical industry in
Taiwan, in March 2010. Because of a lack of respondents, we collected only 16
copies of the valid pre-test questionnaires, which were completed in detail by our
respondents. None of these questionnaires were invalid 5.

4.5.6.1 Validity Analysis
Validity of one measurement tool (or technique) refers to the preciseness and
accuracy of measurement results. In other words, validity asks to what degree the
expected targets are actually measured by the designated scale or questionnaire.
Validity of one measurement can be tested in three aspects. “Content Validity 6 ”
focuses on the extent to which a measure represents all facets of a given situation.
“Criterion-related validity 7 ” is used to demonstrate the accuracy of a measure or

5

One of the pretest samples was considered as invalid because one question in it was left unanswered.

Moving averages and the median method were not used to substitute the unanswered item.
6

Content Validity refers to the extent to which a measure represents all facets of a given situation.

Those who want to evaluate content validity need to be highly aware of target subjects of one
measurement, and to analysis measurement resulting systematically and logically. Validity content
focuses on breadth, coverage, and of content, coverage and richness to serve as the main basis for
external inference (Chiu, 2005; Lin, 2006, p.198).
7

Criterion-related validity is a measure of how well one variable or set of variables predicts an

outcome based on information from other variables. The key point for the measure is to select valid
criteria to reflect the validity of the score outcome. The criterion not only has to reflect the
characteristic and personality of an independent measure, but also has to be accepted by the public and
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procedure by comparing it with another measure or procedure which has been
demonstrated to be valid. “Construct Validity 8 ” refers to the degree to which a
theoretical definition matches an experimentally determined definition. However, it
was not possible to obtain construct validity by statistical analysis9, because only 16
samples were available for the pre-test.

The measurement was amended based on theoretical foundations demonstrated by
experts and scholars (Dickson and Ginter, 1987; Wong and Saunders, 1993). Some
items’ “factor loading” values which were below 0.5 and “Corrected Item-total
Correlation” value below 0.3 were deleted, thus resulting in a better Cronbach’s
Alpha (α) value (See the next section: Validity Analysis and Project Analysis for an
explanation in detail). This measure can still be trusted for its content validity on the
based on theoretical grounds.

general researchers as an index to specifically reflect a particular characteristic of the measurement
information. (An index, 2005; Lin, 2006, p.198).
8

Construct validity refers to the degree to which the theoretical constructs can be measured. Construct

validity includes convergent validity and discriminant validity. Convergent validity is the degree to
which an operation is similar to (converges on) other operations that it theoretically should also be
similar to. And similarities are highly expected between these two operations. Discriminant validity
describes the degree to which the operationalisation is not similar to (diverges from) other
operationalisations that it theoretically should not be similar to. Similarity between two operations is
not wanted in this case (Lin, 2006:199).
9

A factor analysis model is needed for the development of construct validity. A prerequisite to running

a factor analysis model is to consider the correlation between the sample size and the number of survey
questions. Normally, the sample size has to be three to five times larger than the number of survey
questions. However, the research includes too many survey questions and thus it is not going to be easy
to develop construct validity using a factor analysis model (Chen et al., 2003).
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Although it is impossible to ensure the validity of the questionnaire by factor analysis,
appropriate questions for the questionnaire can still be determined by project analysis
and reliability analysis. Project analysis and reliability analysis of the questionnaire
design were as follows:

4.5.6.2 Validity Analysis and Project Analysis
Project analysis of individual items in the questionnaire
A “consistency test” was used in this study to analyse factors, and factor analysis was
used to decide the final version of questionnaire. (see Table 4.6 for a project analysis
of the scale of Value Creation; Table 4.7 for a project analysis of the scale of Strategic
Value or Resources; Table 4.8 for a project analysis of the scale of Corporate
Communication; Table 4.9 for a project analysis of the scale of Brand Positioning;
Table 4.10 for a project analysis of the scale of Product Differentiation; Table 4.11 for
a project analysis of the scale of Product Segmentation; Table 4.12 for a project
analysis of the scale of Medicine Price). Consistency of questions in the
questionnaires was tested by “Cronbach’s α”, and according to the principle of
Cronbach’s α, the question (or item) with the highest Cronbach’s α values, on an
indicated dimension, were deleted. This was to ensure that all the questions in the
questionnaire consistently asked about the target characteristics.

The appropriateness of the questions was examined by modifying the correlation
coefficient between individual questions and overall scores. Questions (Q1, Q20 from
the value creation construct; Q6 from the corporate communication construct; Q7
from the brand positioning construct; Q6 from the brand differentiation construct; Q1,
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Q7 from the brand segmentation construct) were deleted because they had a Corrected
Item-total Correlation value lower than 0.3 in their correlation coefficients.

Confirmatory factor analysis (CFA), based on PLS (Partial Least Square), was used to
estimate the value of standardised factor loading. The value of standardised factor
loading was used as the criterion to test homogeneous consistency of Questions (Q1,
Q4, Q20, Q23 from the value creation construct; Q6, Q7 from the corporate
communication construct; Q3, Q7 from the brand positioning construct; Q6 from the
brand differentiation construct; Q1, Q7 from the brand segmentation construct; Q5
from the medicine price construct) were deleted because they had a standardised
factor loading value lower than 0.5.

Reliability analysis of questionnaires
Project analysis is used to examine the reliability of individual questions in the
questionnaire, and reliability analysis is used to estimate the reliability and stability of
the questionnaire. The coefficient of internal consistency10 of statistics, obtained from
the pre-test samples, has been examined by reliability analysis. The analysis results
indicated that the value of Cronbach’s α, in individual cases, were all higher than 0.7.
Based on this, the questionnaire was proved to be highly reliable.

10

Coefficient of internal consistency includes the alternate forms of reliability, split-half reliability,

Kuder-Richardson reliability (KR20). They all refer to the internal homogeneity, consistency, and
stability of the measuring instrument. α coefficient is now the most accepted criterion for judging
reliability (Chiu, 2005).
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(1) Project analysis and reliability analysis of the scale of “value creation” for the
purpose of measuring the uses of corporate reputation.

Table 4.7: Value creation items and reliability analysis
Questionnaire Questions

Factor
Loading

Corrected
Item-Total
Correlation

Cronbach’s
α if Item
Deleted

Cronbach’s α

1. Our firm’s corporate reputation promises
good quality products and service to
customers.

0.197

0.179

0.955

0.954

2. The corporate reputation of our firm helps
to reduce transaction costs.

0.849

0.799

0.951

3. Our firm competes by creating useful
products.

0.758

0.713

0.951

4.

Our firm competes by creating the correct
product attributes for its targeted
customers.

0.496

0.431

0.954

5. Our firm competes by providing good
financial performances.

0.852

0.807

0.951

6. Our firm competes by providing product
with appropriate outcomes.

0.902

0.884

0.950

7. Our firm’s value-chain activity is consistent
with functional value creation.

0.538

0.537

0.953

8. Our firm’s resource allocation is consistent
with functional value creation.

0.629

0.610

0.952

9. Our firm’s products compete by appealing
to the senses.

0.918

0.903

0.949

10. Our firm competes by creating appropriate
emotions (e.g. fun, pleasure, excitement,
relaxation, etc.)

0.924

0.913

0.948

11. Our firm competes by facilitating social
relationships (e.g. bonds, attachments and
togetherness).

0.809

0.790

0.950

12. Our firm competes by creating epistemic
value (e.g. knowledge and novelty).

0.923

0.909

0.948

13. Our firm’s value-chain activity is
consistent with experiential value creation
(e.g. happiness, affection and excitement...).

0.743

0.687

0.951

14. Our firm’s resource allocation is consistent
with experiential value creation.

0.778

0.729

0.951

15. Our firm competes by enhancing its
customers’ self-identity.

0.769

0.767

0.951

16. Our firm competes by enhancing its
customers’ self-concept (or self-image).

0.836

0.823

0.950
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17. Our firm competes by enhancing its
customers’ self-worth.

0.664

0.616

0.952

18. Our firm competes by facilitating selfexpression.

0.802

0.795

0.950

19. Our firm competes by offering economic
value (low prices, value in use, life costs).

0.745

0.693

0.952

20. Our firm competes by simplifying the
purchasing process for its consumers (ease of
use, ease of doing business, simplicity, and
availability of purchasing, accessibility).

0.338

0.299

0.957

21. Our firm competes by enabling ease of use
of its products (time, effort, energy).

0.725

0.666

0.952

22. Our firm competes by minimising customer
risk (personal, technological, strategic).

0.522

0.498

0.954

23. Our firm’s value-chain activity is consistent
with symbolic value creation.

0.500

0.496

0.954

24. Our firm’s resource allocation is consistent
with symbolic value creation.

0.623

0.618

0.952

(2) Project analysis and reliability analysis of the scale of “strategic resources” in the purpose
of measuring the uses of corporate reputation

Table 4.8: Strategic resources items and reliability analysis
Questionnaire Questions

Factor
Loading

1. In our organization, corporate reputation
serves as a competitive advantage.

0.928

0.884

Cronbach’s α if
Item
Deleted
0.935

2. Our firm’s corporate reputation sends a
strong signal to its customers.

0.532

0.541

0.939

3. Our firm’s corporate reputation implies
efficient sales and marketing.

0.609

0.619

0.937

4. Our firm’s corporate reputation implies it
has advanced R&D.

0.578

0.558

0.940

5. Our firm’s corporate reputation implies
that we are able to enter markets early.

0.932

0.877

0.929

6. Our firm’s corporate reputation gains the
firm more opportunity for strategic alliance
or business cooperation.

0.689

0.697

0.935

7. Our firm’s corporate reputation is
enhancing the prices by validating them in
published clinical reports.

0.675

0.605

0.937
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8. Our firm’s corporate reputation enables
the firm to enter the market more easily.

0.814

0.742

0.933

9. Our firm’s corporate reputation gains
more customers for the firm.

0.933

0.918

0.928

10. Our firm’s corporate reputation makes
the marketing system work more efficiently.

0.926

0.867

0.929

11. Our firm’s corporate reputation makes it
easier for us to find a downstream reseller.

0.843

0.785

0.932

12. Our firm’s corporate reputation can
enhance our firm’s sales force.

0.698

0.637

0.937

13. Our firm’s corporate reputation helps the
new product to enter the market.

0.822

0.738

0.933

14. Our firm’s corporate reputation helps the
strategic link with complementary products.

0.778

0.702

0.935

(3) Project analysis and reliability analysis of the scale of “corporate communication” for the
purpose of measuring the uses of corporate reputation

Table 4.9: Corporate communication items and reliability analysis
Questionnaire Questions

Factor
Loading

1. Our firm’s corporate reputation shapes
the perceptions of shareholders and other
stakeholders.

0.624

Corrected
Item-Total
Correlation
0.599

2. Our firm’s corporate reputation builds a
relationship between the firm and its
customers.

0.770

0.657

0.817

3. Our firm’s corporate
influences consumer choices.

reputation

0.880

0.866

0.797

4. Our firm’s corporate reputation is based
on the experience of the sales people.

0.793

0.642

0.817

5. Our firm’s corporate reputation is based
on the sales ability of the sales people.

0.772

0.647

0.816

6. Our firm’s corporate reputation is based
on the firm's awareness of social
responsibility.

0.278

0.252

0.862

7. Our firm’s corporate reputation can be
used for all types of negotiations with our
customers, competitors or the government.

0.387

0.326

0.857

8. Our firm’s corporate reputation helps
internal
communication
(the
communication between our firm and our
staffs).

0.899

0.732

0.809
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9. Our firm’s corporate reputation helps
external
communication
(the
communication between our firm and our
customers).

0.802

0.629

0.830

(4) Project analysis and reliability analysis of the scale of “brand positioning” for the purpose
of measuring brand image strategy

Table 4.10: Brand positioning items and reliability analysis
Questionnaire Questions

Factor
Loading

1. Our firm’s corporate brand positioning
strategy signifies high quality to its
customers.

0.796

Corrected
Item-Total
Correlation
0.557

Cronbach’s
α if Item
Deleted
0.719

2. Our firm’s corporate brand positioning
strategy
signifies
better
product
performance for its customers.

0.820

0.562

0.721

3. Our firm’s corporate brand positioning
strategy is to achieve a higher frequency of
advertising.

0.468

0.406

0.733

4. Our firm’s corporate brand positioning
strategy involves a long distribution chain.

0.842

0.790

0.613

5. Our firm’s corporate brand positioning
strategy is to provide a much better service
to its customers.

0.680

0.407

0.730

6. Our firm’s corporate brand positioning
strategy tries to fulfil the basic needs of our
customers.

0.632

0.597

0.678

7. Our firm’s corporate brand positioning
strategy tries to target upmarket audiences.

0.483

0.299

0.766

Cronba
ch’s α
0.744

(5) Project analysis and reliability analysis of the scale of “product differentiation” for the
purpose of measuring brand image strategy

Table 4.11: Brand differentiation items and reliability analysis
Questionnaire Questions

Factor
Loading
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1. Our corporate brand is perceived
differently according to whether consumers
have experienced our products.

0.820

0.667

0.728

2. Our corporate brand is
differently by word of mouth.

perceived

0.818

0.660

0.743

3. Our corporate brand
differently by promotion.

perceived

0.722

0.529

0.744

4. Our corporate brand is actually created
differently by product characteristics.

0.652

0.531

0.739

5. Our corporate branding may be directed at
different market segments.

0.858

0.793

0.708

6. Our corporate brand may utilize physical
product characteristics.

0.095

0.026

0.824

7. Our corporate brand may utilise nonphysical product characteristics.

0.618

0.475

0.757

8. Our firm’s corporate brand positioning
strategy is based on advanced R&D which
leads the needs of the targeted market.

0.749

0.657

0.721

is

0.772

(6) Project analysis and reliability analysis of the scale of “product segmentation” for the
purpose of measuring brand image strategy

Table 4.12: Brand segmentation items and reliability analysis
Questionnaire Questions

Factor
Loading

1. Our corporate brand strategy has one
particular form of demand function
modification.

0.396

Corrected
Item-Total
Correlation
0.255

2. Our corporate brand strategy requires
product differentiation.

0.807

0.603

0.700

3. Our corporate brand strategy requires
changes in point distribution location.

0.840

0.660

0.662

4. Our corporate brand strategy requires
changes in importance attached to a nonphysical product.

0.855

0.667

0.668

5. Our corporate brand strategy requires
changes in importance attached to a physical
product.

0.695

0.402

0.729

6. Our corporate brand strategy is decided by
the needs of the customers to decide the
product differentiation.

0.564

0.553

0.696

7. Our corporate brand strategy is based on
different channels of distribution.

0.205

0.219

0.778
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(7) Project analysis and reliability analysis of the scale of “medication price” for the purpose
of measuring medication price

Table 4.13: Medicine price construct and reliability analysis
Factor
Loadin
g
0.7896

Corrected
Item-Total
Correlation
0.581

Cronbach’s
α if Item
Deleted
0.814

2. A medicine with a higher price shows a better
image of the company it belongs to.

0.7879

0.648

0.801

3. A medicine with a higher price usually
captures the value that is generated in the
product.

0.5422

0.565

0.812

4. Our firm customises price by value that is
perceived by our customers.

0.5219

0.444

0.822

5. Our firm customises price by distinguishing
customers who pursue high values and customers
with strict budgets.

0.4377

0.534

0.812

6. Our firm customises price by offering coupons,
regional prices, limited consumption or
negotiatory prices to a specific group of
customers.

0.7374

0.444

0.829

7. Our firm customises price according to the
characteristics of the customers.

0.7926

0.670

0.794

8. Our firms customise price according to the
trading characteristics.

0.5919

0.689

0.792

9. Our firm pays considerable attention to
effective publicity and communication while
operating bulk buying/discounts.

0.7896

0.404

0.824

Questionnaire Questions
1. A medicine with a higher price shows a higher
quality of product to its customers.

4.6 Main Survey

4.6.1 Targeted Respondents and Collection Procedure
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Following the development of the measurement scales, a main questionnaire survey
was conducted with pharmaceutical companies in Taiwan. In this section, the target
respondents and the data collection procedure in this research will be discussed.

4.6.1.1 Targeted respondents
The targeted participants of the main survey were managers (marketing managers,
sales managers, general managers and business executives) from the pharmaceutical
industry in Taiwan. The pharmaceutical companies were chosen because it was
argued in the previous literature that a firm’s corporate reputation has a huge impact
on its financial performance (Sobol and Farrell, 1988; Deephouse, 1997; Brown, 1997;
Roberts and Dowling, 1997; Caruana, 1997; Sabate and Puente, 2003). However, in
the relationship between a firm’s reputation and its performance, there are some
issues regarding how each strategist sets and generates their segmentation and
positioning strategies.

Therefore, the respondents for this study needed to have

experience in setting brand strategies which related to several strategies of corporate
reputation. Such experience was held by the Taiwanese respondents in this study. The
respondents were asked questions regarding the effects of the uses of corporate
reputation on brand image strategy setting.

4.6.1.2 Data collection procedure
The researcher started the procedure by contacting a relevant professional association
to ask for its support and more information about the Taiwanese pharmaceutical
companies. The Taiwanese BNHI (Bureau of National Health Insurance) provides a
list of contacts of its association members.
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pharmaceutical companies in the Taiwanese pharmaceutical industry in the database
to inform them about this research project and to confirm their current addresses.

Since it is not possible to collect data from all managers, the researcher employed a
sampling method to initiate a sample of pharmaceutical managers. However, because
of data protection, it is likely that the pharmaceutical companies may not allow the
researcher to access the staff database.

In this case, the research could neither

identify nor enumerate sampling units. Therefore, a probability-based sampling could
not be conducted. However, when a probability-based sampling cannot be conducted
due to some limitations, a non-probability sampling technique is considered to be an
appropriate choice although the generalisability of statistical results can be relatively
limited (Baker, 2002; Denscombe, 2002).

In this study, a judgement sample as a non-probability-based sampling technique was
used. The researcher plans to distribute a questionnaire to pharmaceutical managers
because they tend to be familiar with brand strategy decision making within the
pharmaceutical industry.

It is noted that this sampling method may be biased toward the respondents (brand
managers) because they may evaluate managers’ strategic decisions on the adoption
of the uses of corporate reputation based on a firm’s strategic use of its intangible
assets rather than as a consequence of a firm’s operation. However, the chosen group
of brand managers were desirable for this study because it was the group that could
estimate the effects of the uses of corporate reputation in pharmaceuticals on brand
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image strategy. Moreover, it was one of the most accessible groups of respondents,
which could help to facilitate the survey process.

The 61 probability selected samples (of the 200 overall targeted respondents) were
collected from an online survey and are anonymous. Appendix 5 presents the targeted
respondents and their company background information (i.e., firm history, firm size,
position of the respondent in the company, and service the company provide).

4.6.1.3 Sample size
The researcher used confirmatory factor analysis (CFA) for finalising the scales (de
Vellis, 1991). A minimal sample size for CFA is usually recommended to be more
than the number of covariances in the input data matrix (Netemeyer et al., 2003; Hair
et al., 2006). The researcher plans to use PLS (Partial Least Squares, one of the
structural equation modelling software) to perform CFA. However, an empirical ratio
of at least five observations per parameter has also been proposed (Bollen, 1989;
Joreskog and Sorbom, 1989). Floyd and Widaman (1995) assert that a sample size of
around five to ten observations per parameter is likely to be sufficient. Based on the
discussion above, the sample size in this study will be approximately 60.

Therefore, PLS was chosen because of small sample size of this research. However,
as identified 173 companies, the target respondents are managers in Taiwanese
pharmaceutical industry, and the whole population of the target respondents is around
200. Therefore, this small sample size was considered and tested by suitable software
designed for a small number of respondents, namely PLS.
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Table 4.14 illustrates the study’s overall domain, including corresponding items.
Table 4.14: Details about questionnaires and respondents
Number of distributed questionnaires to managers
Number of questionnaires received from managers
Usable questionnaires

200 sets
61 sets (30% response rate)
61 sets

Corporate history less than 30 years
Corporate history more than 30 years

65%
35%

Size more than 100 employees (include)
Size less than 100 employees (exclude)

65.57 %
34.43 %

Local company (manufacturing + sales )
Original company or dealers in European pharmaceuticals
Original company or dealers in American pharmaceuticals
Original company or dealers in Asian pharmaceuticals

43.37 %
15.66 %
18.07 %
22.89 %

Turnover over 16.67 million US dollars
Turnover between 1.67 and 16.67 million US dollars
Turnover below 1.67 million US dollars
*(1 British pound = 1.45 US dollars = 50 TWDollars)

25%
52%
23%

The quantitative questionnaires were collected through an online questionnaire
website. At the beginning of the questionnaire, respondents specified the background
information of their firm, including company history, company size, and the service
each company provided. Of the 61 respondent companies, 14 (23%) had company
turnovers below US$1.67 million, 15 (25%) had company turnovers over US$16.67
million, and 32 (52%) had company turnover between US$1.67 million and US$1.67
million. In addition, in all companies, staff numbers were fewer than 3,000 people.
Therefore, 75% of the surveyed companies were categorised as small to mediumsized enterprises (which is the main component of the Taiwanese business
environment). Moreover, 66% of surveyed companies had fewer than 100 people, 21
(34%) had more than 100 people, and 7 (11%) had an even number of 300 staff
members.
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4.6.2 Data analysis techniques

Following the main survey, confirmatory factor analysis (CFA) was performed on the
main survey data. The following sections will discuss the data analysis techniques
which the researcher plans to apply to this study.

4.6.2.1 Confirmatory factor analysis (CFA)
Following the main survey, purified measurement scales were to be subjected to
confirmatory factor analysis (CFA) as a method to finalise the scales (de Vellis,
1991). CFA was performed on the main survey data (Gerbing and Anderson, 1988;
Diamantopoulos and Siguaw, 2000; Hair et al., 2006). According to de Vellis (1991),
CFA is used to confirm that the number of latent variables underlying the items
corresponds to the number that the researcher expects.

Moreover, “if the factor

analysis ‘discovers’ precisely the item groupings that [researchers] intended when
creating the items, [the researchers] will have strong confirmation of their initial
hypothesis concerning how the items should relate to one another” (de Vellis, 1991, p.
109).

In this study, CFA was used for testing whether the pre-specified relationship
predicted by the theory is presented in the data (Huang, 2001; Hair et al., 2006). Like
EFA, CFA can be used to reduce the number of items (Netemeyer at al., 1996).
However, the researcher employed CFA after EFA had been performed on the data
obtained from the pilot study. This is because EFA can provide insight about the
potential dimensionality by revealing items that load poorly on an intended factor or
load highly on more than one factor, whereas CFA can assess both the quality of a
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factor solution and the specific parameters which constitute a model (Kelloway,
1998). Generally, CFA is used as an assessment of construct validity 11to ensure that
the theoretical meaning of a construct is empirically captured by its indicators
(Steenkamp and van Trijp, 1991). This basis is very important for theory testing and
development (Steenkamp and van Trijp, 1991).

Following recommendations by Anderson and Gerbing (1982, 1988), the researcher
conducted model-testing in two stages. The first stage was the development of a
measurement model. This was to confirm the relationships between the construct and
its indicators. The second stage involved the testing of the model to show the causal
relationships between the latent constructs (Anderson and Gerbing, 1982;
Diamantopoulos and Siguaw, 2000).

Testing the measurement model was assisted by CFA (Diamantopoulos and Siguaw,
2000).

When the measurement model was estimated using CFA, the fundamental

dimensions which affect the validity of a construct were assessed (Anderson and
Gergin, 1988). The dimensions of construct validation include: unidimensionality of
a construct; reliability; convergent validity; discriminant validity; and nomological
validity 12 13(Peter, 1981; Anderson and Gergin, 1988, Steenkamp and Trijp, 1991).
The research used PLS, structural equation modelling software, to perform CFA.

4.6.2.2 Model testing

11

More details about an assessment of construct validity will be provided later in section 4.6.2.3.

12

The definition of several types of validity will be provided later in section 4.6.2.3.

13

More details about the assessment of validity can be found in Section 4.6.2.3.
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Anderson and Gerbing (1988, p.416) state that “after a measurement model has been
estimated, a researcher should assess how well the specified model accounted for the
data with one or more overall goodness-of-fit indices”. In order to test how well a
measurement model fits a set of observations, researchers are recommended to assess
the model’s overall fit. The aim of a model’s overall fit is to confirm that consistency
of a theoretical model and confirm that the estimated model is based on the observed
values (Diamantopoulos and Siguaw, 2000; Hair et al., 2006). The model’s overall fit
is evaluated on the basis of both incremental and absolute goodness of fit measures.
Although, there are many statistics developed to test the overall fit of a model
(Joreskog and Sorbom, 1989), none of them alone can provide an absolute assurance
of model fit. Each measure can be superior to the others under different conditions
such as “sample size, estimation procedure, model complexity, violation of
underlying assumptions of multivariate normality and variable independence”
(Diamantopoulos and Siguaw, 2000, p.83).

The goodness-of-fit measures indicate the extent to which the sample covariances are
reproduced by the observed covariance or correlation matrix (Hair et al., 2006). The
researcher used all the indices to select the best latent variable for the model as
suggested by modification indices and fit indices (Gerbing and Anderson, 1988;
Kohli et al., 1993). The final variable that has the appropriate indices was selected.
Then, the average value of each item was used to represent the latent variables.
Afterwards, the latent variables were used in the hypotheses. Composite score (i.e.
summated score), which is the average of value of each item, was used to represent
the latent variables used in the hypotheses testing (Netemayer et al., 2003; Hair et al.,
2006).
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4.6.2.3 The assessment of reliability and validity
According to the research processes of this study, after the content and the relevance
of the multi-item scales had been refined on the basis of qualitative and quantitative
data gathered from the exploratory research and the pilot study, the scale was
validated on the basis of the quantitative data obtained from the main survey.
Following the main survey, confirmatory factor analysis (CFA) was performed on the
main survey data, followed by the model testing (Gerbing and Anderson, 1988; Hair
et al., 2006; Diamantopoulos and Siguaw, 2000). Based on the research design, the
assessment of reliability and validity during these processes is discussed in this
section.

Several marketing researchers (e.g. Jacoby, 1978; Churchill, 1979; Peter, 1979; 1981;
Zaichkowsky, 1985; Lichtenstein et al., 1990; Kotabe, 1990; Melewar; 2001)
emphasised the need for attention to be paid to investigating the validity and
reliability of measures used. Validity refers to “the degree to which instruments truly
measure the constructs which they are intended to measure” (Peter, 1979, p.6),
whereas according to Peter (1979, p. 6), reliability is a necessary condition for validity
as it ensures that “measures are free from error and therefore yield consistent results”.
In order to assess reliability, coefficient α is the basic statistic for determining the
reliability of a measure (Churchill, 1979).

As discussed earlier (See Section 4.5.5), this research assessed the reliability (internal
consistency reliability) by measuring the coefficient alphas as well as item-to-total
correlations. The coefficient α is widely used as a measure of reliability (de Vellis,
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1991). A coefficient α check was initially applied to quantitative data gathered from
the pilot study. Theoretically, the coefficient α is concerned with “the degree of
interrelatedness among a set of items designed to measure a single construct”
(Netemeyer et al., 2003, p. 49). The coefficient alphas were computed as a mean to
check for the reliability of the measurement scales (Churchill, 1979; de Vellis, 2003).
Based on a standard of reliability, values of α equal to or above 0.70 indicate
reliability (Nunnally, 1967; Nunnally and Bernstein, 1994; de Vaus, 2002; Hair et al.
(2006). While an item-to-total correlation was above 0.35, the question needed to be
corrected (Saxe and Weitz, 1982).

In addition, to finalise a measurement scale, it is very important that measurement
scale validity also be investigated. Scale validity refers to the extent to which an
operational measure truly reflects the concept being investigated or the extent to
which the latent construct is the underlying cause of item co-variation (de Vellis,
2003; Peter, 1981). In line with existing research (e.g. Peter and Churchill, 1986;
Melewar and Karaosmanoglu, 2006), the types of validity which will be evaluated in
this study are: (1) content validity; (2) face validity; (3) convergent validity; (4)
discriminant validity; (5) nomological validity; and (6) ecological validity (see Table
4.15).

Table 4.15: Types of validity assessment in this study
Types
Content validity

Definitions
refers to the extent by which the elements of measurement scales are
relevant to, and representative of, the targeted construct for a particular
assessment purpose

Face validity

refers to an assessment of how adequately items of a scale measure the
construct of interest

Convergent validity

refers to the extent to which independent measures of the same construct
converge or are highly correlated
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Discriminant validity

refers to the extent to which measures diverge from other
operationalisations from which the construct is conceptually distinct

Nomological validity

refers to the examination of the hypothesised relationships between
constructs and the empirical link between indicators and their underlining
dimensions

Ecological validity

refers to the degree to which the behaviour observed in a study reflect the
behaviour that actually occurs in natural settings (Denscombe, 2002).

Source: Based on the literature (e.g. Peter, 1981; Peter and Churchill, 1986;
Denscombe, 2002; Morgan et al., 2004; Homburg and Furst, 2005; Netemeyer et al.,
2005)

In this research, content validity and face validity of scale were examined in the
second step of the scale’s development procedure (Figure 4.2). Content validity
evaluates the overall validity of the measures used in the data collection instrument
(Peter and Churchill, 1986). It is used to assess the extent by which the elements of
measurement scales are relevant to and representative of the targeted construct for a
particular assessment purpose. Face validity is used to assess the extent by which
items on a scale adequately measure the construct of interest. In order to assess
content validity and face validity, the list of domains and examples of scale items
were shown to the interviewees.

Respondents were asked to give opinions on

whether they agree with the lists and provide specific reasons, if any.

Convergent and discriminant validity were assessed after the confirmatory factor
analysis had been performed (Anderson and Gerbing, 1988). In other words, the
convergent and discriminant validity were assessed when testing the measurement
model. Convergent validity refers to the extent by which the latent variable correlates
to indicators pre-specified to measure the same latent variable (Peter and Churchill,
1986; Anderson and Gerbing, 1988; Steenkamp and van Trijp, 1991). It can be
assessed by examining whether the factor loadings of items (i.e. pattern coefficient) in
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their respective constructs are large 14 and statistically significant 15 (Anderson and
Gerbing, 1988; Joreskog and Sorbom, 1996).

The presence of discriminant validity is indicated when the correlation between two
constructs is significantly lower than 1.00 (Anderson and Gerbing, 1988). According
to (Joreskog and Sorbom, 1996, p. 416), discriminant validity is assessed for each pair
of constructs at a time “by constraining the estimated correlation parameter between
them to unity (1.0) and then performing a chi-square difference test on the values
obtained for the constrained and unconstrained models”. A significantly lower chisquare value for the model in which the correlations between latent variables are not
constrained to unity indicates that those latent variables are not perfectly correlated
and that discriminant validity is achieved (Bagozzi and Phillips, 1982)

Convergent and discriminant validity are subtypes of construct validity.

A validity

of a construct is an essential condition for further theory testing and development
(Carmines and Zeller, 1979; Steenkamp and van Trijp, 1991). Construct validity
(Cronbach and Meehl, 1955 cited in de Vellis, 1991, p.47) is concerned with the
theoretical relationship of one variable to other variables. Validity of a construct
implies the degree to which the construct is empirically captured by its indicators
(Steenkamp and van Trijp, 1991). According to several authors (e.g. Peter, 1981;
Gerbing and Anderson, 1988; Steenkamp and van Trijp, 1991), apart from the
convergent validity and the discriminant validity, in order to claim that a construct is
14

Factor loading which is equal to or greater than 0.6 is considered the minimum level at which

convergent validity could be suggested(Bagozzi and Yi, 1998)
15

Any factor loading whose corresponding t-value is greater than 1.96 for 95% confidence level will be

considered statistically significant.
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valid the following criteria should also be assessed: unidimensionality of a construct;
reliability and nomological validity.

When the measurement model is estimated using CFA (Chau, 1997; Diamantopoulos
and Siguaw, 2000; Huang, 2001), the unidimensionality of a construct, reliability and
nomological validity can be also assessed. The researcher used EFA (after the pilot
study) and CFA (after the main survey) for testing the unidimensionality of a scale.
According to Anderson and Gerbing (1988), the unidimensionality of a construct
should be achieved initially before any attempt at further theory testing (Anderson
and Gerbing, 1988) because it implies that the multiple indicators of a construct are
internally consistent and externally distinct from other measures. CFA ensures that a
construct is unidimensional, so that it is composed of a set of logical (theoretical)
indicators (Gerbing and Anderson, 1988; Steenkamp and van Trijp, 1991; Hair et al.,
2006). It permits the computation of the criteria for assessing convergent validity,
discriminate validity, as well as nomological validity.

As discussed earlier, given acceptable convergent and discriminate validity, CFA as a
test of structural model then constitutes a confirmatory assessment of nomological
validity (Anderson and Gerbing, 1988).

Nomological validity refers to the

examination of the hypothesised relationships between constructs and the empirical
link between indicators and their underlining dimensions (Peter, 1981; Peter and
Churchill, 1986). In short, it concerns the overall fit of a model. Lagas (2000) and
Steenkamp and van Trijp (1991) suggest the utilisation of goodness-of-fit indices in
order to assess nomological validity.
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In addition, ecological validity is considered in this study.

Melewar and

Karaosmanoglu (2006, p. 847) state that “any theoretical or conceptual argument
needs to be tested in actual application” (also See Allen and Janiszewski, 1989). A
study which does not represent the actual procedure of a real-life situation is seen as
being low in ecological validity, whereas a study which can be generalised beyond the
setting in which the study was carried out is seen as high in ecological validity
(Brewer, 2000). Ecological validity is the degree to which the behaviour observed in
a study reflects the behaviour that actually occurs in natural settings (Denscombe,
2002).

It refers to how well findings from a study are linked to the social

environment in which they occurred (Denscombe, 2002).

For a study to have

ecological validity, the methods and setting of the study must approximate the reallife situation that is under investigation (Brewer, 2000). Ecological validity is closely
related to external validity, which states the limits of generalisation that
operationalisation imposes (Payne and Payne, 2004). However, a study that has
ecological validity may not have external validity because they are independent
(Brewer, 2000; Shadish et al., 2002). Nevertheless, improving the ecological validity
of a study typically improves the external validity (Brewer, 2000; Shadish et al.,
2002).

The aim of this research is to develop a better understanding of branding strategy
decisions in pharmaceutical companies through examining three dimensions of the
uses of corporate reputations and for the manager to put these into their strategy
decision considerations. The researcher has reviewed the existing literature on the
uses of the corporate reputation concept and the effects of brand image strategy.
Following this, the researcher has proposed a conceptual model of the uses of
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corporate reputation in pharmaceutical companies based on the literature.

The

researcher plans to empirically examine how the effects of the uses of corporate
reputation are in practice, in comparison to its theoretically defined effects.

By

examining the brand managers’ views, the researcher will demonstrate how each
dimension of the uses of corporate reputation and its effects have been explained and
perceived in practice from the pharmaceutical brand manager’s perspective. In line
with Melewar and Karaosmanoglu (2006), the researcher believes that this approach
will enable the researcher to operationalise the proposed conceptual framework by
examining it in an “ecologically valid environment” (Smith et al., 1998, p. 64) rather
than at a theoretical level. The findings of this study are linked to the real-life social
environment in which they occurred, which means this study has ecological validity
(Denscombe, 2002).

4.7 Hypothesis Testing

After testing the scale for reliably and validity, the hypothesised relationships will be
assessed.

PLS (Partial Least Squares) will be used at the expense of structural

equation modelling (SEM), even though SEM is appropriate for simultaneously
testing structural relationships among latent variables.

The researcher plans to employ PLS, in order to test the research hypotheses. The
researcher will use a regression model to test the model, which consists of three
independent

variables:

value

creation,
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communication; one moderator variable (medicine price); and three dependent
variables (brand segmentation, brand differentiation and brand positioning).

As suggested by Baron and Kenny (1986), in order to test for moderating effects, the
first step of hypothesis testing is to find the significant level for the relationships
between the independent variables and the dependent variable. The second step is
then to find the significant level for the relationships between the moderator variables
and the dependent variable. Subsequently, the moderator hypotheses are supported if
the interactions between moderator variables and independent variables are
significant.

4.8 Summary

In summary, this chapter has discussed the research design of the study and the detail
of each stage has been presented. A mixed-method, with a quantitative basis, is
employed in this study. In order to develop measurement scales for constructs in the
model, the procedures for developing measurement suggested by Churchill (1979) are
mainly employed.

The research design incorporates information from three stages of data collection.
First, the qualitative research (exploratory research) will be conducted – these are the
in-depth interviews. This phase is expected to provide more insights into the subject
of interest, and to support the design of the research instrument. Then, the first draft
of the qualitative questionnaire (see Appendix 3) will be designed based on the items
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generated from interviews and existing literature. After that, a pilot study will be
conducted in order to purify the measurement. Subsequently, questionnaires
containing purified items from this step will be edited and prepared for the main
survey. The results from the survey will then be used to test the hypotheses.

This research attempts to examine the relationship between firms’ use of corporate
reputation and their brand image strategy. During the decision-making process, firms’
use three types of activities related to corporate reputation—namely value creation,
strategic resources and corporate communication—to help inform their brand image
strategy. Therefore, in line with the quantitative research presented previously, this
study hypothesises that the three types of corporate reputation positively influence
three types of brand image strategy (brand segmentation, brand differentiation and
brand positioning). Table 4.16 provides a list of the summarised hypotheses and the
research framework.

Table 4.16: Summary hypotheses and research framework
H1

Value creation, as one dimension of the uses of corporate reputation, has a positive
impact on a firm’s brand segmentation strategy.

H2

Value creation, as one dimension of the uses of corporate reputation, has a positive
impact on a firm’s brand differentiation strategy.

H3

Value creation, as one dimension of the uses of corporate reputation, has a positive
impact on a firm’s brand positioning strategy.

H4

Strategic resource, as one dimension of the uses of corporate reputation, has a positive
impact on a firm’s brand segmentation strategy.

H5

Strategic resource, as one dimension of the uses of corporate reputation, has a positive
impact on a firm’s brand differentiation strategy.

H6

Strategic resource, as one dimension of the uses of corporate reputation, has a positive
impact on a firm’s brand positioning strategy.

H7

Corporate communication, as one dimension of the uses of corporate
reputation, has a positive impact on a firm’s brand segmentation strategy.

H8

Corporate communication, as one dimension of the uses of corporate reputation, has a
positive impact on a firm’s brand differentiation strategy.

H9

Corporate communication, as one dimension of the uses of corporate reputation, has a
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positive impact on a firm’s brand positioning strategy.
H10

Medicine price moderate the relationship between the uses of corporate reputaiton and
brand image strategy.
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CHAPTER FIVE: DATA ANALYSIS AND
RESEARCH FINDINGS

5.1 Introduction

Firstly, this chapter presents the qualitative result. Content analysis was used to
analyse the 14 interview findings. Secondly, this chapter provides an explanation of
how the quantative study was completed by explaining the data analysis and results. It
details the process of the data collection and the results. As discussed in Chapter 4,
this involved a multi-stage procedure. The data examination and the screening to
prepare for subsequent quantitative analyses are presented first, followed by the
descriptive statistics. A reliability test was performed on the measurement scales to
ensure that they achieve an acceptable level of reliability for further analysis. The
resulting solutions were then re-assessed using confirmatory factor analysis. Finally,
PLS (Partial Least Squares) was used to test the hypothesized relationships between
the research constructs as postulated in the conceptual model, and to assess the overall
goodness-of-fit between the proposed model and the collected data set. Conclusions
are drawn in the last section.

5.2 Qualitative Interview Findings

5.2.1 Interviews about the Uses of Corporate Reputation
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5.2.1.1 Interview results on value creation
The experts generally clearly believe that value creation is important. Experts
discussed the importance of the ability to create value for the uses of corporate
reputation in pharmaceutical companies as follows:

“We can discuss the value of brand from two different aspects.
Brand value could be considered as a brand reputation that people
recognize. Employees’ commitment toward this company, in fact, is
actually the strength to support a brand value from inside out. By
saying employees’ commitment, I mean that workers and their
family members must be proud of this company. One company can
make a brand name more famous by stretching its tentacles to
different industries. Take our company as an example; our company
might want to invest in [the] real estate industry. By expanding a
company’s size like this, it is possible that this company will
eventually become a conglomerate. I have gone too far. What I
really want to say is that a company with a good reputation will
always attempt to expand its size.” [Manager in company #F]

“What we value the most is the remedial effect of the medicine. It is
fair to say that medication from original pharmaceutical companies
is usually more expensive. Lots of people believe that an expensive
drug guarantees its effects. However, I focus more on the efficacy of
the medication. Our company is now one of the biggest
pharmaceutical companies in Taiwan, and manufactures drugs with
better quality. Good quality of medicine and affordable price are the
two most important factors for a pharmaceutical company to
promote its products. A pharmaceutical company needs to firstly
make one product affordable for customers. Besides, it needs to
provide medication with good quality to its customers.” [Manager
in company #A]
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Additionally, the value created by the firm helps a firm to establish their
marketing plan. The following comment of an interviewee reflects these points:

“A: A pharmacist could persuade a customer to buy one product by
saying this product is manufactured by a famous pharmaceutical
company. A pharmacist who says this is not standing on the
patient’s side. An original or big pharmaceutical company tends to
convince customers by its company image and value of performance.
The medication which comes from a big, famous company is always
more expensive than medication produced by pharmaceutical
companies in Taiwan. For doctors and patients, what really matters
about a medicine is its remedial effects, not its country of origin.
That is, medicine produced by a local company can be as good as
one manufacture overseas. International pharmaceutical companies
spend lots of money on building company images compared with
pharmaceutical companies in Taiwan. Our company focuses on
more than that. The reputation of our company in markets
represents the image of our company. Marketing is the next step for
the biggest pharmaceutical companies.” [Manager in company #A]

Another conclusion to be drawn is that, several different aspects of value can be
created for the customers based on different customer characteristics. The following
statement illustrates this:

“B: I suppose that four aspects are all included. But different
companies may emphasize disproportionately on these aspects. The
sales language has been recognized in medication industry since the
1970s and 1980s. When saying ‘value creation’, each company will
always refer to the same aspects with only differing emphasis on
each aspect. When talking about company reputation, headquarters
will focus on general practice. It could take a lot of effort for one
company to take care of general practice. It costs a large proportion
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of operating expense. Our company has a control over the variety of
products, since we owned some ancient prescriptions. Procurement
departments in hospitals will check this company’s website when
having trouble on medicine purchase. This could demonstrate the
superior reputation that our company has established in the past
eighty years.” [Manager in company #F]

However, they had different opinions about which type of value creation is the most
important. The most commonly given answer, functional value created by their firm,
is the most popular strategy in the pharmaceutical company. The following statement
illustrates this:

“The offshore pharmaceutical companies, compared with local
pharmaceutical companies in Taiwan, give less focus on the value of
medical efficacy. The offshore pharmaceutical companies, instead,
may focus more on customers’ thoughts toward their products.
Their marketing strategy emphasizes the value of experience and
happiness. That is, they put users as the first priority. In most
situations, the sale of one medicine relies heavily on doctors’
recommendations for a product. This is because doctors are those
who really contact with patients directly. By convincing patients to
buy medicine, doctors need to prove the medicine is effective.
Doctors can introduce the efficacy and some weaknesses of one
medical product and speak about the benefits and effects that this
medical product can bring to the patients. It is not necessary to
mention the value of the company or product as people are all
familiar with the power of a famous brand name. Pharmaceutical
companies in Taiwan could improve the image of their products by
connecting the company to socially-economically disadvantaged
groups or charity institutes. For example, there are several charity
groups that provide financial and emotional support for patients
with cancer. In my opinion, I suppose the efficacy is the most
important element for a good medicine.” [Manager in company #I]
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On the other hand, experiential value creation is an important aspect in forming the
corporate reputation of Taiwanese pharmaceutical companies. The following
statement illustrates this:

“A: This step [the experiential value creation], in my opinion, is the
value of experience and happiness to our company, and it will
definitely affect the value creation. One thing happened to me which
could be an example that explains what I just said. I attended my
50th primary school reunion one Saturday, and I talked to my
teacher on that day. I passed my name card to my teacher to
introduce the business I am in and the company I am running. He
said, I knew this company had reputation for its great ointment. This
is to prove its technical strategy using empirical evidence works
very well to create its good company image in its ointment having a
good curative effect. The ointment works very well. Of course this is
maybe you can say that this is how functionality works on this
strategy.” [Manager in company #F]

5.2.1.2 Interview results on strategic resources
The research undertaken has revealed that a firm with a good reputation has some
strategic advantages. It is agreed by the experts that the use of corporate reputation as
a strategic resource is important. A good corporate reputation attracts good
salespeople, helps a company to launch its new products into the market, helps a firm
to merge with other smaller pharmaceutical producers or to expand the market, to cooperate with and add more sales channels to the company and aids in raising funds.
The following statements illustrate this:

“It’s all about products. Reputation is something that a company
must emphasize. According to my past experience, a successful
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marketing requires a good integration between production
department and sales department. A group of strong salesman could
be a crucial part for our company to promote our products
successfully. Characteristics of a good salesman have changed over
time. A person, who speaks articulately, has good social skills and
loves drinking used to be considered as a good sales person.
However, the quality that makes an individual a top sales person is
totally different from it used to be. This is because the way of
business negotiation has changed. I can assure you that you’ve
found the right sales person and he is doing great in this position.”
[Manager in company #E]

“In my opinion, a company with a good reputation is more likely to
succeed in introducing the market to their new product. From sales
department’s point of view, product launch can easily impress the
market if the product is from a reputable company. The good first
impression of a product may come from customers’ expectations.
Once a company’s reputation is established, the value of the brand
will definitely benefit the stated four strategic resources…. The
potential meaning of using the corporate reputation as a strategic
resource could be expanded in breadth and depth beyond its literal
meaning. From the salesman’s point of view, new products are more
likely to be popular when we promote our product on a regular time
frame and a good company image or reputation.” [Manager in
company #F]

“I suppose that good company reputation can boost product sales
and push products into markets more quickly. A firm’s reputation
can affect other substantial elements of marketing strategy,
including human resources, retailers and product price.” [Manager
in company #I]

“Our company owns a few subsidiaries. It was established in 1945
as a pharmaceutical company. Recently the company decided to use
157

`

the pharmaceutical product equipments to produce health
supplement food with medication standard and high quality. Along
with the reputable medicine product for a long history, it is easier
for the health supplement food to launch into the market. Now the
health supplement food produced is expected to be on the shelves of
Carrefour.” [Manager in company #A]

“A company needs to raise a huge amount of funds to expand its
size. To be frankly, funds are the single most important element for
a company to expand. A company with a good reputation may
consider seeking for assistance from financial institutes.” [Manager
in company #A]

Additionally, a good corporate reputation can effectively enhance sales and marketing,
and also enable a new product’s entry to the market. It makes the firm easier to sell
products to its customers. The following statement from a Japanese company Taiwan
branch’s sales manager illustrates this:

“The marketing strategy of a company must be effective and feasible.
A big company can use its reputation to promote its products in
markets. A big company with good reputation can always control
the markets. A big company can take advantage from availability of
huge amount of funds, professionals in the company and a big group
of customers. A small company without good reputation can find it
difficult to promote its products in markets.” [Manager in company
#B]

Moreover, a good corporate reputation also makes it easier for the firm to sell
products to distributors.
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“A company can use customer loyalty as a part of a marketing
strategy. I can rely on the reputation of my company. My company
is attractive to distributors because of its good reputation. In other
words, distributors will be more confident and interested to do
business with a company with a good reputation. My company can
also benefit from the human resource in distributors. There are a lot
of top salesmen in retail shops. My company can promote its
products successfully by just offering salesmen commission on the
products they sell. Thus, it is significant to co-operate with a
powerful retailer in the first place. And I will then make my products
more popular and more attractive to the market by presenting a
good reputation and good image of my company.” [Manager in
company #B]

5.2.1.3 Interview results on corporate communication
The research undertaken has revealed that a firm’s corporate reputation encourages
greater commitment from employees and internal communication within the company.
The following statement illustrates this:

“I have spent my most valued 30 years in this company. There must
be a reason for me to stay for such a long time. And this reason is
the commitment to this company. I was proud to say Taiwan Biotech
Co. in each time I am asked the company I work for. I am not proud
of my company because of the easy money I earned. I am proud of
company because I stay in a good company.” [Manager in company
#A]

Moreover, a firm’s corporate reputation can not only be used to communicate with its
stakeholders but also builds the relationship between the firm and its customers. That
is, the corporate reputation also builds external communication with the customer. An
example was given by one of the experts talking about how a firm with a good
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corporate reputation can influence its customers and also make customers have a
better perception of the company and its FABs (Features, Advantages and Benefits):

“Employees’ commitments toward the company and good
communication between company and customers are the most
important factors for a successful company. The sale of products
relies heavily on good communications between company and
customers.” [Manager in company #A]

“Most pharmaceutical companies can produce medicine with
similar effects to METAPOLITAN, which is used to treat diabetic
patients in endocrinology and metabolism departments. One doctor
could meet several salesmen from five or six different companies to
promote the medicine for diabetic patients. What really affects
doctors’ decisions on choosing the medicine is the reputation of the
pharmaceutical company. Company reputation can come from
customers’ trust in products of this company, and customers trust is
established on the quality service that a company provides.”
[Manager in company #A]
“The ways we use to communicate with consumers includes building
a relationship between company and consumers. A well-reputed
company gains more trust from the customers. This helps to
strengthen the relationship between the company and the customers.
If you have a strong relationship with customers, you will have more
resources to market your products and achieve your sales target.
The next step is to send the message to customers. The
pharmaceutical company will promote its products and
communicate with customers using a professional medical
conference, an academic research result presentation or a seminar
on product introduction when launching a new product. No matter
just for product promotion or launching a new product, you can still
send a message to customers. These communication methods can be
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used in different circumstances and markets.” [Manager in company
#H]

One way that a good corporate reputation can tighten the relationship between the
company and its customer is stated below:

“For a company with a good reputation, it is able to attract loyal
customers to participation into your marketing events. However,
this will not work for a small company. A well-known company with
a good name has great fundamentals and a strong relationship to
interact with customers using an indirect communication and
marketing method, such as a professional medical conference. In a
medical conference, there will be professionals and scholars invited
to make a presentation on academic topics. This is placement
marketing for promoting the product indirectly. Also, customers will
receive messages from an academic research result presentation
delivered by respected international scholars as an indirect
communication method.” [Manager in company #H]

However, some time is needed for a customer to recognize a firm as a “well-reputed”
firm:

“A company with a good reputation can always influence customers’
decisions. But it could take a lot of effort for the company to
establish its reputation. The establishment of company reputation
could require 10 or 20 years of hard work.” [Manager in company
#B]
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Furthermore, some firms sell their stock in the market. By advertising a company’s
core values, a firm can enhance its market price. The following statement illustrates
this:

“TTY BioPharm can be used to illustrate this idea. The stock price
per share of this company has increased from 50–60 dollars to more
than 100 dollars, and hit its peak. This pharmaceutical company
specialises in producing anti-cancer medication and protein biotech.
According to the director, the commercial advertisement of this
company keeps emphasizing their hard work on studying the
treatment for cancer. The findings of their study on cancer are
already a breakthrough, although the discovered treatment is not
promised to be also effective on the human body. However, once the
treatment, which was introduced in the commercial, is proved to be
effective for patients with cancer, the company will get enormous
success. In order to show their findings in the study of cancer, one
of this company’s factories was opened for customers and visitors
last Friday. The market share of this company is big. This resulted
from their efforts on promoting their findings related to the cancer
study. This improved the image of the company, and lots of share
holders and investors will feel more confident about the future of
this company. Shareholders with this company may get a $2
dividend for a $200 share from this company. But they may get $2
dividend for a $20 share from another company. Will TTY
BioPharm still be attractive for the investors? Yes, it will. Some
findings of the company’s study are at the forefront. The financial
report of this company has been revealed publicly, and this report
has passed more positive messages to the customers. There could be
more and more people investing in this company because of this.
Market share of this company in cancer treatment is big.
Communication is a bridge between the company and our customers.
This bridge it meant to strengthen the communication between the
company and our customers. In short, the reputation of our
company is established on the trusts from all customers in the past
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80 years. These customers could be a powerful resource for us. To
utilise the resource, our company needs to understand marketing
strategies that different customers used. Some medicine retailers
like to create a homey atmosphere for customers, while some
distributors want to show a professional image and trophies to their
consumers. The idea of making our products sweet came from
retailers’ suggestions. Salespeople need to find out different
strategies to do business with different retailers on a daily basis.
There could be plenty of marketing strategies that salespeople can
use. Our products can only differentiate market segments. Rhodiola
with three stars could be an example for a market segment. The
medical product has some features which are different from other
products’.” [Manager in company #F]

From the above, we know that the communication with customers is
important; moreover, the respondent stated that:

“Our firm’s corporate reputation with a good manufacturing
history, a reputable product experience, helps the communication
with our customers.” [Manager in company #F]

5.2.2 Interviews about Brand Image Strategy

5.2.2.1 Interview results on brand segmentation
As was argued in the literature review, segment development is important in
implementing a firm’s brand image strategy. However, segmentation is based on
differentiating the needs of the customer. Similar factors of target segments of
customers enable managers to implement a strategy, but there are different ways of
implementing segmentation within one organisation. According to the manager in
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company F:

A: “I prefer using diseases for market segmentation. I mean that
diseases are used for identification of niche products. For example,
every patient with cancer will visit an oncology department. This is
a good example of using disease for market segmentation because it
uses differences between products to introduce a new product. Also,
we can use price to create market segmentation such as with OTC
products. Furthermore, we can use the national health insurance
system to identify niche products for prescription drugs. Moreover,
age or sex, male and female, is also a good way to identify niche
products. For example, our company has Viagra products for
impotence symptoms. We can thus use price or sex to identify our
niche products. Therefore, you can apply these niche products as
yours and we can also produce these drugs for different sexes and
ages. For instance, we are making drugs for alopecia. Not many
companies are doing these drugs for those who are worried about
getting bald. It won’t be difficult to identify niche products as long
as you think about many different factors, not just only one factor.”
[Manager in company #F]

However, it is customer oriented/based to implement segmentation strategy,
according to several interviewees:

“They are all customers. The only difference is they present
different types of customers. We have to manage these customers
based on their characteristics and use these different characteristics
for market segmentation.” [Manager in company #B]

B: “The product itself can be used for market segmentation.
However, that is not the only factor for market segmentation. We
can also use customers as a good factor for market segmentation.
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There are many factors to choose from for market segmentation,
including sales and service.” [Manager in company #F]

Moreover, some companies use different channels of distribution to implement
segmentation strategy, such as hospitals, clinics and pharmacies. The following
statement illustrates this:

“Market segmentation can be done via pointing out the difference
between its [this company’s] product and other competitors’
products. It is difficult to find complementary medicines for other
competitors’ products…. We could probably talk about evidence to
prove the product’s advantage. For example, our strategy is to focus
on medicines for CV and cardiology. Why do we only choose these
two products given so many different kinds of products to choose
from? The reason is to focus on our distribution channels. The large
corporations have their own hospital channels to promote their
products. That is how they can produce the best outcome via proper
allocation of their staffs and use of the existing resources. Take Tung
Yang as a good example for market segmentation, they did their own
research on anti-cancer drugs. This helps them to strengthen their
company name for consumers and industry peers, especially on
anti-cancer drugs. They thus control the distribution channel and
social networks. That is how they achieved market segmentation.”
[Manager in company #I]

However, the product manager in company F thinks it is unnecessary to
implement segmentation in the beginning when you launch a new product:

“When you make a strategy, you have to know your position in a
market. If you spend too much time in positioning your products in
the market, there will be more than 20 manufacturers already
making the same products. If you just start the market segmentation
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strategy, you will have no market for your product. Then you can
only rely on customers for market segmentation. Customers will
decide whether your product is in a leading role or a supporting
role. If your product just plays a supporting role, it will rely on your
customers for deciding your market place. Those contracted
products mostly play a supporting role. If a medication product
plays a leading role, it must be able to cure diseases. For example,
if you can manufacture hypertension drugs, you can become hugely
successful in the industry. That is impossible. It is because
customers have different kinds of hypertension drugs to choose from.
Therefore, you have to promote this product in a different way. After
spending much time, you realise this product can help patients
against stroke. That will be the feature for us to promote this
product. This will be a useful product. You have to keep promoting
the feature because the hypertension drugs are already too many in
the market.
I want to summarize the point. Now we know the market positioning
strategy for the product and the niche to promote the product. We
will know how to position the product in the market. We then use the
market position for market segmentation. Then we can think about
where the customer is and how the customer will respond to the
product.… That is what I say about using customers to position your
product for market segmentation.” [Manager in company #F]

Other interviewees suggested that there are many other factors, such as whether there
is a focus on R&D, that decide the type of segmentation. The following statement
illustrates this:

“Tung Yang is a good example of this. Tung Yang is a very unique
company. It is never a follower. It is the first pharmaceutical
company which successfully manufactured anti-cancer drugs. Its
anti-cancer drug is just as successful as Panadol.… However, it
continues to focus on this niche product because it has no choice but
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continues to work on promoting this product. After three to five
years, it provides clinical reports regarding new knowledge about
cancer, and builds a strong relationship with clinics. Its products
become accepted by these clinics. It then makes very good money….
Its total operating profit is about $500 million. This proves its
success with anti-cancer drugs. It has now started to make other
medications. However, it is still famous for its anti-cancer drug. It is
now in the top 50 small to medium enterprises in Taiwan. It has
successfully built its brand name.” [Manager in company #E]

Besides R&D, different channels of distribution can be the basis of brand
segmentation. The following statement illustrates this:

B: “The distribution channel for these products will be hospitals
since the price of our products is relatively high. Hospitals normally
can accept products with a higher price range. However, these
products won’t be popular for clinics given that the doctor in a
clinic is the boss. They care about medication costs. Therefore, they
probably won’t use the medicine from an original manufacturer
given the price is too high for them.” [Manager in company #E]
5.2.2.2 Interview results on brand differentiation
As it was argued in the literature review, to enable a good brand image strategy, brand
differentiation has to be applied as well. However, achieving brand differentiation is
very difficult in this particular industry. There is a standard procedure (bioequivalence
and bioavailability, as explained in the following paragraph) that has to be followed
during production in the pharmaceutical industry. Thus in the end it is not possible to
distinguish between original and generic products. The following statement illustrates
this:
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“It looks like it is simple to start a business in the pharmaceutical
industry. The entry barrier will be whether you can successfully
make a product or whether you can copy the successful business
model and products from the original manufacturer. The key point is
to make exactly the same product as the original manufacturer.
… If the difference does not exceed a certain level, you conclude
that there is no significant difference between these two products
but you still cannot claim these two products are exactly the same. It
is said that there will be no significant difference and the
manufacturing procedure for BE (bioequivalence) and BA
(bioavailability) testing is almost the same.” [Manager in company
#E]

Even if it is hard to implement brand differentiation strategy in this industry, there are
two ways of implementing brand differentiation strategy: product oriented and
customer based. First, the product packaging can make the company image; this can
be behind the logic of brand image strategy making. The following statement
illustrates this:

“There are so many things to be done to differentiate your drug
products, including dosage, product features, packaging, drug in
tablet or liquid form, flavours, clinical evidence and approval
certificate by Health Department etc. We can apply and combine
these products features and the use of end users to differentiate our
brand.” [Manager in company #F]

“The product package represents a company’s image. It is not
limited to real packaging. A nice looking package of course can
attract consumers to buy your products. You don’t want your
consumers to complain to doctors about how uncomfortable they
are after taking the drug and the package doesn’t look right,
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including packaging colour fading or cracking. This is all about a
company’s image. You can also put a photo of charity events funded
by your company such as a running event for cancer patients. You
can find many charity events or organisations overseas.” [Manager
in company #A]

A common way of differentiation for pharmaceutical products is to make them into
different forms of a medical product, such as liquid, tablets or capsules. Different
forms of the medicine enable different brand image strategies to be applied. The
following statement illustrates this:

“No one will care about brand differentiation if your drugs and
other competitors’ drugs are both within legal limits. However,
there are definitely differences between your products and others.
The only job is just you have to know what the difference is and how
you can show the brand differentiation to your consumers. For
example, if you feel like making a drug as a tablet, capsule or film
coating and if is not easy to get the drug to a certain feature, you
then turn to make the drug in liquid form, such as syrup or
injections. However, a drug in liquid form is normally unstable.
That is what you can use to promote your drug, just like using a
slogan ‘our product as a tablet is better and stable’.” [Manager in
company #E]

In addition to packaging, some creative R&D combine two ingredients into one tablet
to enable the consumer to use the medical product more easily – thereby creating a
differentiation:

“I don’t know whether you have noticed that few of the modern drug
products contain only one ingredient. Most of the modern drug
products tend to combine two ingredients called a ‘combo’. Take
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hypertension drugs as an example. Actually a diuretic can be used
to cure hypertension. How do we combine a hypertension drug and
a diuretic to make a good hypertension drug? What proportions of
these two ingredients will perfectly combine to work better in curing
hypertension patients? This will rely on our directors’ professional
opinions because some of our directors are doctors with actual
experiences of curing hypertension patients. With actual experience
from our directors, sales people, customers, and pharmacists, we
can identify the market trends.… Therefore we are the original
company. Our competitors can only import similar products from
overseas.” [Manager in company #A]

Second, categorising customers can have an impact on the entire production and
marketing scheme. The following statement illustrates this:

“I will differentiate my products for the end users, doctor and
pharmacist. No matter whether we differentiate our products for the
end users or any other ways, we all want the same result, which is to
influence the customers’ behaviour. I will tend to promote sales to
the end users and strengthen our aftersales service to achieve this.”
[Manager in company #F]

There are different ways to implement customer-based brand differentiation:

“The price of TWD $75 for three days applies to every clinic and
every patient (a current medicine policy in Taiwan). How can we
promote more sales under this kind of condition? Because
consumers want more of these products after they get used to these
products. That is how we become successful. That is why Ying-Jie
continues to focus on making eye drops.
We have another way to win the battle, which is signing contracts.
We are very flexible in signing sales contracts. That will make our
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sales people easily get the sales contract signed by our customers.
Our salesman can flexibly change the contract and tailor the
contract based on their sales volume.…” [Manager in company #F]

Some other ways of implementing a customer-based differentiation strategy, by using
low prices, spread by word of mouth and using opinion leaders to lead consumer
thinking, give quick results for brand differentiation. The following statement
illustrates this:

“The best and most direct method to differentiate your brand name
is to create the product value by a cheaper price. Then your
customers can accept your products easily and quickly given that
they recognize the differentiation in your product. They will help to
promote your product as a cheap and good product via word of
mouth. Consumers nowadays want a good value product and that
really works on them….
That is so-called endorsement by opinion leader. Where shall we go
to sell the drug products to consumers? We can differentiate our
product via hiring an opinion leader in the medical industry to
endorse our products with their own good experiences and
treatment results.… It is a great advantage for products to be able
to sell in 7–11 stores. Then your distribution channel will not be
limited to pharmacies. If the products can only be sold in a
pharmacy, we can only use the end user, such as a doctor, to help us
to differentiate the product. I use the power of word of mouth among
consumers to promote our products. When it comes to drug products,
word of mouth marketing is pretty basic. That is how we
differentiate our products.” [Manager in company #I]
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5.2.2.3 Interview results on brand positioning
As was argued in the literature review, one of the most important factors in
implementing positioning strategy is price. A good example is a business scheme by
which the medicine produced in Taiwan is targeted at high-income customers in
mainland China:

“The high-end market is attractive for pharmaceutical companies.
The maternity medicine Ann Bao, which stabilizes physical
conditions when a woman is pregnant, is now popular in the highend market in mainland China. Ann Bao is sold at a high price in
mainland China, both needle shots and tablets of this medicine are
available for customers.” [Manager in company #A]

Some companies position their product as a premium product because they have a
very good corporate image or appear frequently in commercials. This kind of
positioning strategy is based on the corporate image. The following statement
illustrates this:

“A company with a good reputation can also promote their products
more easily by improving company image and by connecting itself
to the distributors. For example, we usually advertise in the medical
journals or show up at the medical conferences to enhance our
reputation. A debut conference and a product commercial are often
used to boost customers’ confidence in a new medical product and
to position well this product. Thus it also builds an unseen
positioning strategy within customers’ minds.” [Manager in
company #B]
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Another way to position their product at the high-end market is to use ingredients
from a certain country. For example, products from the USA, Europe or Taiwan can
be positioned for the high-end market and sold for a high price. The following
statement illustrates this:

“Pharmaceutical companies in Taiwan are very likely to succeed in
product positioning…. We prefer ingredients for medicine
production from Europe and India, and we would rather not use
ingredients from China. People can find out the differences between
ingredients from different regions when testing these ingredients.
The medical ingredients from China may survive testing on effects,
but these ingredients always fail impurity tests.” [Manager in
company #A]

Some companies implement their positioning strategy by basing it on medical
effectiveness. This positioning strategy is based on customer needs:

“A company needs to take all aspects, such as efficacy of the
medicine, of one medication into consideration before doing product
positioning. Anti-wrinkle products with good effects on skin could
be an example for product positioning. Medication with good
efficacy will be recognised as a high-end product, even if producing
expense of this medication is not high.” [Manager in company #B]

However, some companies which are more manufacturer-oriented would rather
position their products as good quality by focusing on customer relationships. A
statement from one manager illustrates this:
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“I’d rather do business with small firms. A company is more likely
to make the profit from the business with small firms, and this sort
of business allows the company to make bigger profit from the
products they have sold.…
The quality and efficacy of medical products have been improved a
lot in recent years. The retailers and distributors are also strong on
promoting medical products. And a pharmaceutical company can
rely on good post-sales service. Pharmaceutical companies are
doing well in almost everything.” [Manager in company #E]

“A good post-sale service is required after the value of one product
is recognized by customers. A good post-sale service is to strengthen
customer’s faith in the product value and to influence doctors’
prescriptions. This is to enlarge the market share of a single
product.” [Manager in company # I]

Company F positions the company to sell different types of medical products, which
suit three different types of customer need. The following statement illustrates this:
“Pharmaceutical companies always want to produce the most
evolutional drug one step ahead others. However, it could be really
difficult to really get there. In real situations, pharmaceutical
companies produce medicines, which have been introduced by other
companies, after patents of these medicines have expired. TTY
BioPharm is poised to introduce its newest medicine. The efficacy of
this medicine remains unrevealed.
Similar customer groups are targeted by different companies.
Product positioning of three affiliations, including Ying Yung, Ying
Jie and Ying Ann, could be an example for this. Ying Yung
concentrates on ordinary medical products, such as medicine for
headache relief, cold and flu. They also have flu syrup, needle shots
and ointments. People are suggested to check up with Ying Yung, if
they can’t find what they want in the market. Therefore Ying Yung is
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targeting to very popular stores like Carrefour. Ying Jie, on the
other hand, only focuses on one product called “idrop”. This
company’s 50 per cent profit comes from the sale of idrop. Its
position is on particular one kind of product….” [Manager in
company #F]

5.2.3 Interviews about Medicine Price

In all of the interviews, price turns out to be a major issue in the Taiwanese
pharmaceutical industry. Currently Taiwanese pharmaceutical companies are at the
stage of producing generic products and not able to invest a lot of money in inventing
new products. Therefore price is a critical factor. However, it is agreed by most of the
consumers that a medicine with a higher price suggests a better quality of product and
a better company image.

“I suppose that good company reputation can boost product sales
and push products into markets more quickly. A good corporate
image can affect other substantial elements of marketing strategy,
including human resources, retailers, and product price. Inevitably,
a product with a higher price sometimes shows its better function or
produces a better company image.” [Manager in company #I]

A medicine with a higher price usually captures the value that is generated in the
product.

“When a new product in a new area comes on the market, as for my
experience, if you use the brand value to make a price-oriented
segmentation, 90 per cent of the time it will be success.” [Manager
in company #B]
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“I think the symbolic or expressive value is important. For example,
some companies give the customers an impression of high class
because the company’s products are located in the market as a
pioneer product. This means the company has good ability with
R&D, therefore, the product is considered to be good quality and
requires a higher price.” [Manager in company #B]
“Actually it [price] is the value that is perceived in the consumer’s
mind. A medicine with a higher price, and if its marketing campaign
runs well, gives the customer an impression that it has more
effectiveness and maybe other combined functions or added value.”
[Manager in company #G]

Price can also be a useful factor for creating segmentation. The following statement
illustrates this:

“My company’s reputation will be bad if we have a different
segmentation with the Chinese firms which have the product with an
average or poor quality. This will also impact on the price, which
has the so-called price segmentation as well.” [Manager in
company #D]

“The product price will be a very crucial factor when it comes to
market segmentation.… That is the reason I want to point it out here
regarding the adoption of price for market segmentation. It is used
to create a new market and expand your business. We used to say
that you have to use the best medication for liver or kidney diseases.
That will create economic value or benefit for us. The benefit from
these medications can strengthen our competitiveness compared to
other competitors. Otherwise, you won’t be able to make money
under the national health insurance system or under the civil service
insurance and labour insurance system…. However, even if you
lower your price, you can still earn more money if you achieve more
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sales.… Thus, I will adopt pricing strategy and price my product
higher to achieve the purpose of market segmentation.” [Manager in
company #A]

Some companies also customize price by distinguishing between customers who
pursue high values and customers with strict budgets.

“There are two kinds of hospital customers. Because products with
higher prices could put pressure on profits, some hospitals could
lose money because of this. One kind is pursuing high values added
to the medical product. They would like to give a good price and get
the service and use high-level products. The other kind of hospital
customers makes strict budgets and put pressure to cut medicine
prices so they are very low, so that these hospitals can have profit
margins.” [Manager in company #G]
From the interview, what the respondent said supported the idea that having a higherpriced product usually signals a better quality or higher level of products. Therefore,
the qualitative result indirectly indicates that the medicine price moderates the
relationship of the uses of corporate reputation and a firm’s brand image strategy.

5.2.4 Qualitative analysis conclusion

From the analysis of the qualitative data, it may be concluded that experts suggested
new items for each construct. The interviewees suggested adding eight new items to
the strategic resource construct, which are: (1) gains more opportunities for strategic
alliances or business cooperation; (2) enhances prices by validating medicines in
published clinical reports; (3) makes market entry easier; (4) gains more customers for
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the firm; (5) makes the marketing system work more efficiently; (6) makes it easier
for the firm to find a downstream reseller; (7) enhances the firm’s sales force; (8)
develops strategic links with complementary products.

Six items were suggested as additions to the previous corporate communication
construct: (1) the experience of the sales people; (2) the sales ability of the sales
people; (3) the firm’s awareness of social responsibility; (4) using all types of
negotiations with customers, competitors or the government; (5) helps internal
communication; (6) helps external communication.

One additional item was

recommended for the brand differentiation construct: advanced R&D leads the needs
of the target market. And two items were suggested for the brand segmentation
construct: to be based on customer needs, and to be based on different channels of
distribution.

Finally, a whole new construct is suggested to act as a link between the relationship of
the uses of corporate reputation and brand image strategy: namely, medicine price.

This exploratory qualitative study provided a richness of data forming the basis for
developing the quantitative study. The study provided a better understanding of the
research question. (RQ [research question] - How do Taiwanese pharmaceutical
companies use their corporate reputation to develop brand image strategy?). The
qualitative research of the interviews gave the researcher more knowledge about how
corporate reputation is used in practice and how the brand strategies operate
practically.
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The findings of this exploratory qualitative study generally confirmed the research
model. None of the original items were to be deleted. However, some items were
suggested as additions, as stated above. And the findings also confirmed the research
hypotheses with the exception of a moderating construct of “price”. The following
framework (see Figure 5.1) is the outcome of the literature search and is supported by
the qualitative study. One hypothesis regarding the way price moderates the
relationship between the uses of corporate reputation and brand image strategy was
added.

Figure 5.1: Revised conceptual framework

Srouce: Developed by the researcher

5.3 Main Study: Measurement Scales Validation and Hypothesis
Testing
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5.3.1 Descriptive statistical analysis

With regard to the company histories, there are three in the “less than 10 years”
category, accounting for 4.92%, 36 in the “11–30 years”, accounting for 59.02%, 16
in the “31–50 years” category, accounting for 26.23%, five in the “51–80 years”
category, accounting for 8.20%, and one in the “more than 81 years” category,
accounting for 1.64%. For the details, please see Table 5.1.

Table 5.1: Descriptive analysis table of company statistics
Variable

Category of information

No. of Percentage
samples
(%)

Cumulative
percentage (%)

3

4.92

4.92

36

59.02

63.93

16

26.23

90.16

5

8.20

98.36

1

1.64

100.00

(1) < 1 million pounds

14

22.95

22.95

(2) 1 million to 2.99 million sterling
pounds (£)

17

27.87

50.82

Sales turnover (3) 3 million to 9.99 million sterling
pounds (£)

15

24.59

75.41

(4) Over 10 million sterling pounds
(£)

15

24.59

100.00

(1) Fewer than 50 people

25

40.98

40.98

15

24.59

65.57

14

22.95

88.52

7

11.48

100.00

20

32.79

32.79

(1) less than 10 years
(2) 10–30 years
Firm history

(3) 30–50 years
(4) 50–80 years
(5) Over 80 years

How many (2) 51–100 people
people work for
your company? (3) 101300 people
(4) More than 300 people
Which

(1) Sales department
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department do (2) Marketing department
you belong to?
(3) Management department
(1) Board chairman
Which position
(2) General manager
do you hold in
your company?
(3) Department manager
(1) Less than 1 year
(2) 2–3 years
How many years
have you worked (3) 4–10 years
in this company?
(4) 11–20 years
(5) More than 20 years
(1) A foreign-owned company
(American company)
(2) A foreign–owned company
(European company)
(3) A foreign–owned company
(Asian company)
Firm character (4) A trader company (American
(multiple choice) company)
(5) A trader company (European
company)
(6) A trader company (Asian
company)

15

24.59

57.38

26

42.62

100.00

3

4.92

4.92

10

16.39

21.31

48

78.69

100.00

4

6.56

6.56

8

13.11

19.67

21

34.43

54.10

15

24.59

78.69

13

21.31

100.00

1
0
2
7
9
22
38

(7) Local company

Source: Developed by the researcher

After the pilot study, in the questionnaire, we assigned each item a code name making
it easier for us to observe the correlation of each item with the construct. Regarding
the codes for each item, please refer to Table 5.2.

Table 5.2: Measurement items of the theoretical constructs and their codes
Construct
Value creation

Items wording
The corporate reputation of our firm helps to reduce transaction
costs.
Our firm competes by creating useful products.
Our firm competes by providing good financial performances.
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VC1
VC2
VC3
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Value creation

Strategic resources

Corporate
communication

Our firm competes by providing products with appropriate outcomes.
Our firm’s value-chain activity is consistent with functional value
creation.
Our firm’s resource allocation is consistent with functional value
creation.
Our firm’s products compete by appealing to the senses.
Our firm competes by creating appropriate emotions (e.g. fun,
pleasure, excitement, relaxation, etc.)
Our firm competes by facilitating social relationships (e.g. bonds,
attachments and togetherness).
Our firm competes by creating epistemic value (e.g. knowledge and
novelty).
Our firm’s value-chain activity is consistent with experiential value
creation (e.g. happiness, affection and excitement...).
Our firm’s resource allocation is consistent with experiential value
creation.
Our firm competes by enhancing its customers’ self-identity.
Our firm competes by enhancing its customers’ self-concept (or selfimage).
Our firm competes by enhancing its customers’ self-worth.
Our firm competes by facilitating self-expression.
Our firm competes by offering economic value (low prices, value in
use, life costs).
Our firm competes by enabling ease of use of its products (time,
effort, energy).
Our firm competes by minimizing customer risk (personal,
technological, strategic).
Our firm’s resource allocation is consistent with symbolic value
creation.
In our organization, corporate reputation serves as a competitive
advantage.
Our firm’s corporate reputation sends a strong signal to its
customers.
Our firm’s corporate reputation implies efficient sales and marketing.
Our firm’s corporate reputation implies it has advanced R&D.
Our firm’s corporate reputation implies that we are able to enter
markets early.
Our firm’s corporate reputation gains the firm more opportunity for
strategic alliance or business cooperation.
Our firm’s corporate reputation is enhancing the prices charged by
validating them in published clinical reports.
Our firm’s corporate reputation enables the firm to enter the market
more easily.
Our firm’s corporate reputation gains more customers for the firm.
Our firm’s corporate reputation makes the marketing system work
more efficiently.
Our firm’s corporate reputation makes it easier for us to find a
downstream reseller.
Our firm’s corporate reputation can enhance our firm’s sales force.
Our firm’s corporate reputation helps new products to enter the
market.
Our firm’s corporate reputation helps the strategic link with
complementary products.
Our firm’s corporate reputation shapes the perceptions of
shareholders and other stakeholders.
Our firm’s corporate reputation builds a relationship between the
firm and its customers.
Our firm’s corporate reputation influences consumer choices.
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VC4
VC5
VC6
VC7
VC8
VC9
VC10
VC11
VC12
VC13
VC14
VC15
VC16
VC17
VC18
VC19
VC20
SR1
SR2
SR3
SR4
SR5
SR6
SR7
SR8
SR9
SR10
SR11
SR12
SR13
SR14
CC1
CC2
CC3
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Brand positioning

Brand
differentiation

Brand
segmentation

Medicine price

Our firm’s corporate reputation is based on the experience of the
sales staff.
Our firm’s corporate reputation is based on the sales ability of the
sales staff.
Our firm’s corporate reputation helps internal communication (the
communication between our firm and our staff).
Our firm’s corporate reputation helps external communication (the
communication between our firm and our customers).
Our firm’s corporate brand positioning strategy signifies high quality
to its customers.
Our firm’s corporate brand positioning strategy signifies better
product performance for our customers.
Our firm’s corporate brand positioning strategy involves a long
distribution chain.
Our firm’s corporate brand positioning strategy is to provide a much
better service to our customers.
Our firm’s corporate brand positioning strategy tries to fulfil the
basic needs of our customers.
Our corporate brand is perceived differently according to whether
consumers have experienced our products.
Our corporate brand is perceived differently by word of mouth.
Our corporate brand is perceived differently by promotion.
Our corporate brand is actually created differently by product
characteristics.
Our corporate branding may be directed at different market
segments.
Our corporate brand may utilize physical product characteristics.
Our corporate brand may utilize non-physical product characteristics.
Our corporate brand strategy requires product differentiation.
Our corporate brand strategy requires changes in point distribution
location.
Our corporate brand strategy requires changes in importance attached
to a non-physical product.
Our corporate brand strategy requires changes in importance attached
to a physical product.
Our corporate brand strategy is decided by the needs of the
customers when determining product differentiation.
A medicine with a higher price shows a higher quality of product to
our customers.
A medicine with a higher price shows a better image of the company
it belongs to.
A medicine with a higher price usually captures the value that is
generated in the product.
Our firm customizes price by value that is perceived by our
customers.
Our firm customizes price by distinguishing between customers who
pursue high values and customers with strict budgets.
Our firm customizes price by offering coupons, regional prices,
limited consumption or negotiatory prices to a specific group of
customers.
Our firm customizes price according to the characteristics of the
customers.
Our firm customizes price according to the trading characteristics.
Our firm pays considerable attention to effective publicity and
communication while operating bulk buying/discounts.

Resource: Developed by the researcher
183

CC4
CC5
CC6
CC7
BP1
BP2
BP3
BP4
BP5
BD1
BD2
BD3
BD4
BD5
BD6
BD7
BS1
BS2
BS3
BS4
BS5
PP1
PP2
PP3
PP4
PP5
PP6
PP7
PP8
PP9
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5.3.2 Descriptive statistical analysis of measurement items

5.3.2.1 Value creation scales
In terms of “value creation,” the mean values of the respective measurement items are
between 3.590 and 4.508; the average score of the dimension is 3.943. The dimension
with the highest score (4.508) was “Our firm competes by minimizing customer risk”.
Other dimensions which were scored higher than the average were “Our firm
competes by enabling ease of use of its products”, “Our firm’s value-chain activity is
consistent with experiential value creation”, “The corporate reputation of our firm
helps to reduce transaction costs”, “Our firm competes by creating useful products”,
“Our firm competes by enhancing its customers’ self-worth”, “Our firm’s resource
allocation is consistent with experiential value creation”, “Our firm’s resource
allocation is consistent with functional value creation”, “Our firm’s value-chain
activity is consistent with functional value creation”, “Our firm competes by
providing product with appropriate outcomes”, “Our firm competes by providing
good financial performances”, and “Our firm competes by minimizing customer risk”.

The dimension with the lowest score (3.590) was “Our firm competes by facilitating
self-expression”. Other dimensions which scored lower than the average were “Our
firm competes by enhancing its customers’ self-identity”, “Our firm competes by
enhancing its customers’ self-concept or self-image”, “Our firm competes by offering
economic value”, “Our firm’s resource allocation is consistent with symbolic value
creation”, “Our firm competes by creating appropriate emotions”, “Our firm competes
by facilitating social relationships”, “Our firm’s products compete by appealing to the
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senses”, “Our firm competes by creating epistemic value” and “Our firm competes by
facilitating self-expression”. The above data is compiled in Table 5.3.

Table 5.3: Descriptive statistical analysis of the value creation scales
Item
code

Item

1. The corporate reputation of our firm helps to
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

reduce transaction costs.
Our firm competes by creating useful products.
Our firm competes by providing good financial
performances.
Our firm competes by providing product with
appropriate outcomes.
Our firm’s value-chain activity is consistent with
functional value creation.
Our firm’s resource allocation is consistent with
functional value creation.
Our firm’s products compete by appealing to the
senses.
Our firm competes by creating appropriate
emotions (e.g. fun, pleasure, excitement,
relaxation, etc.)
Our firm competes by facilitating social
relationships (e.g. bonds, attachments and
togetherness).
Our firm competes by creating epistemic value
(e.g. knowledge and novelty).
Our firm’s value-chain activity is consistent with
experiential value creation (e.g. happiness,
affection and excitement...).
Our firm’s resource allocation is consistent with
experiential value creation.
Our firm competes by enhancing its customers’
self-identity.
Our firm competes by enhancing its customers’
self-concept (or self-image).
Our firm competes by enhancing its customers’
self-worth.
Our firm competes by facilitating self-expression.
Our firm competes by offering economic value
(low prices, value in use, life costs).
Our firm competes by enabling ease of use of its
products (time, effort, energy).
Our firm competes by minimizing customer risk
(personal, technological, strategic).
Our firm’s resource allocation is consistent with
symbolic value creation.
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VC1
VC2
VC3
VC4
VC5
VC6
VC7

Mean of
dimension
3.943

Mean

Std
deviation

3.951

.921

9

3.984

1.162

8

4.393

.759

2

4.311

.765

3

4.066

.750

4

4.049

.784

5

3.623

1.267

18

3.738

1.182

16

3.656

1.209

17

3.623

1.098

19

3.951

.939

10

4.016

.866

6

3.885

1.127

12

3.885

1.185

13

4.000

1.155

7

3.590

1.202

20

3.885

1.142

14

3.951

.990

11

4.508

.722

1

3.787

1.002

15

Ranking

VC8

VC9

VC10
VC11

VC12
VC13
VC14
VC15
VC16
VC17
VC18
VC19
VC20
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5.3.2.2 Strategic resource scales
In terms of “strategic resources”, the mean values for the respective measurement
items are between 3.525 and 4.426, and the mean dimension is 4.103. The dimension
with the highest score (4.426) was “Our firm’s corporate reputation gains the firm
more opportunity for strategic alliance or business cooperation”. Other dimensions
which were scored higher than the average were “Our firm’s corporate reputation
implies that we are able to enter markets early”, “Our firm’s corporate reputation
helps the strategic link with complementary products”, “Our firm’s corporate
reputation implies efficient sales and marketing”, “Our firm’s corporate reputation
enables the firm to enter the market more easily”, “Our firm’s corporate reputation
helps a new product to enter the market”, “Our firm’s corporate reputation gains more
customers for the firm”, “Our firm’s corporate reputation makes the marketing system
work more efficiently”, “In our organization, corporate reputation serves as a
competitive advantage”, “Our firm’s corporate reputation sends a strong signal to its
customers”, “‘Our firm’s corporate reputation makes it easier for us to find a
downstream reseller”, and “Our firm’s corporate reputation gains the firm more
opportunity for strategic alliance or business cooperation” are higher than the mean
dimension. The dimension with the lowest score (3.525) was “Our firm’s corporate
reputation implies it has advanced R&D”. Other dimensions which were scored lower
than the average were “Our firm’s corporate reputation can enhance our firm’s sales
force”, “Our firm’s corporate reputation is enhancing our prices by validating them in
published clinical reports” and “Our firm’s corporate reputation implies it has
advanced R&D”. The above data is compiled in Table 5.4.
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Table 5.4: Descriptive statistical analysis of strategic values and resource scales
Item

Item
code

Mean of
dimension

Mean

Std
deviation

Ranking

4.262

.893

4

4.279

.915

3

4.148

.813

9

3.525

1.246

14

4.115

.950

11

4.426

.805

1

3.590

1.174

13

4.164

.969

8

4.213

.897

6

4.213

.859

5

4.328

.908

2

3.852

1.06 2

12

4.180

.958

7

4.148

1.078

10

4.103
1. In our organization, corporate reputation
serves as a competitive advantage.
2. Our firm’s corporate reputation sends a
strong signal to its customers.
3. Our firm’s corporate reputation implies
efficient sales and marketing.
4. Our firm’s corporate reputation implies
it has advanced R&D.
5. Our firm’s corporate reputation implies
that we are able to enter markets early.
6. Our firm’s corporate reputation gains
the firm more opportunity for strategic
alliance or business cooperation.
7. Our firm’s corporate reputation is
enhancing our prices by validating them in
published clinical reports.
8. Our firm’s corporate reputation enables
the firm to enter the market more easily.
9. Our firm’s corporate reputation gains
more customers for the firm.
10. Our firm’s corporate reputation makes
the marketing system work more
efficiently.
11. Our firm’s corporate reputation makes
it easier for us to find a downstream
resaler.
12. Our firm’s corporate reputation can
enhance our firm’s sales force.
13. Our firm’s corporate reputation helps a
new product to enter the market.
14. Our firm’s corporate reputation helps
the strategic link with complementary
products.

SR1
SR2
SR3
SR4
SR5
SR6
SR7
SR8
SR9
SR10
SR11
SR12
SR13
SR14

5.3.2.3 Corporate communication scales
In terms of “corporate communication,” the mean values of the respective
measurement items are between 3.213 and 4.344. The mean of dimension is 3.977.
The dimension with the highest score (4.344) was “Our firm’s corporate reputation
builds a relationship between the firm and its customers”. Other dimensions which
were scored higher than the average were “Our firm’s corporate reputation
influences consumer choices”, “Our firm’s corporate reputation shapes the
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perceptions of shareholders and other stakeholders”, “Our firm’s corporate
reputation helps external communication”, and “Our firm’s corporate reputation
builds a relationship between the firm and its customers”. The dimension with the
lowest score (3.213) was “Our firm’s corporate reputation is based on the
experience of the sales staff”. Other dimensions which scored lower than the average
were “Our firm’s corporate reputation is based on the sales ability of the sales
staff”, “Our firm’s corporate reputation helps internal communication” and
“Our firm’s corporate reputation is based on the experience of the sales staff.”
The above data is compiled in Table 5.5.

Table 5.5: Descriptive statistical analysis of corporate communication scales
Item
1. Our firm’s corporate reputation shapes the
perceptions of shareholders and other
stakeholders.
2. Our firm’s corporate reputation builds a
relationship between the firm and its customers.
3. Our firm’s corporate reputation influences
consumer choices.
4. Our firm’s corporate reputation is based on the
experience of the sales staff.
5. Our firm’s corporate reputation is based on the
sales ability of the sales staff.
6. Our firm’s corporate reputation helps internal
communication (the communication between our
firm and our staff).
7. Our firm’s corporate reputation helps external
communication (the communication between our
firm and our customers).

Item
code

Mean of
dimension
3.977

Mean

Std.
deviation

Ranking

4.180

.806

3

4.344

.750

1

4.148

1.014

4

3.213

1.185

7

3.869

.885

5

3.820

1.133

6

4.262

.728

2

CC1
CC2
CC3
CC4
CC5
CC6
CC7

5.3.2.4 Brand positioning scales
In terms of “brand positioning,” the mean values of the respective measurement items
are between 3.852 and 4.443. The mean of dimension is 3.977. The dimension with
the highest score (4.443) was “Our firm’s corporate brand positioning strategy
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signifies better product performance for its customers”. Other dimensions which
scored higher than the average were “Our firm’s corporate brand positioning strategy
is to provide a much better service to its customers”, “Our firm’s corporate brand
positioning strategy signifies high quality to its customers’, and ‘Our firm’s corporate
brand positioning strategy signifies better product performance for its customers”.
The dimension with the lowest score (3.852) was “Our firm’s corporate brand
positioning strategy involves a long distribution chain”. Another dimension which
scored lower than the average was “Our firm’s corporate brand positioning strategy
tries to fulfil the basic needs of our customers” and “Our firm’s corporate brand
positioning strategy involves a long distribution chain.” The above data is compiled in
Table 5.6.

Table 5.6: Descriptive statistical analysis of brand positioning scales
Item

Item
code

Mean of
dimension

Mean

Std.
deviati
on

Rankin
g

4.410

.783

2

4.443

.696

1

3.852

1.167

5

4.246

.907

3

4.148

.963

4

4.220
1. Our firm’s corporate brand positioning
strategy signifies high quality to its customers.
2. Our firm’s corporate brand positioning
strategy signifies better product performance for
its customers.
3. Our firm’s corporate brand positioning
strategy involves a long distribution chain.
4. Our firm’s corporate brand positioning
strategy is to provide a much better service to its
customers.
5. Our firm’s corporate brand positioning
strategy tries to fulfil the basic needs of our
customers.

BP1
BP2
BP3
BP4
BP5

5.3.2.5 Brand differentiation scales
In terms of “product differentiation,” the mean values of the respective
measurement items are between “3.361 and 4.098. The mean of dimension is 3.827.
The dimension with the highest score (4.098) was “Our corporate brand is perceived
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differently according to whether consumers have experienced our products”. Other
dimensions which scored higher than the average were “Our corporate brand is
perceived differently by word of mouth”, “Our corporate branding may be directed
at different market segments”, ‘Our firm’s corporate brand positioning strategy is
based on advanced R&D which meets the needs of the targeted market” and “Our
corporate brand is perceived differently according to whether consumers have
experienced our products.” The dimension with the lowest score (3.361) was “Our
corporate brand is perceived differently by promotion”. Other dimensions which
scored lower than the average were “Our corporate brand may utilize non-physical
product characteristics”, “Our corporate brand is actually created differently by
product characteristics”, and “Our corporate brand is perceived differently by
promotion.” The above data is compiled in Table 5.7.

Table 5.7: Descriptive statistical analysis of brand differentiation scales
Item
code

Item

Mean of
dimension

Mean

Std.
deviati
on

Rankin
g

4.098

.851

1

3.827
1. Our corporate brand is perceived
differently according to whether consumers
have experienced our products.

BD1

2. Our corporate brand is
differently by word of mouth.

perceived

BD2

3.869

1.056

4

3. Our corporate brand
differently by promotion.

perceived

BD3

3.361

1.330

7

4. Our corporate brand is actually created
differently by product characteristics.

BD4

3.639

1.126

6

5. Our corporate branding may be directed at
different market segments.

BD5

4.066

.946

3

6. Our corporate brand may utilize nonphysical product characteristics.

BD6

3.689

1.177

5

7. Our firm’s corporate brand positioning
strategy is based on advanced R&D which
meets the needs of the targeted market.

BD7

4.066

.998

2

is
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5.3.2.6 Brand segmentation scales
In terms of “brand segmentation,” the mean values of the respective measurement
items are between 3.426 and 3.902. The mean of dimension is 3.643. The dimension
with the highest score (3.902) was “Our corporate brand strategy requires product
differentiation”. Another dimension which scored higher than the average was
“Our corporate brand strategy requires changes in importance attached to a physical
product” and “Our corporate brand strategy requires product differentiation.” The
dimension with the lowest score (3.426) was “Our corporate brand strategy requires
changes in importance attached to a non-physical product”. Other dimensions which
scored lower than the average were “Our corporate brand strategy is decided by the
needs of the customers when determining product differentiation” and “Our
corporate brand strategy requires changes in point distribution location” and “Our
corporate brand strategy requires changes in importance attached to a nonphysical
product.” The above data is compiled in Table 5.8.

Table 5.8: Descriptive statistical analysis of brand segmentation scales
Item

Item
code

Mean of
dimension

Mean

Std.
deviation

Ranking

3.643
1. Our corporate brand strategy requires
product differentiation.

BS1

3.902

.995

1

2. Our corporate brand strategy requires
changes in point distribution location.
3. Our corporate brand strategy requires
changes in importance attached to a nonphysical product.

BS2

3.508

1.233

4

3.426

1.117

5

4. Our corporate brand strategy requires
changes in importance attached to a physical
product.

BS4
3.869

1.008

2

5. Our corporate brand strategy is decided by
the needs of the customers when
determining product differentiation.

BS5
3.508

1.337

3

BS3
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5.3.2.7 Medicine price scales
In terms of “medicine price,” the mean values of the respective measurement items
are between 3.230 and 3.803. The mean of dimension is 3.446. The dimension with
the highest score (3.803) was “Our firm pays considerable attention to effective
publicity and communication while operating bulk buying/discounts”. Other
dimensions which scored higher than the average were “Our firms customize price
according to the trading characteristics”, “A medicine with a higher price shows a
better image of the company it belongs to”, “A medicine with a higher price
usually captures the value that is generated in the product”, and “Our firm pays
considerable attention to effective publicity and communication while operating bulk
buying/discounts.” The dimension with the lowest score (3.230) was “Our firm
customizes price by value that is perceived by our customers”. Other dimensions
which were scored lower than the average were “A medicine with a higher price
shows a higher quality of product to its customers”, “Our firm customizes price
according to the characteristics of the customers”, “Our firm customizes price by
offering coupons, regional prices, limited consumption or negotiatory prices to a
specific group of customers”, “Our firm customizes price by distinguishing
between customers who pursue high values and customers with strict budgets” and
“Our firm customizes price by value that is perceived by our customers.” The
above data is compiled in Table 5.9.

Table 5.9: Descriptive statistical analysis of medicine price scales
Item

Item
code

Mean of
dimension

Mean

Std.
deviat
ion

3.410

1.243

5

3.508

1.299

3

3.721

1.127

2

Ranking

3.446

1. A medicine with a higher price shows

PP1

a higher quality of product to its
customers.
2. A medicine with a higher price shows a
better image of the company it belongs to.
3. A medicine with a higher price usually

PP2
PP3
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captures the value that is generated in the
product.
4. Our firm customizes price by value that
is perceived by our customers.
5. Our firm customizes price by
distinguishing between customers who
pursue high values and customers with
strict budgets.
6. Our firm customizes price by offering
coupons,
regional
prices,
limited
consumption or negotiatory prices to a
specific group of customers.
7. Our firm customizes price according to
the characteristics of the customers.
8. Our firms customize price according to
the trading characteristics.
9. Our firm pays considerable attention to
effective publicity and communication
while operating bulk buying/discounts.

PP4

3.230

1.383

9

3.262

1.303

8

3.295

1.321

7

3.295

1.229

6

3.492

1.120

4

3.803

1.166

1

PP5

PP6

PP7
PP8
PP9

5.4 Confirmatory factor analysis (CFA) (questionnaire reliability and
validity analysis/measurement model analysis)

The validity and reliability of the questionnaire in this research were tested through
confirmatory factor analysis (CFA) and Cronbach’s coefficient as described below.
This section is divided into two parts: the validity analysis and the reliability analysis.

5.4.1 Validity analysis

In this study, the confirmatory factor analysis has been adopted to test the suitability
of the respective dimension measurement models in order to determine whether the
dimensions have enough convergent validity and discriminant validity. The
convergent validity and discriminant validity are analysed as follows.
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5.4.1.1 Convergent validity analysis
In this study, evaluations were based on the convergent validity analysis criteria
suggested by Anderson and Gerbing (1988), the confirmatory factor analysis (CFA)
criteria proposed by Bagozzi and Yi (1988) and the goodness of fit (GoF) proposed by
Gefen, Straub and Boudreau (2000). The three evaluation criteria are: (1) the factor
loadings of all indicators have reached significance; (2) the Composite Reliability
(CR) of the dimensions is higher than 0.7; (3) the average variance extracted (AVE) is
higher than 0.5. Data analysis of the items in the dimensions was then conducted
using PLS1.04.

Value creation scales
In the measurement model of “value creation scales”, the Cronbach Alpha is 0.938,
and the factor loadings of the respective measurement indicators have reached
significance; the Composite Reliability (CR) and the Average Variance Extracted
(AVE) are 0.945 and 0.469 respectively, indicating the CR and AVE are both higher
than 0.7 and 0.4. Therefore, the data analysis shows that the convergent validity of
“value creation” is within the acceptance range. This data is compiled in Table 5.10.

Table 5.10: Confirmatory factor analysis of value creation
Estimated MLE
parameter
Factor
Measureloading
ment error
(λx)
(δ)

Variable

1.

The corporate reputation of our firm helps to reduce
transaction costs.
2. Our firm competes by creating useful products.
3. Our firm competes by providing good financial
performances.
4. Our firm competes by providing products with
appropriate outcomes.
5. Our firm’s value-chain activity is consistent with
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0.590

0.652

0.462

0.786

0.644

0.585

0.607

0.631

0.548

0.700

Compo
-site
Reliability
(CR)
0.945

Average
Variance
Extracted
(AVE)
0.469
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Table 5.10: Confirmatory factor analysis of value creation
Estimated MLE
parameter
Factor
Measureloading
ment error
(λx)
(δ)

Variable

functional value creation.
6. Our firm’s resource allocation is consistent with
functional value creation.
7. Our firm’s products compete by appealing to the
senses.
8. Our firm competes by creating appropriate emotions
(e.g. fun, pleasure, excitement, relaxation, etc.)
9. Our firm competes by facilitating social relationships
(e.g. bonds, attachments and togetherness).
10. Our firm competes by creating epistemic value (e.g.
knowledge and novelty).
11. Our firm’s value-chain activity is consistent with
experiential value creation (e.g. happiness, affection and
excitement...).
12. Our firm’s resource allocation is consistent with
experiential value creation.
13. Our firm competes by enhancing its customers’ selfidentity.
14. Our firm competes by enhancing its customers’ selfconcept (or self-image).
15. Our firm competes by enhancing its customers’ selfworth.
16. Our firm competes by facilitating self-expression.
17. Our firm competes by offering economic value (low
prices, value in use, life costs).
18. Our firm competes by enabling ease of use of its
products (time, effort, energy).
19. Our firm competes by minimizing customer risk
(personal, technological, strategic).
20. Our firm’s resource allocation is consistent with
symbolic value creation.

0.623

0.612

0.783

0.387

0.675

0.545

0.693

0.520

0.652

0.575

0.743

0.449

0.714

0.491

0.858

0.263

0.865

0.252

0.893

0.202

0.791

0.375

0.656

0.569

0.593

0.648

0.436

0.810

0.651

Compo
-site
Reliability
(CR)

Average
Variance
Extracted
(AVE)

0.576

Cronbach Alpha =0.938; the factor loading is a standardized value, indicating p<0.001

Strategic value and resources scales
In the measurement model of “value creation and resources scales,” the Cronbach
Alpha is 0.955, and the factor loadings of the respective measurement indicators have
reached significance; the Composite Reliability (CR) and Average Variance Extracted
(AVE) are 0.964 and 0.662 respectively, indicating the CR and AVE are both higher
than 0.7 and 0.5. Therefore, the data analysis shows that the convergent validity of
“strategic value and resources scales” is within the acceptance range. This data is
compiled in Table 5.11.
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Table 5.11: Confirmatory factor analysis of strategic value and resources scales
Estimated MLE parameter
Variable

Factor loading
(λx)

1. In our organization, corporate reputation
serves as a competitive advantage.
2. Our firm’s corporate reputation sends a
strong signal to its customers.
3. Our firm’s corporate reputation implies
efficient sales and marketing.
4. Our firm’s corporate reputation implies it
has advanced R&D.
5. Our firm’s corporate reputation implies
that we are able to enter markets early.
6. Our firm’s corporate reputation gains the
firm more opportunity for strategic alliance
or business cooperation.
7. Our firm’s corporate reputation is
enhancing prices by validating them in
published clinical reports.
8. Our firm’s corporate reputation enables
the firm to enter the market more easily.
9. Our firm’s corporate reputation gains
more customers for the firm.
10. Our firm’s corporate reputation makes
the marketing system work more efficiently.
11. Our firm’s corporate reputation makes it
easier for us to find a downstream resaler.
12. Our firm’s corporate reputation can
enhance our firm’s sales force.
13. Our firm’s corporate reputation helps a
new product to enter the market.
14. Our firm’s corporate reputation helps the
strategic link with complementary products.

Measurement error
(δ)

0.793

0.371

0.895

0.200

0.788

0.380

0.668

0.554

0.892

0.204

0.813

0.339

0.692

0.521

0.935

0.127

0.830

0.312

0.904

0.183

0.838

0.299

0.588

0.655

0.916

0.161

0.756

0.428

Compo
-site
Reliability
(CR)
0.964

Average
Variance
Extracted
(AVE)
0.662

Cronbach Alpha =0.955; the factor loading is a standardized value, indicating p<0.001

Corporate communication scales
In the measurement model of “corporate communication scales,” the Cronbach
Alpha is 0.840, and the factor loadings of the respective measurement indicators have
reached significance; the Composite Reliability (CR) and Average Variance Extracted
(AVE) are 0.892 and 0.547 respectively, indicating the CR and AVE are both higher
than 0.7 and 0.5. Therefore, the data analysis shows that the convergent validity of
“corporate communication” is within the acceptance range. This data is compiled
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in Table 5.12.

Table 5.12: Confirmatory factor analysis of corporate communication scales
Estimated MLE parameter
Variable

Factor loading
(λx)

1. Our firm’s corporate reputation shapes the
perceptions of shareholders and other
stakeholders.
2. Our firm’s corporate reputation builds a
relationship between the firm and its
customers.
3. Our firm’s corporate reputation influences
consumer choices.
4. Our firm’s corporate reputation is based
on the experience of the sales staff.
5. Our firm’s corporate reputation is based
on the sales ability of the sales staff.
6. Our firm’s corporate reputation helps
internal communication (the communication
between our firm and our staff).
7. Our firm’s corporate reputation helps
external communication (the communication
between our firm and our customers).

Measurement error
(δ)

0.816

0.335

0.827

0.316

0.637

0.594

0.545

0.703

0.741

0.451

0.767

0.412

0.798

0.364

Compo
-site
Reliability
(CR)
0.892

Average
Variance
Extracted
(AVE)
0.547

Cronbach Alpha =0.840; the factor loading is a standardized value, indicating p<0.001

Brand positioning scales
In the measurement model of “brand positioning scales,” the Cronbach Alpha is
0.851, and the factor loadings of the respective measurement indicators have reached
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE)
are 0.902 and 0.650 respectively, indicating the CR and AVE are both higher than 0.7
and 0.5. Therefore, the data analysis shows that the convergent validity of “brand
positioning” is within the acceptance range. This data is compiled in Table 5.13.
Table 5.13: Confirmatory factor analysis of brand positioning scales
Estimated MLE parameter
Variable

Factor loading
(λx)
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Measurement error
(δ)

Compo
-site
Reliability
(CR)

Average
Variance
Extracted
(AVE)
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Table 5.13: Confirmatory factor analysis of brand positioning scales
Estimated MLE parameter
Variable

Factor loading
(λx)

1. Our firm’s corporate brand positioning
strategy signifies high quality to its
customers.
2. Our firm’s corporate brand positioning
strategy signifies better product performance
for its customers.
3. Our firm’s corporate brand positioning
strategy involves a long distribution chain.
4. Our firm’s corporate brand positioning
strategy is to provide a much better service
to its customers.
5. Our firm’s corporate brand positioning
strategy tries to fulfil the basic needs of our
customers.

Measurement error
(δ)

0.751

0.437

0.866

0.250

0.816

0.335

0.878

0.230

0.707

0.500

Compo
-site
Reliability
(CR)
0.902

Average
Variance
Extracted
(AVE)
0.650

Cronbach Alpha =0.851; the factor loading is a standardized value, indicating p<0.001

Brand differentiation scales
In the measurement model of “brand differentiation scales,” the Cronbach Alpha is
0.874, and the factor loadings of the respective measurement indicators have reached
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE)
are 0.909 and 0.590 respectively, indicating the CR and AVE are both higher than 0.7
and 0.5. Therefore, the data analysis shows that the convergent validity of “product
differentiation” is within the acceptance range. This data is compiled in Table 5.14.

Table 5.14: Confirmatory factor analysis of brand differentiation scales
Estimated MLE parameter
Variable

Factor loading
(λx)

1. Our corporate brand is perceived
differently according to whether consumers
have experienced our products.
2. Our corporate brand is perceived
differently by word of mouth.
3. Our corporate brand is perceived
differently by promotion.
4. Our corporate brand is actually created
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Measurement error
(δ)

0.813

0.340

0.752

0.434

0.679

0.539

0.852

0.275

Compo
-site
Reliability
(CR)
0.909

Average
Variance
Extracted
(AVE)
0.590
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Table 5.14: Confirmatory factor analysis of brand differentiation scales
Estimated MLE parameter
Variable

Factor loading
(λx)

differently by product characteristics.
5. Our corporate branding may be directed at
different market segments.
6. Our corporate brand may utilize nonphysical product characteristics.
7. Our firm’s corporate brand positioning
strategy is based on advanced R&D which
meets the needs of the targeted market.

Measurement error
(δ)

0.779

0.393

0.664

0.559

0.818

0.331

Compo
-site
Reliability
(CR)

Average
Variance
Extracted
(AVE)

Cronbach Alpha =0.874; the factor loading is a standardized value, indicating p<0.001

Brand segmentation scales
In the measurement model of “brand segmentation scales,” the Cronbach Alpha is
0.896, and the factor loadings of the respective measurement indicators have reached
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE)
are 0.927 and 0.717 respectively, indicating the CR and AVE are both higher than 0.7
and 0.5. Therefore, the data analysis shows that the convergent validity of “product
segmentation” is within the acceptance range. This data is compiled in Table 5.15.

Table 5.15: Confirmatory factor analysis of product segmentation scales
Estimated MLE parameter
Variable

Factor loading
(λx)

1. Our corporate brand strategy requires
product differentiation.
2. Our corporate brand strategy requires
changes in point distribution location.
3. Our corporate brand strategy requires
changes in importance attached to a nonphysical product.
4. Our corporate brand strategy requires
changes in importance attached to a physical
product.
5. Our corporate brand strategy is decided by
the needs of the customers when
determining product differentiation.

Measurement error
(δ)

0.836

0.300

0.909

0.174

0.879

0.227

0.816

0.334

0.788

0.378

Cronbach Alpha =0.896; the factor loading is a standardized value, indicating p<0.001
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-site
Reliability
(CR)
0.927

Average
Variance
Extracted
(AVE)
0.717
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Medicine price scales
In the measurement model of “medicine price scales,” the Cronbach Alpha is 0.906,
and the factor loadings of the respective measurement indicators have reached
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE)
are 0.924 and 0.577 respectively, indicating the CR and AVE are both higher than 0.7
and 0.5. Therefore, the data analysis shows that the convergent validity of “medicine
price scales” is within the acceptance range. This data is compiled in Table 5.16.

Table 5.16: Confirmatory factor analysis of medicine price scales
Estimated MLE parameter
Variable

Factor loading
(λx)

A medicine with a higher price shows a
higher quality of product to its
customers.
2. A medicine with a higher price shows a
better image of the company it belongs to.
3. A medicine with a higher price usually
captures the value that is generated in the
product.
4. Our firm customizes price by value that is
perceived by our customers.
5. Our firm customizes price by
distinguishing between customers who
pursue high values and customers with strict
budgets.
6. Our firm customizes price by offering
coupons,
regional
prices,
limited
consumption or negotiatory prices to a
specific group of customers.
7. Our firm customizes price according to
the characteristics of the customers.
8. Our firms customize price according to
the trading characteristics.
9. Our firm pays considerable attention to
effective publicity and communication while
operating bulk buying/discounts.

Measurement error
(δ)

1.

0.724

0.476

0.660

0.565

0.654

0.573

0.728

0.471

0.851

0.275

0.794

0.370

0.878

0.228

0.824

0.320

0.685

0.531

Cronbach Alpha =0.906; the factor loading is a standardized value, indicating p<0.001

5.4.1.2 Discriminant validity analysis
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The study was conducted in line with the two criteria of discriminant validity
proposed by Gask and Nevin (1985): (1) the correlational coefficient between the two
dimensions is less than 1; (2) the correlational coefficients of the two dimensions are
smaller than the individual Cronbach’s reliability coefficients, indicating the two
dimensions possess discriminant validity. In addition, following Fornell and Larcker
(1981), a third criterion for determining the discriminant validity has been proposed:
(3) the correlational coefficients of the two dimensions are smaller than the square
root of AVE, indicating that the two dimensions possess discriminant validity. In this
study, SPSS 15.0 and PLS 1.04 were used to analyse the correlational coefficient
matrixes of the measurement variables. The analysis data results as shown in Table
5.16 are consistent with the three discriminant validity criteria mentioned above,
indicating good discriminant validity.

5.4.2 Reliability analysis

The study was conducted in accordance with the internal consistency of the
Cronbach’s coefficient questionnaire (as shown in Table 5.16) proposed by Bagozzi
and Yi (1988). In terms of the respective scales, the items were examined to determine
whether or not the item-total correlations of the respective items are higher than 0.5.
The Cronbach’s coefficient of the “value creation” dimension is greater than 0.5,
indicating that the “value creation” scales possess good reliability and internal
consistency. The Cronbach’s coefficient of the “strategic resources” is 0.955, and the
item-total correlations are all greater than 0.5, indicating that the “strategic resources”
scales possess good reliability and internal consistency. The Cronbach’s coefficient of
the “corporate communication” dimension is 0.840, and the item-total correlations are
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all greater than 0.5, indicating that the “corporate communication” scales possess
good reliability and internal consistency. The Cronbach’s coefficient of the “brand
segmentation” dimension is 0.896, and the item-total correlations are all greater than
0.5, indicating that the“brand segmentation” scales possess good reliability and
internal consistency. The Cronbach’s coefficient of the “brand differentiation”
dimension is 0.874, and the item-total correlations are all greater than 0.5, indicating
that the “brand segmentation” scales possess good reliability and internal consistency.
The Cronbach’s coefficient of the “brand positioning” dimension is 0.851, and the
item-total correlations are all greater than 0.5, indicating the “brand segmentation”
scales possess good reliability and internal consistency. The Cronbach’s coefficient of
the “medicine price” dimension is 0.906, and the item-total correlations are all greater
than 0.5, indicating that the “medicine price” scales possess good reliability and
internal consistency. This data is compiled in Table 5.17.
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Table 5.17: Table of discriminant validity analysis and correlational coefficients of variables

Dimension

Value creation
Strategic
resources
Corporate
communication
Brand
segmentation
Brand
differentiation
Brand
positioning
Product price

Value Strategic
Corporate
Brand
Brand
Brand
creation resources communication segmentation differentiation positioning

Medicine
price

.777
.829

.751

.730

.796

.826

.546

CR

AVE

Composite
Reliability
(CR)

Average
Variance
Extracted
(AVE)

0.945

0.469

0.964

0.662

0.892

0.547

0.927

0.717

0.909

0.590

0.902

0.650

0.924

0.577

.871

.745

.755

.790

.847

.586

.818

.805

.825

.762

.484

.895

.947

.830

.636

Mean
Variance
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.839

.867

.579

.866

.527

.836

`

Cornbach’s α

0.938

0.955

0.840

0.896

0.874

0.851

0.906

The diagonal value is the square root of AVE; CR represents Composite Reliability; AVE represents Average Variance Extracted; the lower triangle is
Pearson correlation.
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5.5 Structural Equation Modelling Analysis
To further validate the relationship between each dimension based on the conceptual
framework mentioned in this study, structural equation modelling analysis was
conducted to understand the relationship of the modelling as a whole. The overall
structural equation modelling combines the factor analysis and path analysis of
traditional statistics. In addition, the simultaneous equation in econometrics was
included to simultaneously process the relationship of a series of dependent variables,
which is suitable for the discussion of the causal relationship of the overall modelling in
this study. Therefore, in order to further examine the relationship between each
dimension mentioned in the theoretical framework in this section, all the samples
underwent structural equation modelling analysis to verify the conceptual framework
mentioned in this study and to understand the relationship between each dimension.
With regard to the analysis procedures of the structural equation modelling, in this study
the two-stage structural equation modelling analysis proposed by Anderson and Gerbing
(1988) and Williams and Hazer (1986) was conducted: (1) the first stage targets the
respective research dimensions and items to conduct confirmatory factor analysis and
Cronbach’s coefficient analysis. Moreover, through analysis of convergent validity,
discriminant validity and reliability, a stable measurement model was developed; (2) the
second stage focuses on the reduction of multiple measurement items into a few
measurement indicators in which the structural model was used to verify the hypotheses
in this study. The advantage of the two-stage analysis is that the measurement model
and structural model were differentiated. If the reason for the test results not reaching
significance cannot be ascertained, the analysis can still help researchers to clarify
questions related to the measurement model or the dimensions. The stage 1 analysis can
be found in 5.3 of this chapter, so it will not be explained further in this section. In this
section, the stage 2 to 4 analyses are included.

5.5.1 Development of the Overall Modelling
Section 5.3 of this chapter shows that the measurement models of the respective
dimensions are stable. In addition, the convergent validity, discriminant validity and
reliability have all reached acceptable standards. Since the variables in the research
framework are within a single dimension, the single dimension was adopted during the
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verification. Therefore, in terms of the measurement models of “value creation”,
“strategic resource”, “corporate communication”, “brand differentiation”, “brand
segmentation”, “brand positioning” and “medicine price”, the scores of the
measurement items in the respective dimensions served as the measurement indicators
to measure the theoretical model. In this study, there are 61 samples for analysis using
the PLS package software. At the same time, the correlational coefficient matrixes of
the respective measurement variables are as shown in Table 5.18. The measurement
variables that are correlated have reached significance, indicating the structural equation
modelling analysis is suitable.

5.5.2 Hypothesis Validation and Result Analysis
As the PLS gives emphasis to the capabilities of the formative indicators and reflective
indicators, while the concomitant variable estimation methods for the different indicator
samples vary, the measurement values of the Goodness of Fit (GoF) have not been
provided. The explanatory power of the model is represented by R square, which
indicates an ability of the cause indicators to explain the potential variables. The size of
the load value determines the strength of the respective indicators in affecting the
dimensions, and the path coefficients are standardized estimation values in which their
significance can be determined by the p-value obtained from the Bootstrapping analysis.
The structural modelling analysis results in this study are as follows: in the structural
model, the forecast variables are “value creation”, “strategic resources” and “corporate
communication”, which were used to predict the dependent variables including “brand
segmentation”, “brand differentiation” and “brand positioning”. In terms of the
regression model, with “brand segmentation” as a dependent variable, the standardized
value for “value creation” is 0.232 (t-value=1.537), the standardized value of “strategic
resources”

is

0.164

(t-value=1.521),

the

standardized

value

of

“corporate

communication” is 0.517 (t-value=3.679) and the model’s explanatory power R is 0.723.
In terms of the regression model, with “brand differentiation” as a dependent variable,
the standardized value of “value creation” is 0.334 (t-value=2.459), the standardized
value of “strategic resources” is 0.143 (t-value=1.256), the standardized value of
“corporate communication” is 0.477 (t-value=3.878) and the model’s explanatory power
R is 0.783. In terms of the regression model, with “brand positioning” as a dependent
variable, the standardized value of “value creation” is 0.327 (t-value=2.595), the
standardized value of “strategic resources” is 0.363 (t-value=1.996), the standardized
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value of “corporate communication” is 0.278 (t-value=2.643) and the model’s
explanatory power R is 0.808. A model with path values and t-values is shown in Figure
5.2.

Figure 5.2: Path values (structural path relationships) and t-value (significance of
structural path based on t-value) in brackets

In this study, with “medicine price” as the regulatory variable, the effect of the uses of
corporate reputation on brand image strategy was explored. The analysis results have
found that the standardized estimate value of the uses of corporate reputation is 0.736 (tvalue=11.444), the standardized estimate value of medicine price is 0.211 (tvalue=3.223), the standardized estimate value of the regulatory effect variables between
the uses of corporate reputation and brand image strategy is -0.177 (t-value=-3.068),
while the explanatory power R of the model is 0.845. The result findings show that
medicine price has a negative moderating effect on the uses of corporate reputation in
“brand image strategy” (Please refer to Figure 5.2). In other words, the more recognized
medicine price is, the less helpful its role will be in having an effect on the the uses of
corporate reputation in brand image strategy. The negative effect of medicine price on
brand image strategy will interfere with the positive effect of the uses of corporate
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reputation in brand image strategy. A model of the moderating effect between the
relationship of the uses of corporate reputation and brand image strategy is shown in
Figure 5.3.

Figure. 5.3: Moderating effect between the relationship of the uses of corporate
reputation and brand image strategy

Table 5.18: Table of standardized path coefficients and hypothesis validation of the
research model
Hypothesis

Path

Correlation between dimensions

H1

β1

H2

β4

H3

β7

H4

β2

H5

β5

H6

β8

H7

β3

H8

β6

H9

β9

H10

β10

Value creation  Brand segmentation
(VCBS)
Value creation  Brand differentiation
(VCBD)
Value creation  Brand positioning
(VCBP)
Strategic
resources

Brand
segmentation (SRBS)
Strategic
resources

Brand
differentiation (SRBD)
Strategic resources  Brand positioning
(SRBP)
Corporate communication  Brand
segmentation (CCBS)
Corporate communication  Brand
differentiation (CCBD)
Corporate communication  Brand
positioning (CCBP)
Moderating
effects
of
medicine
priceBrand image
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Path
coefficient
0.232

t-value

Test results

1.537

Rejected

0.334*

2.459

Accepted

0.327*

2.595

Accepted

0.164

1.521

Rejected

0.143

1.256

Rejected

0.363*

1.996

Accepted

0.517*

3.679

Accepted

0.477*

3.878

Accepted

0.278*

2.643

Accepted

-0.177*

-3.0768

Accepted
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According to the results, we assume that there were some issues as follows. First, the
comparatively small sample size with some of the constructs having too many items (i.e.
there are 20 items in the value creation construct). To reduce the number of items, some
items, based on factor loading below 0.7, are deleted. Only those items which have with
higher loadings are retained. Second, there is a lack of discriminant validity in the
analysis. For the above reason, the model was run again with the constructs of the
deleted items.

5.5.3 Second Round Analysis

5.5.3.1 Direct effects
Based on Henseler et al. (2009), some items with a factor loading (absolute standardized
outer loading) below 0.7 (≈ √0.5) were deleted. Thus, VC1, VC2, VC3, VC4, VC5,
VC6, VC7, VC8, VC9, VC10, VC11, VC12, VC17, VC18, VC19, VC20 were deleted
from the value creation construct and VC13, VC14, VC15, VC16 were retained. SR1,
SR3, SR4, SR6, SR7, SR9, SR12, SR14 were deleted from the strategic resource
construct and SR2, SR5, SR8, SR10, SR11, SR13 retained. CC3, CC4, CC5 and CC6
were deleted from the corporate communication construct and CC1, CC2, CC7 were
retained. BP1, BP5 were deleted from the brand positioning construct and BP2, BP3,
BP4 three items are retained. BD3, BD6 were deleted from the brand differentiation
construct and BD1, BD2, BD4, BD5, BD7 retained. Finally, BS4 and BS5 were deleted
from the brand segmentation construct and BS1, BS2, BS3 were retained. PP4, PP5,
PP6, PP8, and PP9 were deleted from the medicine price construct and PP1, PP2, PP3
and PP7 were retained.
According to Henseler et al. (2009), “cross-loadings offer another check for
discriminant validity. If an indicator has a higher correlation with another latent variable
than with its respective latent variable, the appropriateness of the model should be
reconsidered.” Therefore, the cross loading was checked, as is shown in Table 5.19. For
example, the BDBD cross loadings should be higher than the loadings of BD with
other constructs. The same rule can be applied to other constructs.
According to Henseler et al. (2009), “the essential criterion for this (structural model)
assessment is the coefficient of determination (R square) of the endogenous latent
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variables. Chin (1998) describes R square values of 0.67, 0.33, and 0.19 in PLS path
models as substaintial, moderate, and weak, respectively.” Therefore, in this second
round of analysis, it is shown that the R square values of BD, BP and BS are 0.6536,
0.7508 and 0.6633 respectively. The average value of R square is 0.689233, which,
according to Chin’s (1998) description, is “substaintial”.
Table 5.19: Cross loadings table
BD

BP

BS

CC

SR

VC

BD1
BD2
BD4

0.8398
0.7754
0.8453

0.7371
0.5751
0.6452

0.6806
0.6353
0.8024

0.6962
0.6175
0.6121

0.6436
0.5148
0.6124

0.5485
0.4777
0.5654

BD5
BD7
BP2
BP3

0.7874
0.8746
0.7799
0.6379

0.7022
0.6061
0.8253
0.8761

0.7176
0.6755
0.6694
0.7545

0.4854
0.6936
0.7127
0.5403

0.6316
0.6124
0.6508
0.6909

0.5174
0.4573
0.5374
0.752

BP4
BS1
BS2
BS3

0.6777
0.8082
0.7574
0.7657

0.9298
0.7014
0.748
0.7085

0.6583
0.8661
0.9439
0.9218

0.6512
0.6285
0.6284
0.6196

0.8129
0.6471
0.6268
0.5706

0.6622
0.5475
0.7192
0.7144

CC1
CC2
CC7
SR10

0.652
0.6762
0.6752
0.61

0.6034
0.6313
0.6678
0.7354

0.5939
0.6288
0.5892
0.5461

0.8946
0.9187
0.8328
0.7115

0.6747
0.7164
0.6974
0.9324

0.4117
0.439
0.5109
0.6187

SR11
SR13
SR2
SR5

0.5676
0.6642
0.689
0.7555

0.7095
0.7592
0.8096
0.7197

0.5671
0.6704
0.6051
0.6604

0.6542
0.6775
0.6921
0.7954

0.8606
0.9286
0.9097
0.8887

0.6149
0.6755
0.7096
0.5912

SR8
VC13
VC14
VC15

0.6906
0.5457
0.5586
0.6192

0.7489
0.7068
0.6729
0.7958

0.6115
0.6519
0.6675
0.7173

0.7789
0.4473
0.4996
0.5187

0.944
0.6406
0.6347
0.7024

0.5679
0.9355
0.9418
0.9566

VC16

0.5797

0.565

0.6669

0.441

0.5802

0.8725

The construct level discriminant validity is computed using the Fornell-Larcker
criterion (1981), where the square root of the latent variables shared variance (i.e. AVE)
of each variable is higher than the other variables’ correlation (See the row and coloum
in the Table). Even though the inter-construct correlation was very high between the
latent constructs (e.g., BSBD = 0.81 or 81%), the criterion of discriminant validity is
still satisfied (i.e. BD= 0.83 or 83%).
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Table 5.20: Inter-construct correlation
BD
BP
BS
CC
SR
VC

BD

BP

BS

CC

SR

VC

0.83*
0.79
0.81
0.76
0.73
0.62

0.88
0.79
0.72
0.82
0.74

0.91
0.69
0.67
0.73

0.88
0.79
0.52

0.91
0.69

0.93

* is square root of AVE replaced by diagonal value 1.

According to Henseler et al. (2009), to access the structural model, the average variance
extracted (AVE) and R square should be checked as well. Also, the “R square values of
0.67, 0.33, or 0.19 for endogenous latent variables in the inner path model are described
as substaintial, moderate, or weak” (Chin, 1998, p. 323) The AVE value and R square
are shown in Table 5.21.
Moreover, according to Henseler et al. (2009), “the PLS goodness-of-fit proposal by
Tenenhaus et al. (2005) is the geometric mean of the average communalities (outer
measurement model) and the average R square of endogenous latent variables, and is
normed between 0 and 1, where a higher value represents better path model estimations.”
In this research, the result of the second round of data analysis shows that the GoF value
is 73%, which is more than 50% of value.
Table 5.21: Over view of model
AVE
BD
BP
BS
CC
SR
VC

0.6812
0.771
0.8303
0.7793
0.8301
0.8596

Composite
Reliability
0.9142
0.9097
0.9361
0.9136
0.967
0.9607

R-Square
0.6536
0.7508
0.6633

Cronbachs
Alpha
0.8824
0.8503
0.8974
0.8573
0.9589
0.9452

Communality

Redundancy

0.6812
0.771
0.8303
0.7793
0.8301
0.8596

0.3438
0.2057
0.3463

AVEsquare
0.83
0.88
0.91
0.88
0.91
0.93

GoF= 0.738793

According to Henseler et al. (2009), in order to assess the structural model, the path
coefficient should be checked. Therefore, the path coefficients of each construct are
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shown in Table 5.22. The p-value is calculated by using a two-tailed student t-test; as is
shown in the table, H2, H5 and H9 are not acceptible.
Table 5.22: Path coefficient table
Hypo
thesis

Original
Sample
(O)

Sample
Mean
(M)

Standard
Deviation
(STDEV)

Standard
Error
(STERR)

T-Statistics
(|O/STERR
|)

p-value

Test results

H1

VC -> BS

0.5351

0.521

0.1197

0.1197

4.4686

0.000***

Accepted

H2

VC -> BD

0.2526

0.2428

0.1147

0.1147

2.2015

0.029**

Accepted

H3

VC -> BP

0.3495

0.3588

0.0993

0.0993

3.5205

0.001***

Accepted

H4

SR -> BS

-0.0576

-0.0632

0.1865

0.1865

0.3086

0.758

Rejected

H5

SR -> BD

0.1607

0.1885

0.2144

0.2144

0.7495

0.454

Rejected

H6

SR -> BP

0.4069

0.423

0.1436

0.1436

2.8342

0.005**

Accepted

H7

CC -> BS

0.4547

0.4783

0.2198

0.2198

2.0687

0.040*

Accepted

H8

CC -> BD

0.5004

0.4918

0.1604

0.1604

3.1191

0.002**

Accepted

H9

CC -> BP

0.2181

0.2047

0.1127

0.1127

1.9352

0.054

Rejected

5.5.3.2 Moderating effects
The second model analysis tested the moderating role on each hypothesis. In Table 5.23
(path coefficient of moderating effects), the moderating effects of medicine price (PP)
on each construct of the uses of corporate reputation (VC, SR and CC) on each
construct of brand image strategy (BP, BD and BS) are shown, and none of the
moderating effects are supported. However, the medicine price is supported as a
predictor of BS, which shared 26% of variance (beta value or standard estimation) and
its t-value was 2.7803. A model with path values and t-values is shown in Figure 5.4.

Table 5.23: Path coefficient value of moderating effects

CC * PP -> BP
CC * PP -> BD
CC * PP -> BS
SR * PP -> BP
SR * PP -> BD
SR * PP -> BS
VC * PP -> BP
VC * PP -> BD
VC * PP -> BS

Original
Sample
(O)
-0.216
0.1658
0.1817
-0.0692
0.0787
-0.1506
-0.051
-0.3136
-0.2312

Sample
Mean
(M)
-0.099
-0.0225
0.1042
-0.1219
0.199
-0.0874
-0.0369
-0.0767
-0.1696

Standard
Deviation
(STDEV)
0.1554
0.1876
0.1677
0.1473
0.2213
0.1804
0.1416
0.2066
0.1937
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Standard
Error
(STERR)
0.1554
0.1876
0.1677
0.1473
0.2213
0.1804
0.1416
0.2066
0.1937

T Statistics
(|O/STERR|)
1.3903
0.8838
1.0835
0.4699
0.3556
0.835
0.3603
1.5176
1.1933

Test results
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected
Rejected

`

Figure 5.4: Path values (structural path relationships) and t-value (significance of
straturactural path based on t-value) in brackets ( path supported; - -> path
unsupported)

* t-values greater than 1.96 were significant.

Source: Developed for the current study

5.5.4 Third-Round Analysis
In this section, several items from the first- and second-round analyses were deleted to
refine the model by reducing cross-loadings, which consequently increased the
discriminant validity of the model (Fornell and Larcker, 1981; Henseler et al., 2009).
For example, BD2 (loading=0.77) was deleted because of the cross-loading with BS and
CC (0.63 and 0.61, respectively) (see Table 5.19); BD5 was deleted because of the
cross-loading with BP, BS and SR; SR5 was deleted because of the cross-loading with
BD, BP and CC; SR11 was deleted because of the cross-loading with BP; and VC16
was deleted because of the cross-loading with BS.
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Table 5.20 and Table 5.26 show the effect of the deletion of the cross-loadings. As
Table 5.20 shows, the square root of the average variance extracted (AVE) was close to
the inter-construct correlation (e.g., 0.81 between BD and BS), which has a lower
discriminant validity between the constructs; Table 5.26 reveals that the difference was
higher than the square root of AVE and inter-construct correlations and thus satisfies the
criterion of discriminant validity (Fornell and Larcker, 1981).
In order to increase the discriminant validity, three highest loading items for each
construct were kept to run the third round analysis. Other items were deleted. Therefore,
BD1, BD4 and BD7 were retained for the brand differentiation construct; BP2, BP3 and
BP4 were retained for the brand positioning contruct; BS1, BS2 and BS3 were retained
for the brand segmentation construct; CC1, CC2 and CC7 were retained for the
corporate communication construct; PP1, PP2 and PP3 were retained for the medicine
price construct and SR8, SR10 and SR13 were retained for the strategic resource
construct. And finally, VC13, VC14 and VC15 were retained for the value creation
construct. And in order to simplify the model, paths that are not supported in the last
round of analysis were deleted. A new path of the relationship of PP and BS was added
from the last round of analysis. A model with path values and t-values is shown in
Figure 5.5.
Table 5.24: Outer loadings
BD1
BD4
BD7
BP2
BP3
BP4
BS1
BS2
BS3
CC1
CC2
CC7
PP1
PP2
PP3
SR10
SR13

BD
0.8371
0.8687
0.9058

BP

BS

CC

PP

SR

0.8227
0.8779
0.9303
0.8705
0.9434
0.9185
0.8956
0.921
0.8295
0.9288
0.9494
0.9408
0.9487
0.9397
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SR8
VC13
VC14
VC15

0.9578
0.9489
0.9454
0.9736

Table 5.25: Cross loadings
BD1
BD4
BD7
BP2
BP3
BP4
BS1
BS2
BS3
CC1
CC2
CC7
PP1
PP2
PP3
SR10
SR13
SR8
VC13
VC14
VC15

BD
0.8371
0.8687
0.9058
0.7913
0.6105
0.6252
0.7841
0.7352
0.7431
0.658
0.7252
0.6493
0.3823
0.5492
0.5255
0.5805
0.6494
0.6662
0.5403
0.5357
0.5826

BP
0.7353
0.6453
0.6047
0.8227
0.8779
0.9303
0.7008
0.7483
0.7089
0.6028
0.6295
0.6674
0.4556
0.5731
0.4874
0.7357
0.7598
0.749
0.7074
0.6739
0.7965

BS
0.6808
0.8032
0.677
0.671
0.7536
0.6589
0.8705
0.9434
0.9185
0.5947
0.6297
0.5889
0.4957
0.5835
0.5637
0.5474
0.6717
0.613
0.6512
0.6644
0.7165

CC
0.6955
0.6123
0.6943
0.7133
0.539
0.65
0.6289
0.6281
0.6192
0.8956
0.921
0.8295
0.3632
0.4161
0.4244
0.7107
0.6771
0.7784
0.4468
0.4989
0.5175

PP
0.5525
0.3552
0.4447
0.5203
0.4227
0.4878
0.5594
0.5621
0.4812
0.4383
0.2704
0.432
0.9288
0.9494
0.9408
0.5327
0.4761
0.4888
0.5746
0.5048
0.5952

SR
0.5905
0.571
0.5776
0.588
0.6644
0.812
0.634
0.5962
0.5373
0.6555
0.6737
0.6849
0.3666
0.5538
0.5455
0.9487
0.9397
0.9578
0.6047
0.6061
0.6724

VC
0.5362
0.5277
0.4477
0.5465
0.769
0.6815
0.5221
0.7109
0.6961
0.4141
0.4344
0.5037
0.5086
0.6572
0.4758
0.6169
0.6866
0.568
0.9489
0.9454
0.9736

Table 5.26: Fornell-Larcker criterion: square inter-construct correlation
BD

BP

BS

CC

PP

SR

BD
BP

0.7586
0.580796

0.771

BS
CC
PP
SR

0.681285
0.5909
0.27238
0.444356

0.62331
0.515237
0.29214
0.622205

0.8304
0.469773
0.342459
0.41538

0.7795
0.183698
0.578969

0.8831
0.276571

0.9001

VC

0.335357

0.580035

0.503532

0.261019

0.342342

0.432832

VC

0.914

Table 5.27: Overview model
AVE
BD
BP

0.7586
0.771

Composite
Reliability
0.904
0.9097

R Square

Cronbachs
Alpha
0.8404
0.8503

0.6379
0.7565
215

Communality

Redundancy

0.7586
0.771

0.4329
0.2428
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BS
CC
PP
SR
VC

0.8304
0.7795
0.8831
0.9001
0.914

0.9362
0.9137
0.9577
0.9643
0.9696

0.6648

0.8974
0.8573
0.9339
0.9445
0.9529

0.8304
0.7795
0.8831
0.9001
0.914

0.3254

Table 5.28: Path coefficient
Hypot
hesis

Path

H8
H9

CC -> BD
CC -> BP

Original
Sample
(O)
0.6398
0.2691

Sample
Mean
(M)
0.6545
0.2729

Standard
Deviation
(STDEV)
0.0871
0.1168

Standard
Error
(STERR)
0.0871
0.1168

T Statistics
(|O/STERR|)

Test result

7.3456
2.3032

H7
H6
H2
H3

CC -> BS
SR -> BP
VC -> BD
VC -> BP

0.4056
0.3056
0.2522
0.4231

0.4328
0.3128
0.2478
0.4108

0.151
0.154
0.1035
0.1

0.151
0.154
0.1035
0.1

2.6864
1.9851
2.4369
4.2321

Accepted
Partially
supported
Accepted
Accepted
Accepted
Accepted

H1

VC -> BS

0.3979

0.3832

0.1553

0.1553

2.5614

Mainly supported

Figure 5.5: Path values (structural path relationships) and t-value (significance of
straturactural path based on t-value) in brackets ( path fully supported; - -> path
partially supported)

* t-values greater than 1.96 were significant.

Source: Developed for the current study
As a condition of that we took the supported path from the second round. The result of
the third round analysis is that, apart from the fact that the paths of the relationship of
PP and BS and the relationship of VC and BS are not supported, other paths are
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supported. Therefore, we conclude that paths of PP and BS and VC and BS are partially
supported.

5.5.5 Fourth Round Analysis

According to Barclay et al. (1995), a rule of thumb for robust PLS path modelling
estimations, the sample size in the inner path model should be larger than “ten times the
largest number of structural paths directed at a particular construct” (Henseler et al.,
2009). Therefore, because of the small number of respondents, based on the previous
model of analysis, we tried to simplify the model by separating one model into three
simpler models for the fourth round of analysis. A model with path values and t-values
is shown in Figure 5.6, Figure 5.7 and Figure 5.8.

Table 5.29: Outer loadings
BP
BP2
BP3
BP4
SR10
SR13
SR8
VC13
VC14
VC15

SR

VC

0.8101
0.885
0.9336
0.9487
0.9398
0.9577
0.9494
0.9441
0.9742

Table 5.30: Cross loadings
BP

SR

VC

BP2
BP3

0.8101
0.885

0.588
0.6644

0.5476
0.7695

BP4
SR10
SR13
SR8

0.9336
0.7381
0.7623
0.7501

0.812
0.9487
0.9398
0.9577

0.6821
0.6175
0.6869
0.5681

VC13
VC14
VC15

0.7091
0.6779
0.7992

0.6047
0.6062
0.6725

0.9494
0.9441
0.9742
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Table 5.31: Fornell-Larcker criterion:
square inter-construct correlation
BP
BP
SR
VC

SR

0.7704
0.625523
0.585837

VC

0.9001
0.433491

0.9139

Table 5.32: Overview model
BP
SR
VC

AVE
0.7704
0.9001
0.9139

Composite
Reliability
0.9094
0.9643
0.9696

R Square
0.7312

Cronbachs
Alpha
0.8503
0.9445
0.9529

Communality

Redundancy

0.7704
0.9001
0.9139

0.4177

Table 5.33: Path coefficient
Hypot
hesis
H6
H3

Path
SR -> BP
VC -> BP

Original
Sample
(O)
0.5065
0.4319

Sample
Mean
(M)
0.5148
0.4243

Standard
Deviation
(STDEV)
0.0935
0.0967

Standard
Error
(STERR)
0.0935
0.0967

T Statistics
(|O/STERR|)

Test
result

5.419
4.4664

Accepted
Accepted

Figure 5.6: Path values (structural path relationships) and t-value (significance of
straturactural path based on t-value) in brackets ( path fully supported; - -> path halfsupported)

* t-values greater than 1.96 were significant.

Source: Developed for the current study
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Table 5.34: Outer loadings
BD
BD1
BD4
BD7
CC1
CC2
CC7
VC13
VC14
VC15

CC

VC

0.8368
0.8689
0.906
0.8978
0.9247
0.8232
0.949
0.9459
0.973

Table 5.35: Corss loadings
BD1

BD
0.8368

CC
0.6941

VC
0.5358

BD4
BD7
CC1
CC2

0.8689
0.906
0.658
0.7252

0.6125
0.6955
0.8978
0.9247

0.5275
0.4478
0.4141
0.4344

CC7
VC13
VC14
VC15

0.6492
0.5402
0.5357
0.5825

0.8232
0.4456
0.4977
0.5153

0.5032
0.949
0.9459
0.973

Table 5.36: Fornell-Larcker criterion:
sqare inter-construct correlation
BD
CC
VC

BD

CC

0.7586
0.590746
0.335009

0.7797
0.259183

VC

0.914

Table 5.37: Overview model
AVE
BD
CC

0.7586
0.7797

Composite
Reliability
0.904
0.9137

VC

0.914

0.9696

R Square
0.6382

Cronbachs
Alpha
0.8404
0.8573

Communality

Redundancy

0.7586
0.7797

0.4329

0.9529

0.914

Table 5.38: Path coefficient
Hypot
hesis

Path

H8

CC -> BD

Original
Sample
(O)
0.6398

H2

VC -> BD

0.2531

Sample
Mean
(M)
0.6524

Standard
Deviation
(STDEV)
0.0889

Standard
Error
(STERR)
0.0889

T Statistics
(|O/STERR|)

Test result

7.1961

Accepted

0.2453

0.106

0.106

2.3879

Accepted
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Figure 5.7: Path values (structural path relationships) and t-value (significance of
straturactural path based on t-value) in brackets ( path fully supported)

* t-values greater than 1.96 were significant.

Source: Developed for the current study
Table 5.39: Outer loadings
BS
BS1
BS2
BS3
CC1
CC2
CC7
PP1
PP2
PP3
VC13
VC14
VC15

CC

PP

VC

0.8704
0.9434
0.9185
0.898
0.9222
0.8258
0.9288
0.9494
0.9408
0.9481
0.9467
0.9731

Table 5.40: Cross loadings
BS

CC

PP

VC

BS1
BS2

0.8704
0.9434

0.6291
0.6277

0.5594
0.5621

0.5211
0.7108

BS3
CC1
CC2
CC7

0.9185
0.5947
0.6296
0.5889

0.6186
0.898
0.9222
0.8258

0.4812
0.4383
0.2704
0.432

0.6968
0.4147
0.4345
0.5034

PP1
PP2
PP3
VC13

0.4957
0.5834
0.5637
0.6512

0.363
0.4153
0.424
0.4458

0.9288
0.9494
0.9408
0.5746

0.5086
0.6563
0.4752
0.9481

VC14
VC15

0.6644
0.7165

0.4984
0.5163

0.5048
0.5952

0.9467
0.9731
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Table 5.41: Fornell-Larcker criterion: sqare
inter-construct correlation
BS
BS
CC
PP
VC

CC

0.8304
0.469362
0.342459
0.503248

PP

VC

0.7796
0.18327
0.260202

0.8831
0.34164

0.914

Table 5.42: Overview model
AVE
BS
CC
PP
VC

0.8304
0.7796
0.8831
0.914

Composite
Reliability
0.9362
0.9137
0.9577
0.9696

R Square

Cronbachs
Alpha
0.8974
0.8573
0.9339
0.9529

0.6649

Communality

Redundancy

0.8304
0.7796
0.8831
0.914

0.3252

Table 5.43: Path coefficient
Hypot
hesis
H7
H1

Path
CC -> BS
VC -> BS

Original
Sample
(O)
0.4055
0.398

Sample
Mean
(M)
0.4354
0.3799

Standard
Deviation
(STDEV)
0.1465
0.1466

Standard
Error
(STERR)
0.1465
0.1466

T Statistics
(|O/STERR|
)
2.7682
2.7146

Test
result
Accepted
Accepted

Figure 5.8: Path values (structural path relationships) and t-value (significance of
straturactural path based on t-value) in brackets ( path fully supported; - -> path
partially supported)

* t-values greater than 1.96 were significant.

Source: Developed for the current study
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The tests in rounds 2, 3 and 4 are accepted, and therefore H1 is supported. For H2, the
tests in rounds 1, 2, 3 and 4 are accepted, and therefore H2 is supported. For H3, the
tests in rounds 1, 2, 3 and 4 are accepted, and therefore H3 is supported. H4 is rejected,
because the tests in rounds 1, 2 and 3 are all rejected. H5 is rejected, because the tests in
rounds 1 and 2 are rejected. For H6, the tests in rounds 1, 2, 3 and 4 are accepted, and
therefore H6 is supported. For H7, the tests in rounds 1, 2, 3 and 4 are accepted, and
therefore H7 is supported. For H8, the tests in rounds 1, 2, 3 and 4 are accepted, and
therefore H8 is supported. H9 is partially supported; the tests in rounds 1 and 3 are
accepted, but in round 2, the test is rejected. H10 is partially supported; the test in round
1 is accepted, but in round 2 the moderating effects are all rejected separately. A
summary of the hypotheses appears in Table 5.44 and Table 5.45, and a diagram of the
final results is depicted in Figure 5.9.
Table 5.44: Table of standardized path coefficients and hypothesis validation of the
research model (numbers based on fourth round analysis)
Hypoth
esis
H1

Path

Correlation between dimensions

β1

H2

β4

H3

β7

H4

β2

H5

β5

H6

β8

H7

β3

H8

β6

H9

β9

H10

β10

Value creation  Brand segmentation
(VCBS)
Value creation  Brand differentiation
(VCBD)
Value creation  Brand positioning
(VCBP)
Strategic resources  Brand segmentation
(SRBS)
Strategic
resources

Brand
differentiation (SRBD)
Strategic resources  Brand positioning
(SRBP)
Corporate communication  Brand
segmentation (CCBS)
Corporate communication  Brand
differentiation (CCBD)
Corporate communication  Brand
positioning (CCBP)
Moderating
effects
of
medicine
priceBrand image

Path
coefficient
0.398

t-value

Test results

2.715

Accepted

0.253

2.388

Accepted

0.432

4.466

Accepted

-

-

Rejected

-

-

Rejected

0.507

5.419

Accepted

0.406

2.768

Accepted

0.640

7.196

Accepted

-

-

-

-

Partially
supported
Partially
supported

Table 5.45: Table of hypothesis about the relationship test results
Hypoth
esis
H1
H2
H3

Hypothesis

Test results

A firm’s corporate reputation, which is used to create value,
has a positive impact on a firm’s brand segmentation
strategy.
A firm’s corporate reputation, which is used to create value,
has a positive impact on a firm’s brand differentiation
strategy.
A firm’s corporate reputation, which is used to create value,
has a positive impact on a firm’s brand positioning strategy.
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Accepted
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H4
H5
H6
H7
H8
H9
H10

A firm’s corporate reputation, which is used as a strategic
resource, has a positive impact on a firm’s brand
segmentation strategy.
A firm’s corporate reputation, which is used as a strategic
resource, has a positive impact on a firm’s brand
differentiation strategy.
A firm’s corporate reputation, which is used as a strategic
resource, has a positive impact on a firm’s brand positioning
strategy.
A firm’s corporate reputation, which is used to communicate
with its stakeholders, has a positive impact on a firm’s brand
segmentation strategy.
A firm’s corporate reputation, which is used to communicate
with its stakeholders, has a positive impact on a firm’s brand
differentiation strategy.
A firm’s corporate reputation, which is used to communicate
with its stakeholders, has a positive impact on a firm’s brand
positioning strategy.
Medicine price moderate the relationship between the uses
of corporate repoutaiton and brand image strategy.

Rejected
Rejected
Accepted
Accepted
Accepted
Partially
supported
Partially
supported

Resource: Developed by the author for the current research
Figure 5.9: Final results diagram

5.6 Results of Testing the Hypotheses
The results are presented in four stages. It is because of the items were firstly, at the
second round, deleted on the basis of the outer loading that is below 0.7. At the third
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round analysis the three highest loadings items of each construct were selected as the
measurements of each construct. At the fourth round the unsupported correlations were
deleted on the basis of Henseler et al.’s (2009) suggestion of the analysed sample size.
In total, ten hypotheses were tested (see Table 5.22). The implications of these results
are further discussed in Chapter 6.

H1: Value creation and brand segmentation (VC
BS)
As shown earlier, hypothesis H1 explained the relationship between the exogenous
variable (Value Creation) and endogenous variable (Brand Segmentation). As outlined
in Table 5.44, the hypothesized relationship was found to be significant (t-value =
4.468). Thus, this hypothesis was supported.

H2: Value creation and brand differentiation (VC
BD)
As shown earlier, hypothesis H4 explained the relationship between the exogenous
variable (Value Creation) and endogenous variable (Brand Differentiation). As outlined
in Table 5.22, the hypothesized relationship was found to be significant (t-value =
2.201). Thus, this hypothesis was supported.

H3: Value creation and brand positioning (VC
BP)
As shown earlier, hypothesis H7 explained the relationship between the exogenous
variable (Value Creation) and endogenous variable (Brand Positioning). As outlined in
Table 5.22, the hypothesized relationship was found to be significant (t-value = 3.520).
Thus, this hypothesis was supported.

H4: Strategic resources and brand segmentation (SR
BS)
As shown earlier, hypothesis H2 explained the relationship between the exogenous
variable (Strategic Resources) and endogenous variable (Brand Segmentation). As
outlined in Table 5.22 and Table 5.44, the hypothesized relationship was found to be
insignificant (t-value = 0.758) in the second round. Thus, this hypothesis was rejected.

H5: Strategic resources and brand differentiation (SR
BD)
As shown earlier, hypothesis H5 explained the relationship between the exogenous
variable (Strategic Resources) and endogenous variable (Brand Differentiation). As
outlined in Table 5.22, the hypothesized relationship was found to be insignificant (tvalue = 1.256) in the second round but insignificant in the second round (t-value =
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0.454). Thus, this hypothesis was not supported.

H6: Strategic resources and brand positioning (SR
BP)
As shown earlier, hypothesis H8 explained the relationship between the exogenous
variable (Strategic Resources) and endogenous variable (Brand Positioning). As
outlined in Table 5.22, the hypothesized relationship was found to be significant (tvalue = 2.834). Thus, this hypothesis was supported.

H7: Corporate communication and brand segmentation (CC
BS)
As shown earlier, hypothesis H3 explained the relationship between the exogenous
variable (Corporate Communication) and endogenous variable (Brand Segmentation).
As outlined in Table 5.22, the hypothesized relationship was found to be significant (tvalue = 2.068). Thus, this hypothesis was supported.

H8: Corporate communication and brand differentiation (CC
BD)
As shown earlier, hypothesis H6 explained the relationship between the exogenous
variable (Corporate Communication) and endogenous variable (Brand Differentiation).
As outlined in Table 5.22, the hypothesized relationship was found to be significant (tvalue = 3.119). Thus, this hypothesis was supported.

H9: Corporate communication and brand positioning (CC
BP)
As shown earlier, hypothesis H9 explained the relationship between the exogenous
variable (Corporate Communication) and endogenous variable (Brand Positioning). As
outlined in Table 5.22, the hypothesized relationship was found to be insignificant (tvalue = 1.935) in the second round but significant (t-value = 2.303) in the third round.
Thus, this hypothesis was partially supported.

H10: Moderating effect of medicine price and brand image
As shown earlier, hypothesis H10 explained the moderating effect of the relationship
between the uses of corporate reputation and brand image strategy. The hypothesized
relationship was found to be significant (t-value = -3.077) in the first round analysis.
However, in testing the moderating effect on each relationship respectively, as outlined
in Table 5.23, none of the moderating effects tested as significant. Thus, this hypothesis
was partially supported.
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5.7 Summary
This chapter reported the results of the data analysis for the quantitative phase of this
thesis. Following this, the demographic characteristics of this sample are described. The
two-step procedure of Anderson and Gerbing (1988), which required measurement
models to be estimated before the structural analysis, was followed. The items for the
exogenous constructs were derived from the literature and the qualitative interview.
After running the reliability test, it was decided to delete 12 items from six constructs,
as they were highly cross-loaded on other factors that could not be theoretically justified,
had low communalities or low reliability. And in the second round analysis, 39 items
with a factor loading below 0.7 were deleted (Henseler et al., 2009).
The second part of data analysis is the use of SEM, which was conducted in two stages:
the measurement model and the structural model. In the first stage, the fit for the
measurement model was assessed by using a CFA. At this point, the assessment of all
indicators was highly loaded on their specified factors and the overall goodness-of-fit
indices suggested acceptance of the model. Each construct was then tested for reliability
and validity.
Cronbach’s alpha, composite reliability and average variance extracted (AVE) were
higher than the required values. Accordingly, all constructs were reliable. In addition,
convergent, discriminant and nomological validity for each construct were confirmed.
The next stage, the assessment of the structural model, has also been undertaken. The
structural model results showed that out of ten hypotheses, six pathways were
significant. The structural model indicated that three variables (value creation, strategic
value and corporate communication) had a different level of impact on three constructs
of brand image strategy. Thus the model provides a strong test of the hypothesized
relationships between the constructs of interest. We have completed GoF indices
suggested by Tenenhaus et al. (2005) and it was 0.738.
The moderating effect of medicine price on the impact of the three dimensions of the
uses of corporate reputation on the three dimensions of brand image strategy was tested.
The results showed that the medicine price construct has a negative effect in moderating
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the impact of the uses of corporate reputation on brand image strategy. Therefore, the
hypothesized moderating effect of medicine price on the relationship between the uses
of corporate reputation and brand image strategy was confirmed. However, in the
second round of analysis, the moderating role of medicine price was tested for the
relationship of each construct in the uses of corporate reputation and each construct in
brand image strategy. The results show that none of the moderating effects was
significant, but that the medicine price is significant as a predictor for the brand
segmentation construct.
The next chapter discusses the above results in detail in order to answer the research
questions outlined in Chapter 1. Further, it draws the implications for both practice and
theory, discusses the limitations of this thesis, describes the directions for further
research and identifies the final conclusions.
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CHAPTER SIX: RESULTS AND DISCUSSION

6.1 Introduction
The purpose of this thesis was to investigate the role of the uses of corporate reputation
in building brand image strategy and the results of this study were presented in the
previous chapter. In this chapter we will discuss the validation of the measurement
model and the research findings in more detail. The findings are ‘fleshed out’ in greater
depth by incorporating qualitative findings where appropriate. The findings are then
further discussed in terms of the contribution to marketing theory and relevance to
marketing managers. In the previous chapter, the items of adapted scales were subjected
to several rounds of adjustments and were finally found to possess acceptable
measurement properties. Reliability and construct validity tests indicated that all scales
satisfied widely accepted criteria such as the minimum reliability of 0.7.
The structure of this chapter is as follows. First, the results of scale purification will be
discussed. Second, an evaluation of the research hypotheses and their significance are
summarized and the findings of all hypotheses testing will be reviewed and compared
with previous research.

6.2 Overview of Study
This research project examined the concept of the uses of corporate reputation and its
dimensions. The study involves factors of the uses of corporate reputation that are most
likely to have a significant influence on brand image strategy within the context of the
Taiwanese pharmaceutical industry. The topic is important because in recent decades, it
is difficult but important for a firm’s product to compete in the market and distinguish
itself from competitors (Dennis et al., 2002; Lili, 2010; Cheng et al., 2010). The uses of
corporate reputation were claimed to affect managers’ decisions when applying a firm’s
brand image strategy (Hatch et al., 1998; Bickerton, 2000; Cretu and Brodie, 2007). As
a consequence, interest in the uses of corporate reputation has increased at an
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astonishing rate (see Chapter 2). However, so far, very limited empirical research has
been carried out in this area to capture the true meaning of the concept (Gale, 1994;
Cravens et al., 2003). Furthermore, a few companies properly adopted the uses of
corporate reputation, but most companies failed to do so because the literature lacks an
integrative theoretical framework to address this research problem (Balmer, 2001a).
A multi-method approach was adopted to investigate this research problem. A
sequential approach consisting of qualitative research, which acts as the foundation for
the quantitative study, was implemented. The qualitative findings generally showed that
three dimensions of the uses of corporate reputation (i.e. value creation, strategic
resources and corporate communication) are applicable to managers’ brand image
strategy implementation for the Taiwanese pharmaceutical industry. The findings were
consistent with other studies on brand image strategy (Urde, 2003; Knox and Bickerton,
2003; Foreman and Argenti, 2005). A qualitative method was used, in conjunction with
quantative methods, to investigate a domain of the uses of corporate reputation that has
received little attention to date (Cable and Graham, 2000; Srivoravilai, 2006).
A questionnaire was developed on the basis of the reviewed literature and the
qualitative study to quantify, supplement and complement the first stage. The
theoretical model was then operationalised in this stage.
As mentioned earlier, in Chapter 4, items generated from both literature review and
qualitative studies were subjected to qualitative and quantitative refinements. Next, the
developed scales were tested using statistical data reduction techniques, i.e.
confirmatory factor analysis (CFA) in the main survey.
The quantitative data was analysed by using PLS 1.04. Additionally, the constructs of
interest showed a high degree of reliability, convergent and discriminant validity. A
number of statistically significant pathways were confirmed between the uses of
corporate reputation and brand image strategy constructs, with satisfactory fit indices
for both the measurement and structural model. Finally, the overall structural model
was evaluated and a discussion of these findings is described in the next section.
A conceptual model was developed that showed the impact of the uses of corporate
reputation that influenced brand image strategy as a consequence. The model was then
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tested using a sample of Taiwanese pharmaceutical managers. The results of the tests
demonstrate strong support for the model. Specifically, the measurement model is
assessed in the main study using the particular samples of Taiwanese pharmaceutical
managers. The confirmatory factor analysis (CFA) showed that the model received a
significant fit to the data, following the principles recommended by Anderson and
Gerbing (1988), Tabachnick and Fidell (2001) and Hair et al (2006).
In testing the hypothesized model, the results presented in Table 5.44 indicated that the
hypotheses H1, H2, H3, H6, H7 and H8 were supported. The standardized estimate for
these hypotheses were all significant (= 0.398, 0.406, 0.253, 0.640, 0.432, 0.507,
respectively).The hypotheses H9 and H10 were partially supported. The hypothesis H4
and H5 were rejected because it was not statistically significant. The following section
evaluates the conceptual model by first summarizing the supporting evidence for the
hypotheses.

6.3 Measurement Scale Purification
The first issue to be discussed is the operationalisation and validation of concepts in this
study. As mentioned in Chapter 4, the researcher developed measurement scales by
extracting items from existing literature scales and qualitative interviews. Face and
content validity were also examined by academic experts and interviewees.
Additionally, the developed measurement scales were subjected to data reduction in
CFA and several statistical tests (e.g. convergent and discriminant validity test,
composite reliability test, etc.).
Overall, the finalized scales were found to have satisfactory validity and reliability and
were subsequently used in the hypotheses testing. In addition, some issues can be
observed as follows. First, the operationalisation of constructs was shown to depend on
research settings (e.g. country, culture, industry, etc.) For instance, when the
pharmaceutical managers were asked to explain how the brand image strategy is applied,
more emphasis was placed on sales experiences. This resembles the findings of studies
such as Flynn (2000), Kargar (2005) and Aura (2010).
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Another example is the applicability of measurement items to items of the strategic
resources tactics with a firm’s corporate reputation. A respondent suggested that the
uses of a firm’s reputation would “gain the firm more opportunity for strategic alliance
or business cooperation”. Based on the Taiwan market environment, this argument
would be appropriate only for huge generic pharmaceutical companies. This is mainly
due to the differences in the corporate strength and a tricky combination of each
company’s different core values.
Second, the dimensionality of almost all constructs is consistent with those reported in
extant literature. For instance, the CFA is applied to confirm the underlying structure
among the variables in the analysis of three constructs in the uses of corporate
reputation and three constructs of brand image strategy.
In summary, the findings of the scale purification suggest two main points. First, when
a scale is applied to another context, it is necessary to measure the relevance of the
definition and the operationalisation of the old scale (Sekaran, 1983; Douglas and
Nijssen, 2003; Srivoravilai and Melewar, 2003, 2005) to achieve the validity of
substantive inferences (Singh, 1995). A vital question may be whether the same
construct exists in another context. And even if it exists in another context, it may not
have the same items (Craig and Douglas, 2000, p.256).
Second, to ensure the applicability of adapted scales, it is important to assess external
validity in addition to internal criteria (i.e. reliability and validity) (Craig and Douglas,
2000, p. 257). In this study, qualitative methods have been employed (Groenland, 2002)
to evaluate the constructs in a Taiwan context and quantitative techniques were used to
examine factorial similarity (i.e. whether scale items load on the same factors as those
in original scale) (Singh, 1995).

6.4 The Uses of Corporate Reputation: Antecedents of Brand Image
Strategy
The quantative findings show that six out of ten hypotheses were supported, three were
partially supported and one was rejected. Therefore, the uses of corporate reputation
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were proved to be somewhat significantly associated with brand image strategy.
Moreover, medicine price was found to play a partially negative moderating effect on
the relationship between the uses of corporate reputation and brand image strategy.
Despite the importance of the theme of the uses of corporate reputation, the construct of
the uses of corporate reputation is not well defined in the marketing literature. A few
definitions of the uses of corporate reputation (discussed earlier in Chapter 2), and also
an analysis of those conceptualizations have been provided (according to Chapter 2, the
conceptualization of the uses of corporate reputation has been taken from six
paradigms). Moreover, items of the construct were found in the literature (Dickson and
Ginter, 1987; Wong and Saunders, 1993). Even there, insufficient empirical research
has been done on finding out the uses of corporate reputation from the managerial
perspective, especially in relation to the brand strategy implementation. This study
therefore attempted to gain meaningful degrees of understanding of the uses of
corporate reputation construct by using qualitative interviews.
The findings of the qualitative study were treated as indicative only due to the
qualitative nature of the study. Furthermore, quantitative research was carried out to
confirm the results of the qualitative study. The quantitative results, specifically,
illustrated three aspects of the uses of corporate reputation construct in the context of
the Taiwanese pharmaceutical industry.
This part of the discussion will start from hypotheses about the impacts of the three
constructs of the uses of corporate reputation on brand segmentation (H1–H3), which
will then be followed by hypotheses about the impacts of the uses of corporate
reputation on brand differentiation (H4–H6) and brand positioning (H7–H9). Then the
results of the test of moderating the relationship between the uses of corporate
reputation and brand image strategy (H10) will be explained. Next, the limitations of
the current study and recommendations are outlined. Finally, implications for future
research are explored. The first implication focuses on the value creation ability that a
firm possesses so it becomes a core value to compete with other competitors.
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6.4.1 Effects of the Uses of Corporate Reputation on Brand Segmentation
In this study, two of the uses of corporate reputation have a statistically significant
relationship with brand segmentation. The relationship between each kind of use of
corporate reputation (i.e.

value

creation,

strategic

resources and

corporate

communication) and brand segmentation is somehow found to be positively related.
First, the relationship between value creation and brand segmentation has been found to
be statistically significant. Second, the relationship of strategic resources to brand
segmentation

has

been

rejected.

Last,

the

relationship

between

corporate

communication and brand segmentation was also found to be statistically significant.
This suggests that, other things being equal, the more a firm concentrates its focus on its
value creation ability and corporate communication, the easier it will be to build its
brand segmentation strategy.
In general, a pharmaceutical company that implements brand segmentation strategy
signals that the firm has solid and strong marketing capabilities. A pharmaceutical
company that achieves brand segmentation means that to a certain level it can manage
its company reputation very well. In addition, a pharmaceutical company depends on
how its sales or marketing managers use their reputation to establish a solid and strong
image in its customers’ minds (Temporal and Burnett, 1993; Ensign, 1998).
According to Table 5.44, another issue should also be noted. It is managerially and
theoretically fruitful to understand what type of the uses of corporate reputation has
more impact on brand segmentation as previously not enough literature has addressed
this issue. The researcher therefore assessed the relative influence of each dimension of
the uses of corporate reputation on brand segmentation by comparing their path
coefficients.
In this case, the path coefficient of value creation (β = 0.398) is only slightly different
from that of corporate communication (β = 0.406), this indicating the relatively equal
importance of value creation and corporate communication. This is considered sensible,
at least in the Taiwanese pharmaceutical context, because value creation demonstrates
that not only can the company create value for its consumers – by which the consumers
can evaluate a firm’s R&D ability – but it also shows that if a company can organize a
good marketing campaign, which will benefit its customers. At the same time, corporate
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communication depicts the importance of activities and actions by which consumers’
impressions of a firm will be further formed. Moreover, a firm’s value cannot be
perfectly shown if the corporate communication doesn’t do a good job in
communicating this value to the public. Therefore, a similar weight of importance using
quantative analysis is considered to be reasonable.

According to the literature and qualitative data results, value creation (the value created
either for the customer or for the firm) can be divided into four categories:
functional/instrumental, experiential/hedonic, symbolic/expressive, and cost/sacrifice.
The current research is based on the firm’s perspective, and thus value creation herein
pertains to the value created for the firm.
• Cost/sacrifice and symbolic/expressive value
At present, the top 10 local pharmaceutical companies are listed
companies, except for TBC. This is because its director has an
accounting background and is very sensitive to numbers. He wanted
to build the corporate reputation himself. From 1945, TBC focused
on the intravenous drip and did well with it. Starting 20 years ago,
we started to build OLAHOME. It has been going well. Now we are
going into the healthy food market, signing a contract with
Carrefour and opening a store inside of Carrefour stores. It is
TBC’s cosmetics store. And the board chairman is the TBC board
chairman’s son. Now we are a team helping this business. This is
how we use our corporate reputation to extend the business. Also,
we can use corporate reputation to make a leveraged buyout.
[Manager in company A]
• Symbolic/expressive value
If you can enter the market earlier, even this is not a new thing.
Usually only foreign-funded enterprises do this, and their R&D are
not in Taiwan. They usually have several centres, one in New York,
one in Australia, and one in Asia Pacific, usually in Japan, or
Singapore. It is because Taiwanese local pharmaceutical companies
don’t deal with this part. Only foreign-funded company try to enter
the market in advance. They schedule the top line for the most recent
ten years, three years, and five years. In every category they try to
manage the company in several areas, such as CV, heart department,
and metabolism department etc., which are categorised as aged
problem. Because the organs function is in decline when people get
old. [Manager in company A]
• Experience/hedonic value
Although TBC is not a listed company, it has shareholders. So before
they make any decision, they have to report to the board of directors,
let them understand what’s the next step the company is heading to,
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such as an overall market layout for the next year. However, the
message the company sends to its customers is very important. It
relies on the sales people because it has so many similar things. For
example, for metabolism, almost every company has this medicine
because so many people have diabetes. It means that each doctor is
approached by five or six sales people from different companies. So
why do I use your brand? [Manager in company A]
A pharmaceutical company’s value creation ability can be used as a statement of its
corporate reputation. It may become known for creating functional value with a high
standard of product; it may also create a good impression through the use or purchasing
of its product or its customer service; it may also be known for having the long history
or having an iconic impression in the industry, or for savings the customer’s money or
having the lowest cost for its product. The value created for the customers is judged by
the customers to be helpful in their life. Slowly the customers benefit from the value
that a firm has created for them, will start to appreciate the company as a reputable one.
In this way, managers can build with that for segmenting their customers, depending on
customer needs.
A firm can apply the following activities to improve its segmentation strategy and build
best practices: First, a firm should strive to enhance its value-chain activity to make it
consistent with experiential value creation—for example, integrating the medicinal
material supply with innovation, R&D, manufacturing, and after-sales service. Second,
the firm should allocate resources to be more consistent with experiential value creation.
Third, the firm should try to enhance the customers’ self-identity. Fourth, the firm
should communicate more effectively with shareholders and other stakeholders to shape
their perceptions about the firm. Fifth, the firm should build customer relationship.
Sixth, the firm should negotiate with competitors to take advantage of joint resources
and to ensure its product suits the market better. Seventh, the firm should negotiate with
the government to affect policy.
However, in practice, recently the National Health Service (NHS) in Taiwan changed its
medicine price policy. As a result of focusing on cutting the medicine price,
pharmaceutical companies received little benefit from elaborating their brand.
Distinguishing a brand either by more functional or experiential value created in their
products cannot provide a higher benefit, therefore causing fierce price competition.
The effects on medicine price policy are stated by a manager as follows:
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“We, the Gentle Pharma., are less than excellent, but more than
general. This is to boast ourselves. So we can segment the market,
that you can buy a bit less than excellent, but much cheaper. Maybe
they will accept us. So we just follow the excellent companies. We
don’t compete with the cheapest ones. We compete with the
excellent ones. This is our position of our company or brand you
can say. But nowadays there’s no difference between each
company after the NHS set up the price policy. We don’t have the
price difference for the NHS price. And moreover now the hospitals
only want the price difference when they bid for the medicine.”
[Manager in company C]
“Now in Taiwan we are trying to carry out the PIC/s (The
Pharmaceutical Inspection Cooperation Scheme) standard. It
means we are following the international GMP standard. However,
they want us to go through the PIC/s standard examination. They
will send a representative to examine our factory. So we have to
reach the PIC/s standard if we want to sell our product to Europe
or England.” [Manager in company C]
A pharmaceutical company can also use its corporate reputation to apply brand
segmentation. A pharmaceutical company can enhance its corporate reputation by
making it qualified to the PIC/s. From time to time, the requirement for GMP (Good
Manufacturing Practice), CGMP (Current Good Manufacturing Practice) and nowadays
PIC/s makes the new pharmaceutical companies improve their hardware and software.
Then they are qualified to export their products to advanced countries (i.e. Europe,
America etc.).
In this specific industry, in this particular environment, the researcher found that the
result doesn’t support these hypotheses perhaps for the following reasons. That is:

“If I say now I want to sell to China, I will have a different
corporate reputation with a Chinese company. The corporate
reputation will create segmentation, as does the price segmentation.
Now Taiwan can be approved by international markets. Actually
the Chinese may achieve the US FDA standard and Taiwan can
also achieve the US FDA. Everyone producing the product can
achieve the US FDA standard. Actually if we talk about strategy,
products from everywhere we shall consider as having the same
quality. We consider that for one company, even if they have
factories all over the world, the same company product should go
through the same standards of quality control.” [Manager in
company D]
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6.4.2 Effects of the Uses of Corporate Reputation on Brand
Differentiation
According to Dannenberg and Kleinhans (2004), brand management is becoming the
central capability for auto makers to differentiate themselves. And value creation
occupies an important part of the brand management in the vehicle engineering and
production. Moreover, according to Sheth and Parvatiyar (1995), “in the face of
competition, marketers realized the benefits of focusing on specific groups of customers
for whom they could tailor their marketing programs and successfully differentiate
themselves from their competitors” (Peterson, 1962) by providing different value
created to their customers. Also according to Lynch and Chernatony (2004), emotional
brand value development may also cause value creation for their customers that can be
a means of developing a sustainable differential advantage.
According to Table 5.44, the researcher assessed the relative influence of all types of
uses of corporate reputation on brand differentiation by comparing their path
coefficients. The direct effects of two dimensions of the uses of corporate reputation
(e.g. value creation and corporate communication) on brand differentiation were found
to be positive and statistically significant. However, the relationship between strategic
resource and brand differentiation had to be rejected. This suggests that, given that all
other factors are equal, the more value creation is employed, and the more corporate
communication is established by a firm with their customers, the easier it is to build a
firm’s brand differentiation strategy.
In this case, the path coefficient of value creation (β = 0.253) differs hugely from that of
corporate communication (β = 0.640). This indicates a higher importance for corporate
communication than the value creation on the brand differentiation. This is considered
reasonable in the Taiwanese pharmaceutical context because how a brand is
differentiated from another depends more on how a firm communicates with its
stakeholders (e.g. by using advertisements or showing how professional are its sales
representatives) than on the real value a firm creates for its customers.
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Moreover, according to the literature and qualitative results of data, several issues were
raised by the interviewees regarding the uses of corporate reputation on building the
brand differentiation strategy. For example, the NATURAL-oriented products were
created as a value added to the brand by company D. And a manager in company F
suggested doing differentiation from the customer’s side.
“Nowadays there are many things using herbal products; some
cosmetics are herbal too. They say ‘We don’t use chemical stuff,
but use herbal products’. So this is included in a firm’s reputation.
Before, our cosmetics usually added some fragrances, nowadays
there’s less fragrance in them. Cosmetics actually don’t need any
fragrance because it just has to protect us. But fragrance is just a
thing that makes you more comfortable, and is not helpful in
protecting us. So nowadays people use this kind of strategy that
emphasizes that the product is more natural – which the added
fragrance was not since it is distilled from other stuff. Therefore, a
firm’s reputation creates the brand value and brand differentiation.”
[Manager in company D]
“I strongly agree with this idea. And I would rather hope to create
differentiation from the customer side. This means we shall apply a
differentiation strategy for pharmacists and doctors. Because the
differentiations of medicine, unlike food, are very rigid and
confined, there is not too much variance for them. If you want to
create brand differentiation, rather than product differentiation, I
would suggest creating it from the customer side. And do it
reversely. It will come out with the same result. Because whether it
is product differentiation, or customer differentiation, with both
what you have to influence is the result. Therefore, from the
customer side to apply brand differentiation, one way of doing it is
through sales behaviour, and the other one is customer service.”
[Manager in company F]
“As I mentioned before, our success is because of signing the
contract. Our contract is very flexible, and variable. It aims to let
the front line people change the contract decision according to the
customer’s needs. It is not necessary to reach a big amount for us
to agree to send the product. Because some of the clinics are too
small they can only order a very small amount of stock – maybe not
even one thousand in one season. Therefore, in order to cooperate
with these clients, our contract is flexible and variable. ” [Manager
in company F]
“I think so. However, for brand positioning, communication is
related to the different ways that the shareholders deal with things.
All these will influence customer choice. And the customer’s
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choice is related to knowledge transferring. In other words, this is
one kind of customer service. For example, nowadays each month
we issue a magazine called Yun-Shin medicine information. We
usually distribute the magazine to doctors, drug store pharmacists
etc. In this magazine it usually discusses about the topics of
medical common sense, or clinical experiments from abroad, our
product conditions etc. Therefore, our corporate reputaion can
help us find some information, and some communication tool. This
product provides this kind of service, it has some educational
position. It is because the professionals don’t really have spare
time to read other books. However, this magazine has satisfied
their wish to update their knowledge. Since there is no other
company doing this, the customers would consider our company to
have better service quality. Some products have side effects, some
newly issued drugs that might affect some races but others not etc.
Such information is needed by doctors. Most people think it’s
reasonable to spend time to get the most updated information.
Therefore, it shows our brand positioning has its own value.”
[Manager in company D]

The non-significant coefficient of strategic resources indicates a different view from
that of marketing research as existing literature generally suggests that the more uses of
strategic resources for a firm’s reputation, the better a firm can apply their
differentiation strategy (Yeoh and Roth, 1999; Cornwell et al., 2001; Priem and Butler,
2001). On the other hand, respondents from follow-up interviews did not fully agree
with this statistical finding as they showed their mixed comments on the relative
importance of three dimensions of the uses of corporate reputation. Some interviewees
put more emphasis on customer service whereas others stressed the importance of
corporate communication such as knowledge transferring and advertising. For example,
the quote from the manager in company F (see above) does not support the statistical
finding, whereas the comments from manager in company D do. These mixed views
reveal a need for further examination of the relative significance of different types of
corporate reputation use. Future research on this issue should help researchers and
practitioners to better understand about how to use a firm’s corporate reputation to
benefit its differentiation strategy.
A pharmaceutical company can also enhance its branding strategy through other uses of
corporate reputation, including value creation and corporate communication. Both the
quantitative and the qualitative data show that when pharmaceutical company managers
use value creation and corporate communication to implement their brand
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differentiation strategy (Holsapple and Singh, 2001; Lynch and de Chernatony, 2004;
Harrington, 2007), they reach their targets more easily. Thus, companies can apply the
same seven activities as mentioned previously: that is, firms should (1) strive to enhance
its value-chain activity to make it consistent with experiential value creation, (2)
allocate resources to be more consistent with experiential value creation, (3) try to
enhance the customers’ self-identity, (4) communicate more effectively with
shareholders and other stakeholders to shape their perceptions about the firm, (5) build
customer relationship, (6) negotiate with competitors to take advantage of joint
resources and to ensure its product suits the market better, and (7) negotiate with the
government to affect policy, all to improve their brand differentiation strategy and build
best practice. Moreover, according to Lynch and de Chernatony (2004) and Harrington
(2007), firms can implement the strategy in two ways: One is based on emotional
characteristics, and the other is based on knowledge sharing (Holsapple and Singh,
2001).
The statistical support of H4 and H6 (value creation and corporate communication is
positively associated with brand differentiation) is evidence of this claim. Moreover,
this finding also confirms and expands existing knowledge in other research such as
corporate communication (Shelby, 1993). For instance, it provides an explanation as to
why there is a relationship between corporate communication and knowledge transfer
(Von Krog et al., 1997; Van Riel and van Bruggen, 2002).

6.4.3 Effects of the Uses of Corporate Reputation on Brand Positioning
Finally, the relationship between two dimensions of the uses of corporate reputation (e.g.
value creation and strategic resources) and brand positioning is also found to be
supported in statistical analysis. Moreover, the relationship between corporate
communication and brand positioning is found to be partially supported. This suggests
that, all other things being equal, the more a firm can create value for its customer, and
the more a firm uses their corporate reputation as a strategic resource, the easier it will
be to build its brand positioning strategy.
According to Table 5.44, another issue should also be noted. It is managerially and
theoretically fruitful to understand that the uses of corporate reputation have an impact
on brand positioning. The researcher assessed the relative influence of all types of uses
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of corporate reputation on brand differentiation by comparing their path coefficients.
The direct effects of two dimentions of the uses of corporate reputation (e.g. value
creation and strategic resources) on brand positioning were found to be positive and
statistically significant. However, the relationship between corporate communication
and brand positioning is found to be only partially supported. This suggests that the
more value creation is employed, and the more strategic resources are applied by a firm
to their customers, the easier it will be to build a firm’s brand positioning strategy.
In this case, the path coefficient of value creation (β = 0.432) is not very different from
that of the strategic resources (β = 0.507). This indicates that the use of corporate
reputation as strategic resource is somehow more important than the use of corporate
reputation as value creation in brand positioning strategy. This is considered reasonable
in the Taiwanese pharmaceutical context because using the corporate reputation as a
strategic resource, for example, to enter the market early, and to obtain large cash
resources can help a firm to provide its brand with a good image in the consumer’s
mind. In addition, a firm’s value creation ability can create an image for the consumer’s
mind. And the managers can use this kind of core competence as an announcement to
the public that the firm’s R&D is strong so customers can trust it. Such a relationship
showed that value creation ability enhances brand positioning strategy. This finding
helps to further explain evidence pertaining to research about value-based theory.
Moreover, according to the literature and qualitative result of data, there are several
issues raised by the interviewees regarding the uses of corporate reputation in building
the brand positioning strategy. For example, the products from Taiwan are considered
as top market products in China.
“In China, our product is sold as a better value than products from
Europe. Maybe it is because luckily it was a turning point in the
market condition. Actually some of the European companies, such
as Bayer, were angry with this. A previous government official had
heart disease. He was having treatment in the heart department in
one of the big hospitals in Beijing. They use the Bayer Aspirin. It is
commonly known that it will cause discomfort in the stomach when
one takes aspirin. So this old person was feeling uncomfortable in
the stomach. Afterwards we went to see that doctor, and told the
doctor that if you take our pill, then your stomach will not get
uncomfortable. Therefore, this product has the advantage of no
side effects. Because people with heart disease are usually elders,
for safety reasons, they use our product. So we changed a little bit
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from the original product, and added some other ingredients, so it
has fewer side effects. Under these circumstances, I think in the
beginning we can ask a higher price, meaning we can position our
product in a higher market.This product was then taken off the
market but brought back again because they say it’s very effective
medicine and safe. So the market was back for this product. So our
firm’s corporate reputation signifies that our product is effective
and safe. It therefore can be positioned as a high priced product.
And also, it will lead other product…. ” [Manager in company D]
“From the product point of view, let me take Yin-Yuan as an
example. We have three companies, one is Yin-Yuan, another one is
Yin-Jie and the third one is Yin-An. The positioning strategy for
each company is clear. Yin-Yuan is targeting everyday products,
such as headache pain killer, flu and syrup etc. Yin-Yuan has
everything you want. If you cannot find something in the market,
just give a phone call to Yin-Yuan see if we have it. The other one
is Yin-Jie. There are above 50% of its performance comes from
eye-drops. Eye-drops are Yin-Jie’s competitive product. Therefore,
now we faced a problem, which is the blind competition from the
new competitor in this area.…… However, through last year, we
found that the situation is not that bad. We traced back that the
reason for this might be an important action that we did, which was
to sign a contract. This action protected us from the severe
competition. The other company Yin-An was focusing on injections.”
[Manager in company F]
The positive relationship between strategic resources and brand positioning can be
explained by the interviewee’s way of locating different resources in each company
(Bowman and Hurry, 1993). This postulates that a firm can manage its reputation by
allocating similar resources together and targeting different customers (Turnbull and
Valla, 1993).
“If I want to make an advertisement, I would have to collect a big
amount of funds from others. The original company might spend a
billion pounds of operating fees for a new product to enter the
market. Maybe I can build my company image or reputation
through marketing channels in order to advertise or market my
company. Believe it or not, if you have a distributor, you should
offer a seminar when you want your new product to enter the
market. You should position this product and make the consumer
confident about it. For example, in sales marketing, the
advertisement may target the consumers…. Or it aims to influence
customers’ perception of such a marketing strategy. Or they can
hold a seminar, in order to build up a new product line. However,
as a product manager, I will have to coordinate this, which is
called “psychological education” or “confidence education”.
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Because if others doubt your product and the salesperson is afraid,
they cannot get a good performance. Therefore for a good
marketing manager, confidence is very important. It is important to
believe in his product when selling it. Second, he needs to think the
product is good too, so that he can answer customer’s questions
and explain to them. Then you will get good performance. So you
can market your corporate reputation and brand to your agent,
your salespeople, and then to the customers. And then use
advertisements to market to your consumers. This is marketing
strategy.” [Manager in company B]

A firm can undertake activities as best practice to achieve a better brand positioning
strategy. These activities include (1) improving its value-chain activity to make it
consistent with experiential value creation, (2) allocating its resources to be more
consistent with experiential value creation, (3) enhancing the customers’ self-identity, (4)
entering the market earlier, (5) more efficiently managing the marketing system and (6)
maintaining customer relationship. These activities give the brand a clearer image,
provide consumers with a more thorough understanding of the firm and the brand and
effectively transfer the product or brand information to the consumers.
In summary, this chapter provides comments on the results of the measurement scales
purification and hypotheses testing. Follow-up interviews have been used as a tool to
help explain the findings. Both statistical findings and interview results support a
proposition that a company may be able to apply brand image strategy via knowledge
transfer and conformity with international manufactory standards (e.g. GMP, cGMP,
PIC/s… etc.) (Li and Houston, 2001). Moreover, good brand image strategy is
confirmed to be positively associated with the proper use of a firm’s corporate
reputation such as value creation and corporate communication. However, some
comments from interviewees raise questions about the external conditions or
environmental factors (government policy) which may distort or even suppress the
relationship found in this study. For instance, it has been noticed that the uses of
corporate reputation may not lead to brand image strategy setting if price regulation has
interfered in this relationship.
Finally, the medicine price is found to negatively moderate the relationship between the
overall uses of corporate reputation and the overall application of brand image strategy
(H10). According to Table 5.18, a negative overall moderating effect was found in the
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statistical test. This indicates from the interviews that the medicine price was playing an
important moderating role, even though there was not enough literature to support this
view. After the statistical test, it turned out there was not support for each path.
Therefore this suggests that the medicine price is partially and negatively supported in
the relationship between the uses of corporate reputation and brand image strategy.
In the next chapter, theoretical, managerial and policy implications will be presented.
Research limitations will also be noted and other potential research directions will be
discussed in more detail.

6.5 Recommendations

Several decades ago, when the Taiwan economy was growing rapidly, the Taiwanese
government tried to increase and strengthen the development of small and mediumsized enterprises. Therefore, the pharmaceutical industry in Taiwan generally comprises
private, small and medium-sized firms. Moreover, Taiwan’s government now also
encourages the transformation of economic status and firm development and upgrading
in such a crowded business environment. For example, many of the Taiwanese
manufacturers currently applying the original equipment manufacturer (OEM) business
model are transforming their model to one based on branding.
This study categorised three types of pharmaceutical companies according to the size of
the firm; size is a key feature to measure the amount of production or transaction of the
business in the Taiwanese pharmaceutical industry. Therefore, the study used the total
number of employees, as follows: small (0–49 employees), medium (50–299 employees)
and large (more than 300 employees). First, compared with smaller firms, larger firms
tend to have more capital, are more influential and tend to assume a leading role in the
industry. Therefore, this study recommends that these firms pay more attention to
corporate social responsibility and the feedback it receives to transform their ‘corporate
philosophy’ into practice, thus gaining a higher corporate reputation. Moreover, because
larger firms are more powerful than smaller firms, they are better able to negotiate with
the government to set new policies to benefit and direct industry rights and interests,
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thereby also benefiting small and medium-sized firms’ strategy decision. Thus, larger
firms tend to maintain a leading role in the industry.
Second, medium-sized companies can adjust their value-chain activity and resource
allocation to be more consistent with experiential value creation (happiness, affection
and excitement), and thereby enhance their customer identity. These points emphasize
the role of customers’ experiences and how customers see the firm. The company thus
should create more experiential value for customers, because within this ‘selfexperience’, customer can learn the companies’ self-identity more easily (who they are
and what they think they are).
Third, small firms also should improve their value-chain activity and resource allocation
to align with international standardised processes, thus creating a functional value to the
customers. After gaining the customers’ basic trust about product quality, these firms
can begin to build their reputation by creating functional/good-quality products, the
foundation of the pharmaceutical industry. Moreover, small firms can try to revise
components of generic medicine to improve the effectiveness of the medicine itself or
attempt to build their R&D to undertake more underlying functions of a medicine.
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CHAPTER SEVEN: CONCLUSION

7.1 Introduction
This research examines the roles of the uses of corporate reputation (i.e. value creation,
strategic resources and corporate communication) factors in the process of brand image
strategy building. It also investigates how medicine price plays a moderating role in the
relationship of the uses of corporate reputation and brand image strategy in the
Taiwanese pharmaceutical industry. The study helps fill research gaps mainly by
providing alternative insights to the uses of corporate reputation on the consequences of
applications in brand image strategy and by testing theories in a non-western setting to
increase their external validity. The study employs a hybrid methodology comprising a
dominant quantitative (i.e. survey) and a less-dominant qualitative (i.e. interview)
component to develop measurement scales and test hypotheses.
Statistical and qualitative findings generally support the framework proposed in Chapter
3. According to Figure 5.2, the medicine price is found to be negatively associated with
brand image strategy and completely moderates the relationship of the uses of corporate
reputation (as a whole) impact on brand image strategy (as a whole). The uses of
corporate reputation are also found to be generally positively correlated with brand
image strategy. The discussion on these findings and follow-up interviews also points
out that there are limitations but potential for future research.
In this chapter, research contributions in two aspects (theoretical and managerial) will
be presented. Limitations and future research directions will also be discussed in more
detail. This chapter will start by discussing the theoretical and managerial implications
of this research. The limitations of the study will then be reviewed. Finally, future
research directions on two different levels, theoretical and methodological, will be
presented.
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7.2 Research Contributions
7.2.1 Theoretical Implications
This research contributes to existing literature on reputation and other fields in at least
six ways. First, most studies in corporate reputation literature have concentrated on the
general concept of corporate reputation theoretically rather than relating it to actual
practice. This study contributes to existing knowledge by linking the theoretical
corporate reputation theory with a firm’s strategic usage of it in practice. There is a lack
of literature investigating the relationship between corporate reputation and branding
issues. Although a few studies addressing the uses of corporate reputation have already
been conducted (e.g. Okano et al., 1999; Bickerton, 2000; Michell et al., 2001; Davies
and Chun, 2002), they have been done without empirical evidence explicating the
relationships between these constructs.
Second, most studies in strategy and marketing have ignored the corporate literature on
the uses of corporate reputation that can cause an impact on the corporate and brand
strategy. This study contributes to existing knowledge by theoretically building the
constructs with regard to how corporate reputation is practically used in three
dimensions from six different perspectives. Six different perspectives on uses of
corporate reputation were collected and then categorized into three dimensions which
serve as the original concepts in strategic uses of corporate reputation. The concepts
were then linked to brand image strategies based on three main theories (value-based
theory, resource-based theory and integrated marketing communication theory). The
theories are borrowed to explain how to use corporate reputation to build brand image
strategy. In particular, the relative impacts of three uses of corporate reputation (i.e.
value creation, strategic resources and corporate communication) on brand image
strategy (i.e. brand segmentation, brand differentiation and brand positioning) are
evaluated.
Statistical results show that some hypotheses are accepted, some are partially accepted,
and a few are rejected. Overall uses of corporate reputation are found to be significant
when correlated with brand image strategy. The relative explanatory powers of different
uses of these three constructs (value creation, strategic resources and corporate
communication) are found to be asymmetrical. These findings of this research indicate
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that six perspectives of concepts can be used effectively to explain the variation in the
uses of corporate reputation and its consequences.
Third, this research advances current understanding about a generative process by which
brand image strategy is formed and applied, with statistical evidence followed by the
theory building. The current literature (e.g. Okano et al., 1999; Michell et al., 2001;
Davies and Chun, 2002) has only conceptualized the direct impacts for each construct of
the uses of corporate reputation on each brand image strategy but none has empirically
examined these relationships.
Fourth, no previous study has empirically examined the moderating effects involved in
creating brand image strategy in the pharmaceutical practice. For example, this study
finds that medicine price negatively moderates the impact of the overall uses of
corporate reputation on overall brand image strategy.
Fifth, it provides partial evidence to a long-standing debate about how to construct the
uses of corporate reputation. Some past studies suggest the link of corporate
communication as one of several dimensions in the uses of corporate reputation. A
firm’s corporate reputation can be used for corporate communication as it creates
knowledge transfer, such as the communication of the sales staff to the customer, basic
medical knowledge education, research outcomes updated, product information or
effects revealed, and the newest research reported and delivered.
In terms of methodology, the major contribution of this study is twofold. First, this
research is one of the few that tests reputation-and-branding-building models outside of
the USA and Europe. Reputation researchers (e.g. Nguyen and Leblanc, 2001; Gardberg
and Fombrun, 2002; Roberts and Dowling, 2002) have highlighted a global trend in
reputation management and raised their concerns about the necessity for cross-cultural
research. Other researchers in general have also been aware of the applicability of their
theories across nations and have encouraged new studies to establish their external
validity (e.g. Sekaran, 1981; Boyacigiller and Adler, 1991; Peng et al., 1991). The
research to some extent responds to those calls for global investigations by testing a
reputation-building model in Taiwan, a country in Southeast Asia. Examining the model
there could render additional insights into extant literature because Taiwanese
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consumers and their cultural backgrounds are substantially different from those of
western countries (Hsieh and Scammon, 1993; Hsieh and Tsai, 2009).
The findings of the study suggest that the uses of corporate reputation are recognized as
an important concept in western countries (according to literature, see Chapter 2) as
well as to Taiwanese companies. Taiwanese show a similar understanding about the
overall concept to those reported in literature but place more weight on different
domains. In addition, the model explains well the dimensions and the consequences of
the uses of corporate reputaiton, indicating that these concepts may be effectively used
in other management research in other countries as well.
Second, this study verifies, adapts and purifies existing measurement instruments in a
country which is culturally different from the setting in which these items were first
developed. For instance, the value creation scale was purified and tested in an attempt to
fill a gap suggested by recent research (e.g. Sweeney and Soutar, 2001; Ulaga Eggert,
2003). Similar processes were also completed for other constructs.
According to the findings, all scales generally appear valid in their original content but
the number of dimensions in purified scales is not the same as those of the original
scales. For instance, some of the measurement items were dropped because of the
Cronbach’s α (reliability) scale did not reach 0.7, whereas its original scale comprises
more items (see Chapters 4 and 5). Future cross-national research could benefit from
future investigations about essential conditions in which the comparability of scales
across countries is affected.
Finally, this study also advances existing knowledge in marketing and strategic
management. From the marketing viewpoint, the study contributes to the literature in
the corporate reputation construct and another construct for practitioners called the uses
of corporate reputation (how do firms use their corporate reputation to …). For instance,
it confirms the findings that a well-reputed firm can create a distinctive position for the
company in the mind of stakeholders (Fombrun and Shanley, 1990; Gregory, 1991;
Marconi, 1991; Day, 1994; Fortune, 1995; Fombrun and van Riel, 2004) and enables
customers to gauge the merits of a product or service, especially when customers are
faced by vague corporate or product information (Fombrun and Shanley, 1990).
Moreover, it adds evidence about the impact of advertising on levels of customer
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attitudes and customer loyalty (Hartwick, 1990; Yoon et al, 1993; Saxton, 1998;
Campbell, 1999; Nguyen and Leblanc, 2001). In particular, it informs the marketing
literature about the mechanism through which a well-known firm’s reputation gives
confidence to its customers about its products and service quality.
From a strategic management perspective, this research shows that the concept of the
uses of corporate reputation can complement the resource-based view (RBV) in
explaining how corporate reputation qualifies as a source of intangible assets and
competitive advantage. To resource-based theorists, corporate reputation is a valuable
asset because it is considered rare, non-substitutable and not easy to imitate (Barney,
1986, 2001; Dierickx and Cool, 1986). However, RBV focuses more on the
characteristics of resource and market to explain firms’ competitive advantage and pays
less attention to using these advantages to enhance the level of branding strategy by
implementing an intangible asset to become a strategic resource. Strategy researchers
have scarcely incorporated social and economic factors into their studies about strategic
resource accumulation. This research helps bridge such a gap by adding another
example about how an intangible resource can be acquired within a pharmaceutical
setting.

7.2.2 Managerial Implications
Current reputation management models have mostly been formulated from economic or
strategic angles. Often, corporations build their reputation without fully using it. They
do not link it very well into developing some strategy from it or applying it to practical
use. Reputation issues are usually been fully aware of and strategies will be applied
when a firm has to confront reputation damage. Firms are likely to passively manage
their reputation rather than actively control it and make a full use of it.
This study offers practical guidelines for managers in actively managing the reputation
of their companies and makes a full use of it from six different perspectives. Three
dimensions of synthesised constructs of the uses of corporate reputation are
recommended to be adopted into practical management by their company. For example,
the findings from this research suggest that firms can develop the firm’s brand
segmentation strategy by incorporating value creation and the corporate communication
ability of the firm. Companies that can maintain their operations and apply their brand
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image strategies effectively may able to regenerate their reputation signal to their
customers.
For example, given a specific industry, companies may design a set of strategies that
might be led by a certain level of use of each corporate reputation dimension. These
image strategies aim to influence the targeted consumer’s mind. They could also take a
more proactive measure by incorporating their customers into the strategy-making
structures (i.e. let their customer take part in shaping their strategy) (Hart, 1990). In
short, this is similar to the concepts about customer focus in management research.

7.3 Limitations and future research
As with all research projects, this study has several limitations. The following section
elaborates the limitations posed by the research setting, research design and
measurement issues.

7.3.1 Limitations of the study
The researcher attempted to expand the understanding of the construct of the uses of
corporate reputation and its consequences for strategy planning. Although the
endeavour was worthwhile, it was not without its limitations.
Like other studies in marketing and strategy, this research contains some limitations.
First, for the methodological weaknesses of this study, this study is cross-sectional
representing static relationships between variables in the framework. By the nature of
cross-sectional study, the researcher is only allowed to capture the linkage of variables
over a short span of time (Bordens and Abbott, 2008).
A further limitation is regarding the normality of data and contruct reliability. Even the
examination of a model analysed by SEM provides strong support for the acceptable
structure path and measurement weights, but the psychometric properties of
measurement items were weak in some points. Therefore, some of the measurement
items were removed during the item purification process. The deletion of these items
was due to the fact that the items cannot perfectly measure the construct domain. Hence,
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removing some of the items from the original dimensions limits the generalizability of
the original constructs.
There is also a limitation regarding the issue of the external validity. This study was
conducted in a single setting, which provided the researcher with a better control over
market and environmental anomalies (Conant et al., 1990) and industry effects (Rao,
1994) but does limit the generalizability of findings. The small and mediun enterprise
(SME) setting also enabled the researcher to clearly detect the effects of corporate
factors. However, although the SME in a pharmaceutical context provides many
opportunities for corporate issues–manager relations that raise strategy issues for firm
managers (Napier and Smith, 1987; Baysinger and Hoskisson, 1990), the focus of this
research on the pharmaceutical industry would certainly limit the generalizability of the
findings to industries other than pharmaceutical industry. In addition, the study focuses
on only one industry in Taiwan which would be significantly different compared to
other studies which compare more than two industries in Taiwan – this factor may have
influenced the survey results. Furthermore, the findings may be limited to the Taiwnese
context and may not necessarily reflect managers’ brand image strategies in other
countries. Therefore, there is a need to replicate and extend this study to other contexts.
Moreover, this study has used small-number sample size analysis because the entire
number of targeted respondents is around 200 people. Also because of the researcher’s
limited time and resources, firm managers rather than customers of the pharmaceutical
companies were selected as the targeted respondents. This study only reveals the
perception of the branding strategy at manager level and cannot be generalized for
individual customer perception. Also, this study used a non-probability sampling
method to select the respondents that limits understanding the benefit of the probability
sampling such as: (1) “the resulting sample is likely to provide a representative crosssection of the whole” (Denscombe, 2002, p. 12) and (2) “the accuracy and validity of
the finding from the survey by referencing to the degree of error and/or bias which may
be present in it as measured by well understood statistical methods” (Baker, 2002, p.
106).
Finally, this research may also possess a respondent bias towards managers who have
their own opinions about their own company. However, the selected group of
respondents was desirable for this study due to two reasons. First, it was the group that
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could estimate the uses of corporate reputation and brand image strategy of
pharmaceutical companies more accurately than others could due to their direct
experience of management and strategy planning. Second, it was one of the most
accessible groups of respondents, which helped facilitate the survey procedure.
The findings of this research may also suffer from common method bias, which is
possible when perceptual data for independent (e.g. the uses of corporate reputation
constructs) and dependent variables (e.g. the brand image strategy constructs) are
collected from the same source (managers). However, it is hard to avoid one party (as
managers) from being have biased. Additionally, the researcher further investigated this
potential problem by following Podsakoff and Organ’s (1986) approach. Harmon’s onefactor test was performed in a confirmatory manner (e.g. Morgan et al., 2004; Vorhies
and Morgan, 2005). If the problem exists, CFA should yield a well-fitted one-factor
model which contains all observed variables.

7.3.2 Directions for Future Research
Having identified the limitations of the study, this section then provides some
suggestions for future research to extend the current body of knowledge in the literature
on corporate reputation, corporate strategy and brand strategy.
Four directions for future research can be identified. First, this study focuses on the uses
of corporate reputation which a company has used for creating brand image strategies.
In a context of imperfect information, according to some scholars (Weigelt and Camerer,
1988; Wartick, 1992; Herbig and Milewicz, 1993) customers tend to use corporate
reptutation to deduce the quality of a particular product or service offered by a company
or to try to forecast its future action. Based on this logic, a firm manager can use its
corporate reputation to deploy a strategy that has some level of influence on the
customer’s perception.
This research has been applied to examine the Taiwanese pharmaceutical industry.
However, this whole process of theoretical building can be applied to other contexts of
study such as another industry or another country, for digging indepth regarding the
branding strategy issue in different contexts. Future research can be structured in a
similar way to the theoretical building of this research. It is suggested to go through
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another qualitative interview process to purify the proposed measurement scales. Some
different measurement items would be removed during the item purification process
when examining under a different context. This process is necessary for the researcher
to perfectly measure the construct domain in a specific context.
This study applied to one industry in one country in far eastern Asia; it would be
significantly different for other studies which compare more than two industries in
Taiwan or compare the same (pharmaceutical) industry in more than two countries.
Future research as a comparative study, possibly with more than two different industries
or countries is recommended in order to understand this theoretical structure more
thoroughly. Thus, there is a need to replicate and extend this study to other contexts
either in other industries or countries.
Extensive studies about the relative influences of different dimensions of the uses of
corporate reputation on image strategy should also be conducted, which can partly help
answer the question about whether a firm’s reputation can have an impact on its brand
image (Bickerton, 2000). Practically, it should also help managers to effectively select
reputation-building activities, consequently allocate their budgets and build a brand
image strategy based on a firm’s intangible asset.
Another future direction of this research would be to develop a measurement to measure
the relationship between this current study and financial performance. The reputation–
performance literature from many areas of study is huge and has been researched for a
long period of time, showing both positive and negative links between the two. From a
review of the literature, for example, marketing scholars (Fombrun, 1996; Caruana,
1997; Srivastava et al., 1997) assert that a good corporate reputation generates good
returns and affects corporate performance. Accounting scholars affirmed that a firm’s
corporate reputation enables it to profit from a variety of benefits (Herremans et al.,
1993). At the same time economic scholars (Sabate and Puente, 2003; Sobol and Farrell,
1988) and management scholars (Deephouse, 1997; Brown, 1997; Roberts and Dowling,
1997) indicate that a good corporate reputation is used by firms to enhance corporate
performance and financial performance (Roberts and Dowling, 2002; Kotha et al., 2001;
McGuire et al., 1990). Therefore, a link of this current study and financial performance
is suggested for examination in future research.
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Appendix 1a – Taiwan and Its Pharmaceutical Industry
A1.1 Taiwan at a glance

Geography

Maximum Length
Maximum Width
Land Area

394 km
144 km
36,190 sq.km.

Population

23.02 Million*
(2.59 Million in Taipei, the Capital city)
* Based on July 2010 estimation of US
Bureau of the Census based on statistics
from population censuses

Religion

Buddhist and Taoist
Christian
Others

Currency

TWD (Approximately 30TWD/US$ or
48TWD/£)

Language

Mandarin Chinese

Government

Presidential system
President of Taiwan: Ma, Ying-jeou

Econimic
Indicators

2009 GDP
2009 Export
2009 Import
2009 Intrest Rate (Prime Rate)
International Reserve

93%
4.5%
2.5%

US$ 379.03 Billion
US$ 203.67 Billion
174.36 Billion
US$ 380.51 Billion

(Source: German Trade Office Taipei; http://www.taiwan.ahk.de/taiwan/taiwan-at-aglance/)
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Appendix1. Table 1b: Benefits and limitations of alternative approaches for measuring business performance
Category

Label

“Within-Cell”
Approaches Performance Measurement
(Refer Figure 2)

1

2

3

Description
Financial data from
secondary sources

Financial data from
primary sources

Operational data from
secondary sources

Benefits

Limitations

(a)
Provides data on
financial aspects, which may not
be otherwise available;
(b)
Can be used especially
in a single/dominant business
type sample, and in “withinindustry” studies.
(c)
Possibility of
employing stock market
indicators of performance.

(a) Differences in accounting
policies may limit its use
for comparison purposes
(unless stock-market
indicators are adopted).
(b) Cannot be meaningfully
used at strategic business
unit level due to
“aggregation” problems.

(a)
Provides self-reported
financial data with fewer
problems of external
interpretation and aggregation
of data;
(b)
Can be used at both
corporate and strategic business
unit level of analysis.
(a)
Provides performance
data when financial data either
may not be available or may be
inappropriate.

(a)
Data is likely to be
biased;
(b)
Complete data may
not be available due to
confidentiality reasons.

(a)
Problems of data
availability on various
indicators to develop the
requisite measures;
(b)
Some operational data
may be industry-specific and
may not lend itself to multiindustry studies;
(c)
Relationship to
financial performance not
known.

Key methodological considerations when
using this approach
(a) Examine the feasibility of using
stock-market indicators as well as
the measure of return on value
added (ROVA) in view of its
“invariance” across industrial
contexts, as noted by Hofer (1983)
(b) Use industry-relative performance
when multiple industries are
included in the sample
(c) Access differences in accounting
policies when feasible.
(a) Choose target respondents based on
specific criteria (position, function,
etc.).
(b) Use multiple respondents to
examine the extent of systematic
bias as well as minimize
measurement error.
(a) Use industry as the reference point
for developing measures;
(b) Attempt to define concepts such as
market-share, efficiency, etc., as
consistently as possible across
industries.

Illustrative studies
reference
Rumelt (1974)
Montgomery & Singh
(1984)
Bettis and Hall (1982)

Dess and Robinson (1984)
(PIMS-based studies’ use
of ROI measure)

-market-share data in
Schendel and Patton
(1978)
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4

“Across-Cell”
Approaches to Performance Measurement
(continued)

A

B

Operational data from
primary sources

Financial data from
both primary and
secondary sources

Business performance
viewed in terms of
both financial and
operational indicators,
with data from
secondary sources.

(a)
Provides some basis to
include considerations of
performance in the research
design;
(b)
Less likely to be
influenced by reasons of
confidentiality, sensitivity, etc.
(a)
Provides scope for
assessing convergent validity to
enhance the “quality” of
measurement.

(a)
Provides a more
comprehensive
operationalization of business;
(b)
Enables one to
examine the relationship
between financial and
operational aspects of
performance.

(c)
Data is likely to be
biased;
(d)
Relationship to
financial performance not
known.
(a) Compatible data from
two different data
sources may not be
readily available;
(b) Cannot be meaningfully done when
research studies are
designed at the
strategic business unit
level due to problems
of obtaining
secondary data;
(c) Operational aspects of
performance are not
covered.
(c)
Inability to validate
operationalizations across
different data sources;
(d)
Cannot be
meaningfully used at a
strategic business unit level of
analysis.

(a)
Choose target respondents based on
specific criteria (position, function, etc.)
(b)
Use multiple respondents to
examine the extent of systematic bias as well
as to minimize measurement error.
(a) Check for definitional consistency;
(b) Identify reasons for nonconvergence, if observed and
reconceptualize the concept if
necessary;
(c) Examine
substitutability/interchangability of
one measure for the other;
(d) Use industry referent measures in
multi-industry studies;

-market-share data in
PIMS-based studies
Venkatraman and
Ramanujam (1985)

(e) Evaluate the feasibility of using
stock-market measures or ROVA.
(a) Define financial and operational
indicators in industry-relative
terms;
(b) Assess differences in accounting
policies;
(c) Address the dimensionality issue
both theoretically and empirically.

Schendel and Patton
(1978)
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“Across-Cell”
Approaches to Performance
Measurement
(continued)

C

Operational data from
both primary and
secondary sources

(a)
Provides scope for
assessing convergent validity of
operationalization using two
different methods.

(b)
Data availability may
prove to be a key limitation;
(c)
Financial aspects of
performance are not
considered, and the
relationships between financial
and operational indicators are
not known.
(a) Inability to validate
operationalizations across
different data sources.

D

Business performance
viewed in terms of
both financial and
operational indicators,
with data from primary
sources

(a) Provides a more
comprehensive
operationalization of business
performance;
(b) Enables one to examine the
relationship between financial
and operational aspect of
performance;
(c) Can also be adopted at the
strategic business unit level.

E

Financial data from
secondary sources and
operational data from
primary sources

F

Operational data from
secondary sources and
financial data from
primary sources

(a) Provides a scheme to enlarge (a) Limited use at a strategic
the conceptualization of
business unit level of analysis.
business performance, when
financial data may not be
forthcoming due to reasons of
confidentiality.
Unlikely option since if financial data are available through
primary sources, it is equally likely that operational data also may
be available from the same sources.

(a) Check for definitional consistency;
(b) Identify reasons for
nonconvergence, if observed;
(c) Examine
substitutability/interchangeability
of operationalizations.
(a) Choose target respondents based on
specific criteria;
(b) Define indicators in industry-relative
terms;
(c) Address the dimensionality issue both
theoretically and empirically;
(d) Use multiple respondents to examine
systematic bias due to position, level, etc., as
well as minimize measurement error.

Burgeois (1980)
Gupta and Govindarajan
(1984)
Woo and Willard (1983)

(a) Limited use at a strategic business unit
level of analysis.

a Although in an isolated study (Venkatraman and Ramanujam, 1985), positive and statistically significant association between perceptual (primary) and secondary data on three performance
indices were observed, the possibility of bias cannot be completely ruled out, and should be specifically tested in each study.
b All the PIMS-based strategy studies are not separately listed. For a review see Ramanujam and Venkatraman (1984).

Source: Adapted from Venkatraman and Ramanujam (1986)
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Appendix 1. List of Journals in the Literature Search

Following is the list of journals included in the literature search as part of the
measurement scale development process:
(1) Academy of Management Journal
(2) Academy of Management Review
(3) Corporate Reputation Review
(4) European Journal of Marketing
(5) European Management Journal
(6) Harvard Business Review
(7) Journal of the Academy of Marketing Science
(8) Journal of Advertising
(9) Journal of Business and Industrial Marketing
(10) Journal of Business Ethics
(11) Journal of Business Research
(12) Journal of Consumer Research
(13) Journal of General Management
(14) Journal of International Business Studies
(15) Journal of Management
(16) Journal of Management Studies
(17) Journal of Marketing
(18) Journal of Marketing Management
(19) Journal of Marketing Research
(20) Journal of Public Relations Research
(21) Management Science
(22) Strategic Management Journal
(23)The Marketing Review
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Appendix 2. Face-to-face semi-structured interview participant consent form

Application of the uses of corporate reputation on brand image
strategy
Marketing Department
Brunel Business School PhD Study
Brunel University
This interview is being conducted on behalf of the Brunel Business School led by Brunel University.
Please read the separate information sheet for a description of the aim and purpose of this research.
This study aims to determine the three uses of corporate reputation dimensions and its application on
the establishment of an image strategy. This semi-structured interview allows a fairly open
conversational framework. A number of questions were designed ahead of time to guide the
conversation. However, during the interview, both the interviewer and the interviewee have the
flexibility to steer the conversation to achieve the purpose of this study. It is open to discuss about
various details in order to present the main ideas that may not be discussed by using a formal, closed
question set. You have been chosen randomly from company managers in the Taiwanese
pharmaceutical industry to participate in the study.
An audio recording may be required by the researcher to aid subsequent data analysis. If so, you will be
informed at the beginning of the interview. All records of the interview, including the notes, audio file
and transcripts (if produced), will be kept secure and at all times personal data will be treated in ways
that are consistent with the data protection principles set out in the UK Data Protection Act 1998.
The interview will take approximately one hour to complete. You may withdraw from the interview at
any time and any data already recorded will be discarded if you choose.
If you have any questions or comments regarding this interview, please contact:
Chen Chu Chen
Brunel Business School, Brunel University
01895 266386
Chen.chu.chen@brunel.ac.uk

□ I agree to take part in this interview.
□ I confirm that I have read the associated information sheet and understand the intent
and purpose of this research.
□ I agree that data captured by this interview can be shared amongst the academia which
engage and support projects to conduct further analysis*, and
□ I agree that anonymised extracts from the interview transcript may be used in
documents intended for public dissemination.*
Name: ______________________________________
Email: ______________________________________
Signature: ___________________________________
Date: _______________________________________
* Ticking these agreement statements is optional.
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Title: ______________________________________________________________

Interviewer: ______________________________________________________________
•

Position: ________________________________________________________

•

Personal responsibilities:
relations manager

•

How long have you been with the company? ______ years and ______ months

•

How many staff are there in your company? _________________________

General manager

Marketing manager

Sales Manager

Public

Name of company: ________________________________________________

Date: ___________________________________________________________

Introduction: My name is Chen-Chu Chen and I am currently a Doctoral student at Brunel Business
School, Brunel University, Uxbridge, UK.
The research title of this study is: The use of corporate reputation in the development of brand image
strategy and its effects on brand market shares in the Taiwanese pharmaceutical industry. The aim of
this study is to investigate the uses of corporate reputation. It explores the factors of the uses of
corporate reputation that influence a manager’s strategy decisions and whether the uses of a firm’s
corporate reputation can be applied to making a firm’s brand image strategy. This research examines
the main effectiveness of a firm’s reputation as a device for developing a firm’s brand image strategy
by managers. The brand image strategy is based on competitive positioning, product differentiation and
segment development.
The purpose of this study is to build a firm’s brand image in order to provide managers with guidelines
on the uses of a firm’s reputation to implement their brand image strategy effectively. Therefore, it
studies the three main dimensions of the uses of corporate reputation that influence brand image
strategy setting at a corporate level.
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Qualitative interview questions – part 1. Research conceptual framework and content of the interview questions

Research conceptual framework (with items for each construct)

Resource: Developed by the author
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Research questions, hypotheses and qualitative questions (English version)
How do (Taiwanese pharmaceutical) companies use their corporate reputation to develop brand image strategy?
RQ:

*RQ: Key research question
SRQ1. Can a firm’s corporate reputation have an impact on its product’s market segment development?
Do you think a firm’s corporate reputation, which is used to create value, has a positive impact on a firm’s brand image strategy in terms of a
product’s segment development?
Can you suggest the characteristics of value creation which tend to encourage the setting of a product’s segment development? And why do you suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create a product’s segment development. What value creation
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so?
The items for value creation are suggested as follows (please see List 1)
The items for segment development are suggested as follows (please see List 4)
Do you think a firm’s corporate reputation, which is used as a strategic resource, has a positive impact on a firm’s brand image strategy in terms of a
product’s segment development?
Can you suggest the characteristics of strategic resources which tend to encourage the setting of brand segmentation and positioning strategy? And why do you
suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create brand segmentation and positioning strategy. What strategic
resource characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so?
The items for strategic resource are suggested as follows (please see List 2).
Do you think a firm’s corporate reputation, which is used to communicate with its stakeholders, has a positive impact on a firm’s brand image setting
in terms of a product’s market segment development?
Can you suggest the characteristics of corporate communication which tend to encourage the setting of brand segmentation and positioning strategy? And why
do you suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create brand segmentation and positioning strategy. What
communication characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so?
The items for corporate communication are suggested as follows (please see List 3).
301

SRQ2. Can a firm’s corporate reputation have an impact on its product differentiation?
Do you think a firm’s corporate reputation, which is used to create value, has a positive impact on a firm’s brand image strategy in terms of its product
differentiation?
Can you suggest the characteristics of value creation which tend to encourage the setting of its product differentiation? And why do you suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your product differentiation. What value creation
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so?
The items for value creation are suggested as follows (please see List 1).
The items for product differentiation are suggested as follows (please see List 5).
Do you think a firm’s corporate reputation, which is used as a strategic resource, has a positive impact on a firm’s brand image strategy in terms of its
product differentiation?
Can you suggest the characteristics of strategic resources which tend to encourage the setting of your product differentiation? And why do you suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your product differentiation. What strategic resource
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you think so?
The items for strategic resource are suggested as follows (please see List 2).
Do you think a firm’s corporate reputation, which is used to communicate with its stakeholders, has a positive impact on a firm’s brand image setting
in terms of its product differentiation?
Can you suggest the characteristics of corporate communication which tend to encourage the setting of your product differentiation? And why do you suggest
this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your product differentiation, what communication
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you suggest this?
The items for corporate communication are suggested as follows (please see List 3).
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SRQ3. Can a firm’s corporate reputation have an impact on a brand’s competitive position?
Do you think a firm’s corporate reputation, which is used to create value, has a positive impact on a firm’s brand image strategy in terms of the
brand’s competitive position?
Can you suggest the characteristics of value creation which tend to encourage the setting of your brand positioning strategy? And why do you suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your brand’s positioning strategy. What value creation
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you think so?
The items for value creation are suggested as follows (please see List 1).
The items for product differentiation are suggested as follows (please see List 6).
Do you think a firm’s corporate reputation, which is used as a strategic resource, has a positive impact on a firm’s brand image strategy in terms of a
brand’s competitive position?
Can you suggest the characteristics of strategic resources which tend to encourage the setting of your brand positioning strategy? And why do you suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your brand positioning strategy. What strategic resource
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you think so?
The items for strategic resource are suggested as follows (please see List 2).
Do you think a firm’s corporate reputation, which is used to communicate with its stakeholders, has a positive impact on a firm’s brand image setting
in terms of its product differentiation?
Can you suggest the characteristics of corporate communication which tend to encourage the setting of your brand positioning strategy? And why do you
suggest this?
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your brand positioning strategy, what communication
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you suggest this?
The items for corporate communication are suggested as follows (please see List 3).
Source: Developed by the author
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Qualitative interview questions – part 2. Items of each construct
List 1. Items for the uses of corporate reputation – value creation (Wong and Saunders, 1993)
Function/Instrumental Value

Compete by creating useful products.

Compete by creating correct/accurate attributes

Compete by appropriate performances.

Compete by appropriate outcomes.

Value-chain activity/resource allocation consistent with functional value creation.
Experiential/Hedonic Value

Compete by creating sensory value or appealing to the senses.

Compete by creating appropriate emotions (fun, pleasure, excitement, relaxation, etc.)

Compete by facilitating social relationships (bonds, attachments, togetherness)

Compete by creating epistemic value (knowledge, novelty, fantasy).

Compete by creating epistemic value (knowledge, novelty, fantasy).

Value-chain activity/resource allocation consistent with experiential value creation.
Symbolic/Expressive Value

Compete by enhancing self-identity, self-concept, self-worth.

Compete by creating personal meaning.

Compete by facilitating self-expression.
Cost/Sacrifice Value

Compete by offering economic value (low prices, value in use, life costs).

Compete by minimizing psychological investment of customers (ease of use, ease of doing business, simplicity, availability, accessibility).

Compete by minizing personal investment of customers (time, effort, energy).

Compete by minimizing customer risk (personal, technological, strategic).

Value-chain activity/resource allocation consistent with symbolic value creation.
List 2. Items for the uses of corporate reputation – strategic resource (Wong and Saunders, 1993)

Product differentiation

Segmentation and positioning

Efficient sales and marketing

Advanced R&D

Early to market
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Large cash resources

List 3. Items for the uses of corporate reputation – corporate communication (Johar and Sirgy, 1989; Hooley et al., 2004; Ogilvy, 1963; Sirgy, 1989; Reeves, 1961;
Madhavaram et al., 2005; Vargo and Lusch, 2004; Dickson and Ginter, 1987; Peltier and Schribrowsky, 1997; Nandan, 2005; Flint, 2004)
• Shape the perception of shareholders and stakeholders
• Influence consumer choices
•
Build a relationship between the firm and the customers
•
It is used as a signal to customers
•
To influence consumer choices
List 4. Items for brand image strategy – segment development (Dickson and Ginter, 1987)

This brand has one particular form of demand function modification

This brand requires product differentiation in exitence or as a complementary strategy

This brand may entail change in ideal point location

This brand may entail change in importance attached to a physical or nonphysical product
List 5. Items for brand image strategy – product differentiation (Dickson and Ginter, 1987)

This brand is created perceptual differently by usage experience, word of mouth, and promotion

This brand is actually created differently by product characteristics

This brand maybe directed at entire market or at one (or more segments)

This brand may utilize either physical or non-physical product characteristics
List 6. Items for brand image strategy – competitive position (Wong and Saunders, 1993)

Very superior quality

Superior quality

Better product performance

Higher advertising

Long distribution chain

Service much better

Fulfils basic need
•
Upmarket
Source: Adapted from previous literature as stated

305

Appendix 3 Questionnaire (First version, developed directly from literature)
The uses of corporate reputation scale
For each of the following statements, please indicate the response that most closely describes your organization.
Strongly
disagree
1
Value creation
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________
__________________

Moderately
disagree
2

01.
02.
03.
04.
05.
06.
07.
08.
09.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.

__________________ 22.

Neither agree
nor disagree 3

Moderately
agree
4

Strongly agree
5

Our firm’s corporate reputation promises good quality products and service to customers.
The corporate reputation of our firm helps to reduce transaction costs.
Our firm competes by creating useful products.
Our firm competes by creating the correct product attributes for its targeted customers.
Our firm competes by appropriate performances.
Our firm competes by appropriate outcomes.
Our firm’s value-chain activity is consistent with functional value creation.
Our firm’s resource allocation is consistent with functional value creation.
Our firm competes by appealing to the senses.
Our firm competes by creating appropriate emotions (fun, pleasure, excitement, relaxation, etc.)
Our firm competes by facilitating social relationships (bonds, attachments, and togetherness).
Our firm competes by creating epistemic value (knowledge, novelty, fantasy).
Our firm’s value-chain activity is consistent with experiential value creation.
Our firm’s resource allocation is consistent with experiential value creation.
Our firm competes by enhancing its customers’ self-identity.
Our firm competes by enhancing its customers’ self-concept.
Our firm competes by enhancing its customers’ self-worth.
Our firm competes by creating personal meaning.
Our firm competes by facilitating self-expression.
Our firm competes by offering economic value (low prices, value in use, life costs).
Our firm competes by simplifying the purchasing process for its consumers (ease of use, ease of doing business, simplicity,
availability, accessibility).
Our firm compete by enabling ease of use of its products (time, effort, energy).
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__________________ 23.
__________________ 24.
__________________ 25.

Our firm competes by minimising customer risk (personal, technological, strategic).
Our firm’s value-chain activity is consistent with symbolic value creation.
Our firm’s resource allocation is consistent with symbolic value creation.

Strategic value or resource
__________________ 01.
__________________ 02.
__________________ 03.
__________________ 04.
__________________ 05.

In our organisation, corporate reputation serves as a competitive advantage.
Our firm’s corporate reputation sends a strong signal to its customers.
Our firm’s corporate reputation implies efficient sales and marketing.
Our firm’s corporate reputation implies its advanced R&D.
Our firm’s corporate reputation implies that we are able to enter markets early.

Corporate communication
__________________ 01.
__________________ 02.
__________________ 03.

Our firm’s corporate reputation shapes the perceptions of shareholders and other stakeholders.
Our firm’s corporate reputation builds a relationship between the firm and its customers.
Our firm’s corporate reputation influences consumer choices.
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Brand image strategy scale
For each of the following statements, please indicate the response that most closely describes your organisation.
Strongly
disagree
1

Moderately
disagree
2

Neither agree
nor disagree 3

Moderately
agree
4

Competitive position
___________________
___________________
___________________
___________________
___________________
___________________
___________________

1.
2.
3.
4.
5.
6.
7.

Our firm’s corporate brand positioning strategy signifies high quality to its customers.
Our firm’s corporate brand positioning strategy signifies better product performance to its customers.
Our firm’s corporate brand positioning strategy is to achieve a higher frequency of advertising.
Our firm’s corporate brand positioning strategy involves a long distribution chain.
Our firm’s corporate brand positioning strategy is to provide a much better service to its customers.
Our firm’s corporate brand positioning strategy tries to fulfil the basic needs of our customers.
Our firm’s corporate brand positioning strategy tries to target upmarket audiences.

Product differentiation
___________________
___________________
___________________
___________________
___________________
___________________
___________________

1.
2.
3.
4.
5.
6.
7.

How our corporate brand is perceived varies according to whether consumers have experienced our products.
How our corporate brand is perceived varies by word of mouth.
How our corporate brand is perceived varies by promotion.
Our corporate brand is actually created differently by product characteristics.
Our corporate branding maybe directed at different market segments.
Our corporate brand may utilise physical product characteristics.
Our corporate brand may utilise non-physical product characteristics.

Strongly agree
5

Segment development
___________________ 1.
Our corporate brand strategy has one particular form of demand function modification.
___________________ 2.
Our corporate brand strategy requires product differentiation.
___________________ 3.
Our corporate brand strategy requires changes in point distribution location.
___________________ 4.
Our corporate brand strategy requires changes in importance attached to a non-physical product.
___________________ 5.
Our corporate brand strategy requires changes in importance attached to a physical product.
______________________________________________________________________________________________________________________________________
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Appendix 4. Questionnaire (A revised version after qualitative interview):

Value creation items:
1. Our firm’s corporate reputation promises good quality products and service to
customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. The corporate reputation of our firm helps to reduce transaction costs.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. Our firm competes by creating useful products.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

4. Our firm competes by creating the correct product attributes for its targeted
customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our firm competes by providing good financial performances.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our firm competes by providing product with appropriate outcomes.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

7. Our firm’s value-chain activity is consistent with functional value creation.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

8. Our firm’s resource allocation is consistent with functional value creation.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

9. Our firm’s products compete by appealing to the senses.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

10. Our firm competes by creating appropriate emotions (e.g. fun, pleasure, excitement,
relaxation, etc.)
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

11. Our firm competes by facilitating social relationships (e.g. bonds, attachments and
togetherness).
Disagree

1

2

3

4

5

□

□

□

□

□
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Agree

12. Our firm competes by creating epistemic value (e.g. knowledge and novelty).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

13. Our firm’s value-chain activity is consistent with experiential value creation (e.g.
happiness, affection and excitement...).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

14. Our firm’s resource allocation is consistent with experiential value creation.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

15. Our firm competes by enhancing its customers’ self-identity.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

16. Our firm competes by enhancing its customers’ self-concept (or self-image).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

17. Our firm competes by enhancing its customers’ self-worth.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

18. Our firm competes by facilitating self-expression.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

19. Our firm competes by offering economic value (low prices, value in use, life costs).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

20. Our firm competes by simplifying the purchasing process for its consumers (ease of
use, ease of doing business, simplicity, availability of purchasing, accessibility).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

21. Our firm competes by enabling ease of use of its products (time, effort, energy).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

22. Our firm competes by minimizing customer risk (personal, technological, strategic).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

23. Our firm’s value-chain activity is consistent with symbolic value creation.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

24. Our firm’s resource allocation is consistent with symbolic value creation.
Disagree

1

2

3

4

5

□

□

□

□

□
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Agree

Strategic resources items:
1. In our organization, corporate reputation serves as a competitive advantage.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. Our firm’s corporate reputation sends a strong signal to its customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. Our firm’s corporate reputation implies efficient sales and marketing.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

4. Our firm’s corporate reputation implies it has advanced R&D.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our firm’s corporate reputation implies that we are able to enter markets early.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our firm’s corporate reputation gains the firm more opportunity for strategic alliance
or business cooperation.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

7. Our firm’s corporate reputation is enhancing the prices by validating them in
published clinical reports.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

8. Our firm’s corporate reputation enables the firm to enter the market easier.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

9. Our firm’s corporate reputation gains more customers for the firm.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

10. Our firm’s corporate reputation makes the marketing system work more efficiently.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

11. Our firm’s corporate reputation makes it easier for us to find a downstream reseller.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

12. Our firm’s corporate reputation can enhance our firm’s sales force.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

13. Our firm’s corporate reputation helps the new product to enter the market.
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Disagree

1

2

3

4

5

□

□

□

□

□

Agree

14. Our firm’s corporate reputation helps the strategic link with complementary
products.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

Corporate communication items:
1. Our firm’s corporate reputation shapes the perceptions of shareholders and other
stakeholders.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. Our firm’s corporate reputation builds a relationship between the firm and its
customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. Our firm’s corporate reputation influences consumer choices.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

4. Our firm’s corporate reputation is based on the experience of the sales people.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our firm’s corporate reputation is based on the sales ability of the sales people.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our firm’s corporate reputation is based on the firm's awareness of social
responsibility.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

7. Our firm’s corporate reputation can be used for all types of negotiations with our
customers, competitors or the government.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

8. Our firm’s corporate reputation helps internal communication (the communication
between our firm and our staffs).
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

9. Our firm’s corporate reputation helps external communication (the communication
between our firm and our customers).
Disagree

1

2

3

4

5

□

□

□

□

□
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Agree

Brand positioning items:
1. Our firm’s corporate brand positioning strategy signifies high quality to its customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. Our firm’s corporate brand positioning strategy signifies better product performance
for its customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. Our firm’s corporate brand positioning strategy is to achieve a higher frequency of
advertising.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

4. Our firm’s corporate brand positioning strategy involves a long distribution chain.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our firm’s corporate brand positioning strategy is to provide a much better service to
its customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our firm’s corporate brand positioning strategy tries to fulfil the basic needs of our
customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

7. Our firm’s corporate brand positioning strategy tries to target upmarket audiences.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

Brand differentiation items:
1. Our corporate brand is perceived differently according to whether consumers have
experienced our products.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. Our corporate brand is perceived differently by word of mouth.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. Our corporate brand is perceived differently by promotion.
1

2

3

4
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5

Disagree

□

□

□

□

□

Agree

4. Our corporate brand is actually created differently by product characteristics.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our corporate branding may be directed at different market segments.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our corporate brand may utilize physical product characteristics.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

7. Our corporate brand may utilize non-physical product characteristics.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

8. Our firm’s corporate brand positioning strategy is based on advanced R&D which
leads the needs of the targeted market.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

Brand segmentation items:
1. Our corporate brand strategy has one particular form of demand function
modification.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. Our corporate brand strategy requires product differentiation.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. Our corporate brand strategy requires changes in point distribution location.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

4. Our corporate brand strategy requires changes in importance attached to a
nonphysical product.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our corporate brand strategy requires changes in importance attached to a physical
product.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our corporate brand strategy is decided by the needs of the customers to decide the
product differentiation.
Disagree

1

2

3

4

5

□

□

□

□

□
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Agree

7. Our corporate brand strategy is based on different channels of distribution.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

Medicine price items:
1. A medicine with a higher price shows a higher quality of product to its customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

2. A medicine with a higher price shows a better image of the company it belongs to.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

3. A medicine with a higher price usually captures the value that is generated in the
product.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

4. Our firm customizes price by value that is perceived by our customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

5. Our firm customizes price by distinguishing customers who pursue high values and
customers with strict budgets.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

6. Our firm customizes price by offering coupons, regional prices, limited consumption
or negotiatory prices to a specific group of customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

7. Our firm customizes price according to the characteristics of the customers.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

8. Our firms customize price according to the trading characteristics.
Disagree

1

2

3

4

5

□

□

□

□

□

Agree

9. Our firm pays considerable attention to effective publicity and communication while
operating bulk buying/discounts.
Disagree

Thank

you

1

2

3

4

5

□

□

□

□

□

very

much
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for

Agree

your

co-operation

Appendix 5. Survey respondents background information
1. Company
History:

2. Turnover
(Million
Pounds):

11–30 years

Between 1 and 3

11–30 years

Under 1

31–50 years

Under 1

31–50 years

Above 10

11–30 years

Under 1

11–30 years

Under 1

11–30 years

Under 1

11–30 years

Under 1

11–30 years

Under 1

11–30 years

Between 1 and 3
millions

31–50 years

Above 10

11–30 years

Between 1 and 3

3. Service Type (Multiple):
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade European
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
A trader company (Trade American
company products)
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0–49

Sales department
Management
department

General manager
Department
manager
Department
manager

7. Years of
experience in
the company:
More than 25
years
Between 6 to 14
years
More than 25
years
Between 15 to 24
years
Between 15 to 24
years
Between 15 to 24
years
More than 25
years
Between 15 to 24
years
Between 6 to 14
years

50–99

Management
department

Board chairman

More than 25
years

Management
department
Management
department

Department
manager
Department
manager

Between 6 to 14
years
Between 2 to 5
years

4. Size
(People):
0–49
0–49
0–49
50–99
0–49
0–49
0–49
0–49

50–99
0–49

5. Department:
Marketing
department
Management
department

6. Position:
Department
manager
Department
manager

Sales department
Management
department
Management
department

Board chairman
Department
manager
Department
manager
Department
manager

Sales department
Management
department

11–30 years

Above 10

11–30 years

Under 1

Less than 10
years
Less than 10
years

Under 1
Between 1 and 3

31–50 years

Between 3 and 10

31–50 years

Between 3 and 10

31–50 years

Above 10

31–50 years

Between 3 and 10

11–30 years

Between 1 and 3

11–30 years

Between 1 and 3

31–50 years
11–30 years

Between 1 and 3
Above 10

A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade European
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
A trader company (Trade American
company products)
A trader company (Trade American
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
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0–49

Marketing
department
Management
department

General manager

0–49

Sales department

Department
manager

0–49
100 – 299

Sales department
Management
department

50–99

Sales department

100 – 299

0–49

Sales department
Marketing
department
Management
department

50–99

50–99
0–49

over 300

100 – 299

Department
manager

General manager
General manager
Department
manager
Department
manager

Between 2 to 5
years
Between 6 to 14
years

Less than 1 year
Between 6 to 14
years
More than 25
years
Between 15 to 24
years

Sales department

General manager
Department
manager

Less than 1 year
More than 25
years
Between 15 to 24
years
Between 6 to 14
years

Management
department
Management

Department
manager
Department

Less than 1 year
Between 15 to 24

General manager

31–50 years

Between 3 and 10

11–30 years

Between 1 and 3

11–30 years

Between 1 and 3

51–80 years

Above 10

11–30 years

Above 10

11–30 years

Between 1 and 3

11–30 years

Between 1 and 3

11–30 years

Between 1 and 3

11–30 years

Above 10

31–50 years

Above 10

company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
A trader company (Trade European
company products)
Taiwanese local company
(Manufacture+Sell)
A foreign owned company (Asian
company) (Manufacture+Sell)
A trader company (Trade European
company products)
A foreign owned company (American
company) (Manufacture+Sell)
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department
Marketing
department

manager
Department
manager

years
Between 15 to 24
years

50–99

Marketing
department
Marketing
department

Department
manager
Department
manager

More than 25
years
Between 6 to 14
years

over 300

Sales department

Department
manager

Between 2 to 5
years

0–49
50–99

Sales department
Marketing
department

50–99

Sales department

Department
manager
Department
manager
Department
manager

Between 6 to 14
years
Between 2 to 5
years
Between 6 to 14
years

50–99

Management
department

Department
manager

More than 25
years

Sales department
Marketing
department

Department
manager
Department
manager

Between 15 to 24
years
Between 6 to 14
years

over 300

0–49

100 – 299
over 300

11–30 years

Between 1 and 3

11–30 years

Between 3 and 10

51–80 years

Between 3 and 10

51–80 years

Between 3 and 10

11–30 years

Between 3 and 10

Over 81 years

Between 3 and 10

31–50 years

Under 1000

11–30 years

Under 1000

11–30 years

Under 1000

11–30 years

Under 1000

31–50 years

Above 10

11–30 years

Above 10

A trader company (Trade American
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
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0–49
100 – 299
100 – 299
100 – 299

Management
department
Management
department
Marketing
department
Marketing
department

Department
manager
Department
manager
Department
manager
Department
manager

Between 6 to 14
years
More than 25
years
Between 6 to 14
years
Between 6 to 14
years

Management
department
Management
department

Department
manager

0–49

Sales department
Management
department
Management
department
Management
department

General manager
Department
manager

Between 2 to 5
years
Between 15 to 24
years
More than 25
years
Between 15 to 24
years
More than 25
years
Between 6 to 14
years

50–99

Management
department

Department
manager

Between 6 to 14
years

over 300

Marketing
department

Department
manager

Between 2 to 5
years

100 – 299
100 – 299
0–49
0–49
0–49

General manager
Board chairman
Department
manager

Less than 10
years

Under 1

31–50 years

Between 3 and 10

31–50 years

Between 3 and 10

31–50 years
11–30 years

Between 3 and 10
Between 1 and 3
million

11–30 years

Above 10

31–50 years

Between 3 and 10

11–30 years

Between 1 and 3

51–80 years

Above 10

11–30 years

Above 10

11–30 years

Between 1 and 3

company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade European
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
A trader company (Trade American
company products)
Taiwanese local company
(Manufacture+Sell)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade American
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
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0–49

Department
manager

50–99

Sales department
Management
department
Marketing
department
Marketing
department

General manager
Department
manager
Department
manager
Department
manager
Department
manager

Less than 1 year
More than 25
years
Between 15 to 24
years
More than 25
years
Between 6 to 14
years
Between 15 to 24
years
Between 15 to 24
years
Between 6 to 14
years

over 300

Sales department

Department
manager

Between 2 to 5
years

0–49

Sales department

50–99

Sales department

Department
manager
Department
manager

Between 6 to 14
years
Between 6 to 14
years

100 – 299
50–99
100 – 299
50–99
0–49
over 300

Sales department
Management
department
Sales department
Marketing
department

General manager
Department
manager

11–30 years

Above 10

11–30 years

Between 1 and 3

51–80 years

Between 3 and 10

11–30 years

Between 3 and 10

A foreign owned company (Asian
company) (Manufacture+Sell)
A trader company (Trade European
company products)
A trader company (Trade American
company products)
A trader company (Trade European
company products)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
A trader company (Trade Asian
company products)
Taiwanese local company
(Manufacture+Sell)
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Sales department

Department
manager

Between 15 to 24
years

100 – 299

Management
department
Marketing
department

Department
manager
Department
manager

Between 6 to 14
years
Between 6 to 14
years

100 – 299

Management
department

Department
manager

Between 2 to 5
years

100 – 299

0–49

Appendix 6. List of overall company profile in Taiwanese pharmaceutical industry
Company
Koda Pharmaceutical Co. Ltd.
Yuan Chou Chemical & Pharmaceutical
Co., Ltd.

Address
area code
324

Email Address
koda@koda.com.tw

Tel. No. (+886=0)
(03)4696105

Fax No. (+886=0)
(03)4691447

a2256666@ms71.hinet.net

(049)2255-330

540

(04)888-3608
(06)572-6535
(02)2908-5268
(02)27413511
(02)2876-5845
(02)2536-2326

521
721
242
303
328
206

Website
www.koda.com.tw

Fu Tan Pharmaceutical Co.,Ltd.
Chen Ta Pharmaceutical Co.,Ltd.
Nysco Co., Ltd.
Chun Da Co., Ltd.
Aerolead International Ltd.
Taiwan Shionogi & Co.,Ltd
San You Biotech & Pharmaceutical Co.,
Ltd.
AND Pharmaceutical & Chemical Industry
Co Ltd.

a481069@yahoo.com.tw
a7211111@ms24.hinet.net
accounting@nysco.net
adm@paolyta.com.tw
aled@aerolead.com.tw
alice@shionogi.com.tw

(049)2253190
(04)8884138,
(04)8884139
(06)5721102
(02)29017321
(03)5983150
(03)4839606
(02)24512466-7

allcare@sun-you.com.tw

(06)6353338

(06)6353656

731

and.lin@msa.hinet.net

(04)763-1369

500

Kuang Nan Pharmaceutical Co., Ltd.
ARICH Enterprise Co., Ltd.
Astar Chemical & Pharmaceutical Co Ltd.
Kuo Chang Pharmaceutical Co., Ltd.
Caleb Pharmaceuticals, Inc.
China Biological & Chemical Co Ltd.
Chunghwa Chemical Synthesis & Biotech
Co., Ltd.
Chu Chen Ind. Co., Ltd.
Century Chem. & Pharm.Co.,Ltd.
Chang An Chemical Industries Co.,Ltd.
Chin Ang Pharmaceutical Co.,Ltd.
Cheng Fong Chemical Co., Ltd.

angus@iloveyou-bio.com
arich@ms7.hinet.net
astarnet@ms25.hinet.net
biomist@anet.net.tw
caleb@caleb-pharm.com
cbc.pharmal@msa.hinet.net

(04)7621135
(03)9382954,
(03)9383235
(02)25057295
(03)5591158-9
(06)2613165-7
(03)579-5858
(02)26235507

(03)9386-916
(02)25047665
(03)559-0028
(06)261-6296
(03)579-5656
(02)8631-0200

260
104
304
702
300
251

www.iloveyou-bio.com
www.arich.com.tw

ccsb@ccsb.com.tw
cctmj@kingcar.com.tw
century.ct115@msa.hinet.net
chanan66@ms23.hinet.net
changmp@ch-angmp.com.tw
cheng.fong@msa.hinet.net

(02)8684-3318
(07)6967156
(02)24967112
(04)7695126
(05)2216025-6
(03)3868383

(02)8684-3202
(02)2368-8128
(02)2496-8307
(04)769-5120
(05)221-8833
(02)2966-9575

238
821
224
506
621
337

www.ccsb.com.tw
www.kingcar.com.tw
www.century115.com

322

www.yuanchou.com.tw

www.nysco.net

www.sun-you.com.tw

www.gcnkh.com
www.caleb-pharm.com
www.cbcl.com.tw

www.ch-angmp.com.tw
www.cf-chemical.com.tw

Chien Min Pharmaceutical Co., Ltd.
Chia Shin Pharmaceutical Co Ltd.
Chin Teng Pharmaceutical Industrial
Co.,Ltd.
Chiu Jern Chem. & Pharm. Co., Ltd.
Overseas Chinese Pharmaceutical Co.,
Ltd.
Chung Mei Pharmaceutical Co Ltd.

chenmin.chenmin@msa.hinet.net
chiashin2@yahoo.com.tw

(04)23500663
(05)2354872-3

(04)2350-5329
(05)2358496

407
600

chinteng@ms12.hinet.net
chiu.jern@msa.hinet.net

(04)26812468
(02)26211111-2

(04)2681-6878
(02)2623-5324

437
251

chwovc@yahoo.com.tw
cmnet001@ms21.hinet.net

(02)22866217
(04)7524161

(02)22874228
(04)761-3986

241
500

www.chungmei.com.tw

Sheng Foong Co., Ltd.
Chung Tai Sing Chemical Industry Co.,
Ltd.

company@shengfoong.com.tw

(03)9905900

(02)2769-8785

270

www.shengfoong.com.tw

cts@crocoil.com.tw

(03)5387-539

300

www.crocoil.com.tw

curie.cr@msa.hinet.net
d3565@ms34.hinet.net
dauge@ms2.hinet.net

(03)5387135
(02)26214538,
(02)26231666,
(02)26256365
(02)26711597
(08)7070705

(02)2623-1249
(02)2307-9171
(08)707-0606

251
237
913

www.dauge.com.tw

dcpclee@seed.net.tw
deltayc@ms25.hinet.net
dfe688@ms23.hinet.net
everestm@ms38.hinet.net

(03)3869200
(02)22685604
(07)7038748
(05)2218686

337
236
831
621

Forever Chemical Co., Ltd.
Ya Sian Biotech Co., Ltd.

fcco1999@yahoo.com.tw
felix@eusol-biotech.com.tw

337
248

www.forever-chem.com.tw

Fisherman Pharmaceutical Co Ltd.
Eisai Taiwan Inc.
Fuh Teng PharmaceuticalCo.,Ltd.
Fung Song Pharm .Biotechnology .Co .,
Ltd.
Fu Yuan Chem. & Pharm. Co., Ltd.
Genuine Chemical

fisher.mar@msa.hinet.net
fmchang@eisai.com.tw
fu.tain@msa.hinet.net

(03)3862421
(02)22994836
(07)3417718,
(07)3416396
(06)6985180
(04)7989696

(03)386-9202
(02)2268-0895
(07)7022558
(05)221-3383
(02)8861-3292,28829663
(02)22996026
(07)341-8266
(02)2531-0063
(04)798-0796

813
720
509

www.fisher-man.com.tw
www.eisai.com.tw

fung.song@msa.hinet.net
fuyuan17303@seed.net.tw
gcpc2030@ms37.hinet.net

(06)6987396
(02)24972872
(03)4524382

(06)6990039
(02)2433-2079
(03)462-7749

720
224
320

The Curie Chem & Pharm
Manufacturing Co Ltd.
Shun Hwa Pharmaceutical Co., Ltd.
Daw Jih Pharmacy Works Co Ltd.
Danver Chemical & Pharmaceutical Co
Ltd.
Delta Synthetic Co., Ltd.
Factor PharmaceuticalCo.,Ltd.
Everest Pahrm. Industrial Co., Ltd.

323

www.chinteng.com.tw

Pharmaceutical Co., Ltd.
Gentle Pharmaceutical Co., Ltd.
New Bellus Entierprises Co., Ltd.

(05)5911101-2
(03)4572121
(08)7226222,
(08)8000381~2

(05)591-1103
(02)2393-7001

631
320

(08)8000383

900

(02)2999-1911
(04)26818462
(06)2673-084

327
437
701

hengan23593019@yahoo.com.tw
hk23rd36th@yahoo.com.tw
hkc@huikwang.com
hong.shingf@msa.hinet.net
hongchusis@yahoo.com.tw
hsien.ju@msa.hinet.net

(03)4775185
(04)26811733
(06)2673036
(04)23593019,
(04)23593222
(04)23592993
(06)5702181
(03)4521818
(04)7356825
(05)2209897

(04)2359-0120
(04)2359-3841
(06)5700065
(02)2708-8800
(04)736-1180
(05)220-9685

407
408
721
320
500
621

Syngen Biotech Co., Ltd.
Hwang's Pharmaceutical Co Ltd.
Hsin Wan Jen Chem.&Pharm.Co.,Ltd.
Union Chem & Pharm Co Ltd.
Formosa Laboratories Inc.
Taiwan Biotech Co Ltd.

huang.adam@syngen.com.tw
hwangs.ltd@msa.hinet.net
hwj@greenoil.com.tw
ict.union@msa.hinet.net
info@formosalab.com
info@mail.sintong.com

(06)6323588
(05)5971197
(04)25269105
(02)22833001-3
(03)3240895
(03)3612131

730
630
42049
247
338
330

Sinphar Pharmaceutical Co., Ltd.
Jen Chang Sheng Chem.& Pharm.Co.,Ltd.
Jen Sheng Pharmaceutical Co., Ltd
Center Laboratories, Inc.
Jilly Pharmaceutical Co., Ltd.

info@sinphar.com
jcsc.jcsc@msa.hinet.net
jena@jensheng.com
jessie@centerlab.com.tw
jilly.gmp@gmail.com

Jinup Enterprise Co. Ltd.
Johnson Chem. Pharm. Works Ltd.
Jeou Song Chemical Enterprise Co.,Ltd.

jinup@ms37.hinet.net
johnson.twjcp@msa.hinet.net
jschem@ms39.hinet.net

(03)9581101-5
(04)7354976-7
(04)23592345
(03)5981829
(04)8223141-3
(05)2262395,
(05)2262769
(02)22878405
(04)7695106-7

(06)6361964
(02)2771-2573
(04)2524-2570
(02)2281-7044
(03)324-0923
(03)367-0029
(03)9583040,
(02)27699918
(04)735-4978
(04)2359-1997
(02)2545-3562
(04)823-4162
(05)226-8393
(02)2971-2579
(04)769-5108

621
241
504

Hansen Pharmaceutical Co., Ltd.
Hui Chun Tang Pharmaceutical Works Co
Ltd.
Health Chemical Pharmaceutical Co Ltd.
Tainan Peng Lai Enterprise Co. Ltd.
Heng An Pharmaceutical
Industrial Co.,Ltd.
Hwa Kuo Pharmacy Co., Ltd.
Hui Kwang Chemical Co.,Ltd.
Hong Shing Pharmaceutical Co., Ltd.
Unifarma Co., Ltd.
Taiwan Dersan Pharmaceutical Co. Ltd

gen11101@ms36.hinet.net
gkimail@tpts5.seed.net.tw
han.sheng88@msa.hinet.net
hctpharm@ms65.hinet.net
healthcgmp@yahoo.com.tw
helen106@ms13.hinet.net

324

269
508
407
303
512

www.grapeking.com.tw

www.hctpharm.com.tw

www.huikwang.com
www.hongshing.com.tw

www.syngen.com.tw
www.hwangs.com.tw
www.greenoil.com.tw
www.formosalab.com
www.sintong.com
www.sinphar.com
http://www.jensheng.com
www.centerlab.com.tw

Taiwan Three Mast
Pharmaceuticl Co., Ltd.
Taiwan Veterans Pharmaceutical Co Ltd.
Everlight Chemical Industrial Corp.
Kink Laboratories Co Ltd.
Chirogate International Inc.
Kojar Pharmaceutical Ind Co Ltd.
Tien Liang Biotech Co., Ltd.
Panion&BF Biotech, INC.
Li Ta Pharmacy Co Ltd.

kamtamt@seed.net.tw
kate_wu@taiwanvpc.com.tw
kingdavid@ecic.com.tw
kink@ms29.hinet.net
kirogate@ms63.hinet.net
kojar.c9388@msa.hinet.net
ktl.chan@msa.hinet.net
leesufen@pbf.com.tw
lita.wang@msa.hinet.net

Tolin Pharmaceutical Industries Co.,Ltd.
Long Der Pharmaceutical Co.,Ltd.

long_jacyyang@yahoo.com.tw
longder@seed.net.tw

(06)2042345
(03)4651190
(03)4838088
(04)22263921
(03)4963808
(04)26815051-3
(03)4696792
(03)4697159
(04)26872345
(04)25364377,
(04)25363677
(07)6220909

Lotus Pharmaceutical Co Ltd.
Long Shin Biotech & Pharmaceutical Co.,
Ltd.
Meider Pharmaceutical Co Ltd.
Mey See Pharmaceutical Co Ltd.

lotus@lotuspharm.com

SCI Pharmtech,Inc.
Ming Ta Chemistry Pharmacy Co., Ltd.
Min Ton Pharmaceutical Co., Ltd.
Tong Yang Pharmaceutical Co., Ltd.
Mingtai Chemical Co., Ltd.

ls928@aptg.net
meider.drugs@msa.hinet.net
mey.see@msa.hinet.net
michele.seah@scipharmtech.com.tw
mingta52@ms45.hinet.net
mintong@ms6.tisnet.net.tw
msa@ms8.hinet.net
mtchem@ms24.hinet.net

Mu Tsu Pharmaceutical Chemical Co Ltd.
Nan Tu Chemical Pharmaceutical Co.,Ltd.
Chung His Chemical Plant, Ltd.

mtpc.komt@msa.hinet.net
nan.tu@msa.hinet.net
nancylee@chunghsi.com.tw

Newai Chemical Industries Ltd.
New Chemical International
Enterprise Co. Ltd.

newai.company@msa.hinet.net
newchem@giga.net.tw

(06)2637414
(03)465-7381
(02)27031386
(04)2223-3041
(03)4963800
(04)26816198
(02)2647-5179
(02)26558318
(04)2686-8381

710
320
328
411
32657
437
324
324
437

www.3mast.com.tw
www.taiwanvpc.com.tw
www.ecic.com

427
828

http://www.tolya.com.tw

(049)2250411

(04)2536-1020
(07)622-6461
(02)27782798,
(02)27115262

540

www.lotuspharm.com.tw

(06)7220666
(03)4723567
(07)3711234

(06)722-9548
(03)521-4179
(07)3736359

722
326
814

www.lsbiopharma.com

(03)3543133
(04)26870115-7
(04)23590107
(06)6987661
(03)3682295
(04)8330229,
(04)8321229
(06)7260339
(03)5772551-2
(05)5571111,
(05)5571405
(06)6550550,
(06)6550551
325

(03)354-3137
(04)2687-0118
(04)2359-4256
(06)698-7663
(02)2721-6326

33856
438
408
720
334

(04)833-7702
(06)726-1128
(02)2351-2884

510
722
300

www.chunghsi.com.tw

(06)274-5456

640

www.newai.com.tw

(06)655-0552

737

www.newchem.com.tw

www.chirogate.com
www.kojar.com.tw

www.meysee.com.tw
www.sci-pharmtech.com.tw

www.tong-yang.com.tw
www.mingtai.com

Nang Kuang Pharmaceutical Co., Ltd.
Oasis Chemical IndustriesCo.,Ltd.
Sage Biotechnology Co., LTD.
Tung Chou Chemical & Pharmaceutical
Co., Ltd.
Panbiotic Laboratories
You Zhi Bao Biopharmaceuticals Co., Ltd.
Bei Chin International Inc.
Pfoshen Pharmaceutical Co Ltd.
Timing-Life Medical, Inc
Prince Pharmaceutical Co., Ltd.
Hua Shin Chemical Pharmaceutical
Works Co.,Ltd.
San Yo Pharmaceutical Industrial Co., Ltd.
Taiwan Yang Sheng Pharmaceutical
Ind. Co.,Ltd.
Root Chemical Pharmacy Co Ltd.
Royal Chemical & Pharmaceutical Co Ltd.
Synmax Biochemical Co., Ltd.
De Licacy Garment Co., Ltd.
San Nang Chemical Co.,Ltd.
Shou Chan Industrial Co.,Ltd.
SuChiang Chemical &
Pharmaceutical Co., Ltd.
Sheng Chang Pharmaceufical Co.,Ltd
Shyh Dar Pharmaceuticl
Industrial Co., Ltd.
Sen Tai Pharmaceutical Co Ltd.
Ming Hwa Drug Co., Ltd.
Pei Li Pharmaceutical Industrial Co Ltd.
Synpac-Kingdom Pharmaceutical Co Ltd.
TTY Biopharm Co., Ltd.

nkcp@ms15.hinet.net
oasis@ms65.hinet.net
onpylu@ms52.hinet.net

(06)5984121-6
(02)27671288
(02)24978076

(06)597-2033
(02)2762-3883
(02)2321-5861

712
105
224

www.nangkuang.com.tw

orichem@ms41.hinet.net
panbio@ksts.seed.net.tw
Passalip@Yahoo.com.tw
peijin@ms6.hinet.net
ph.119@yahoo.com.tw
ppin0214@yahoo.com.tw
prince30@ms14.hinet.net

(02)22815252
(07)7317861
(06)6525757
(02)27089462
(04)7223923
(07)3715106
(03)5981438

(02)2281-8282
(07)731-6002
(06)6373177
(02)26486748
(04)723-2498
(07)372-1182
(02)2988-5137

247
833
730
106
500
814
303

www.oriental.com.tw
www.panbiotic.com.tw

propr2@hspg.com.tw
qcwen2007@hokia.com.tw

(04)8832121
(07)7871266

(04)883-0916
(07)224-3456

522
831

www.hspg.com.tw

r2681132@ms43.hinet.net
rootph.com@msa.hinet.net
rp7310@ms23.hinet.net
sales@synmax.com.tw
san.hord@msa.hinet.net
sannan168@yahoo.com.tw
sc254221@ms14.hinet.net

(08)7524112
(04)26882666-7
(07)7310537
(03)4863160
(04)25322867
(04)7692668-9
(049)2254221-3

(08)753-9476
(04)2688-2667
(07)731-0538
(02)23820559
(04)2532-8821
(04)769-0306
(049)2254-617

900
437
833
327
420
504
540

sccpcl@ms38.hinet.net
sctechli@gmail.com

(02)25618026
(03)4909682

(02)2542-2497
(02)23011269

104
320

sdpi@shyhdar.com
sentai.tw@msa.hinet.net

(04)23593862
(06)6529887-9

(04)2359-3966
(06)652-9884

407
730

service.minghwa@msa.hinet,net
service@peili.com.tw
service@sking.com.tw
service@tty.com.tw

(02)24978397
(04)23592576
(02)22605490
(03)4522160

(02)2497-8398
(04)2359-0992
(02)25816608
(02)27180648

224
407
236
320

326

www.synmax.com.tw
www.1pco.com.tw

www.herb.com.tw
http://www.shyhdar.com

www.peili.com.tw
www.sking.com.tw
www.tty.com.tw

Seven Star Pharm Co., Ltd.

sevensta@seed.net.tw

(02)22685871

(02)2268-1706

236

Shinlon Pharmaceutical Industrial Co Ltd.
Shunjan Pharmaceutical Co., Ltd.
Siu Guan Chem. Ind. Co., Ltd.
Shinlin Sinseng Pharmaceutical Co Ltd.
Sun Laboratories Co., Ltd.
Swiss Pharmaceutical Co.,Ltd.
San Yueh Chemical Corporation.
Syn-Tech Chem. & Pharm.Co., Ltd.
Ta Fong Pharmaceutical Co Ltd.
Tah-An Chemical & Pharmaceutical Co.,
Ltd.
Tai Ho Tang Pharmaceutical Co., Ltd.
Taisho Pharmaceutical (Taiwan) Co., Ltd.
Tai Yu Chemical & Pharmaceutical Co
Ltd.
Daiichi Sankyo ProPharma Co., Ltd.
TehSeng Pharmaceutical Mfg. Co., Ltd.
Tai Fu Pharmaceutical Co., Ltd.
Tian I Pharmaceutical Co.,Ltd.
Tien Chen Pharmaceutical Co., Ltd.
Taiwan Patron Chemical &
Pharmaceutical Co Ltd.
Chen Ho Pharmaceutical Co.,Ltd.
InnoPharmax, Inc.
Taiwan Tanabe Seiyaku Co Ltd.
Tung Fa Pharmaceutical Co., Ltd.
Orient Europharma Co Ltd.

shinlon.pharm@msa.hinet.net
shunjan.gmp@msa.hinet.net
siuguan@ms66.hinet.net
ss.pharm@msa.hinet.net
sunlab@ms35.hinet.net
swiss404@ms1.hinet.net
sycp@ms24.hinet.net
syntech@msl.hinet.net
tafong2@giga.net.tw

(06)270-4821
(049)2251-279
(05)2865232
(03)470-2646
(02)2894-0576
(06)211-0728
(05)221-1063
(06)635-1165
(04)7138178

717
540
600
325
112
710
621
730
500

tah.an@msa.hinet.net
taiho.tang@msa.hinet.net
taisho.tw@msa.hinet.net

(06)2705711-2
(049)2251668
(05)2360636-9
(03)4703248
(02)28914125-8
(06)2326853
(05)2219068
(06)6362121-3
(04)7138165
(06)2030503、
(06)2328797
(06)2633911-3
(03)5982624-5

(06)2377750
(06)264-7293
(02)2559-6496

710
702
303

taiyu.act@msa.hinet.net
tds1002@ms27.hinet.net
teh.seng@msa.hinet.net
tffuji@ms47.hinet.net
tian.yi@msa.hinet.net
tien3502@ms64.hinet.net

(03)5826655
(03)4580802
(06)2311636
(03)3865117
(06)6985978-9
(06)7941788

(03)582-2389
(02)87862569
(06)2334596
(03)386-5118
(06)698-6662
(06)794-3519

310
324
710
337
720
725

tpc6216126@seed.net.tw
tracy@chenho.com.tw
tring7477@innopharmax.com
ttanabep@ms38.hinet.net
tungfa01@ms23.hinet.net
ty_plant@oep.com.tw

(07)6216126
(06)6529311-3
(02)87977607
(03)5983655
(08)7530177
(03)3614102
(03)4773411,
(03)4775177-8
(03)4523183

(07)622-0930
(06)652-8563
(02)87975627
(02)2753-4789
(08)753-6017
(02)2702-4324

820
730
114
303
900
330

(03)4777121
(03)452-3964

327
320

U Chu Pharmaceutical Co., Ltd.
U-Liang Pharmaceutical Co., Ltd.

ucp210@ucpharm.com.tw
uliang@ms27.hinet.net

327

www.sevenstarpharm.com.tw

www.shunjan.com.tw

www.swisspharm-fac.com.tw
www.syn-tech.com.tw
http://www.tfp.com.tw

www.taihotang.com.tw
www.twtaisho.com.tw
www.tai-yu.com.tw
www.tehseng.com
www.tian-i.com.tw

www.chenho.com.tw
http://www.innopharmax.com
www.tanabe.com.tw
www.oep.com.tw
www.ucpharm.com.tw

Tian Machinery Technologies Co., Ltd.
Shiteh Organic Pharmaceutical Co Ltd.
Synmosa Biopharma Corp.
WEIDAR CHEM. & PHARM. CO., LTD.
Chiuann Feng Tarng
Pharmaceutical Co.,Ltd.
Chi Sheng Chemical Corporation
GenMont Biotech Inc.
Genovate Biotechnbology Co., Ltd.
Winston Medical Supply Co Ltd.
Wan-Kuo Pharmaceuticals Co., Ltd.
Washington Pharmaceutical Co., Ltd.
Wu-Fu Laboratories Co.,Ltd
China Chemical & Pharmaceutical Co.,
Ltd.
Ying Yuan Chemical &
Pharmaceutical Co Ltd.
Sheng Chung Chun Tang Pharmaceutical
Industrial Co., Ltd.
Souriree Biotech Pharmaceutical Co Ltd.
Y F Chemical Corp.
Yung Sine Pharmaceutical Co Ltd.
Yung Shin Pharm Ind. Co., Ltd.
Yung Zip Chemical Co.,Ltd.
Yusheng Pharmaceutical Co., Ltd.
Yih Sheng Tang Pharmaceutical Co., Ltd.
Chung I PharmaceuticalCo.,Ltd.
Savior Lifetec Co., Ltd.

vicky11251983@yahoo.com.tw
vivian@healthcare.com.tw
wayne3001@mail.synmosa.com.t
w
wd830121@ms8.hinet.net/judych
ang@weidar.com.tw

(02)29421916
(02)29811451

(02)2941-0742
(02)2298-1565

231
241

www.shiteh.com.tw

(03)5983500
(04)23593847,
(04)23593852

(03)598-1390

303

www.synmosa.com.tw

(04)2359-3336

408

www.weidar.com.tw

webmaster@ox-brand.com
wen@csop.com.tw
william@genmont.com.tw
williechiang@genovate-bio.com
winstons@ms11.hinet.net
wkp@wkp.com.tw
wp3711651@yahoo.com.tw

(03)4737995
(03)598-2855
(06)5052152
(03)5982804
(06)2538590
(06)2919723
(07)3714801

328
303
741
303
710
701
814

www.ox-brand.com

wufu.lab@msa.hinet.net

(03)4737996
(03)5983811
(06)5052151
(03)5982221
(06)2533124-6
(06)3310999
(07)3711651
(03)9901470,
(03)9902489

(03)9902-487

270

y.n.sun@ccpc.com.tw

(03)5599866

(02)2361-5143

304

www.ccpc.com.tw

y2654883@ms17.hinet.net

(06)2654883

(06)264-3511

702

www.ying-yuan.com.tw

ycheng2@herbalmed.com.tw
ye@souriree.com.tw
yfc@yfchem.com.tw
ys3688@ms15.hinet.net
ysp@yungshingroup.com
yspgyzc@yungshingroup.com
yspharm@ms14.hinet.net
ystc430@ms38.hinet.net
yuenuo.biotec@seed.net.tw
sales@saviorlifetec.com.tw

(06)2325155
(02)26726032
(02)22021112
(03)3688321-4
(04)26815181
(04)26811344
(04)23593968
(03)5983406
(06)2662163
(037)580100

(06)233-5076
(02)25216124
(02)2204-1116
(03)368-6507
(04)26869418
(04)2682-1007
(04)2359-0924
(02)2311-8928
(06)366-1057
(037)580200

328

710
237
242
334
437
437
40850
303
717
350

www.genmant.com.tw
www.genovate-bio.com

www.shengchun.com
www.yfchem.com.tw
www.yungshingroup.com
www.yungzip.com
www.yusheng.com.tw

http://champlee.myweb.hinet.net

